breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Predicted mutations | ||||||
---|---|---|---|---|---|---|
evidence | position | mutation | freq | annotation | gene | description |
RA | 393 | T→G | 30.0% | R19R (CGT→CGG) | thrA → | fused aspartokinase I and homoserine dehydrogenase I |
RA | 1,044 | C→T | 42.1% | D236D (GAC→GAT) | thrA → | fused aspartokinase I and homoserine dehydrogenase I |
RA | 1,407 | C→T | 49.5% | S357S (AGC→AGT) | thrA → | fused aspartokinase I and homoserine dehydrogenase I |
RA | 1,665 | A→C | 33.6% | V443V (GTA→GTC) | thrA → | fused aspartokinase I and homoserine dehydrogenase I |
RA | 2,247 | T→A | 32.2% | S637S (TCT→TCA) | thrA → | fused aspartokinase I and homoserine dehydrogenase I |
RA | 7,456 | G→T | 28.8% | R168R (CGC→CGA) | yaaJ ← | predicted transporter |
RA | 7,459 | G→C | 28.8% | A167A (GCC→GCG) | yaaJ ← | predicted transporter |
RA | 7,496 | C→G | 32.7% | G155A (GGC→GCC) | yaaJ ← | predicted transporter |
RA | 7,498 | A→G | 31.5% | Y154Y (TAT→TAC) | yaaJ ← | predicted transporter |
RA | 9,238 | G→A | 34.7% | intergenic (+47/‑68) | talB → / → mog | transaldolase B/predicted molybdochelatase |
RA | 10,173 | C→T | 62.8% | V108I (GTA→ATA) | yaaH ← | conserved inner membrane protein associated with acetate transport |
RA | 11,087 | C→G | 22.1% | R90R (CGG→CGC) A86A (GCC→GCG) |
yaaW ← htgA → |
conserved hypothetical protein hypothetical protein |
RA | 15,001 | C→T | 27.2% | G278G (GGC→GGT) | dnaJ → | chaperone Hsp40, co‑chaperone with DnaK |
RA | 17,076 | C→A | 21.4% | A349A (GCC→GCA) | nhaA → | sodium‑proton antiporter |
RA | 17,513 | T→C | 22.4% | I86I (ATT→ATC) | nhaR → | DNA‑binding transcriptional activator |
RA | 17,516 | G→C | 22.5% | V87V (GTG→GTC) | nhaR → | DNA‑binding transcriptional activator |
RA | 17,531 | A→G | 19.0% | E92E (GAA→GAG) | nhaR → | DNA‑binding transcriptional activator |
RA | 17,537 | T→C | 21.2% | N94N (AAT→AAC) | nhaR → | DNA‑binding transcriptional activator |
RA | 20,146 | C→G | 49.2% | P26P (CCC→CCG) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,463 | C→T | 57.8% | S465S (TCC→TCT) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,472 | C→T | 59.1% | R468R (CGC→CGT) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,481 | T→C | 60.4% | G471G (GGT→GGC) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,484 | A→G | 54.1% | V472V (GTA→GTG) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,514 | G→A | 46.6% | T482T (ACG→ACA) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,520 | G→A | 46.6% | E484E (GAG→GAA) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,535 | C→T | 34.7% | T489T (ACC→ACT) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,538 | T→C | 34.7% | L490L (CTT→CTC) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,574 | C→T | 45.2% | V502V (GTC→GTT) | ileS → | isoleucyl‑tRNA synthetase |
RA | 21,895 | T→C | 24.7% | N609N (AAT→AAC) | ileS → | isoleucyl‑tRNA synthetase |
RA | 22,613 | T→G | 33.3% | S849A (TCG→GCG) | ileS → | isoleucyl‑tRNA synthetase |
RA | 24,212 | T→C | 53.7% | S86S (AGT→AGC) | ispH → | 1‑hydroxy‑2‑methyl‑2‑(E)‑butenyl 4‑diphosphate reductase, 4Fe‑4S protein |
RA | 25,217 | G→A | 52.3% | E83K (GAA→AAA) | rihC → | ribonucleoside hydrolase 3 |
RA | 25,774 | G→T | 100% | V268V (GTG→GTT) | rihC → | ribonucleoside hydrolase 3 |
RA | 26,138 | G→A | 100% | E29E (GAG→GAA) | dapB → | dihydrodipicolinate reductase |
RA | 26,789 | C→T | 24.4% | G246G (GGC→GGT) | dapB → | dihydrodipicolinate reductase |
RA | 27,553 | A→T | 37.1% | V75V (GTA→GTT) | carA → | carbamoyl phosphate synthetase small subunit, glutamine amidotransferase |
RA | 27,559 | A→C | 36.5% | A77A (GCA→GCC) | carA → | carbamoyl phosphate synthetase small subunit, glutamine amidotransferase |
RA | 27,925 | T→C | 49.2% | F199F (TTT→TTC) | carA → | carbamoyl phosphate synthetase small subunit, glutamine amidotransferase |
RA | 27,949 | G→T | 80.9% | R207R (CGG→CGT) | carA → | carbamoyl phosphate synthetase small subunit, glutamine amidotransferase |
RA | 28,911 | T→C | 33.3% | I139I (ATT→ATC) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 28,977 | C→A | 68.8% | D161E (GAC→GAA) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 28,980 | G→T | 67.8% | V162V (GTG→GTT) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 29,400 | A→G | 34.0% | P302P (CCA→CCG) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 29,403 | C→T | 31.7% | R303R (CGC→CGT) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 29,409 | C→G | 34.1% | S305S (TCC→TCG) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 29,541 | G→A | 37.1% | E349E (GAG→GAA) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 30,714 | G→A | 62.8% | T740T (ACG→ACA) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 30,808 | A→G | 100% | M772V (ATG→GTG) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 31,416 | C→T | 67.6% | T974T (ACC→ACT) | carB → | carbamoyl‑phosphate synthase large subunit |
RA | 34,045 | T→C | 42.8% | Q491Q (CAA→CAG) | caiC ← | predicted crotonobetaine CoA ligase:carnitine CoA ligase |
RA | 34,051 | G→A | 35.4% | C489C (TGC→TGT) | caiC ← | predicted crotonobetaine CoA ligase:carnitine CoA ligase |
RA | 34,059 | G→A | 41.5% | R487C (CGC→TGC) | caiC ← | predicted crotonobetaine CoA ligase:carnitine CoA ligase |
RA | 34,063 | A→G | 41.5% | F485F (TTT→TTC) | caiC ← | predicted crotonobetaine CoA ligase:carnitine CoA ligase |
RA | 34,465 | C→G | 44.2% | G351G (GGG→GGC) | caiC ← | predicted crotonobetaine CoA ligase:carnitine CoA ligase |
RA | 34,469 | A→G | 41.6% | V350A (GTG→GCG) | caiC ← | predicted crotonobetaine CoA ligase:carnitine CoA ligase |
RA | 34,492 | T→C | 48.3% | R342R (CGA→CGG) | caiC ← | predicted crotonobetaine CoA ligase:carnitine CoA ligase |
RA | 37,432 | G→A | 29.8% | T211T (ACC→ACT) | caiA ← | crotonobetaine reductase subunit II, FAD‑binding |
RA | 38,629 | A→G | 32.7% | Y327Y (TAT→TAC) | caiT ← | predicted transporter |
RA | 39,361 | C→T | 34.1% | P83P (CCG→CCA) | caiT ← | predicted transporter |
RA | 39,415 | A→G | 23.7% | G65G (GGT→GGC) | caiT ← | predicted transporter |
RA | 39,505 | T→C | 29.2% | A35A (GCA→GCG) | caiT ← | predicted transporter |
RA | 39,812 | A→T | 43.0% | intergenic (‑203/‑269) | caiT ← / → fixA | predicted transporter/predicted electron transfer flavoprotein subunit, ETFP adenine nucleotide‑binding domain |
RA | 41,783 | G→A | 29.8% | A306A (GCG→GCA) | fixB → | predicted electron transfer flavoprotein, NAD/FAD‑binding domain and ETFP adenine nucleotide‑binding domain‑like |
RA | 42,478 | G→C | 33.7% | G207G (GGG→GGC) | fixC → | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
RA | 42,766 | C→T | 37.2% | A303A (GCC→GCT) | fixC → | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
RA | 43,706 | T→C | 25.5% | G74G (GGT→GGC) | yaaU → | predicted transporter |
RA | 43,712 | T→C | 24.6% | I76I (ATT→ATC) | yaaU → | predicted transporter |
RA | 44,126 | C→A | 32.3% | I214I (ATC→ATA) | yaaU → | predicted transporter |
RA | 45,539 | A→T | 46.1% | V31V (GTA→GTT) | kefC → | potassium:proton antiporter |
RA | 48,236 | C→T | 46.8% | S222N (AGC→AAC) | apaH ← | diadenosine tetraphosphatase |
RA | 49,231 | A→G | 44.8% | A18A (GCT→GCC) | apaG ← | protein associated with Co2+ and Mg2+ efflux |
RA | 49,644 | T→C | 40.2% | K155K (AAA→AAG) | ksgA ← | S‑adenosylmethionine‑6‑N',N'‑adenosyl (rRNA) dimethyltransferase |
RA | 50,330 | A→G | 50.4% | L255L (CTT→CTC) | pdxA ← | 4‑hydroxy‑L‑threonine phosphate dehydrogenase, NAD‑dependent |
RA | 50,516 | C→G | 38.2% | R193R (CGG→CGC) | pdxA ← | 4‑hydroxy‑L‑threonine phosphate dehydrogenase, NAD‑dependent |
RA | 51,307 | A→G | 36.5% | T358T (ACT→ACC) | surA ← | peptidyl‑prolyl cis‑trans isomerase |
RA | 51,445 | A→G | 33.3% | A312A (GCT→GCC) | surA ← | peptidyl‑prolyl cis‑trans isomerase |
RA | 53,522 | G→A | 24.6% | D422D (GAC→GAT) | imp ← | exported protein required for envelope biosynthesis and integrity |
RA | 53,750 | C→T | 35.9% | K346K (AAG→AAA) | imp ← | exported protein required for envelope biosynthesis and integrity |
RA | 53,762 | A→G | 36.2% | D342D (GAT→GAC) | imp ← | exported protein required for envelope biosynthesis and integrity |
RA | 53,789 | C→T | 26.2% | K333K (AAG→AAA) | imp ← | exported protein required for envelope biosynthesis and integrity |
RA | 54,086 | C→T | 30.8% | K234K (AAG→AAA) | imp ← | exported protein required for envelope biosynthesis and integrity |
RA | 57,596 | C→T | 82.3% | E143E (GAG→GAA) | rluA ← | pseudouridine synthase for 23S rRNA (position 746) and tRNAphe(position 32) |
RA | 58,975 | T→C | 30.5% | S656S (TCA→TCG) | hepA ← | RNA polymerase‑associated helicase protein |
RA | 58,978 | A→G | 30.5% | A655A (GCT→GCC) | hepA ← | RNA polymerase‑associated helicase protein |
RA | 58,995 | G→A | 22.6% | L650L (CTG→TTG) | hepA ← | RNA polymerase‑associated helicase protein |
RA | 59,005 | T→C | 29.3% | V646V (GTA→GTG) | hepA ← | RNA polymerase‑associated helicase protein |
RA | 59,017 | A→G | 31.8% | I642I (ATT→ATC) | hepA ← | RNA polymerase‑associated helicase protein |
RA | 62,814 | G→A | 49.1% | Y215Y (TAC→TAT) ‡ | polB ← | DNA polymerase II |
RA | 62,816 | A→G | 51.0% | Y215H (TAC→CAC) ‡ | polB ← | DNA polymerase II |
RA | 62,817 | G→A | 50.9% | N214N (AAC→AAT) ‡ | polB ← | DNA polymerase II |
RA | 62,818 | T→G | 55.1% | N214T (AAC→ACC) ‡ | polB ← | DNA polymerase II |
RA | 62,820 | G→C | 58.7% | A213A (GCC→GCG) | polB ← | DNA polymerase II |
RA | 64,573 | G→A | 15.1% | I344I (ATC→ATT) | leuC ← | 3‑isopropylmalate isomerase subunit, dehydratase component |
RA | 66,162 | C→T | 33.2% | A179A (GCG→GCA) | leuB ← | 3‑isopropylmalate dehydrogenase |
RA | 66,174 | G→A | 52.3% | I175I (ATC→ATT) | leuB ← | 3‑isopropylmalate dehydrogenase |
RA | 66,180 | T→C | 51.5% | E173E (GAA→GAG) | leuB ← | 3‑isopropylmalate dehydrogenase |
RA | 67,358 | C→T | 27.0% | V304V (GTG→GTA) | leuA ← | 2‑isopropylmalate synthase |
RA | 67,361 | G→A | 27.4% | G303G (GGC→GGT) | leuA ← | 2‑isopropylmalate synthase |
RA | 67,373 | T→G | 36.6% | I299I (ATA→ATC) | leuA ← | 2‑isopropylmalate synthase |
RA | 67,547 | C→A | 34.6% | L241L (CTG→CTT) | leuA ← | 2‑isopropylmalate synthase |
RA | 67,673 | G→A | 39.2% | I199I (ATC→ATT) | leuA ← | 2‑isopropylmalate synthase |
RA | 68,518 | C→A | 65.6% | intergenic (‑70/‑590) | leuL ← / → leuO | leu operon leader peptide/DNA‑binding transcriptional activator |
RA | 68,533 | C→A | 51.3% | intergenic (‑85/‑575) | leuL ← / → leuO | leu operon leader peptide/DNA‑binding transcriptional activator |
RA | 68,539 | G→T | 51.4% | intergenic (‑91/‑569) | leuL ← / → leuO | leu operon leader peptide/DNA‑binding transcriptional activator |
RA | 68,540 | C→T | 54.5% | intergenic (‑92/‑568) | leuL ← / → leuO | leu operon leader peptide/DNA‑binding transcriptional activator |
RA | 68,549 | T→G | 46.2% | intergenic (‑101/‑559) | leuL ← / → leuO | leu operon leader peptide/DNA‑binding transcriptional activator |
RA | 69,701 | G→A | 39.1% | K198K (AAG→AAA) | leuO → | DNA‑binding transcriptional activator |
RA | 69,716 | A→G | 33.9% | K203K (AAA→AAG) | leuO → | DNA‑binding transcriptional activator |
RA | 69,870 | T→C | 23.1% | L255L (TTG→CTG) | leuO → | DNA‑binding transcriptional activator |
RA | 71,761 | C→T | 38.3% | Y464Y (TAC→TAT) | ilvI → | acetolactate synthase III, large subunit |
RA | 72,264 | A→G | 20.1% | V56V (GTA→GTG) | ilvH → | acetolactate synthase III, thiamin‑dependent, small subunit |
RA | 72,273 | G→A | 20.8% | Q59Q (CAG→CAA) | ilvH → | acetolactate synthase III, thiamin‑dependent, small subunit |
RA | 72,887 | T→A | 55.0% | A40A (GCT→GCA) | fruR → | DNA‑binding transcriptional dual regulator |
RA | 72,890 | G→A | 54.9% | V41V (GTG→GTA) | fruR → | DNA‑binding transcriptional dual regulator |
RA | 75,688 | C→T | 23.8% | G285G (GGC→GGT) | mraW → | S‑adenosyl‑dependent methyltransferase activity on membrane‑located substrates |
RA | 75,694 | A→G | 16.8% | L287L (TTA→TTG) | mraW → | S‑adenosyl‑dependent methyltransferase activity on membrane‑located substrates |
RA | 76,644 | G→A | 47.2% | E164E (GAG→GAA) | ftsI → | transpeptidase involved in septal peptidoglycan synthesis |
RA | 76,656 | C→T | 39.8% | Y168Y (TAC→TAT) | ftsI → | transpeptidase involved in septal peptidoglycan synthesis |
RA | 76,662 | G→A | 45.7% | P170P (CCG→CCA) | ftsI → | transpeptidase involved in septal peptidoglycan synthesis |
RA | 76,677 | T→C | 50.0% | T175T (ACT→ACC) | ftsI → | transpeptidase involved in septal peptidoglycan synthesis |
RA | 78,700 | T→C | 28.0% | I265I (ATT→ATC) | murE → | UDP‑N‑acetylmuramoyl‑L‑alanyl‑D‑glutamate:meso‑ diaminopimelate ligase |
RA | 78,739 | A→C | 37.9% | E278D (GAA→GAC) | murE → | UDP‑N‑acetylmuramoyl‑L‑alanyl‑D‑glutamate:meso‑ diaminopimelate ligase |
RA | 79,533 | T→C | 54.9% | F48F (TTT→TTC) | murF → | UDP‑N‑acetylmuramoyl‑tripeptide:D‑alanyl‑D‑ alanine ligase |
RA | 80,412 | T→C | 29.7% | T341T (ACT→ACC) | murF → | UDP‑N‑acetylmuramoyl‑tripeptide:D‑alanyl‑D‑ alanine ligase |
RA | 80,415 | A→C | 35.2% | A342A (GCA→GCC) | murF → | UDP‑N‑acetylmuramoyl‑tripeptide:D‑alanyl‑D‑ alanine ligase |
RA | 80,418 | A→T | 34.1% | A343A (GCA→GCT) | murF → | UDP‑N‑acetylmuramoyl‑tripeptide:D‑alanyl‑D‑ alanine ligase |
RA | 80,421 | C→T | 27.5% | V344V (GTC→GTT) | murF → | UDP‑N‑acetylmuramoyl‑tripeptide:D‑alanyl‑D‑ alanine ligase |
RA | 80,427 | A→T | 27.0% | V346V (GTA→GTT) | murF → | UDP‑N‑acetylmuramoyl‑tripeptide:D‑alanyl‑D‑ alanine ligase |
RA | 81,158 | C→G | 35.3% | V139V (GTC→GTG) | mraY → | phospho‑N‑acetylmuramoyl‑pentapeptide transferase |
RA | 83,694 | G→A | 31.1% | V184V (GTG→GTA) | ftsW → | integral membrane protein involved in stabilising FstZ ring during cell division |
RA | 83,853 | A→C | 48.2% | I237I (ATA→ATC) | ftsW → | integral membrane protein involved in stabilising FstZ ring during cell division |
RA | 83,944 | C→T | 49.5% | L268L (CTG→TTG) | ftsW → | integral membrane protein involved in stabilising FstZ ring during cell division |
RA | 83,964 | C→T | 56.4% | G274G (GGC→GGT) | ftsW → | integral membrane protein involved in stabilising FstZ ring during cell division |
RA | 83,970 | T→G | 54.3% | L276L (CTT→CTG) | ftsW → | integral membrane protein involved in stabilising FstZ ring during cell division |
RA | 83,976 | G→A | 53.8% | G278G (GGG→GGA) | ftsW → | integral membrane protein involved in stabilising FstZ ring during cell division |
RA | 85,795 | C→A | 36.8% | A97A (GCC→GCA) | murC → | UDP‑N‑acetylmuramate:L‑alanine ligase |
RA | 85,885 | G→A | 41.3% | T127T (ACG→ACA) | murC → | UDP‑N‑acetylmuramate:L‑alanine ligase |
RA | 87,227 | A→C | 45.4% | G85G (GGA→GGC) | ddlB → | D‑Alanine:D‑alanine ligase |
RA | 87,241 | C→T | 49.3% | A90V (GCA→GTA) | ddlB → | D‑Alanine:D‑alanine ligase |
RA | 87,815 | C→T | 39.7% | S281S (AGC→AGT) | ddlB → | D‑Alanine:D‑alanine ligase |
RA | 87,821 | G→A | 36.7% | V283V (GTG→GTA) | ddlB → | D‑Alanine:D‑alanine ligase |
RA | 88,344 | A→T | 38.2% | E150D (GAA→GAT) | ftsQ → | membrane anchored protein involved in growth of wall at septum |
RA | 89,165 | A→G | 14.1% | G148G (GGA→GGG) | ftsA → | ATP‑binding cell division protein involved in recruitment of FtsK to Z ring |
RA | 90,611 | G→A | 41.6% | L189L (CTG→CTA) | ftsZ → | GTP‑binding tubulin‑like cell division protein |
RA | 90,635 | T→C | 36.3% | A197A (GCT→GCC) | ftsZ → | GTP‑binding tubulin‑like cell division protein |
RA | 90,917 | T→C | 57.0% | T291T (ACT→ACC) | ftsZ → | GTP‑binding tubulin‑like cell division protein |
RA | 92,124 | G→T | 39.4% | L276L (CTG→CTT) | lpxC → | UDP‑3‑O‑acyl N‑acetylglucosamine deacetylase |
RA | 92,127 | G→A | 39.3% | A277A (GCG→GCA) | lpxC → | UDP‑3‑O‑acyl N‑acetylglucosamine deacetylase |
RA | 92,349 | C→A | 74.1% | intergenic (+135/‑96) | lpxC → / → secM | UDP‑3‑O‑acyl N‑acetylglucosamine deacetylase/regulator of secA translation |
RA | 92,382 | G→T | 61.8% | intergenic (+168/‑63) | lpxC → / → secM | UDP‑3‑O‑acyl N‑acetylglucosamine deacetylase/regulator of secA translation |
RA | 92,519 | T→C | 37.9% | V25V (GTT→GTC) | secM → | regulator of secA translation |
RA | 93,174 | A→G | 38.7% | A52A (GCA→GCG) | secA → | preprotein translocase subunit, ATPase that targets protein precursors to the SecYE core translocon |
RA | 93,594 | G→A | 39.9% | A192A (GCG→GCA) | secA → | preprotein translocase subunit, ATPase that targets protein precursors to the SecYE core translocon |
RA | 93,618 | G→A | 43.5% | Q200Q (CAG→CAA) | secA → | preprotein translocase subunit, ATPase that targets protein precursors to the SecYE core translocon |
RA | 93,879 | G→T | 100% | V287V (GTG→GTT) | secA → | preprotein translocase subunit, ATPase that targets protein precursors to the SecYE core translocon |
RA | 93,885 | G→A | 100% | E289E (GAG→GAA) | secA → | preprotein translocase subunit, ATPase that targets protein precursors to the SecYE core translocon |
RA | 95,017 | T→C | 8.3% | L667L (TTG→CTG) | secA → | preprotein translocase subunit, ATPase that targets protein precursors to the SecYE core translocon |
RA | 95,901 | A→G | 20.5% | I40V (ATT→GTT) | mutT → | nucleoside triphosphate pyrophosphohydrolase, marked preference for dGTP |
RA | 95,912 | T→C | 19.3% | G43G (GGT→GGC) | mutT → | nucleoside triphosphate pyrophosphohydrolase, marked preference for dGTP |
RA | 96,401 | T→C | 19.3% | E62E (GAA→GAG) | yacG ← | conserved hypothetical protein |
RA | 96,629 | C→T | 100% | P237P (CCG→CCA) | yacF ← | conserved hypothetical protein |
RA | 96,648 | G→C | 100% | T231S (ACT→AGT) | yacF ← | conserved hypothetical protein |
RA | 98,996 | C→A | 45.5% | S271S (TCC→TCA) | guaC → | GMP reductase |
RA | 99,394 | C→T | 49.5% | A357A (GCG→GCA) | hofC ← | assembly protein in type IV pilin biogenesis, transmembrane protein |
RA | 99,507 | T→C | 39.2% | T320A (ACC→GCC) | hofC ← | assembly protein in type IV pilin biogenesis, transmembrane protein |
RA | 99,532 | T→G | 51.7% | Q311H (CAA→CAC) | hofC ← | assembly protein in type IV pilin biogenesis, transmembrane protein |
RA | 99,964 | G→A | 50.3% | I167I (ATC→ATT) | hofC ← | assembly protein in type IV pilin biogenesis, transmembrane protein |
RA | 100,916 | A→G | 44.6% | T308T (ACT→ACC) | hofB ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 100,925 | C→G | 55.8% | A305A (GCG→GCC) | hofB ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 101,323 | G→C | 57.4% | P173A (CCA→GCA) | hofB ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 102,699 | T→A | 60.7% | G229G (GGA→GGT) | nadC ← | quinolinate phosphoribosyltransferase |
RA | 102,711 | G→A | 65.0% | A225A (GCC→GCT) | nadC ← | quinolinate phosphoribosyltransferase |
RA | 103,122 | T→A | 43.2% | I88I (ATA→ATT) | nadC ← | quinolinate phosphoribosyltransferase |
RA | 103,899 | T→C | 51.3% | C143R (TGC→CGC) | ampD → | N‑acetyl‑anhydromuranmyl‑L‑alanine amidase |
RA | 103,907 | G→A | 50.0% | P145P (CCG→CCA) | ampD → | N‑acetyl‑anhydromuranmyl‑L‑alanine amidase |
RA | 103,919 | A→T | 52.5% | K149N (AAA→AAT) | ampD → | N‑acetyl‑anhydromuranmyl‑L‑alanine amidase |
RA | 104,233 | A→G | 34.6% | L71L (CTA→CTG) | ampE → | predicted inner membrane protein |
RA | 104,845 | A→G | 73.7% | A275A (GCA→GCG) | ampE → | predicted inner membrane protein |
RA | 104,896 | T→C | 58.1% | intergenic (+21/+22) | ampE → / ← aroP | predicted inner membrane protein/aromatic amino acid transporter |
RA | 105,125 | C→T | 26.9% | Q389Q (CAG→CAA) | aroP ← | aromatic amino acid transporter |
RA | 105,128 | C→T | 25.5% | K388K (AAG→AAA) | aroP ← | aromatic amino acid transporter |
RA | 105,158 | G→A | 40.7% | S378S (AGC→AGT) | aroP ← | aromatic amino acid transporter |
RA | 105,440 | C→T | 40.7% | V284V (GTG→GTA) | aroP ← | aromatic amino acid transporter |
RA | 105,854 | A→T | 51.0% | V146V (GTT→GTA) | aroP ← | aromatic amino acid transporter |
RA | 105,914 | G→T | 45.9% | P126P (CCC→CCA) | aroP ← | aromatic amino acid transporter |
RA | 106,094 | C→T | 72.7% | L66L (CTG→CTA) | aroP ← | aromatic amino acid transporter |
RA | 106,166 | C→T | 31.2% | Q42Q (CAG→CAA) | aroP ← | aromatic amino acid transporter |
RA | 107,365 | C→T | 31.5% | A178A (GCC→GCT) | pdhR → | DNA‑binding transcriptional dual regulator |
RA | 108,722 | C→T | 22.2% | D322D (GAC→GAT) | aceE → | pyruvate dehydrogenase, decarboxylase component E1, thiamin‑binding |
RA | 108,755 | C→T | 48.0% | Y333Y (TAC→TAT) | aceE → | pyruvate dehydrogenase, decarboxylase component E1, thiamin‑binding |
RA | 108,761 | T→C | 42.6% | R335R (CGT→CGC) | aceE → | pyruvate dehydrogenase, decarboxylase component E1, thiamin‑binding |
RA | 108,941 | C→T | 42.8% | Y395Y (TAC→TAT) | aceE → | pyruvate dehydrogenase, decarboxylase component E1, thiamin‑binding |
RA | 109,697 | C→T | 57.7% | H647H (CAC→CAT) | aceE → | pyruvate dehydrogenase, decarboxylase component E1, thiamin‑binding |
RA | 109,946 | C→G | 44.5% | L730L (CTC→CTG) | aceE → | pyruvate dehydrogenase, decarboxylase component E1, thiamin‑binding |
RA | 110,572 | T→A | 57.8% | V46V (GTT→GTA) | aceF → | pyruvate dehydrogenase, dihydrolipoyltransacetylase component E2 |
RA | 110,575 | G→A | 55.3% | P47P (CCG→CCA) | aceF → | pyruvate dehydrogenase, dihydrolipoyltransacetylase component E2 |
RA | 111,038 | C→T | 35.8% | P202S (CCA→TCA) | aceF → | pyruvate dehydrogenase, dihydrolipoyltransacetylase component E2 |
RA | 111,412 | T→C | 67.5% | Y326Y (TAT→TAC) | aceF → | pyruvate dehydrogenase, dihydrolipoyltransacetylase component E2 |
RA | 112,771 | C→T | 49.4% | T40T (ACC→ACT) | lpd → | lipoamide dehydrogenase, E3 component is part of three enzyme complexes |
RA | 113,344 | C→T | 18.6% | N231N (AAC→AAT) | lpd → | lipoamide dehydrogenase, E3 component is part of three enzyme complexes |
RA | 113,602 | A→G | 24.9% | Q317Q (CAA→CAG) | lpd → | lipoamide dehydrogenase, E3 component is part of three enzyme complexes |
RA | 115,012 | C→T | 25.0% | G330D (GGC→GAC) | yacH ← | hypothetical protein |
RA | 115,740 | C→T | 37.4% | L87L (CTG→CTA) | yacH ← | hypothetical protein |
RA | 115,749 | G→A | 39.9% | P84P (CCC→CCT) | yacH ← | hypothetical protein |
RA | 115,752 | C→T | 39.9% | A83A (GCG→GCA) | yacH ← | hypothetical protein |
RA | 115,755 | G→A | 39.9% | V82V (GTC→GTT) | yacH ← | hypothetical protein |
RA | 115,773 | T→A | 41.0% | A76A (GCA→GCT) | yacH ← | hypothetical protein |
RA | 117,272 | G→A | 66.5% | V306V (GTG→GTA) | acnB → | bifunctional aconitate hydratase 2 and 2‑methylisocitrate dehydratase |
RA | 117,332 | G→A | 51.8% | A326A (GCG→GCA) | acnB → | bifunctional aconitate hydratase 2 and 2‑methylisocitrate dehydratase |
RA | 119,257 | C→G | 40.8% | Q44E (CAA→GAA) ‡ | yacL → | conserved hypothetical protein |
RA | 119,259 | A→C | 40.9% | Q44H (CAA→CAC) ‡ | yacL → | conserved hypothetical protein |
RA | 119,267 | A→G | 39.2% | H47R (CAC→CGC) | yacL → | conserved hypothetical protein |
RA | 119,269 | G→A | 39.1% | A48T (GCA→ACA) ‡ | yacL → | conserved hypothetical protein |
RA | 119,271 | A→G | 39.2% | A48A (GCA→GCG) ‡ | yacL → | conserved hypothetical protein |
RA | 119,274 | G→C | 34.9% | L49L (CTG→CTC) | yacL → | conserved hypothetical protein |
RA | 119,280 | T→C | 29.6% | G51G (GGT→GGC) | yacL → | conserved hypothetical protein |
RA | 119,289 | G→A | 27.8% | R54R (CGG→CGA) | yacL → | conserved hypothetical protein |
RA | 119,298 | A→G | 31.1% | Q57Q (CAA→CAG) | yacL → | conserved hypothetical protein |
RA | 121,082 | A→G | 21.0% | A41A (GCT→GCC) | speE ← | spermidine synthase |
RA | 122,068 | C→T | 22.9% | R82R (CGC→CGT) | cueO → | multicopper oxidase (laccase) |
RA | 122,440 | C→T | 24.0% | A206A (GCC→GCT) | cueO → | multicopper oxidase (laccase) |
RA | 122,446 | C→T | 23.1% | G208G (GGC→GGT) | cueO → | multicopper oxidase (laccase) |
RA | 123,017 | G→A | 68.0% | G399S (GGC→AGC) | cueO → | multicopper oxidase (laccase) |
RA | 124,043 | A→G | 39.1% | I641I (ATT→ATC) | gcd ← | glucose dehydrogenase |
RA | 125,135 | G→A | 32.3% | T277T (ACC→ACT) | gcd ← | glucose dehydrogenase |
RA | 125,165 | A→G | 41.5% | G267G (GGT→GGC) | gcd ← | glucose dehydrogenase |
RA | 125,180 | G→A | 33.2% | H262H (CAC→CAT) | gcd ← | glucose dehydrogenase |
RA | 125,387 | A→C | 26.5% | N193K (AAT→AAG) | gcd ← | glucose dehydrogenase |
RA | 125,390 | A→G | 27.6% | H192H (CAT→CAC) | gcd ← | glucose dehydrogenase |
RA | 125,402 | G→A | 53.5% | A188A (GCC→GCT) | gcd ← | glucose dehydrogenase |
RA | 125,414 | T→C | 47.7% | K184K (AAA→AAG) | gcd ← | glucose dehydrogenase |
RA | 125,420 | C→T | 51.0% | P182P (CCG→CCA) | gcd ← | glucose dehydrogenase |
RA | 125,423 | C→T | 51.0% | S181S (TCG→TCA) | gcd ← | glucose dehydrogenase |
RA | 125,447 | A→G | 46.4% | R173R (CGT→CGC) | gcd ← | glucose dehydrogenase |
RA | 125,477 | T→A | 24.9% | V163V (GTA→GTT) | gcd ← | glucose dehydrogenase |
RA | 125,489 | A→G | 36.9% | A159A (GCT→GCC) | gcd ← | glucose dehydrogenase |
RA | 125,495 | A→T | 36.9% | A157A (GCT→GCA) | gcd ← | glucose dehydrogenase |
RA | 125,498 | A→T | 36.9% | P156P (CCT→CCA) | gcd ← | glucose dehydrogenase |
RA | 128,158 | C→T | 20.1% | L214L (CTG→TTG) | yadG → | predicted transporter subunit |
RA | 128,172 | C→T | 19.6% | T218T (ACC→ACT) | yadG → | predicted transporter subunit |
RA | 129,773 | G→A | 56.3% | intergenic (+16/‑48) | yadI → / → yadE | predicted PTS Enzyme IIA/predicted polysaccharide deacetylase lipoprotein |
RA | 130,273 | T→C | 37.0% | R151R (CGT→CGC) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,303 | A→G | 36.9% | A161A (GCA→GCG) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,402 | A→C | 21.2% | T194T (ACA→ACC) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,742 | G→A | 52.9% | V308I (GTA→ATA) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,756 | C→G | 53.3% | R312R (CGC→CGG) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,759 | A→G | 58.9% | R313R (CGA→CGG) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,762 | C→T | 59.7% | P314P (CCC→CCT) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,768 | A→G | 50.0% | L316L (TTA→TTG) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,885 | C→A | 19.5% | N355K (AAC→AAA) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,903 | C→A | 20.5% | N361K (AAC→AAA) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 130,906 | T→A | 22.2% | D362E (GAT→GAA) | yadE → | predicted polysaccharide deacetylase lipoprotein |
RA | 131,549 | G→A | 39.1% | intergenic (‑115/‑159) | panD ← / → yadD | aspartate 1‑decarboxylase/predicted transposase |
RA | 131,550 | T→G | 39.2% | intergenic (‑116/‑158) | panD ← / → yadD | aspartate 1‑decarboxylase/predicted transposase |
RA | 131,770 | G→A | 27.3% | E21E (GAG→GAA) | yadD → | predicted transposase |
RA | 131,899 | C→T | 20.7% | L64L (CTC→CTT) | yadD → | predicted transposase |
RA | 133,652 | A→G | 15.3% | A230A (GCT→GCC) | panB ← | 3‑methyl‑2‑oxobutanoate hydroxymethyltransferase |
RA | 133,667 | G→A | 22.8% | H225H (CAC→CAT) | panB ← | 3‑methyl‑2‑oxobutanoate hydroxymethyltransferase |
RA | 137,451 | G→C | 24.2% | V34V (GTC→GTG) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,454 | A→G | 22.3% | T33T (ACT→ACC) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,457 | G→A | 22.3% | A32A (GCC→GCT) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,460 | T→G | 20.1% | T31T (ACA→ACC) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,466 | C→A | 20.5% | E29D (GAG→GAT) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,469 | T→G | 20.5% | V28V (GTA→GTC) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,477 | T→C | 20.7% | I26V (ATT→GTT) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,493 | T→C | 22.5% | S20S (TCA→TCG) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,496 | G→A | 22.5% | P19P (CCC→CCT) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 137,499 | T→C | 20.9% | S18S (TCA→TCG) | yadM ← | predicted fimbrial‑like adhesin protein |
RA | 139,690 | T→C | 19.0% | K159K (AAA→AAG) | htrE ← | predicted outer membrane usher protein |
RA | 139,696 | T→A | 19.0% | V157V (GTA→GTT) ‡ | htrE ← | predicted outer membrane usher protein |
RA | 139,698 | C→T | 17.6% | V157I (GTA→ATA) ‡ | htrE ← | predicted outer membrane usher protein |
RA | 139,702 | G→T | 17.8% | A155A (GCC→GCA) | htrE ← | predicted outer membrane usher protein |
RA | 139,705 | T→C | 16.7% | Q154Q (CAA→CAG) | htrE ← | predicted outer membrane usher protein |
RA | 139,708 | A→G | 16.3% | P153P (CCT→CCC) | htrE ← | predicted outer membrane usher protein |
RA | 139,711 | A→G | 19.5% | V152V (GTT→GTC) | htrE ← | predicted outer membrane usher protein |
RA | 139,714 | G→A | 22.0% | D151D (GAC→GAT) | htrE ← | predicted outer membrane usher protein |
RA | 139,717 | T→G | 22.7% | I150I (ATA→ATC) | htrE ← | predicted outer membrane usher protein |
RA | 139,726 | A→G | 20.8% | R147R (CGT→CGC) | htrE ← | predicted outer membrane usher protein |
RA | 139,741 | G→A | 31.8% | D142D (GAC→GAT) | htrE ← | predicted outer membrane usher protein |
RA | 139,744 | A→G | 29.8% | Y141Y (TAT→TAC) | htrE ← | predicted outer membrane usher protein |
RA | 141,287 | A→G | 53.2% | L113L (TTG→CTG) | yadN ← | predicted fimbrial‑like adhesin protein |
RA | 141,288 | A→T | 53.1% | T112T (ACT→ACA) | yadN ← | predicted fimbrial‑like adhesin protein |
RA | 141,291 | C→T | 53.1% | G111G (GGG→GGA) | yadN ← | predicted fimbrial‑like adhesin protein |
RA | 141,333 | A→T | 35.8% | A97A (GCT→GCA) | yadN ← | predicted fimbrial‑like adhesin protein |
RA | 147,876 | C→T | 29.6% | A344A (GCC→GCT) | hrpB → | predicted ATP‑dependent helicase |
RA | 147,879 | G→C | 29.7% | A345A (GCG→GCC) | hrpB → | predicted ATP‑dependent helicase |
RA | 148,890 | C→T | 41.6% | D682D (GAC→GAT) | hrpB → | predicted ATP‑dependent helicase |
RA | 148,905 | A→G | 53.3% | L687L (CTA→CTG) | hrpB → | predicted ATP‑dependent helicase |
RA | 148,908 | C→T | 45.2% | R688R (CGC→CGT) | hrpB → | predicted ATP‑dependent helicase |
RA | 148,925 | G→T | 58.9% | G694V (GGA→GTA) | hrpB → | predicted ATP‑dependent helicase |
RA | 150,912 | T→C | 100% | S481S (AGT→AGC) | mrcB → | fused glycosyl transferase and transpeptidase |
RA | 152,487 | G→A | 52.9% | H407H (CAC→CAT) | hemL ← | glutamate‑1‑semialdehyde aminotransferase |
RA | 154,867 | G→T | 57.1% | T312T (ACG→ACT) | clcA → | chloride channel, voltage‑gated |
RA | 157,237 | T→C | 52.9% | P17P (CCA→CCG) | btuF ← | vitamin B12 transporter subunit |
RA | 157,243 | A→G | 55.3% | L15L (CTT→CTC) | btuF ← | vitamin B12 transporter subunit |
RA | 157,729 | A→G | 34.2% | L84L (TTG→CTG) | pfs ← | 5'‑methylthioadenosine/S‑adenosylhomocysteine nucleosidase |
RA | 160,299 | T→C | 31.1% | F197F (TTT→TTC) | degP → | serine endoprotease (protease Do), membrane‑associated |
RA | 160,302 | T→C | 31.1% | G198G (GGT→GGC) | degP → | serine endoprotease (protease Do), membrane‑associated |
RA | 160,737 | G→A | 43.8% | P343P (CCG→CCA) | degP → | serine endoprotease (protease Do), membrane‑associated |
RA | 160,821 | T→G | 47.1% | G371G (GGT→GGG) | degP → | serine endoprotease (protease Do), membrane‑associated |
RA | 160,882 | T→A | 24.1% | S392T (TCC→ACC) | degP → | serine endoprotease (protease Do), membrane‑associated |
RA | 161,135 | C→T | 21.1% | intergenic (+2/‑153) | degP → / → cdaR | serine endoprotease (protease Do), membrane‑associated/DNA‑binding transcriptional regulator |
RA | 161,956 | T→C | 46.7% | D223D (GAT→GAC) | cdaR → | DNA‑binding transcriptional regulator |
RA | 162,223 | G→A | 45.2% | A312A (GCG→GCA) | cdaR → | DNA‑binding transcriptional regulator |
RA | 162,233 | A→G | 48.7% | T316A (ACG→GCG) | cdaR → | DNA‑binding transcriptional regulator |
RA | 165,064 | T→C | 37.9% | V804V (GTA→GTG) | glnD ← | uridylyltransferase |
RA | 165,472 | A→G | 43.4% | R668R (CGT→CGC) | glnD ← | uridylyltransferase |
RA | 165,784 | T→C | 100% | Q564Q (CAA→CAG) | glnD ← | uridylyltransferase |
RA | 165,787 | G→A | 100% | A563A (GCC→GCT) | glnD ← | uridylyltransferase |
RA | 165,804 | A→G | 100% | L558L (TTG→CTG) | glnD ← | uridylyltransferase |
RA | 166,699 | C→T | 67.3% | R259R (CGG→CGA) | glnD ← | uridylyltransferase |
RA | 171,738 | C→T | 58.5% | D14D (GAC→GAT) | frr → | ribosome recycling factor |
RA | 171,888 | A→T | 32.0% | T64T (ACA→ACT) | frr → | ribosome recycling factor |
RA | 172,545 | C→T | 64.3% | T67M (ACG→ATG) | dxr → | 1‑deoxy‑D‑xylulose 5‑phosphate reductoisomerase |
RA | 172,564 | T→G | 42.9% | G73G (GGT→GGG) | dxr → | 1‑deoxy‑D‑xylulose 5‑phosphate reductoisomerase |
RA | 177,973 | T→G | 28.1% | G407G (GGT→GGG) | yaeT → | conserved hypothetical protein |
RA | 177,982 | C→T | 29.3% | D410D (GAC→GAT) | yaeT → | conserved hypothetical protein |
RA | 178,645 | G→T | 23.7% | G631G (GGG→GGT) | yaeT → | conserved hypothetical protein |
RA | 180,434 | A→T | 43.8% | T213T (ACA→ACT) | lpxD → | UDP‑3‑O‑(3‑hydroxymyristoyl)‑glucosamine N‑acyltransferase |
RA | 180,440 | C→T | 50.0% | I215I (ATC→ATT) | lpxD → | UDP‑3‑O‑(3‑hydroxymyristoyl)‑glucosamine N‑acyltransferase |
RA | 180,446 | C→T | 50.0% | R217R (CGC→CGT) | lpxD → | UDP‑3‑O‑(3‑hydroxymyristoyl)‑glucosamine N‑acyltransferase |
RA | 182,379 | C→A | 44.4% | L69L (CTC→CTA) | lpxB → | tetraacyldisaccharide‑1‑P synthase |
RA | 183,076 | T→C | 45.4% | L302L (TTG→CTG) | lpxB → | tetraacyldisaccharide‑1‑P synthase |
RA | 183,087 | G→A | 54.0% | R305R (CGG→CGA) | lpxB → | tetraacyldisaccharide‑1‑P synthase |
RA | 186,734 | C→A | 34.6% | A928A (GCC→GCA) | dnaE → | DNA polymerase III alpha subunit |
RA | 188,635 | A→G | 31.1% | K44K (AAA→AAG) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 188,890 | A→G | 36.7% | T129T (ACA→ACG) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 189,526 | G→A | 27.6% | P341P (CCG→CCA) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 189,568 | G→A | 24.8% | A355A (GCG→GCA) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 189,592 | A→G | 40.8% | Q363Q (CAA→CAG) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 189,628 | T→G | 42.8% | A375A (GCT→GCG) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,053 | T→A | 53.0% | F517Y (TTC→TAC) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,065 | G→A | 57.7% | R521H (CGT→CAT) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,069 | G→C | 59.2% | G522G (GGG→GGC) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,075 | A→T | 58.5% | V524V (GTA→GTT) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,078 | A→T | 60.0% | V525V (GTA→GTT) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,090 | C→T | 53.6% | G529G (GGC→GGT) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,093 | T→G | 53.7% | P530P (CCT→CCG) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,108 | T→C | 80.6% | F535F (TTT→TTC) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,111 | C→G | 80.5% | L536L (CTC→CTG) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,114 | T→C | 62.6% | F537F (TTT→TTC) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,273 | A→G | 34.9% | A590A (GCA→GCG) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,333 | C→T | 29.4% | F610F (TTC→TTT) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,339 | T→C | 30.1% | T612T (ACT→ACC) | ldcC → | lysine decarboxylase 2, constitutive |
RA | 190,756 | G→A | 49.5% | V19M (GTG→ATG) | yaeR → | predicted lyase |
RA | 190,956 | C→T | 49.1% | D85D (GAC→GAT) | yaeR → | predicted lyase |
RA | 193,541 | A→G | 28.0% | V142V (GTA→GTG) | yaeQ → | conserved hypothetical protein |
RA | 193,546 | C→G | 27.6% | A144G (GCC→GGC) | yaeQ → | conserved hypothetical protein |
RA | 195,472 | C→G | 45.6% | A119A (GCG→GCC) | yaeF ← | predicted lipoprotein |
RA | 195,490 | G→A | 35.5% | I113I (ATC→ATT) | yaeF ← | predicted lipoprotein |
RA | 195,640 | A→T | 25.0% | P63P (CCT→CCA) | yaeF ← | predicted lipoprotein |
RA | 195,644 | G→T | 24.9% | A62E (GCA→GAA) | yaeF ← | predicted lipoprotein |
RA | 196,212 | T→G | 52.4% | R463R (CGA→CGC) | proS ← | prolyl‑tRNA synthetase |
RA | 196,437 | A→G | 42.3% | R388R (CGT→CGC) | proS ← | prolyl‑tRNA synthetase |
RA | 196,446 | T→A | 39.4% | A385A (GCA→GCT) | proS ← | prolyl‑tRNA synthetase |
RA | 196,451 | C→T | 37.9% | V384I (GTT→ATT) | proS ← | prolyl‑tRNA synthetase |
RA | 196,458 | G→A | 38.0% | T381T (ACC→ACT) | proS ← | prolyl‑tRNA synthetase |
RA | 197,160 | G→A | 34.9% | F147F (TTC→TTT) | proS ← | prolyl‑tRNA synthetase |
RA | 197,331 | A→G | 58.1% | G90G (GGT→GGC) | proS ← | prolyl‑tRNA synthetase |
RA | 197,334 | G→A | 58.1% | Y89Y (TAC→TAT) | proS ← | prolyl‑tRNA synthetase |
RA | 197,366 | A→G | 52.3% | L79L (TTG→CTG) | proS ← | prolyl‑tRNA synthetase |
RA | 197,367 | A→T | 52.3% | D78E (GAT→GAA) | proS ← | prolyl‑tRNA synthetase |
RA | 197,370 | G→A | 52.9% | A77A (GCC→GCT) | proS ← | prolyl‑tRNA synthetase |
RA | 197,781 | T→C | 31.4% | L213L (CTA→CTG) | yaeB ← | conserved hypothetical protein |
RA | 198,312 | C→T | 100% | L36L (CTG→CTA) | yaeB ← | conserved hypothetical protein |
RA | 200,183 | A→T | 25.6% | G88G (GGT→GGA) | metI ← | DL‑methionine transporter subunit |
RA | 201,711 | C→T | 32.0% | V18V (GTC→GTT) | gmhB → | D,D‑heptose 1,7‑bisphosphate phosphatase |
RA | 201,981 | T→C | 29.3% | D108D (GAT→GAC) | gmhB → | D,D‑heptose 1,7‑bisphosphate phosphatase |
RA | 204,556 | A→G | 100% | intergenic (+156/‑28) | alaV → / → rrlH | tRNA‑Ala/23S ribosomal RNA |
RA | 208,530 | G→T | 29.3% | T180T (ACG→ACT) | dkgB → | 2,5‑diketo‑D‑gluconate reductase B |
RA | 208,542 | T→C | 28.5% | G184G (GGT→GGC) | dkgB → | 2,5‑diketo‑D‑gluconate reductase B |
RA | 208,545 | G→T | 27.9% | K185N (AAG→AAT) | dkgB → | 2,5‑diketo‑D‑gluconate reductase B |
RA | 208,548 | C→A | 28.0% | A186A (GCC→GCA) | dkgB → | 2,5‑diketo‑D‑gluconate reductase B |
RA | 208,558 | G→A | 31.8% | E190K (GAG→AAG) | dkgB → | 2,5‑diketo‑D‑gluconate reductase B |
RA | 208,575 | C→T | 33.8% | I195I (ATC→ATT) | dkgB → | 2,5‑diketo‑D‑gluconate reductase B |
RA | 208,602 | A→T | 27.1% | A204A (GCA→GCT) | dkgB → | 2,5‑diketo‑D‑gluconate reductase B |
RA | 209,334 | C→T | 39.9% | L124L (TTG→TTA) | yafC ← | predicted DNA‑binding transcriptional regulator |
RA | 209,361 | G→A | 39.3% | F115F (TTC→TTT) | yafC ← | predicted DNA‑binding transcriptional regulator |
RA | 209,373 | T→C | 50.7% | L111L (TTA→TTG) | yafC ← | predicted DNA‑binding transcriptional regulator |
RA | 210,374 | A→C | 45.9% | P143P (CCA→CCC) | yafD → | conserved hypothetical protein |
RA | 210,386 | C→T | 31.3% | T147T (ACC→ACT) | yafD → | conserved hypothetical protein |
RA | 212,234 | T→C | 59.6% | K182K (AAA→AAG) | mltD ← | predicted membrane‑bound lytic murein transglycosylase D |
RA | 213,286 | C→T | 37.6% | T107T (ACG→ACA) | gloB ← | predicted hydroxyacylglutathione hydrolase |
RA | 213,289 | A→G | 37.7% | A106A (GCT→GCC) | gloB ← | predicted hydroxyacylglutathione hydrolase |
RA | 213,333 | C→T | 29.6% | G92S (GGC→AGC) | gloB ← | predicted hydroxyacylglutathione hydrolase |
RA | 214,077 | C→A | 27.0% | T146T (ACC→ACA) | yafS → | predicted S‑adenosyl‑L‑methionine‑dependent methyltransferase |
RA | 214,101 | T→C | 23.5% | F154F (TTT→TTC) | yafS → | predicted S‑adenosyl‑L‑methionine‑dependent methyltransferase |
RA | 214,925 | A→C | 91.5% | D12A (GAT→GCT) | dnaQ → | DNA polymerase III epsilon subunit |
RA | 214,931 | A→C | 92.2% | E14A (GAA→GCA) | dnaQ → | DNA polymerase III epsilon subunit |
RA | 218,450 | C→T | 26.4% | V188V (GTG→GTA) | yafV ← | predicted C‑N hydrolase family amidase, NAD(P)‑binding |
RA | 218,458 | C→T | 25.3% | A186T (GCG→ACG) | yafV ← | predicted C‑N hydrolase family amidase, NAD(P)‑binding |
RA | 219,917 | T→C | 64.6% | P737P (CCA→CCG) | fadE ← | acyl coenzyme A dehydrogenase |
RA | 220,157 | A→G | 41.8% | D657D (GAT→GAC) | fadE ← | acyl coenzyme A dehydrogenase |
RA | 221,894 | C→T | 34.9% | K78K (AAG→AAA) | fadE ← | acyl coenzyme A dehydrogenase |
RA | 221,897 | A→G | 48.3% | R77R (CGT→CGC) | fadE ← | acyl coenzyme A dehydrogenase |
RA | 221,903 | A→T | 42.9% | G75G (GGT→GGA) | fadE ← | acyl coenzyme A dehydrogenase |
RA | 222,888 | T→C | 26.8% | I174I (ATT→ATC) | lpcA → | D‑sedoheptulose 7‑phosphate isomerase |
RA | 222,921 | G→A | 30.8% | L185L (TTG→TTA) | lpcA → | D‑sedoheptulose 7‑phosphate isomerase |
RA | 223,577 | A→G | 50.7% | G151G (GGA→GGG) | prfH → | predicted peptide chain release factor |
RA | 223,627 | T→A | 29.4% | intergenic (+47/+10) | prfH → / ← pepD | predicted peptide chain release factor/aminoacyl‑histidine dipeptidase |
RA | 223,739 | A→G | 40.0% | T452T (ACT→ACC) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 223,754 | A→C | 50.9% | V447V (GTT→GTG) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 223,934 | G→A | 60.7% | G387G (GGC→GGT) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 223,937 | A→T | 60.8% | A386A (GCT→GCA) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 223,952 | C→T | 61.9% | S381S (TCG→TCA) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 224,069 | A→G | 52.3% | V342V (GTT→GTC) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 224,081 | G→T | 44.2% | A338A (GCC→GCA) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 224,084 | T→C | 43.5% | V337V (GTA→GTG) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 224,087 | A→G | 44.3% | D336D (GAT→GAC) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 224,636 | G→A | 20.4% | F153F (TTC→TTT) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 224,639 | C→A | 20.4% | A152A (GCG→GCT) | pepD ← | aminoacyl‑histidine dipeptidase |
RA | 226,492 | G→A | 45.4% | T196T (ACG→ACA) | frsA → | hydrolase, binds to enzyme IIA(Glc) |
RA | 227,362 | A→G | 42.0% | E52E (GAA→GAG) | crl → | DNA‑binding transcriptional regulator |
RA | 227,492 | C→T | 24.8% | L96L (CTG→TTG) | crl → | DNA‑binding transcriptional regulator |
RA | 227,533 | A→G | 13.5% | E109E (GAA→GAG) | crl → | DNA‑binding transcriptional regulator |
RA | 227,540 | A→G | 18.7% | T112A (ACG→GCG) | crl → | DNA‑binding transcriptional regulator |
RA | 227,569 | G→A | 24.4% | A121A (GCG→GCA) | crl → | DNA‑binding transcriptional regulator |
RA | 229,412 | G→T | 48.3% | T141T (ACG→ACT) | proB → | gamma‑glutamate kinase |
RA | 229,430 | C→T | 72.5% | G147G (GGC→GGT) | proB → | gamma‑glutamate kinase |
RA | 229,931 | C→T | 32.6% | R314R (CGC→CGT) | proB → | gamma‑glutamate kinase |
RA | 230,518 | T→C | 40.3% | N138N (AAT→AAC) | proA → | gamma‑glutamylphosphate reductase |
RA | 231,703:1 | +C | 100% | intergenic (+155/+84) | thrW → / ← hemB | tRNA‑Thr/porphobilinogen synthase |
RA | 231,934 | A→G | 50.0% | Y276Y (TAT→TAC) | hemB ← | porphobilinogen synthase |
RA | 232,063 | T→C | 74.7% | S233S (TCA→TCG) | hemB ← | porphobilinogen synthase |
RA | 232,066 | T→C | 76.4% | E232E (GAA→GAG) | hemB ← | porphobilinogen synthase |
RA | 236,687 | A→G | 13.2% | S14S (TCA→TCG) | yaiE → | conserved hypothetical protein |
RA | 237,233 | T→G | 40.8% | D32E (GAT→GAG) | ykiA → | hypothetical protein |
RA | 240,000 | G→A | 39.0% | N317N (AAC→AAT) | araJ ← | predicted transporter |
RA | 240,006 | T→C | 100% | L315L (CTA→CTG) | araJ ← | predicted transporter |
RA | 240,219 | A→C | 13.6% | V244V (GTT→GTG) | araJ ← | predicted transporter |
RA | 240,243 | C→T | 11.7% | A236A (GCG→GCA) | araJ ← | predicted transporter |
RA | 241,084 | C→T | 42.5% | V1047M (GTG→ATG) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 241,093 | T→C | 38.1% | T1044A (ACG→GCG) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 241,118 | G→T | 38.1% | G1035G (GGC→GGA) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 241,121 | G→A | 37.6% | N1034N (AAC→AAT) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 241,259 | C→T | 55.3% | T988T (ACG→ACA) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 241,319 | C→T | 78.4% | S968S (TCG→TCA) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 241,331 | C→T | 62.5% | A964A (GCG→GCA) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 241,346 | A→G | 47.6% | V959V (GTT→GTC) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 241,523 | C→T | 61.6% | Q900Q (CAG→CAA) | sbcC ← | exonuclease, dsDNA, ATP‑dependent |
RA | 244,761 | C→T | 30.1% | G221R (GGG→AGG) | sbcD ← | exonuclease, dsDNA, ATP‑dependent |
RA | 244,855 | C→A | 13.5% | G189G (GGG→GGT) | sbcD ← | exonuclease, dsDNA, ATP‑dependent |
RA | 244,876 | C→A | 41.7% | T182T (ACG→ACT) | sbcD ← | exonuclease, dsDNA, ATP‑dependent |
RA | 247,122 | A→G | 38.6% | G255G (GGA→GGG) | phoR → | sensory histidine kinase in two‑component regulatory system with PhoB |
RA | 247,123 | C→T | 38.5% | L256L (CTG→TTG) | phoR → | sensory histidine kinase in two‑component regulatory system with PhoB |
RA | 247,548 | T→G | 23.4% | A397A (GCT→GCG) | phoR → | sensory histidine kinase in two‑component regulatory system with PhoB |
RA | 247,851 | C→T | 16.2% | intergenic (+198/‑209) | phoR → / → brnQ | sensory histidine kinase in two‑component regulatory system with PhoB/predicted branched chain amino acid transporter |
RA | 249,667 | C→A | 37.7% | A71A (GCC→GCA) | proY → | predicted cryptic proline transporter |
RA | 250,357 | T→C | 21.0% | D301D (GAT→GAC) | proY → | predicted cryptic proline transporter |
RA | 250,366 | C→T | 23.7% | G304G (GGC→GGT) | proY → | predicted cryptic proline transporter |
RA | 252,556 | A→G | 36.9% | S525G (AGT→GGT) | malZ → | maltodextrin glucosidase |
RA | 252,565 | C→T | 60.2% | L528L (CTA→TTA) ‡ | malZ → | maltodextrin glucosidase |
RA | 252,567 | A→G | 59.1% | L528L (CTA→CTG) ‡ | malZ → | maltodextrin glucosidase |
RA | 252,572 | A→G | 59.7% | H530R (CAT→CGT) | malZ → | maltodextrin glucosidase |
RA | 253,007 | C→T | 50.6% | L127L (TTG→TTA) | yajB ← | conserved hypothetical protein |
RA | 253,013 | A→G | 54.2% | N125N (AAT→AAC) | yajB ← | conserved hypothetical protein |
RA | 253,031 | A→G | 79.8% | R119R (CGT→CGC) | yajB ← | conserved hypothetical protein |
RA | 253,035 | G→T | 76.5% | P118Q (CCA→CAA) | yajB ← | conserved hypothetical protein |
RA | 253,046 | C→T | 81.0% | P114P (CCG→CCA) | yajB ← | conserved hypothetical protein |
RA | 253,049 | C→A | 80.9% | L113F (TTG→TTT) ‡ | yajB ← | conserved hypothetical protein |
RA | 253,051 | A→G | 81.0% | L113L (TTG→CTG) ‡ | yajB ← | conserved hypothetical protein |
RA | 256,007 | G→A | 47.7% | A84A (GCG→GCA) | yajC → | SecYEG protein translocase auxillary subunit |
RA | 258,025 | G→A | 13.5% | D18N (GAC→AAC) | secF → | SecYEG protein translocase auxillary subunit |
RA | 260,129 | G→A | 41.9% | F118F (TTC→TTT) | tsx ← | nucleoside channel, receptor of phage T6 and colicin K |
RA | 260,171 | T→C | 43.4% | P104P (CCA→CCG) | tsx ← | nucleoside channel, receptor of phage T6 and colicin K |
RA | 260,678 | G→A | 37.9% | intergenic (‑196/+103) | tsx ← / ← yajI | nucleoside channel, receptor of phage T6 and colicin K/predicted lipoprotein |
RA | 260,895 | G→T | 59.2% | A142A (GCC→GCA) | yajI ← | predicted lipoprotein |
RA | 260,898 | A→G | 52.3% | N141N (AAT→AAC) | yajI ← | predicted lipoprotein |
RA | 261,102 | C→T | 33.2% | P73P (CCG→CCA) | yajI ← | predicted lipoprotein |
RA | 261,352 | A→G | 39.7% | intergenic (‑32/‑119) | yajI ← / → ybaD | predicted lipoprotein/conserved hypothetical protein |
RA | 262,850 | G→A | 31.8% | L309L (CTG→CTA) | ribD → | fused diaminohydroxyphosphoribosylaminopyrimidin e deaminase and 5‑amino‑6‑(5‑phosphoribosylamino) uracil reductase |
RA | 262,906 | G→A | 50.9% | S328N (AGC→AAC) | ribD → | fused diaminohydroxyphosphoribosylaminopyrimidin e deaminase and 5‑amino‑6‑(5‑phosphoribosylamino) uracil reductase |
RA | 262,916 | C→T | 48.4% | R331R (CGC→CGT) | ribD → | fused diaminohydroxyphosphoribosylaminopyrimidin e deaminase and 5‑amino‑6‑(5‑phosphoribosylamino) uracil reductase |
RA | 264,681 | A→G | 34.8% | P193P (CCA→CCG) | thiL → | thiamin‑monophosphate kinase |
RA | 264,912 | T→G | 45.9% | T270T (ACT→ACG) | thiL → | thiamin‑monophosphate kinase |
RA | 265,813 | T→C | 43.5% | T264T (ACA→ACG) | yajO ← | predicted oxidoreductase, NAD(P)‑binding |
RA | 265,816 | C→T | 41.0% | A263A (GCG→GCA) | yajO ← | predicted oxidoreductase, NAD(P)‑binding |
RA | 265,981 | T→C | 34.1% | V208V (GTA→GTG) | yajO ← | predicted oxidoreductase, NAD(P)‑binding |
RA | 265,993 | C→T | 31.6% | E204E (GAG→GAA) | yajO ← | predicted oxidoreductase, NAD(P)‑binding |
RA | 266,955 | G→A | 63.0% | G564G (GGC→GGT) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 266,958 | G→A | 61.2% | G563G (GGC→GGT) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 267,465 | A→G | 100% | T394T (ACT→ACC) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 267,474 | A→G | 100% | I391I (ATT→ATC) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 267,480 | G→A | 100% | V389V (GTC→GTT) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 267,495 | C→G | 64.2% | G384G (GGG→GGC) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 267,498 | A→T | 62.5% | G383G (GGT→GGA) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 268,176 | T→A | 33.7% | A157A (GCA→GCT) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 268,179 | G→A | 33.6% | T156T (ACC→ACT) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 268,233 | T→C | 52.2% | E138E (GAA→GAG) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 268,245 | C→T | 38.4% | A134A (GCG→GCA) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 268,248 | A→G | 41.6% | I133I (ATT→ATC) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 268,251 | A→C | 42.5% | G132G (GGT→GGG) | dxs ← | 1‑deoxyxylulose‑5‑phosphate synthase, thiamine‑requiring, FAD‑requiring |
RA | 269,904 | A→G | 56.7% | intergenic (‑92/‑114) | xseB ← / → thiI | exonuclease VII small subunit/sulfurtransferase required for thiamine and 4‑thiouridine biosynthesis |
RA | 271,049 | T→C | 20.1% | C344C (TGT→TGC) | thiI → | sulfurtransferase required for thiamine and 4‑thiouridine biosynthesis |
RA | 271,052 | T→C | 23.7% | G345G (GGT→GGC) | thiI → | sulfurtransferase required for thiamine and 4‑thiouridine biosynthesis |
RA | 271,058 | C→T | 22.2% | I347I (ATC→ATT) | thiI → | sulfurtransferase required for thiamine and 4‑thiouridine biosynthesis |
RA | 271,637 | C→T | 31.6% | P158P (CCG→CCA) | yajL ← | conserved hypothetical protein |
RA | 274,364 | G→A | 46.3% | L258L (CTA→TTA) | yajR ← | predicted transporter |
RA | 275,944 | C→A | 34.6% | V77V (GTG→GTT) | cyoE ← | protoheme IX farnesyltransferase |
RA | 276,399 | T→C | 53.4% | G39G (GGA→GGG) | cyoD ← | cytochrome o ubiquinol oxidase subunit IV |
RA | 277,691 | G→A | 48.9% | L474L (CTG→TTG) | cyoB ← | cytochrome o ubiquinol oxidase subunit I |
RA | 277,701 | T→C | 54.8% | P470P (CCA→CCG) | cyoB ← | cytochrome o ubiquinol oxidase subunit I |
RA | 277,857 | C→T | 50.0% | A418A (GCG→GCA) | cyoB ← | cytochrome o ubiquinol oxidase subunit I |
RA | 278,199 | G→A | 43.8% | T304T (ACC→ACT) | cyoB ← | cytochrome o ubiquinol oxidase subunit I |
RA | 278,229 | A→T | 47.5% | V294V (GTT→GTA) | cyoB ← | cytochrome o ubiquinol oxidase subunit I |
RA | 278,904 | C→T | 64.2% | L69L (TTG→TTA) | cyoB ← | cytochrome o ubiquinol oxidase subunit I |
RA | 279,186 | G→A | 34.2% | S298S (AGC→AGT) | cyoA ← | cytochrome o ubiquinol oxidase subunit II |
RA | 280,674 | C→T | 69.9% | T447T (ACG→ACA) | ampG ← | muropeptide transporter |
RA | 281,469 | T→C | 33.3% | A182A (GCA→GCG) | ampG ← | muropeptide transporter |
RA | 281,478 | T→C | 25.8% | L179L (TTA→TTG) | ampG ← | muropeptide transporter |
RA | 285,523 | T→C | 56.2% | F126F (TTT→TTC) | clpP → | proteolytic subunit of ClpA‑ClpP and ClpX‑ClpP ATP‑dependent serine proteases |
RA | 287,566 | C→T | 40.5% | T70T (ACC→ACT) | lon → | DNA‑binding ATP‑dependent protease La |
RA | 287,902 | T→C | 18.9% | S182S (TCT→TCC) | lon → | DNA‑binding ATP‑dependent protease La |
RA | 288,179 | T→C | 49.1% | L275L (TTG→CTG) | lon → | DNA‑binding ATP‑dependent protease La |
RA | 288,355 | A→T | 52.3% | R333R (CGA→CGT) | lon → | DNA‑binding ATP‑dependent protease La |
RA | 289,285 | G→A | 26.1% | T643T (ACG→ACA) | lon → | DNA‑binding ATP‑dependent protease La |
RA | 293,984 | A→G | 40.8% | G11G (GGT→GGC) | ybaX ← | predicted aluminum resistance protein |
RA | 294,369 | A→G | 46.8% | T471T (ACT→ACC) | ybaE ← | predicted transporter subunit |
RA | 297,573 | G→C | 51.3% | R78R (CGG→CGC) | mdlA → | fused predicted multidrug transporter subunits and ATP‑binding components of ABC superfamily |
RA | 297,993 | C→T | 25.1% | R218R (CGC→CGT) | mdlA → | fused predicted multidrug transporter subunits and ATP‑binding components of ABC superfamily |
RA | 298,842 | G→A | 71.2% | S501S (TCG→TCA) | mdlA → | fused predicted multidrug transporter subunits and ATP‑binding components of ABC superfamily |
RA | 299,608 | A→G | 37.7% | A168A (GCA→GCG) | mdlB → | fused predicted multidrug transporter subunits and ATP binding components of ABC superfamily |
RA | 299,920 | C→T | 51.7% | G272G (GGC→GGT) | mdlB → | fused predicted multidrug transporter subunits and ATP binding components of ABC superfamily |
RA | 299,954 | C→T | 52.8% | L284L (CTG→TTG) | mdlB → | fused predicted multidrug transporter subunits and ATP binding components of ABC superfamily |
RA | 300,682 | C→T | 31.1% | T526T (ACC→ACT) | mdlB → | fused predicted multidrug transporter subunits and ATP binding components of ABC superfamily |
RA | 300,688 | G→T | 32.9% | L528L (CTG→CTT) | mdlB → | fused predicted multidrug transporter subunits and ATP binding components of ABC superfamily |
RA | 300,691 | A→G | 40.2% | V529V (GTA→GTG) | mdlB → | fused predicted multidrug transporter subunits and ATP binding components of ABC superfamily |
RA | 300,712 | G→A | 57.8% | S536S (TCG→TCA) | mdlB → | fused predicted multidrug transporter subunits and ATP binding components of ABC superfamily |
RA | 300,715 | C→T | 57.8% | T537T (ACC→ACT) | mdlB → | fused predicted multidrug transporter subunits and ATP binding components of ABC superfamily |
RA | 302,589 | C→T | 34.1% | I385I (ATC→ATT) | amtB → | ammonium transporter |
RA | 302,598 | C→T | 32.3% | S388S (TCC→TCT) | amtB → | ammonium transporter |
RA | 303,058 | G→A | 32.0% | D191D (GAC→GAT) | tesB ← | acyl‑CoA thioesterase II |
RA | 303,157 | C→A | 58.6% | L158L (CTG→CTT) | tesB ← | acyl‑CoA thioesterase II |
RA | 303,976 | A→T | 35.3% | P43P (CCA→CCT) | ybaY → | predicted outer membrane lipoprotein |
RA | 304,408 | T→A | 32.6% | P187P (CCT→CCA) | ybaY → | predicted outer membrane lipoprotein |
RA | 304,425 | C→A | 31.7% | intergenic (+5/+26) | ybaY → / ← ybaZ | predicted outer membrane lipoprotein/predicted methyltransferase |
RA | 305,631 | A→G | 29.3% | L486L (TTA→CTA) | ylaB ← | conserved inner membrane protein |
RA | 306,800 | G→A | 24.4% | A96V (GCT→GTT) | ylaB ← | conserved inner membrane protein |
RA | 306,979 | C→T | 44.9% | S36S (TCG→TCA) | ylaB ← | conserved inner membrane protein |
RA | 307,962 | C→T | 47.4% | A142A (GCG→GCA) | maa ← | maltose O‑acetyltransferase |
RA | 307,965 | G→A | 47.9% | R141R (CGC→CGT) | maa ← | maltose O‑acetyltransferase |
RA | 308,299 | T→C | 54.4% | Q30R (CAG→CGG) | maa ← | maltose O‑acetyltransferase |
RA | 309,067 | T→A | 40.5% | V37V (GTA→GTT) | ybaJ ← | hypothetical protein |
RA | 310,164 | C→T | 47.5% | L903L (CTG→CTA) | acrB ← | multidrug efflux system protein |
RA | 311,087 | G→T | 60.9% | H596N (CAT→AAT) | acrB ← | multidrug efflux system protein |
RA | 312,072 | C→T | 51.5% | K267K (AAG→AAA) | acrB ← | multidrug efflux system protein |
RA | 312,078 | G→C | 51.5% | V265V (GTC→GTG) | acrB ← | multidrug efflux system protein |
RA | 312,081 | G→A | 46.5% | D264D (GAC→GAT) | acrB ← | multidrug efflux system protein |
RA | 312,090 | C→T | 47.9% | L261L (CTG→CTA) | acrB ← | multidrug efflux system protein |
RA | 312,225 | C→A | 31.1% | A216A (GCG→GCT) | acrB ← | multidrug efflux system protein |
RA | 312,228 | C→T | 31.0% | A215A (GCG→GCA) | acrB ← | multidrug efflux system protein |
RA | 312,237 | G→A | 47.9% | A212A (GCC→GCT) | acrB ← | multidrug efflux system protein |
RA | 312,246 | C→T | 57.0% | A209A (GCG→GCA) | acrB ← | multidrug efflux system protein |
RA | 312,408 | G→A | 32.0% | S155S (TCC→TCT) | acrB ← | multidrug efflux system protein |
RA | 312,429 | G→A | 43.0% | T148T (ACC→ACT) | acrB ← | multidrug efflux system protein |
RA | 314,859 | T→C | 100% | N210N (AAT→AAC) | acrR → | DNA‑binding transcriptional regulator |
RA | 316,042 | T→A | 44.5% | S346S (TCT→TCA) | kefA → | fused mechanosensitive channel proteins |
RA | 316,051 | T→G | 38.9% | L349L (CTT→CTG) | kefA → | fused mechanosensitive channel proteins |
RA | 317,602 | A→G | 51.1% | L866L (TTA→TTG) | kefA → | fused mechanosensitive channel proteins |
RA | 318,020 | C→A | 18.3% | R1006S (CGT→AGT) | kefA → | fused mechanosensitive channel proteins |
RA | 318,136 | A→G | 35.0% | A1044A (GCA→GCG) | kefA → | fused mechanosensitive channel proteins |
RA | 320,261 | C→T | 100% | D127D (GAC→GAT) | apt → | adenine phosphoribosyltransferase |
RA | 321,361 | G→A | 81.4% | L267L (CTG→CTA) | dnaX → | DNA polymerase III/DNA elongation factor III, tau and gamma subunits |
RA | 321,373 | C→T | 81.4% | A271A (GCC→GCT) | dnaX → | DNA polymerase III/DNA elongation factor III, tau and gamma subunits |
RA | 323,098 | G→A | 44.3% | P75P (CCG→CCA) | recR → | gap repair protein |
RA | 323,233 | G→T | 19.0% | P120P (CCG→CCT) | recR → | gap repair protein |
RA | 323,413 | G→A | 100% | E180E (GAG→GAA) | recR → | gap repair protein |
RA | 323,771 | C→T | 50.0% | G61G (GGC→GGT) | htpG → | molecular chaperone HSP90 family |
RA | 327,386 | C→T | 66.7% | S288F (TCC→TTC) | hemH → | ferrochelatase |
RA | 327,396 | C→G | 53.4% | A291A (GCC→GCG) | hemH → | ferrochelatase |
RA | 327,825 | A→G | 38.7% | R206R (CGT→CGC) | aes ← | acetyl esterase |
RA | 329,175 | A→T | 14.3% | S194S (TCA→TCT) | gsk → | inosine/guanosine kinase |
RA | 329,715 | T→C | 40.4% | H374H (CAT→CAC) | gsk → | inosine/guanosine kinase |
RA | 330,082 | G→A | 44.5% | T542T (ACC→ACT) | ybaL ← | predicted transporter with NAD(P)‑binding Rossmann‑fold domain |
RA | 330,091 | G→A | 39.2% | I539I (ATC→ATT) | ybaL ← | predicted transporter with NAD(P)‑binding Rossmann‑fold domain |
RA | 330,103 | G→A | 43.8% | G535G (GGC→GGT) | ybaL ← | predicted transporter with NAD(P)‑binding Rossmann‑fold domain |
RA | 330,220 | A→G | 20.8% | G496G (GGT→GGC) | ybaL ← | predicted transporter with NAD(P)‑binding Rossmann‑fold domain |
RA | 331,123 | T→C | 56.4% | K195K (AAA→AAG) | ybaL ← | predicted transporter with NAD(P)‑binding Rossmann‑fold domain |
RA | 331,210 | C→T | 20.3% | V166V (GTG→GTA) | ybaL ← | predicted transporter with NAD(P)‑binding Rossmann‑fold domain |
RA | 331,222 | A→G | 24.9% | V162V (GTT→GTC) | ybaL ← | predicted transporter with NAD(P)‑binding Rossmann‑fold domain |
RA | 331,345 | A→G | 24.3% | G121G (GGT→GGC) | ybaL ← | predicted transporter with NAD(P)‑binding Rossmann‑fold domain |
RA | 333,415 | G→A | 30.7% | A11A (GCG→GCA) | ushA → | bifunctional UDP‑sugar hydrolase and 5'‑nucleotidase |
RA | 333,922 | C→T | 34.0% | N180N (AAC→AAT) | ushA → | bifunctional UDP‑sugar hydrolase and 5'‑nucleotidase |
RA | 333,931 | C→T | 42.8% | Y183Y (TAC→TAT) | ushA → | bifunctional UDP‑sugar hydrolase and 5'‑nucleotidase |
RA | 334,384 | T→G | 57.5% | L334L (CTT→CTG) | ushA → | bifunctional UDP‑sugar hydrolase and 5'‑nucleotidase |
RA | 334,390 | T→C | 100% | T336T (ACT→ACC) | ushA → | bifunctional UDP‑sugar hydrolase and 5'‑nucleotidase |
RA | 334,651 | G→A | 39.7% | V423V (GTG→GTA) | ushA → | bifunctional UDP‑sugar hydrolase and 5'‑nucleotidase |
RA | 335,821 | T→G | 59.7% | R243R (CGA→CGC) | ybaP ← | conserved hypothetical protein |
RA | 337,371 | C→T | 25.7% | R826R (CGG→CGA) | copA ← | copper transporter |
RA | 338,292 | A→G | 100% | T519T (ACT→ACC) | copA ← | copper transporter |
RA | 338,301 | T→C | 100% | T516T (ACA→ACG) | copA ← | copper transporter |
RA | 338,325 | A→G | 100% | A508A (GCT→GCC) | copA ← | copper transporter |
RA | 338,643 | A→G | 13.1% | R402R (CGT→CGC) | copA ← | copper transporter |
RA | 339,753 | C→T | 37.7% | E32E (GAG→GAA) | copA ← | copper transporter |
RA | 345,177 | A→C | 29.0% | R42R (CGA→CGC) | ybbM → | predicted inner membrane protein |
RA | 345,441 | T→A | 59.1% | I130I (ATT→ATA) | ybbM → | predicted inner membrane protein |
RA | 346,932 | T→C | 52.0% | Y227C (TAC→TGC) | ybbO ← | predicted oxidoreductase with NAD(P)‑binding Rossmann‑fold domain |
RA | 346,941 | C→G | 47.4% | W224S (TGG→TCG) | ybbO ← | predicted oxidoreductase with NAD(P)‑binding Rossmann‑fold domain |
RA | 347,999 | C→T | 43.3% | C99C (TGC→TGT) | gcl → | glyoxylate carboligase |
RA | 348,014 | A→T | 47.4% | A104A (GCA→GCT) | gcl → | glyoxylate carboligase |
RA | 348,416 | A→G | 37.1% | L238L (CTA→CTG) | gcl → | glyoxylate carboligase |
RA | 348,854 | T→C | 58.2% | G384G (GGT→GGC) | gcl → | glyoxylate carboligase |
RA | 349,604 | T→C | 49.3% | F36F (TTT→TTC) | hyi → | hydroxypyruvate isomerase |
RA | 349,637 | T→G | 52.5% | H47Q (CAT→CAG) | hyi → | hydroxypyruvate isomerase |
RA | 351,261 | T→C | 23.3% | N137D (AAT→GAT) | purK ← | N5‑carboxyaminoimidazole ribonucleotide synthase |
RA | 351,262 | T→G | 23.4% | A136A (GCA→GCC) | purK ← | N5‑carboxyaminoimidazole ribonucleotide synthase |
RA | 351,286 | A→T | 31.3% | G128G (GGT→GGA) | purK ← | N5‑carboxyaminoimidazole ribonucleotide synthase |
RA | 352,455 | C→T | 33.6% | Q187Q (CAG→CAA) | lpxH ← | UDP‑2,3‑diacylglucosamine pyrophosphatase |
RA | 354,219 | A→G | 24.4% | P178P (CCA→CCG) | cysS → | cysteinyl‑tRNA synthetase |
RA | 354,489 | C→T | 40.7% | S268S (TCC→TCT) | cysS → | cysteinyl‑tRNA synthetase |
RA | 354,510 | T→C | 39.3% | F275F (TTT→TTC) | cysS → | cysteinyl‑tRNA synthetase |
RA | 354,519 | C→T | 38.7% | R278R (CGC→CGT) | cysS → | cysteinyl‑tRNA synthetase |
RA | 355,392 | G→A | 36.5% | R79R (CGC→CGT) | ybcI ← | conserved inner membrane protein |
RA | 355,401 | A→C | 44.1% | F76L (TTT→TTG) ‡ | ybcI ← | conserved inner membrane protein |
RA | 355,403 | A→G | 44.1% | F76L (TTT→CTT) ‡ | ybcI ← | conserved inner membrane protein |
RA | 355,755 | C→G | 49.1% | S65T (AGC→ACC) | ybcJ ← | predicted RNA‑binding protein |
RA | 364,740 | G→C | 52.5% | V82V (GTC→GTG) | entD ← | phosphopantetheinyltransferase component of enterobactin synthase multienzyme complex |
RA | 365,118 | G→T | 35.7% | intergenic (‑133/+33) | entD ← / ← fepA | phosphopantetheinyltransferase component of enterobactin synthase multienzyme complex/iron‑enterobactin outer membrane transporter |
RA | 365,150 | A→T | 34.5% | intergenic (‑165/+1) | entD ← / ← fepA | phosphopantetheinyltransferase component of enterobactin synthase multienzyme complex/iron‑enterobactin outer membrane transporter |
RA | 365,160 | G→A | 27.7% | T744T (ACC→ACT) | fepA ← | iron‑enterobactin outer membrane transporter |
RA | 365,163 | G→A | 24.5% | N743N (AAC→AAT) | fepA ← | iron‑enterobactin outer membrane transporter |
RA | 365,166 | T→A | 26.8% | V742V (GTA→GTT) ‡ | fepA ← | iron‑enterobactin outer membrane transporter |
RA | 365,168 | C→T | 26.4% | V742I (GTA→ATA) ‡ | fepA ← | iron‑enterobactin outer membrane transporter |
RA | 365,751 | G→C | 28.3% | V547V (GTC→GTG) | fepA ← | iron‑enterobactin outer membrane transporter |
RA | 365,796 | T→C | 39.0% | K532K (AAA→AAG) | fepA ← | iron‑enterobactin outer membrane transporter |
RA | 366,756 | A→G | 42.4% | R212R (CGT→CGC) | fepA ← | iron‑enterobactin outer membrane transporter |
RA | 368,298 | A→G | 47.1% | Q196R (CAG→CGG) | fes → | enterobactin/ferric enterobactin esterase |
RA | 368,308 | T→G | 35.1% | P199P (CCT→CCG) | fes → | enterobactin/ferric enterobactin esterase |
RA | 369,416 | G→A | 37.8% | Q121Q (CAG→CAA) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 370,210 | T→A | 39.9% | V386E (GTA→GAA) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 370,232 | G→A | 38.3% | E393E (GAG→GAA) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 372,202 | G→A | 53.3% | R1050Q (CGG→CAG) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 372,206 | T→C | 53.4% | R1051R (CGT→CGC) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 372,419 | G→C | 25.2% | T1122T (ACG→ACC) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 372,440 | T→C | 33.3% | H1129H (CAT→CAC) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 372,467 | C→A | 62.0% | S1138S (TCC→TCA) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 372,491 | T→C | 53.0% | G1146G (GGT→GGC) | entF → | enterobactin synthase multienzyme complex component, ATP‑dependent |
RA | 373,537 | C→T | 25.2% | D129D (GAC→GAT) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 373,549 | G→A | 23.7% | E133E (GAG→GAA) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 373,562 | G→C | 26.2% | E138Q (GAA→CAA) ‡ | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 373,563 | A→C | 26.2% | E138A (GAA→GCA) ‡ | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 373,571 | T→C | 23.6% | L141L (TTG→CTG) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 373,918 | T→A | 18.7% | V256V (GTT→GTA) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,053 | G→T | 24.9% | R301R (CGG→CGT) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,062 | T→A | 22.3% | L304L (CTT→CTA) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,081 | G→A | 20.7% | A311T (GCA→ACA) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,084 | C→A | 22.7% | H312N (CAT→AAT) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,087 | G→A | 22.9% | V313I (GTC→ATC) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,218 | C→T | 44.4% | G356G (GGC→GGT) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,222 | C→T | 44.4% | L358L (CTG→TTG) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,230 | C→T | 43.4% | R360R (CGC→CGT) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 374,231 | T→C | 43.5% | Y361H (TAT→CAT) | fepE → | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 375,663 | G→A | 42.9% | G141G (GGC→GGT) | fepG ← | iron‑enterobactin transporter subunit |
RA | 375,669 | G→A | 56.4% | R139R (CGC→CGT) | fepG ← | iron‑enterobactin transporter subunit |
RA | 376,142 | C→G | 33.6% | A315A (GCG→GCC) | fepD ← | iron‑enterobactin transporter subunit |
RA | 376,151 | C→T | 37.0% | V312V (GTG→GTA) | fepD ← | iron‑enterobactin transporter subunit |
RA | 376,561 | C→T | 19.4% | V176I (GTC→ATC) | fepD ← | iron‑enterobactin transporter subunit |
RA | 377,893 | G→A | 46.1% | G233S (GGT→AGT) | ybdA → | predicted transporter |
RA | 378,404 | A→G | 44.7% | H403R (CAT→CGT) | ybdA → | predicted transporter |
RA | 379,015 | T→C | 100% | A131A (GCA→GCG) | fepB ← | iron‑enterobactin transporter subunit |
RA | 380,351 | C→T | 54.2% | V190V (GTC→GTT) | entC → | isochorismate synthase 1 |
RA | 382,496 | G→A | 18.7% | V510V (GTG→GTA) | entE → | 2,3‑dihydroxybenzoate‑AMP ligase component of enterobactin synthase multienzyme complex |
RA | 383,076 | C→G | 32.1% | T162T (ACC→ACG) | entB → | isochorismatase |
RA | 383,184 | C→T | 28.6% | G198G (GGC→GGT) | entB → | isochorismatase |
RA | 383,199 | T→C | 32.2% | T203T (ACT→ACC) | entB → | isochorismatase |
RA | 384,346 | C→T | 32.1% | F50F (TTC→TTT) | ybdB → | conserved hypothetical protein |
RA | 384,349 | T→C | 34.5% | G51G (GGT→GGC) | ybdB → | conserved hypothetical protein |
RA | 384,350 | T→C | 34.5% | L52L (TTA→CTA) ‡ | ybdB → | conserved hypothetical protein |
RA | 384,352 | A→G | 40.4% | L52L (TTA→TTG) ‡ | ybdB → | conserved hypothetical protein |
RA | 384,355 | A→G | 40.4% | L53L (CTA→CTG) | ybdB → | conserved hypothetical protein |
RA | 384,439 | A→G | 84.5% | V81V (GTA→GTG) | ybdB → | conserved hypothetical protein |
RA | 384,445 | A→G | 84.5% | T83T (ACA→ACG) | ybdB → | conserved hypothetical protein |
RA | 384,454 | T→C | 76.7% | N86N (AAT→AAC) | ybdB → | conserved hypothetical protein |
RA | 384,457 | A→C | 100% | A87A (GCA→GCC) | ybdB → | conserved hypothetical protein |
RA | 384,705 | A→G | 37.3% | intergenic (+95/‑86) | ybdB → / → cstA | conserved hypothetical protein/carbon starvation protein |
RA | 385,720 | G→A | 41.0% | L310L (CTG→CTA) | cstA → | carbon starvation protein |
RA | 385,723 | C→T | 41.0% | T311T (ACC→ACT) | cstA → | carbon starvation protein |
RA | 386,498 | T→C | 45.3% | L570L (TTG→CTG) | cstA → | carbon starvation protein |
RA | 388,228 | C→T | 35.9% | A49A (GCG→GCA) | ybdH ← | predicted oxidoreductase |
RA | 388,248 | T→C | 47.1% | K43E (AAA→GAA) | ybdH ← | predicted oxidoreductase |
RA | 389,175 | T→G | 45.7% | V231V (GTT→GTG) | ybdL → | methionine aminotransferase, PLP‑dependent |
RA | 389,178 | T→A | 38.9% | S232S (TCT→TCA) | ybdL → | methionine aminotransferase, PLP‑dependent |
RA | 389,181 | A→G | 35.0% | S233S (TCA→TCG) | ybdL → | methionine aminotransferase, PLP‑dependent |
RA | 389,226 | T→C | 45.3% | C248C (TGT→TGC) | ybdL → | methionine aminotransferase, PLP‑dependent |
RA | 389,235 | A→T | 37.0% | P251P (CCA→CCT) | ybdL → | methionine aminotransferase, PLP‑dependent |
RA | 389,409 | C→T | 49.2% | S309S (AGC→AGT) | ybdL → | methionine aminotransferase, PLP‑dependent |
RA | 389,430 | T→C | 52.5% | C316C (TGT→TGC) | ybdL → | methionine aminotransferase, PLP‑dependent |
RA | 390,449 | T→C | 50.0% | I340V (ATC→GTC) | ybdN ← | conserved hypothetical protein |
RA | 390,450 | G→A | 50.0% | G339G (GGC→GGT) | ybdN ← | conserved hypothetical protein |
RA | 390,468 | G→A | 37.6% | H333H (CAC→CAT) | ybdN ← | conserved hypothetical protein |
RA | 390,474 | A→G | 31.4% | Y331Y (TAT→TAC) | ybdN ← | conserved hypothetical protein |
RA | 390,483 | G→A | 21.8% | I328I (ATC→ATT) | ybdN ← | conserved hypothetical protein |
RA | 395,051 | C→T | 20.8% | D134D (GAC→GAT) | ahpF → | alkyl hydroperoxide reductase, F52a subunit, FAD/NAD(P)‑binding |
RA | 395,912 | C→T | 46.5% | G421G (GGC→GGT) | ahpF → | alkyl hydroperoxide reductase, F52a subunit, FAD/NAD(P)‑binding |
RA | 395,924 | T→A | 57.0% | V425V (GTT→GTA) | ahpF → | alkyl hydroperoxide reductase, F52a subunit, FAD/NAD(P)‑binding |
RA | 396,089 | G→C | 39.1% | V480V (GTG→GTC) | ahpF → | alkyl hydroperoxide reductase, F52a subunit, FAD/NAD(P)‑binding |
RA | 400,786 | A→C | 46.6% | G250G (GGT→GGG) | dacA ← | D‑alanyl‑D‑alanine carboxypeptidase |
RA | 401,428 | A→G | 24.6% | T36T (ACT→ACC) | dacA ← | D‑alanyl‑D‑alanine carboxypeptidase |
RA | 402,421 | C→T | 27.9% | P114P (CCG→CCA) | rlpA ← | minor lipoprotein |
RA | 402,439 | T→C | 31.3% | A108A (GCA→GCG) | rlpA ← | minor lipoprotein |
RA | 405,082 | A→G | 11.9% | I236I (ATT→ATC) | mrdA ← | transpeptidase involved in peptidoglycan synthesis |
RA | 407,006 | G→A | 40.6% | A158A (GCC→GCT) | cobC ← | predicted alpha‑ribazole‑5'‑P phosphatase |
RA | 407,009 | G→A | 40.6% | I157I (ATC→ATT) | cobC ← | predicted alpha‑ribazole‑5'‑P phosphatase |
RA | 407,027 | A→G | 49.5% | G151G (GGT→GGC) | cobC ← | predicted alpha‑ribazole‑5'‑P phosphatase |
RA | 407,336 | A→G | 24.0% | D48D (GAT→GAC) | cobC ← | predicted alpha‑ribazole‑5'‑P phosphatase |
RA | 407,349 | C→T | 22.4% | G44D (GGT→GAT) | cobC ← | predicted alpha‑ribazole‑5'‑P phosphatase |
RA | 410,370 | A→G | 60.9% | G662G (GGT→GGC) | leuS ← | leucyl‑tRNA synthetase |
RA | 412,305 | A→G | 24.0% | H17H (CAT→CAC) | leuS ← | leucyl‑tRNA synthetase |
RA | 412,911 | T→C | 61.5% | Q424Q (CAA→CAG) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 413,091 | C→T | 64.6% | S364S (TCG→TCA) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 413,094 | C→A | 63.6% | S363S (TCG→TCT) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 413,105 | G→A | 50.0% | L360L (CTG→TTG) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 413,265 | C→T | 27.9% | K306K (AAG→AAA) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 413,316 | A→G | 100% | R289R (CGT→CGC) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 413,643 | A→G | 46.3% | S180S (AGT→AGC) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 413,751 | G→T | 51.6% | T144T (ACC→ACA) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 413,754 | C→T | 40.9% | L143L (CTG→CTA) | lnt ← | apolipoprotein N‑acyltransferase |
RA | 414,378 | G→A | 17.6% | V236V (GTC→GTT) | ybeX ← | predicteed ion transport |
RA | 414,381 | T→C | 17.2% | E235E (GAA→GAG) | ybeX ← | predicteed ion transport |
RA | 414,813 | A→G | 42.8% | C91C (TGT→TGC) | ybeX ← | predicteed ion transport |
RA | 417,078 | C→T | 46.1% | S393S (TCG→TCA) | miaB ← | isopentenyl‑adenosine A37 tRNA methylthiolase |
RA | 417,081 | T→A | 46.1% | T392T (ACA→ACT) | miaB ← | isopentenyl‑adenosine A37 tRNA methylthiolase |
RA | 417,084 | A→C | 36.8% | G391G (GGT→GGG) | miaB ← | isopentenyl‑adenosine A37 tRNA methylthiolase |
RA | 418,711 | C→T | 50.0% | L104L (CTG→TTG) | ubiF → | 2‑octaprenyl‑3‑methyl‑6‑methoxy‑1,4‑benzoquinol oxygenase |
RA | 418,722 | T→C | 77.4% | Y107Y (TAT→TAC) | ubiF → | 2‑octaprenyl‑3‑methyl‑6‑methoxy‑1,4‑benzoquinol oxygenase |
RA | 418,848 | G→A | 59.2% | E149E (GAG→GAA) | ubiF → | 2‑octaprenyl‑3‑methyl‑6‑methoxy‑1,4‑benzoquinol oxygenase |
RA | 418,917 | G→A | 55.6% | R172R (CGG→CGA) | ubiF → | 2‑octaprenyl‑3‑methyl‑6‑methoxy‑1,4‑benzoquinol oxygenase |
RA | 421,648 | A→G | 14.4% | G277G (GGT→GGC) | asnB ← | asparagine synthetase B |
RA | 422,899 | T→C | 51.9% | S243S (TCA→TCG) | nagD ← | UMP phosphatase |
RA | 422,902 | C→T | 52.2% | P242P (CCG→CCA) | nagD ← | UMP phosphatase |
RA | 422,914 | G→A | 52.2% | S238S (AGC→AGT) | nagD ← | UMP phosphatase |
RA | 422,917 | G→T | 51.7% | P237P (CCC→CCA) | nagD ← | UMP phosphatase |
RA | 422,926 | A→C | 46.1% | P234P (CCT→CCG) | nagD ← | UMP phosphatase |
RA | 423,196 | A→G | 100% | N144N (AAT→AAC) | nagD ← | UMP phosphatase |
RA | 423,211 | A→G | 100% | R139R (CGT→CGC) | nagD ← | UMP phosphatase |
RA | 423,289 | G→A | 55.1% | F113F (TTC→TTT) | nagD ← | UMP phosphatase |
RA | 423,948 | C→T | 44.4% | E316E (GAG→GAA) | nagC ← | DNA‑binding transcriptional dual regulator |
RA | 424,830 | C→T | 32.4% | A22A (GCG→GCA) | nagC ← | DNA‑binding transcriptional dual regulator |
RA | 424,941 | T→C | 27.9% | K371R (AAG→AGG) | nagA ← | N‑acetylglucosamine‑6‑phosphate deacetylase |
RA | 425,081 | G→A | 60.6% | C324C (TGC→TGT) | nagA ← | N‑acetylglucosamine‑6‑phosphate deacetylase |
RA | 426,121 | T→C | 30.0% | K264K (AAA→AAG) | nagB ← | glucosamine‑6‑phosphate deaminase |
RA | 428,765 | T→G | 38.1% | G507G (GGT→GGG) | nagE → | fused N‑acetyl glucosamine specific PTS enzyme IICBA components |
RA | 428,771 | C→T | 31.5% | V509V (GTC→GTT) | nagE → | fused N‑acetyl glucosamine specific PTS enzyme IICBA components |
RA | 429,630 | T→C | 61.6% | V79V (GTT→GTC) | glnS → | glutamyl‑tRNA synthetase |
RA | 429,633 | G→T | 60.6% | E80D (GAG→GAT) | glnS → | glutamyl‑tRNA synthetase |
RA | 429,921 | A→G | 36.3% | K176K (AAA→AAG) | glnS → | glutamyl‑tRNA synthetase |
RA | 429,936 | A→G | 38.0% | S181S (TCA→TCG) | glnS → | glutamyl‑tRNA synthetase |
RA | 432,675 | T→C | 55.0% | S347S (TCT→TCC) | ybfM → | predicted outer membrane porin |
RA | 434,130 | C→T | 39.9% | intergenic (‑183/+106) | fur ← / ← fldA | DNA‑binding transcriptional dual regulator/flavodoxin 1 |
RA | 435,077 | C→T | 28.7% | Q41Q (CAG→CAA) | ybfE ← | LexA regulated protein |
RA | 435,104 | T→C | 59.2% | E32E (GAA→GAG) | ybfE ← | LexA regulated protein |
RA | 435,666 | T→C | 55.0% | A146A (GCA→GCG) | ybfF ← | conserved hypothetical protein |
RA | 435,681 | A→T | 61.3% | T141T (ACT→ACA) | ybfF ← | conserved hypothetical protein |
RA | 435,693 | C→T | 54.7% | S137S (TCG→TCA) | ybfF ← | conserved hypothetical protein |
RA | 435,813 | T→A | 34.6% | A97A (GCA→GCT) | ybfF ← | conserved hypothetical protein |
RA | 435,831 | G→A | 38.3% | G91G (GGC→GGT) | ybfF ← | conserved hypothetical protein |
RA | 437,386 | G→A | 48.0% | R176R (AGG→AGA) | pgm → | phosphoglucomutase |
RA | 438,503 | C→T | 28.9% | intergenic (+4/‑210) | pgm → / → ybfP | phosphoglucomutase/hypothetical protein |
RA | 438,506 | T→C | 28.9% | intergenic (+7/‑207) | pgm → / → ybfP | phosphoglucomutase/hypothetical protein |
RA | 438,507 | T→A | 31.1% | intergenic (+8/‑206) | pgm → / → ybfP | phosphoglucomutase/hypothetical protein |
RA | 441,066 | A→G | 70.7% | I167I (ATT→ATC) | potE ← | putrescine/proton symporter |
RA | 441,078 | A→G | 62.6% | G163G (GGT→GGC) | potE ← | putrescine/proton symporter |
RA | 441,081 | G→T | 52.3% | V162V (GTC→GTA) | potE ← | putrescine/proton symporter |
RA | 441,084 | G→C | 52.4% | V161V (GTC→GTG) | potE ← | putrescine/proton symporter |
RA | 442,546 | T→C | 73.3% | N406D (AAT→GAT) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,078 | G→A | 28.9% | H228H (CAC→CAT) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,087 | T→C | 30.4% | K225K (AAA→AAG) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,090 | G→A | 32.8% | H224H (CAC→CAT) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,102 | A→G | 32.9% | D220D (GAT→GAC) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,210 | T→A | 19.6% | A184A (GCA→GCT) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,240 | G→A | 26.1% | G174G (GGC→GGT) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,246 | G→A | 22.6% | H172H (CAC→CAT) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,255 | C→A | 30.5% | L169L (CTG→CTT) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 443,261 | G→A | 24.8% | G167G (GGC→GGT) | speF ← | ornithine decarboxylase isozyme, inducible |
RA | 445,418 | T→C | 100% | E766E (GAA→GAG) | kdpD ← | fused sensory histidine kinase in two‑component regulatory system with KdpE |
RA | 445,484 | T→C | 56.1% | V744V (GTA→GTG) | kdpD ← | fused sensory histidine kinase in two‑component regulatory system with KdpE |
RA | 447,521 | T→C | 54.8% | R65R (CGA→CGG) | kdpD ← | fused sensory histidine kinase in two‑component regulatory system with KdpE |
RA | 447,524 | C→A | 49.8% | G64G (GGG→GGT) | kdpD ← | fused sensory histidine kinase in two‑component regulatory system with KdpE |
RA | 449,111 | A→G | 100% | G409G (GGT→GGC) | kdpB ← | potassium translocating ATPase, subunit B |
RA | 449,567 | C→T | 48.5% | A257A (GCG→GCA) | kdpB ← | potassium translocating ATPase, subunit B |
RA | 449,666 | C→G | 70.2% | L224L (CTG→CTC) | kdpB ← | potassium translocating ATPase, subunit B |
RA | 450,085 | G→A | 63.3% | L85L (CTG→TTG) | kdpB ← | potassium translocating ATPase, subunit B |
RA | 451,488 | C→T | 21.8% | A182A (GCG→GCA) | kdpA ← | potassium translocating ATPase, subunit A |
RA | 451,498 | A→G | 27.5% | V179A (GTC→GCC) | kdpA ← | potassium translocating ATPase, subunit A |
RA | 451,502 | G→A | 29.6% | L178L (CTA→TTA) | kdpA ← | potassium translocating ATPase, subunit A |
RA | 451,698 | A→G | 42.4% | N112N (AAT→AAC) | kdpA ← | potassium translocating ATPase, subunit A |
RA | 451,701 | G→A | 40.2% | T111T (ACC→ACT) | kdpA ← | potassium translocating ATPase, subunit A |
RA | 451,725 | C→G | 30.9% | L103L (CTG→CTC) | kdpA ← | potassium translocating ATPase, subunit A |
RA | 452,550 | G→A | 34.3% | R172H (CGC→CAC) | phr → | deoxyribodipyrimidine photolyase, FAD‑binding |
RA | 452,584 | T→G | 26.8% | P183P (CCT→CCG) | phr → | deoxyribodipyrimidine photolyase, FAD‑binding |
RA | 454,239 | G→T | 54.7% | A282A (GCC→GCA) | ybgH ← | predicted transporter |
RA | 454,254 | A→G | 75.8% | S277S (AGT→AGC) | ybgH ← | predicted transporter |
RA | 454,269 | C→G | 66.7% | T272T (ACG→ACC) | ybgH ← | predicted transporter |
RA | 454,272 | C→A | 68.1% | V271V (GTG→GTT) | ybgH ← | predicted transporter |
RA | 454,293 | C→A | 64.8% | R264R (CGG→CGT) | ybgH ← | predicted transporter |
RA | 454,397 | G→A | 59.3% | L230L (CTG→TTG) | ybgH ← | predicted transporter |
RA | 454,398 | T→C | 59.3% | I229M (ATA→ATG) ‡ | ybgH ← | predicted transporter |
RA | 454,400 | T→C | 59.3% | I229V (ATA→GTA) ‡ | ybgH ← | predicted transporter |
RA | 454,683 | C→T | 30.3% | P134P (CCG→CCA) | ybgH ← | predicted transporter |
RA | 460,885 | A→G | 28.0% | D13D (GAT→GAC) | gltA ← | citrate synthase |
RA | 461,006 | T→G | 100% | intergenic (‑83/‑626) | gltA ← / → sdhC | citrate synthase/succinate dehydrogenase, membrane subunit, binds cytochrome b556 |
RA | 464,227 | T→A | 41.5% | D28E (GAT→GAA) | sdhB → | succinate dehydrogenase, FeS subunit |
RA | 464,263 | C→T | 36.4% | I40I (ATC→ATT) | sdhB → | succinate dehydrogenase, FeS subunit |
RA | 464,269 | A→G | 40.9% | L42L (CTA→CTG) | sdhB → | succinate dehydrogenase, FeS subunit |
RA | 464,737 | T→C | 40.8% | S198S (AGT→AGC) | sdhB → | succinate dehydrogenase, FeS subunit |
RA | 464,749 | C→T | 54.2% | S202S (AGC→AGT) | sdhB → | succinate dehydrogenase, FeS subunit |
RA | 465,500 | C→T | 34.7% | L114L (CTG→TTG) | sucA → | 2‑oxoglutarate decarboxylase, thiamin‑requiring |
RA | 466,055 | A→T | 62.5% | M299L (ATG→TTG) | sucA → | 2‑oxoglutarate decarboxylase, thiamin‑requiring |
RA | 466,096 | G→T | 58.2% | V312V (GTG→GTT) | sucA → | 2‑oxoglutarate decarboxylase, thiamin‑requiring |
RA | 467,413 | G→T | 49.3% | P751P (CCG→CCT) | sucA → | 2‑oxoglutarate decarboxylase, thiamin‑requiring |
RA | 468,885 | A→T | 26.2% | A303A (GCA→GCT) | sucB → | dihydrolipoyltranssuccinase |
RA | 468,888 | C→T | 26.1% | V304V (GTC→GTT) | sucB → | dihydrolipoyltranssuccinase |
RA | 468,912 | C→G | 35.3% | T312T (ACC→ACG) | sucB → | dihydrolipoyltranssuccinase |
RA | 471,372 | C→T | 56.0% | G246G (GGC→GGT) | sucD → | succinyl‑CoA synthetase, NAD(P)‑binding, alpha subunit |
RA | 471,378 | G→A | 54.9% | A248A (GCG→GCA) | sucD → | succinyl‑CoA synthetase, NAD(P)‑binding, alpha subunit |
RA | 471,384 | C→G | 57.1% | A250A (GCC→GCG) | sucD → | succinyl‑CoA synthetase, NAD(P)‑binding, alpha subunit |
RA | 471,399 | G→T | 53.8% | G255G (GGG→GGT) | sucD → | succinyl‑CoA synthetase, NAD(P)‑binding, alpha subunit |
RA | 478,602 | T→C | 74.7% | A230A (GCT→GCC) | cydA → | cytochrome d terminal oxidase, subunit I |
RA | 479,895 | A→G | 41.2% | V133V (GTA→GTG) | cydB → | cytochrome d terminal oxidase, subunit II |
RA | 479,986 | T→C | 16.9% | L164L (TTG→CTG) | cydB → | cytochrome d terminal oxidase, subunit II |
RA | 480,138 | T→C | 62.0% | C214C (TGT→TGC) | cydB → | cytochrome d terminal oxidase, subunit II |
RA | 481,239 | C→T | 49.3% | R11R (CGC→CGT) | ybgC → | predicted acyl‑CoA thioesterase |
RA | 481,958 | C→T | 40.6% | N117N (AAC→AAT) | tolQ → | membrane spanning protein in TolA‑TolQ‑TolR complex |
RA | 484,644 | T→C | 54.7% | D150D (GAT→GAC) | tolB → | periplasmic protein |
RA | 484,650 | G→A | 66.1% | V152V (GTG→GTA) | tolB → | periplasmic protein |
RA | 484,668 | C→T | 40.3% | G158G (GGC→GGT) | tolB → | periplasmic protein |
RA | 484,794 | G→A | 62.2% | Q200Q (CAG→CAA) | tolB → | periplasmic protein |
RA | 484,995 | T→C | 73.4% | S267S (AGT→AGC) | tolB → | periplasmic protein |
RA | 485,250 | T→C | 41.5% | N352N (AAT→AAC) | tolB → | periplasmic protein |
RA | 490,274 | G→C | 34.4% | A218A (GCG→GCC) | pnuC → | predicted nicotinamide mononucleotide transporter |
RA | 491,553 | A→G | 41.1% | S74P (TCG→CCG) | ybgS ← | conserved hypothetical protein |
RA | 493,466 | A→G | 22.5% | L195L (CTT→CTC) | gpmA ← | phosphoglyceromutase 1 |
RA | 494,552 | T→C | 51.7% | A247A (GCA→GCG) | galM ← | galactose‑1‑epimerase |
RA | 494,622 | C→T | 41.4% | S224N (AGC→AAC) | galM ← | galactose‑1‑epimerase |
RA | 494,741 | C→T | 50.5% | Q184Q (CAG→CAA) | galM ← | galactose‑1‑epimerase |
RA | 497,197 | C→T | 100% | L96L (CTG→CTA) | galT ← | galactose‑1‑phosphate uridylyltransferase |
RA | 498,623 | T→A | 46.8% | intergenic (‑113/+148) | galE ← / ← modF | UDP‑galactose‑4‑epimerase/fused subunits of molybdate transporter and ATP‑binding components of ABC superfamily |
RA | 498,627 | C→T | 51.0% | intergenic (‑117/+144) | galE ← / ← modF | UDP‑galactose‑4‑epimerase/fused subunits of molybdate transporter and ATP‑binding components of ABC superfamily |
RA | 498,918 | A→C | 26.6% | R442R (CGT→CGG) | modF ← | fused subunits of molybdate transporter and ATP‑binding components of ABC superfamily |
RA | 498,939 | C→G | 37.5% | L435L (CTG→CTC) | modF ← | fused subunits of molybdate transporter and ATP‑binding components of ABC superfamily |
RA | 499,428 | A→T | 30.7% | D272E (GAT→GAA) | modF ← | fused subunits of molybdate transporter and ATP‑binding components of ABC superfamily |
RA | 499,568 | C→T | 5.8% | A226T (GCA→ACA) | modF ← | fused subunits of molybdate transporter and ATP‑binding components of ABC superfamily |
RA | 501,960 | G→C | 40.0% | L139L (CTG→CTC) | modA → | molybdate transporter subunit |
RA | 501,969 | C→T | 39.2% | G142G (GGC→GGT) | modA → | molybdate transporter subunit |
RA | 501,984 | T→C | 46.0% | V147V (GTT→GTC) | modA → | molybdate transporter subunit |
RA | 501,987 | C→T | 43.3% | P148P (CCC→CCT) | modA → | molybdate transporter subunit |
RA | 503,377 | C→T | 40.2% | D123D (GAC→GAT) | modC → | molybdate transporter subunit |
RA | 504,034 | C→T | 70.1% | Y342Y (TAC→TAT) | modC → | molybdate transporter subunit |
RA | 504,079 | G→A | 33.2% | H270Y (CAC→TAC) | ybhA ← | predicted hydrolase |
RA | 505,334 | A→C | 45.6% | V98V (GTA→GTC) | ybhE → | 6‑phosphogluconolactonase |
RA | 508,902 | C→T | 44.5% | T187T (ACC→ACT) | ybhI → | predicted transporter |
RA | 511,079 | A→G | 59.2% | A374A (GCA→GCG) | ybhJ → | predicted hydratase |
RA | 511,646 | T→A | 44.9% | S563S (TCT→TCA) | ybhJ → | predicted hydratase |
RA | 511,682 | C→T | 38.7% | T575T (ACC→ACT) | ybhJ → | predicted hydratase |
RA | 511,688 | T→A | 33.2% | S577S (TCT→TCA) | ybhJ → | predicted hydratase |
RA | 511,700 | C→A | 29.3% | P581P (CCC→CCA) | ybhJ → | predicted hydratase |
RA | 511,757 | G→A | 43.1% | G600G (GGG→GGA) | ybhJ → | predicted hydratase |
RA | 512,180 | G→A | 51.3% | A741A (GCG→GCA) | ybhJ → | predicted hydratase |
RA | 512,666 | C→T | 47.0% | V357V (GTG→GTA) | ybhC ← | predicted pectinesterase |
RA | 515,011 | T→C | 46.5% | I234M (ATA→ATG) | bioA ← | 7,8‑diaminopelargonic acid synthase, PLP‑dependent |
RA | 516,305 | T→C | 100% | T169T (ACT→ACC) | bioB → | biotin synthase |
RA | 516,365 | T→A | 42.8% | S189S (TCT→TCA) | bioB → | biotin synthase |
RA | 520,562 | C→T | 32.3% | R194R (CGC→CGT) | uvrB → | excinulease of nucleotide excision repair, DNA damage recognition component |
RA | 520,580 | A→T | 35.6% | I200I (ATA→ATT) | uvrB → | excinulease of nucleotide excision repair, DNA damage recognition component |
RA | 521,195 | C→T | 31.1% | G405G (GGC→GGT) | uvrB → | excinulease of nucleotide excision repair, DNA damage recognition component |
RA | 521,228 | C→A | 40.5% | T416T (ACC→ACA) | uvrB → | excinulease of nucleotide excision repair, DNA damage recognition component |
RA | 521,231 | A→C | 37.8% | G417G (GGA→GGC) | uvrB → | excinulease of nucleotide excision repair, DNA damage recognition component |
RA | 521,234 | G→A | 36.3% | L418L (TTG→TTA) | uvrB → | excinulease of nucleotide excision repair, DNA damage recognition component |
RA | 521,237 | T→C | 36.3% | L419L (CTT→CTC) | uvrB → | excinulease of nucleotide excision repair, DNA damage recognition component |
RA | 521,525 | G→T | 65.3% | V515V (GTG→GTT) | uvrB → | excinulease of nucleotide excision repair, DNA damage recognition component |
RA | 522,599 | A→C | 45.6% | P168P (CCT→CCG) | ybhK ← | predicted transferase with NAD(P)‑binding Rossmann‑fold domain |
RA | 523,603 | C→T | 35.5% | G35G (GGC→GGT) | moaA → | molybdopterin biosynthesis protein A |
RA | 523,609 | A→G | 37.0% | K37K (AAA→AAG) | moaA → | molybdopterin biosynthesis protein A |
RA | 523,681 | A→T | 41.3% | R61S (AGA→AGT) | moaA → | molybdopterin biosynthesis protein A |
RA | 526,368 | C→T | 18.3% | I10I (ATC→ATT) | ybhL → | predicted inner membrane protein |
RA | 526,404 | T→G | 55.7% | A22A (GCT→GCG) | ybhL → | predicted inner membrane protein |
RA | 526,896 | G→T | 55.9% | T186T (ACG→ACT) | ybhL → | predicted inner membrane protein |
RA | 526,903 | C→T | 40.7% | L189L (CTG→TTG) | ybhL → | predicted inner membrane protein |
RA | 527,724 | G→A | 37.6% | R159R (CGG→CGA) | ybhM → | conserved inner membrane protein |
RA | 527,734 | A→G | 30.9% | I163V (ATA→GTA) | ybhM → | conserved inner membrane protein |
RA | 527,757 | G→C | 32.6% | V170V (GTG→GTC) | ybhM → | conserved inner membrane protein |
RA | 528,351 | T→C | 18.6% | S201S (TCA→TCG) | ybhN ← | conserved inner membrane protein |
RA | 528,660 | C→T | 36.1% | T98T (ACG→ACA) | ybhN ← | conserved inner membrane protein |
RA | 531,429 | A→G | 24.1% | V115V (GTA→GTG) | ybhQ → | predicted inner membrane protein |
RA | 531,622 | G→A | 34.0% | N314N (AAC→AAT) | ybhR ← | predicted transporter subunit |
RA | 534,192 | A→G | 51.3% | G415G (GGT→GGC) | ybhF ← | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 535,693 | A→G | 54.2% | A245A (GCT→GCC) | ybhG ← | predicted membrane fusion protein (MFP) component of efflux pump, membrane anchor |
RA | 535,699 | C→T | 57.8% | V243V (GTG→GTA) | ybhG ← | predicted membrane fusion protein (MFP) component of efflux pump, membrane anchor |
RA | 535,717 | T→C | 57.2% | L237L (CTA→CTG) | ybhG ← | predicted membrane fusion protein (MFP) component of efflux pump, membrane anchor |
RA | 535,720 | T→C | 50.6% | S236S (TCA→TCG) | ybhG ← | predicted membrane fusion protein (MFP) component of efflux pump, membrane anchor |
RA | 535,723 | A→G | 50.0% | V235V (GTT→GTC) | ybhG ← | predicted membrane fusion protein (MFP) component of efflux pump, membrane anchor |
RA | 535,732 | C→T | 41.8% | V232V (GTG→GTA) | ybhG ← | predicted membrane fusion protein (MFP) component of efflux pump, membrane anchor |
RA | 539,201 | T→C | 68.4% | intergenic (+510/+124) | rhlE → / ← dps | RNA helicase/Fe‑binding and storage protein |
RA | 540,292 | C→T | 34.6% | L241L (CTG→CTA) | rhtA ← | threonine and homoserine efflux system |
RA | 540,307 | C→G | 45.4% | R236R (CGG→CGC) | rhtA ← | threonine and homoserine efflux system |
RA | 542,507 | G→C | 46.3% | T336T (ACC→ACG) | ybiP ← | predicted hydrolase, inner membrane |
RA | 544,210 | T→G | 34.4% | L37L (CTT→CTG) | mntR → | transcriptional regulator of mntH |
RA | 545,274 | A→G | 28.1% | A237A (GCA→GCG) | ybiR → | predicted transporter |
RA | 545,280 | C→T | 27.7% | R239R (CGC→CGT) | ybiR → | predicted transporter |
RA | 547,030 | C→T | 50.0% | L51F (CTT→TTT) ‡ | ybiT → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 547,032 | T→A | 46.4% | L51L (CTT→CTA) ‡ | ybiT → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 547,042 | C→T | 44.0% | L55L (CTG→TTG) | ybiT → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 547,857 | C→T | 74.5% | T326T (ACC→ACT) | ybiT → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 548,040 | T→C | 43.5% | Y387Y (TAT→TAC) | ybiT → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 548,043 | T→C | 37.7% | A388A (GCT→GCC) | ybiT → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 548,052 | C→T | 36.7% | H391H (CAC→CAT) | ybiT → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 551,567 | C→T | 30.6% | V653I (GTT→ATT) | ybiW ← | predicted pyruvate formate lyase |
RA | 551,589 | A→G | 34.1% | N645N (AAT→AAC) | ybiW ← | predicted pyruvate formate lyase |
RA | 551,601 | T→C | 37.0% | K641K (AAA→AAG) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,051 | T→C | 53.1% | A491A (GCA→GCG) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,054 | C→T | 53.0% | S490S (TCG→TCA) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,606 | C→T | 26.5% | T306T (ACG→ACA) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,615 | G→C | 27.6% | L303L (CTC→CTG) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,627 | G→A | 36.6% | R299R (CGC→CGT) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,639 | C→T | 58.4% | P295P (CCG→CCA) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,642 | G→A | 64.5% | Y294Y (TAC→TAT) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,675 | T→C | 42.6% | S283S (TCA→TCG) | ybiW ← | predicted pyruvate formate lyase |
RA | 552,723 | C→T | 29.4% | L267L (CTG→CTA) | ybiW ← | predicted pyruvate formate lyase |
RA | 553,997 | T→C | 40.9% | L153L (CTA→CTG) | ybiY ← | predicted pyruvate formate lyase activating enzyme |
RA | 554,004 | A→G | 47.4% | M151T (ATG→ACG) | ybiY ← | predicted pyruvate formate lyase activating enzyme |
RA | 554,030 | C→T | 54.5% | E142E (GAG→GAA) | ybiY ← | predicted pyruvate formate lyase activating enzyme |
RA | 554,036 | A→G | 62.2% | G140G (GGT→GGC) | ybiY ← | predicted pyruvate formate lyase activating enzyme |
RA | 554,039 | C→A | 46.1% | S139S (TCG→TCT) | ybiY ← | predicted pyruvate formate lyase activating enzyme |
RA | 555,416 | T→G | 30.9% | M211L (ATG→CTG) | moeB ← | molybdopterin synthase sulfurylase |
RA | 555,561 | G→C | 33.9% | T162T (ACC→ACG) | moeB ← | molybdopterin synthase sulfurylase |
RA | 555,570 | A→C | 37.0% | G159G (GGT→GGG) | moeB ← | molybdopterin synthase sulfurylase |
RA | 556,511 | C→T | 42.0% | E257E (GAG→GAA) | moeA ← | molybdopterin biosynthesis protein |
RA | 557,423 | A→C | 18.2% | intergenic (‑142/‑62) | moeA ← / → iaaA | molybdopterin biosynthesis protein/L‑asparaginase |
RA | 559,806 | C→G | 46.8% | A351A (GCC→GCG) | cmr → | multidrug efflux system protein |
RA | 559,815 | A→G | 61.8% | G354G (GGA→GGG) | cmr → | multidrug efflux system protein |
RA | 559,842 | T→C | 67.6% | V363V (GTT→GTC) | cmr → | multidrug efflux system protein |
RA | 560,690 | A→G | 29.8% | S175P (TCG→CCG) | ybjI ← | conserved hypothetical protein |
RA | 560,691 | C→T | 29.7% | V174V (GTG→GTA) | ybjI ← | conserved hypothetical protein |
RA | 560,697 | A→G | 34.1% | I172I (ATT→ATC) | ybjI ← | conserved hypothetical protein |
RA | 561,090 | T→C | 12.7% | V41V (GTA→GTG) | ybjI ← | conserved hypothetical protein |
RA | 561,102 | T→G | 11.7% | G37G (GGA→GGC) | ybjI ← | conserved hypothetical protein |
RA | 563,953 | A→G | 22.2% | G316G (GGT→GGC) | ybjL ← | predicted transporter |
RA | 563,956 | T→C | 23.0% | V315V (GTA→GTG) | ybjL ← | predicted transporter |
RA | 563,959 | A→G | 22.8% | A314A (GCT→GCC) | ybjL ← | predicted transporter |
RA | 564,523 | T→A | 25.6% | A126A (GCA→GCT) | ybjL ← | predicted transporter |
RA | 566,936 | T→C | 78.2% | L271L (CTA→CTG) | poxB ← | pyruvate dehydrogenase (pyruvate oxidase), thiamin‑dependent, FAD‑binding |
RA | 566,948 | G→A | 74.5% | D267D (GAC→GAT) | poxB ← | pyruvate dehydrogenase (pyruvate oxidase), thiamin‑dependent, FAD‑binding |
RA | 566,954 | G→A | 66.7% | N265N (AAC→AAT) | poxB ← | pyruvate dehydrogenase (pyruvate oxidase), thiamin‑dependent, FAD‑binding |
RA | 570,909 | A→G | 43.7% | S216S (TCT→TCC) | ybjE ← | predicted transporter |
RA | 571,477 | T→C | 35.5% | K27R (AAA→AGA) | ybjE ← | predicted transporter |
RA | 571,482 | C→T | 35.1% | A25A (GCG→GCA) | ybjE ← | predicted transporter |
RA | 572,195 | A→G | 33.3% | S184S (TCT→TCC) | aqpZ ← | aquaporin |
RA | 572,219 | A→G | 45.7% | I176I (ATT→ATC) | aqpZ ← | aquaporin |
RA | 572,252 | A→G | 29.5% | A165A (GCT→GCC) | aqpZ ← | aquaporin |
RA | 572,255 | G→A | 26.1% | I164I (ATC→ATT) | aqpZ ← | aquaporin |
RA | 572,826 | A→G | 61.1% | intergenic (‑80/‑346) | aqpZ ← / → ybjD | aquaporin/conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 573,489 | C→T | 100% | G106G (GGC→GGT) | ybjD → | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 577,604 | C→T | 56.9% | L187L (CTG→TTG) | macB → | fused macrolide transporter subunits and ATP‑binding component and membrane component of ABC superfamily |
RA | 577,624 | T→C | 64.0% | R193R (CGT→CGC) | macB → | fused macrolide transporter subunits and ATP‑binding component and membrane component of ABC superfamily |
RA | 577,885 | T→A | 48.0% | I280I (ATT→ATA) | macB → | fused macrolide transporter subunits and ATP‑binding component and membrane component of ABC superfamily |
RA | 579,722 | C→T | 22.3% | Y37Y (TAC→TAT) | clpS → | regulatory protein for ClpA substrate specificity |
RA | 581,798 | T→C | 44.4% | T612T (ACT→ACC) | clpA → | ATPase and specificity subunit of ClpA‑ClpP ATP‑dependent serine protease, chaperone activity |
RA | 581,912 | T→C | 36.1% | F650F (TTT→TTC) | clpA → | ATPase and specificity subunit of ClpA‑ClpP ATP‑dependent serine protease, chaperone activity |
RA | 584,788 | T→A | 66.7% | I369I (ATA→ATT) | cydC ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 584,816 | G→T | 60.4% | S360Y (TCT→TAT) | cydC ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 584,839 | A→G | 38.2% | S352S (TCT→TCC) | cydC ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 584,875 | C→T | 37.0% | T340T (ACG→ACA) | cydC ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 584,917 | A→G | 55.9% | F326F (TTT→TTC) | cydC ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 584,926 | C→T | 64.6% | E323E (GAG→GAA) | cydC ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 584,947 | G→A | 46.8% | D316D (GAC→GAT) | cydC ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 585,997 | A→T | 37.0% | V555V (GTT→GTA) | cydD ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 586,692 | G→A | 59.2% | L324L (CTG→TTG) | cydD ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 586,705 | G→A | 65.9% | G319G (GGC→GGT) | cydD ← | fused cysteine transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 591,494 | A→G | 23.1% | P524P (CCA→CCG) | ftsK → | DNA‑binding membrane protein required for chromosome resolution and partitioning |
RA | 593,672 | C→T | 50.0% | S1250S (AGC→AGT) | ftsK → | DNA‑binding membrane protein required for chromosome resolution and partitioning |
RA | 593,687 | T→C | 41.8% | G1255G (GGT→GGC) | ftsK → | DNA‑binding membrane protein required for chromosome resolution and partitioning |
RA | 593,689 | C→T | 43.8% | A1256V (GCG→GTG) | ftsK → | DNA‑binding membrane protein required for chromosome resolution and partitioning |
RA | 594,043 | C→T | 54.1% | intergenic (+131/‑25) | ftsK → / → lolA | DNA‑binding membrane protein required for chromosome resolution and partitioning/chaperone for lipoproteins |
RA | 596,595 | C→T | 42.3% | L157L (CTG→TTG) | serS → | seryl‑tRNA synthetase, also charges selenocysteinyl‑tRNA with serine |
RA | 596,924 | C→T | 17.7% | C266C (TGC→TGT) | serS → | seryl‑tRNA synthetase, also charges selenocysteinyl‑tRNA with serine |
RA | 597,053 | T→C | 46.6% | T309T (ACT→ACC) | serS → | seryl‑tRNA synthetase, also charges selenocysteinyl‑tRNA with serine |
RA | 597,062 | A→G | 36.8% | A312A (GCA→GCG) | serS → | seryl‑tRNA synthetase, also charges selenocysteinyl‑tRNA with serine |
RA | 597,078 | T→C | 33.7% | L318L (TTG→CTG) | serS → | seryl‑tRNA synthetase, also charges selenocysteinyl‑tRNA with serine |
RA | 597,305 | G→T | 37.0% | L393L (CTG→CTT) | serS → | seryl‑tRNA synthetase, also charges selenocysteinyl‑tRNA with serine |
RA | 597,804 | C→T | 52.7% | A49A (GCC→GCT) | dmsA → | dimethyl sulfoxide reductase, anaerobic, subunit A |
RA | 598,245 | C→T | 39.9% | G196G (GGC→GGT) | dmsA → | dimethyl sulfoxide reductase, anaerobic, subunit A |
RA | 598,260 | C→T | 41.0% | Y201Y (TAC→TAT) | dmsA → | dimethyl sulfoxide reductase, anaerobic, subunit A |
RA | 599,499 | C→T | 46.1% | R614R (CGC→CGT) | dmsA → | dimethyl sulfoxide reductase, anaerobic, subunit A |
RA | 599,895 | C→T | 25.9% | N746N (AAC→AAT) | dmsA → | dimethyl sulfoxide reductase, anaerobic, subunit A |
RA | 600,547 | T→C | 22.1% | C145C (TGT→TGC) | dmsB → | dimethyl sulfoxide reductase, anaerobic, subunit B |
RA | 600,553 | G→A | 28.4% | L147L (CTG→CTA) | dmsB → | dimethyl sulfoxide reductase, anaerobic, subunit B |
RA | 600,571 | C→A | 32.4% | G153G (GGC→GGA) | dmsB → | dimethyl sulfoxide reductase, anaerobic, subunit B |
RA | 600,640 | T→C | 40.7% | F176F (TTT→TTC) | dmsB → | dimethyl sulfoxide reductase, anaerobic, subunit B |
RA | 600,667 | C→T | 53.5% | P185P (CCC→CCT) | dmsB → | dimethyl sulfoxide reductase, anaerobic, subunit B |
RA | 600,670 | T→C | 53.5% | N186N (AAT→AAC) | dmsB → | dimethyl sulfoxide reductase, anaerobic, subunit B |
RA | 600,685 | G→A | 54.8% | P191P (CCG→CCA) | dmsB → | dimethyl sulfoxide reductase, anaerobic, subunit B |
RA | 601,089 | A→G | 53.1% | I120V (ATA→GTA) ‡ | dmsC → | dimethyl sulfoxide reductase, anaerobic, subunit C |
RA | 601,091 | A→G | 54.7% | I120M (ATA→ATG) ‡ | dmsC → | dimethyl sulfoxide reductase, anaerobic, subunit C |
RA | 601,112 | C→A | 49.2% | V127V (GTC→GTA) | dmsC → | dimethyl sulfoxide reductase, anaerobic, subunit C |
RA | 601,113 | A→G | 48.7% | I128V (ATC→GTC) | dmsC → | dimethyl sulfoxide reductase, anaerobic, subunit C |
RA | 601,323 | G→A | 100% | V198M (GTG→ATG) | dmsC → | dimethyl sulfoxide reductase, anaerobic, subunit C |
RA | 602,686 | C→T | 52.2% | S39S (TCC→TCT) | ycaD → | predicted transporter |
RA | 608,403 | C→A | 46.1% | T617T (ACG→ACT) | pflB ← | pyruvate formate lyase I |
RA | 608,544 | A→G | 29.7% | N570N (AAT→AAC) | pflB ← | pyruvate formate lyase I |
RA | 611,667 | C→T | 53.1% | P555P (CCG→CCA) | ycaO ← | conserved hypothetical protein |
RA | 611,675 | G→A | 50.0% | L553L (CTG→TTG) | ycaO ← | conserved hypothetical protein |
RA | 611,679 | G→A | 50.0% | Y551Y (TAC→TAT) | ycaO ← | conserved hypothetical protein |
RA | 612,948 | C→T | 31.1% | A128A (GCG→GCA) | ycaO ← | conserved hypothetical protein |
RA | 614,735 | G→T | 50.0% | L128L (CTG→CTT) | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 614,741 | G→A | 51.6% | A130A (GCG→GCA) | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 614,754 | C→A | 47.3% | R135S (CGT→AGT) | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 615,035 | T→C | 36.0% | Y228Y (TAT→TAC) | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 615,055 | G→A | 45.8% | G235D (GGC→GAC) ‡ | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 615,056 | C→T | 45.5% | G235G (GGC→GGT) ‡ | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 615,065 | T→C | 39.3% | F238F (TTT→TTC) | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 615,101 | T→C | 100% | G250G (GGT→GGC) | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 615,142 | A→C | 42.2% | E264A (GAA→GCA) | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 615,152 | A→G | 52.8% | K267K (AAA→AAG) | serC → | 3‑phosphoserine/phosphohydroxythreonine aminotransferase |
RA | 616,302 | T→C | 40.8% | G264G (GGT→GGC) | aroA → | 5‑enolpyruvylshikimate‑3‑phosphate synthetase |
RA | 616,311 | T→C | 48.2% | R267R (CGT→CGC) | aroA → | 5‑enolpyruvylshikimate‑3‑phosphate synthetase |
RA | 616,470 | G→C | 16.6% | T320T (ACG→ACC) | aroA → | 5‑enolpyruvylshikimate‑3‑phosphate synthetase |
RA | 617,155 | C→A | 42.4% | Q65K (CAA→AAA) | ycaL → | predicted peptidase with chaperone function |
RA | 617,160 | C→G | 41.6% | V66V (GTC→GTG) | ycaL → | predicted peptidase with chaperone function |
RA | 617,166 | T→C | 42.0% | S68S (AGT→AGC) | ycaL → | predicted peptidase with chaperone function |
RA | 617,184 | T→G | 42.7% | G74G (GGT→GGG) | ycaL → | predicted peptidase with chaperone function |
RA | 618,082 | A→G | 11.5% | V61V (GTA→GTG) | cmk → | cytidylate kinase |
RA | 619,623 | C→T | 33.5% | D310D (GAC→GAT) | rpsA → | 30S ribosomal subunit protein S1 |
RA | 619,840 | T→C | 56.7% | L383L (TTG→CTG) | rpsA → | 30S ribosomal subunit protein S1 |
RA | 621,170 | C→T | 41.0% | A51V (GCG→GTG) | ycaI → | conserved inner membrane protein |
RA | 622,463 | G→T | 28.5% | G482V (GGA→GTA) | ycaI → | conserved inner membrane protein |
RA | 626,032 | T→C | 55.8% | L323S (TTG→TCG) | lpxK → | lipid A 4'kinase |
RA | 626,245 | C→T | 30.8% | A53V (GCC→GTC) | ycaQ → | conserved hypothetical protein |
RA | 626,252 | T→C | 34.6% | S55S (AGT→AGC) | ycaQ → | conserved hypothetical protein |
RA | 626,273 | T→C | 31.6% | S62S (AGT→AGC) | ycaQ → | conserved hypothetical protein |
RA | 626,283 | A→G | 28.7% | N66D (AAT→GAT) | ycaQ → | conserved hypothetical protein |
RA | 626,915 | G→C | 65.4% | L276L (CTG→CTC) | ycaQ → | conserved hypothetical protein |
RA | 627,664 | T→C | 26.8% | R38R (CGT→CGC) | kdsB → | 3‑deoxy‑manno‑octulosonate cytidylyltransferase |
RA | 628,135 | C→T | 40.4% | Y195Y (TAC→TAT) | kdsB → | 3‑deoxy‑manno‑octulosonate cytidylyltransferase |
RA | 629,369 | A→G | 20.3% | R244R (CGT→CGC) | ycbC ← | conserved inner membrane protein |
RA | 632,854 | T→C | 41.0% | F169F (TTT→TTC) | mukE → | protein involved in chromosome partitioning |
RA | 634,576 | C→T | 46.5% | L518L (CTG→TTG) | mukB → | fused chromosome partitioning proteins |
RA | 634,587 | A→C | 42.9% | R521R (CGA→CGC) | mukB → | fused chromosome partitioning proteins |
RA | 636,105 | T→G | 33.3% | S1027S (TCT→TCG) | mukB → | fused chromosome partitioning proteins |
RA | 636,108 | C→T | 33.2% | Y1028Y (TAC→TAT) | mukB → | fused chromosome partitioning proteins |
RA | 636,129 | C→T | 35.8% | L1035L (CTC→CTT) | mukB → | fused chromosome partitioning proteins |
RA | 636,828 | T→C | 23.3% | G1268G (GGT→GGC) | mukB → | fused chromosome partitioning proteins |
RA | 636,843 | G→A | 37.9% | V1273V (GTG→GTA) | mukB → | fused chromosome partitioning proteins |
RA | 636,849 | C→G | 38.0% | L1275L (CTC→CTG) | mukB → | fused chromosome partitioning proteins |
RA | 636,861 | G→A | 37.9% | V1279V (GTG→GTA) | mukB → | fused chromosome partitioning proteins |
RA | 642,198 | T→G | 84.4% | I71L (ATC→CTC) | aspC ← | aspartate aminotransferase, PLP‑dependent |
RA | 643,235 | G→A | 22.6% | D149D (GAC→GAT) | ompF ← | outer membrane porin 1a (Ia;b;F) |
RA | 646,579 | C→T | 100% | A159A (GCG→GCA) | pncB ← | nicotinate phosphoribosyltransferase |
RA | 646,601 | C→T | 100% | S152N (AGC→AAC) | pncB ← | nicotinate phosphoribosyltransferase |
RA | 646,754 | G→A | 22.6% | S101F (TCC→TTC) | pncB ← | nicotinate phosphoribosyltransferase |
RA | 647,827 | C→T | 61.4% | N169N (AAC→AAT) | pepN → | aminopeptidase N |
RA | 647,833 | C→T | 79.7% | R171R (CGC→CGT) | pepN → | aminopeptidase N |
RA | 647,923 | T→C | 36.6% | F201F (TTT→TTC) | pepN → | aminopeptidase N |
RA | 647,926 | C→T | 36.5% | T202T (ACC→ACT) | pepN → | aminopeptidase N |
RA | 647,929 | G→C | 37.6% | T203T (ACG→ACC) | pepN → | aminopeptidase N |
RA | 647,932 | T→C | 37.6% | R204R (CGT→CGC) | pepN → | aminopeptidase N |
RA | 647,938 | T→C | 37.1% | G206G (GGT→GGC) | pepN → | aminopeptidase N |
RA | 647,941 | C→T | 37.0% | R207R (CGC→CGT) | pepN → | aminopeptidase N |
RA | 647,947 | A→G | 37.1% | V209V (GTA→GTG) | pepN → | aminopeptidase N |
RA | 647,950 | A→G | 45.6% | A210A (GCA→GCG) | pepN → | aminopeptidase N |
RA | 648,652 | T→C | 36.9% | G444G (GGT→GGC) | pepN → | aminopeptidase N |
RA | 648,655 | A→G | 36.9% | T445T (ACA→ACG) | pepN → | aminopeptidase N |
RA | 648,659 | A→G | 37.7% | I447V (ATT→GTT) | pepN → | aminopeptidase N |
RA | 649,279 | G→A | 48.4% | A653A (GCG→GCA) | pepN → | aminopeptidase N |
RA | 649,288 | A→G | 48.4% | L656L (CTA→CTG) | pepN → | aminopeptidase N |
RA | 650,405 | T→C | 69.0% | A113A (GCA→GCG) | ssuB ← | alkanesulfonate transporter subunit |
RA | 650,408 | G→C | 68.9% | A112A (GCC→GCG) | ssuB ← | alkanesulfonate transporter subunit |
RA | 663,694 | T→C | 51.2% | K202K (AAA→AAG) | ycbX ← | predicted 2Fe‑2S cluster‑containing protein |
RA | 663,712 | C→G | 34.9% | V196V (GTG→GTC) | ycbX ← | predicted 2Fe‑2S cluster‑containing protein |
RA | 666,009 | C→T | 36.3% | N489N (AAC→AAT) | ycbY → | predicted methyltransferase |
RA | 666,267 | A→G | 36.1% | E575E (GAA→GAG) | ycbY → | predicted methyltransferase |
RA | 667,181 | T→C | 36.5% | S173S (AGT→AGC) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,193 | G→A | 34.7% | V177V (GTG→GTA) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,194 | C→T | 32.3% | L178L (CTG→TTG) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,197 | T→C | 31.9% | L179L (TTG→CTG) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,202 | T→C | 31.9% | L180L (CTT→CTC) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,205 | T→C | 31.9% | D181D (GAT→GAC) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,214 | A→T | 38.7% | T184T (ACA→ACT) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,544 | A→G | 19.6% | E294E (GAA→GAG) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,565 | G→A | 30.3% | V301V (GTG→GTA) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 667,631 | A→G | 57.9% | E323E (GAA→GAG) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 668,000 | G→T | 45.3% | R446R (CGG→CGT) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 668,010 | C→T | 41.7% | L450L (CTG→TTG) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 668,013 | C→T | 41.7% | L451L (CTG→TTG) | uup → | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 669,695 | G→A | 31.2% | G332G (GGG→GGA) | pqiA → | paraquat‑inducible membrane protein A |
RA | 669,698 | T→C | 31.2% | H333H (CAT→CAC) | pqiA → | paraquat‑inducible membrane protein A |
RA | 673,313 | C→T | 30.5% | A562A (GCG→GCA) | ycbZ ← | predicted peptidase |
RA | 675,311 | T→A | 36.5% | V43E (GTG→GAG) | ycbG → | conserved hypothetical protein |
RA | 675,913 | A→G | 31.0% | S280S (TCT→TCC) | ompA ← | outer membrane protein A (3a;II*;G;d) |
RA | 675,925 | G→A | 32.4% | R276R (CGC→CGT) | ompA ← | outer membrane protein A (3a;II*;G;d) |
RA | 675,938 | C→G | 30.6% | G272A (GGT→GCT) | ompA ← | outer membrane protein A (3a;II*;G;d) |
RA | 676,082 | T→G | 74.5% | N224T (AAC→ACC) | ompA ← | outer membrane protein A (3a;II*;G;d) |
RA | 676,579 | A→T | 42.5% | A58A (GCT→GCA) | ompA ← | outer membrane protein A (3a;II*;G;d) |
RA | 676,582 | G→A | 43.0% | G57G (GGC→GGT) | ompA ← | outer membrane protein A (3a;II*;G;d) |
RA | 677,923 | C→T | 71.1% | G29G (GGC→GGT) | yccR → | conserved hypothetical protein |
RA | 677,935 | G→A | 48.7% | L33L (CTG→CTA) | yccR → | conserved hypothetical protein |
RA | 678,513 | T→C | 37.2% | G690G (GGA→GGG) | yccS ← | predicted inner membrane protein |
RA | 679,872 | C→T | 55.6% | T237T (ACG→ACA) | yccS ← | predicted inner membrane protein |
RA | 680,673 | A→G | 30.4% | V125V (GTT→GTC) | yccF ← | conserved inner membrane protein |
RA | 680,715 | G→A | 30.0% | G111G (GGC→GGT) | yccF ← | conserved inner membrane protein |
RA | 683,687 | C→A | 27.7% | A10S (GCG→TCG) | mgsA ← | methylglyoxal synthase |
RA | 686,819 | T→C | 30.1% | F19F (TTT→TTC) | yccX → | predicted acylphosphatase |
RA | 689,494 | A→G | 57.7% | R219R (AGA→AGG) | hyaA → | hydrogenase 1, small subunit |
RA | 689,507 | C→T | 54.0% | L224L (CTG→TTG) | hyaA → | hydrogenase 1, small subunit |
RA | 691,194 | G→A | 61.8% | A414A (GCG→GCA) | hyaB → | hydrogenase 1, large subunit |
RA | 693,202 | G→A | 27.8% | E50E (GAG→GAA) | hyaE → | protein involved in processing of HyaA and HyaB proteins |
RA | 693,657 | G→A | 49.2% | V70V (GTG→GTA) | hyaF → | protein involved in nickel incorporation into hydrogenase‑1 proteins |
RA | 694,020 | G→T | 24.0% | T191T (ACG→ACT) | hyaF → | protein involved in nickel incorporation into hydrogenase‑1 proteins |
RA | 694,038 | G→A | 24.2% | E197E (GAG→GAA) | hyaF → | protein involved in nickel incorporation into hydrogenase‑1 proteins |
RA | 694,044 | T→C | 32.5% | D199D (GAT→GAC) | hyaF → | protein involved in nickel incorporation into hydrogenase‑1 proteins |
RA | 697,873 | C→T | 28.1% | R186R (CGC→CGT) | appA → | phosphoanhydride phosphorylase |
RA | 709,461 | T→A | 41.3% | A138A (GCA→GCT) | yceJ ← | predicted cytochrome b561 |
RA | 709,728 | G→C | 36.8% | P49P (CCC→CCG) | yceJ ← | predicted cytochrome b561 |
RA | 709,734 | T→C | 36.7% | K47K (AAA→AAG) ‡ | yceJ ← | predicted cytochrome b561 |
RA | 709,736 | T→G | 39.0% | K47Q (AAA→CAA) ‡ | yceJ ← | predicted cytochrome b561 |
RA | 711,123 | T→C | 37.5% | T98A (ACA→GCA) | solA ← | N‑methyltryptophan oxidase, FAD‑binding |
RA | 711,127 | A→G | 29.0% | D96D (GAT→GAC) | solA ← | N‑methyltryptophan oxidase, FAD‑binding |
RA | 711,136 | G→A | 32.0% | G93G (GGC→GGT) | solA ← | N‑methyltryptophan oxidase, FAD‑binding |
RA | 711,139 | A→G | 27.6% | L92L (CTT→CTC) | solA ← | N‑methyltryptophan oxidase, FAD‑binding |
RA | 712,419 | C→T | 35.5% | G339G (GGG→GGA) | pyrC ← | dihydro‑orotase |
RA | 712,689 | A→T | 52.6% | G249G (GGT→GGA) | pyrC ← | dihydro‑orotase |
RA | 712,701 | T→A | 46.6% | R245R (CGA→CGT) | pyrC ← | dihydro‑orotase |
RA | 713,725 | T→C | 44.3% | E126G (GAA→GGA) | yceB ← | predicted lipoprotein |
RA | 715,819 | A→G | 28.9% | G112G (GGT→GGC) | mdtH ← | predicted drug efflux system |
RA | 715,831 | G→A | 38.6% | L108L (CTC→CTT) | mdtH ← | predicted drug efflux system |
RA | 716,482 | T→G | 35.2% | L31L (CTT→CTG) | rimJ → | ribosomal‑protein‑S5‑alanine N‑acetyltransferase |
RA | 719,284 | G→T | 53.9% | P206P (CCG→CCT) | mviN → | predicted inner membrane protein |
RA | 719,287 | C→T | 56.2% | H207H (CAC→CAT) | mviN → | predicted inner membrane protein |
RA | 719,311 | C→T | 43.5% | V215V (GTC→GTT) | mviN → | predicted inner membrane protein |
RA | 719,312 | C→T | 43.5% | L216L (CTG→TTG) | mviN → | predicted inner membrane protein |
RA | 719,317 | G→A | 42.8% | P217P (CCG→CCA) | mviN → | predicted inner membrane protein |
RA | 720,741 | A→G | 42.5% | V961A (GTC→GCC) | rne ← | fused ribonucleaseE endoribonuclease and scaffold for formation of degradosome |
RA | 722,240 | G→C | 54.4% | A461A (GCC→GCG) | rne ← | fused ribonucleaseE endoribonuclease and scaffold for formation of degradosome |
RA | 725,764 | T→G | 36.4% | P29P (CCA→CCC) | yceF ← | hypothetical protein |
RA | 728,538 | T→C | 38.8% | I175I (ATT→ATC) | fabH → | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase III |
RA | 728,565 | T→C | 31.8% | S184S (AGT→AGC) | fabH → | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase III |
RA | 728,790 | T→C | 29.0% | G259G (GGT→GGC) | fabH → | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase III |
RA | 728,796 | T→G | 27.4% | S261S (TCT→TCG) | fabH → | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase III |
RA | 728,802 | T→C | 28.3% | D263D (GAT→GAC) | fabH → | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase III |
RA | 732,551 | C→T | 45.3% | intergenic (+116/‑4) | fabF → / → pabC | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase II/4‑amino‑4‑deoxychorismate lyase component of para‑aminobenzoate synthase multienzyme complex |
RA | 734,426 | A→G | 8.1% | K16K (AAA→AAG) | tmk → | thymidylate kinase |
RA | 739,219 | C→T | 29.5% | A530T (GCT→ACT) | fhuE ← | ferric‑rhodotorulic acid outer membrane transporter |
RA | 740,069 | C→G | 34.0% | S246S (TCG→TCC) | fhuE ← | ferric‑rhodotorulic acid outer membrane transporter |
RA | 740,600 | G→T | 57.4% | T69T (ACC→ACA) | fhuE ← | ferric‑rhodotorulic acid outer membrane transporter |
RA | 740,625 | C→T | 43.9% | S61N (AGC→AAC) | fhuE ← | ferric‑rhodotorulic acid outer membrane transporter |
RA | 741,621 | G→A | 31.3% | L40L (TTG→TTA) | ycfL → | hypothetical protein |
RA | 744,026 | G→C | 38.6% | G226A (GGT→GCT) | nagZ → | beta N‑acetyl‑glucosaminidase |
RA | 744,046 | A→G | 37.3% | T233A (ACC→GCC) | nagZ → | beta N‑acetyl‑glucosaminidase |
RA | 745,050 | C→T | 13.2% | intergenic (+110/‑290) | ycfP → / → ndh | conserved hypothetical protein/respiratory NADH dehydrogenase 2/cupric reductase |
RA | 745,073 | C→T | 32.7% | intergenic (+133/‑267) | ycfP → / → ndh | conserved hypothetical protein/respiratory NADH dehydrogenase 2/cupric reductase |
RA | 745,079 | G→C | 36.8% | intergenic (+139/‑261) | ycfP → / → ndh | conserved hypothetical protein/respiratory NADH dehydrogenase 2/cupric reductase |
RA | 745,114 | T→C | 20.5% | intergenic (+174/‑226) | ycfP → / → ndh | conserved hypothetical protein/respiratory NADH dehydrogenase 2/cupric reductase |
RA | 745,115 | C→A | 20.6% | intergenic (+175/‑225) | ycfP → / → ndh | conserved hypothetical protein/respiratory NADH dehydrogenase 2/cupric reductase |
RA | 746,152 | A→G | 59.6% | V271V (GTA→GTG) | ndh → | respiratory NADH dehydrogenase 2/cupric reductase |
RA | 749,132 | T→C | 36.5% | K166K (AAA→AAG) | ycfS ← | conserved hypothetical protein |
RA | 749,138 | A→C | 38.8% | R164R (CGT→CGG) | ycfS ← | conserved hypothetical protein |
RA | 749,141 | G→C | 44.2% | A163A (GCC→GCG) | ycfS ← | conserved hypothetical protein |
RA | 749,147 | G→A | 48.7% | I161I (ATC→ATT) | ycfS ← | conserved hypothetical protein |
RA | 749,183 | T→C | 33.6% | K149K (AAA→AAG) | ycfS ← | conserved hypothetical protein |
RA | 749,189 | T→A | 33.7% | S147S (TCA→TCT) | ycfS ← | conserved hypothetical protein |
RA | 749,866 | G→A | 30.7% | R1118R (CGC→CGT) | mfd ← | transcription‑repair coupling factor |
RA | 750,205 | C→G | 50.4% | E1005D (GAG→GAC) | mfd ← | transcription‑repair coupling factor |
RA | 752,626 | G→A | 100% | D198D (GAC→GAT) | mfd ← | transcription‑repair coupling factor |
RA | 753,377 | T→A | 100% | S348S (TCA→TCT) | ycfT ← | predicted inner membrane protein |
RA | 754,163 | C→G | 46.1% | R86R (CGG→CGC) | ycfT ← | predicted inner membrane protein |
RA | 755,221 | C→T | 29.5% | S180S (AGC→AGT) | lolC → | outer membrane‑specific lipoprotein transporter subunit |
RA | 756,086 | G→A | 57.6% | Q71Q (CAG→CAA) | lolD → | outer membrane‑specific lipoprotein transporter subunit |
RA | 756,089 | A→G | 57.7% | P72P (CCA→CCG) | lolD → | outer membrane‑specific lipoprotein transporter subunit |
RA | 756,778 | C→T | 52.0% | I68I (ATC→ATT) | lolE → | outer membrane‑specific lipoprotein transporter subunit |
RA | 756,787 | G→A | 57.6% | V71V (GTG→GTA) | lolE → | outer membrane‑specific lipoprotein transporter subunit |
RA | 756,802 | T→C | 74.8% | T76T (ACT→ACC) | lolE → | outer membrane‑specific lipoprotein transporter subunit |
RA | 756,824 | C→A | 100% | H84N (CAC→AAC) | lolE → | outer membrane‑specific lipoprotein transporter subunit |
RA | 759,362 | C→T | 46.6% | G196G (GGC→GGT) | cobB → | deacetylase of acetyl‑CoA synthetase, NAD‑dependent |
RA | 760,905 | C→T | 39.0% | V26I (GTC→ATC) | ymfA ← | predicted inner membrane protein |
RA | 761,731 | A→C | 21.3% | P118P (CCT→CCG) | potD ← | polyamine transporter subunit |
RA | 761,758 | A→G | 24.4% | N109N (AAT→AAC) | potD ← | polyamine transporter subunit |
RA | 761,767 | G→A | 20.6% | N106N (AAC→AAT) | potD ← | polyamine transporter subunit |
RA | 761,770 | T→G | 23.0% | T105T (ACA→ACC) ‡ | potD ← | polyamine transporter subunit |
RA | 761,771 | G→C | 23.0% | T105R (ACA→AGA) ‡ | potD ← | polyamine transporter subunit |
RA | 762,995 | A→G | 43.3% | L235L (CTT→CTC) | potB ← | polyamine transporter subunit |
RA | 763,004 | G→T | 43.4% | V232V (GTC→GTA) | potB ← | polyamine transporter subunit |
RA | 767,700 | T→C | 57.5% | V444V (GTA→GTG) | phoQ ← | sensory histidine kinase in two‑compoent regulatory system with PhoP |
RA | 768,228 | G→A | 34.4% | Y268Y (TAC→TAT) | phoQ ← | sensory histidine kinase in two‑compoent regulatory system with PhoP |
RA | 768,263 | A→G | 71.8% | L257L (TTG→CTG) | phoQ ← | sensory histidine kinase in two‑compoent regulatory system with PhoP |
RA | 769,085 | G→C | 38.0% | P206P (CCC→CCG) | phoP ← | DNA‑binding response regulator in two‑component regulatory system with PhoQ |
RA | 769,100 | A→T | 31.3% | I201I (ATT→ATA) | phoP ← | DNA‑binding response regulator in two‑component regulatory system with PhoQ |
RA | 771,789 | G→C | 73.6% | A33G (GCC→GGC) | hflD ← | predicted lysogenization regulator |
RA | 771,851 | C→A | 45.0% | L12L (CTG→CTT) | hflD ← | predicted lysogenization regulator |
RA | 773,262 | G→C | 66.2% | T94T (ACC→ACG) | ymfB ← | bifunctional thiamin pyrimidine pyrophosphate hydrolase and thiamin pyrophosphate hydrolase |
RA | 774,341 | C→T | 68.2% | intergenic (‑135/‑37) | ymfC ← / → icd | 23S rRNA pseudouridine synthase/isocitrate dehydrogenase, specific for NADP+ |
RA | 774,641 | T→C | 44.1% | T88T (ACT→ACC) | icd → | isocitrate dehydrogenase, specific for NADP+ |
RA | 775,331 | C→T | 65.8% | G318G (GGC→GGT) | icd → | isocitrate dehydrogenase, specific for NADP+ |
RA | 775,352 | T→C | 51.2% | G325G (GGT→GGC) | icd → | isocitrate dehydrogenase, specific for NADP+ |
RA | 775,538 | A→G | 68.8% | K387K (AAA→AAG) | icd → | isocitrate dehydrogenase, specific for NADP+ |
RA | 775,559 | G→A | 56.9% | E394E (GAG→GAA) | icd → | isocitrate dehydrogenase, specific for NADP+ |
RA | 775,571 | T→A | 50.0% | D398E (GAT→GAA) | icd → | isocitrate dehydrogenase, specific for NADP+ |
RA | 775,580 | A→G | 30.0% | K401K (AAA→AAG) | icd → | isocitrate dehydrogenase, specific for NADP+ |
RA | 779,653 | G→A | 48.1% | L12L (CTG→TTG) | ycgK ← | hypothetical protein |
RA | 780,059 | G→T | 36.2% | L55L (CTG→CTT) | ycgL → | conserved hypothetical protein |
RA | 781,790 | C→T | 50.0% | L273L (TTG→TTA) | hlyE ← | hemolysin E |
RA | 783,256 | C→T | 51.5% | G92G (GGC→GGT) | umuD → | DNA polymerase V, subunit D |
RA | 785,203 | C→T | 41.2% | A14A (GCG→GCA) | dsbB ← | oxidoreductase that catalyzes reoxidation of DsbA protein disulfide isomerase I |
RA | 785,969 | G→A | 33.2% | G321G (GGC→GGT) | nhaB ← | sodium:proton antiporter |
RA | 785,972 | A→G | 44.0% | V320V (GTT→GTC) | nhaB ← | sodium:proton antiporter |
RA | 785,978 | C→T | 44.4% | A318A (GCG→GCA) | nhaB ← | sodium:proton antiporter |
RA | 785,989 | A→G | 48.7% | L315L (TTG→CTG) | nhaB ← | sodium:proton antiporter |
RA | 785,990 | C→T | 48.6% | A314A (GCG→GCA) | nhaB ← | sodium:proton antiporter |
RA | 790,744 | T→C | 100% | N320N (AAT→AAC) | dadA → | D‑amino acid dehydrogenase |
RA | 791,603 | G→A | 59.5% | G171S (GGC→AGC) | dadX → | alanine racemase 2, PLP‑binding |
RA | 792,109 | G→A | 83.0% | V339V (GTG→GTA) | dadX → | alanine racemase 2, PLP‑binding |
RA | 792,137 | C→T | 56.2% | L349L (CTA→TTA) | dadX → | alanine racemase 2, PLP‑binding |
RA | 794,838 | C→T | 40.4% | E153K (GAA→AAA) | ldcA ← | L,D‑carboxypeptidase A |
RA | 796,568 | T→C | 35.2% | Q58Q (CAA→CAG) | ycgR ← | protein involved in flagellar function |
RA | 796,571 | A→G | 36.4% | S57S (AGT→AGC) | ycgR ← | protein involved in flagellar function |
RA | 799,135 | G→A | 57.6% | R152R (CGC→CGT) | treA ← | periplasmic trehalase |
RA | 799,144 | C→G | 39.3% | P149P (CCG→CCC) | treA ← | periplasmic trehalase |
RA | 800,303 | T→C | 65.5% | A342A (GCA→GCG) | dhaH ← | fused predicted dihydroxyacetone‑specific PTS enzyme HPr component and EI component |
RA | 800,666 | C→T | 36.9% | G221G (GGG→GGA) | dhaH ← | fused predicted dihydroxyacetone‑specific PTS enzyme HPr component and EI component |
RA | 801,843 | G→A | 32.0% | N43N (AAC→AAT) | dhaL ← | dihydroxyacetone kinase, C‑terminal domain |
RA | 804,017 | G→A | 51.6% | R246R (CGG→CGA) | dhaR → | predicted DNA‑binding transcriptional regulator, dihydroxyacetone |
RA | 804,215 | G→A | 28.2% | L312L (TTG→TTA) | dhaR → | predicted DNA‑binding transcriptional regulator, dihydroxyacetone |
RA | 811,407 | A→T | 62.0% | A537A (GCT→GCA) | ychM ← | predicted transporter |
RA | 811,442 | C→G | 70.4% | V526L (GTG→CTG) | ychM ← | predicted transporter |
RA | 811,467 | C→T | 53.3% | E517E (GAG→GAA) | ychM ← | predicted transporter |
RA | 812,424 | A→G | 40.2% | F198F (TTT→TTC) | ychM ← | predicted transporter |
RA | 813,484 | T→G | 36.0% | S202S (TCA→TCC) | prsA ← | phosphoribosylpyrophosphate synthase |
RA | 815,460 | G→C | 68.8% | L85L (CTC→CTG) | lolB ← | chaperone for lipoproteins |
RA | 816,410 | C→T | 60.6% | S161S (AGC→AGT) | hemA → | glutamyl tRNA reductase |
RA | 817,435 | T→C | 36.9% | D70D (GAT→GAC) | prfA → | peptide chain release factor RF‑1 |
RA | 820,100 | C→T | 54.0% | A189A (GCC→GCT) | ychA → | predicted transcriptional regulator |
RA | 820,109 | G→A | 66.3% | M192I (ATG→ATA) | ychA → | predicted transcriptional regulator |
RA | 820,996 | C→T | 41.1% | C206C (TGC→TGT) | kdsA → | 3‑deoxy‑D‑manno‑octulosonate 8‑phosphate synthase |
RA | 821,005 | G→A | 39.5% | P209P (CCG→CCA) | kdsA → | 3‑deoxy‑D‑manno‑octulosonate 8‑phosphate synthase |
RA | 821,054 | C→A | 27.5% | R226R (CGA→AGA) | kdsA → | 3‑deoxy‑D‑manno‑octulosonate 8‑phosphate synthase |
RA | 824,680 | T→C | 35.9% | D172D (GAT→GAC) | chaC → | regulatory protein for cation transport |
RA | 826,674 | C→T | 53.7% | S357S (AGC→AGT) | ychP → | predicted invasin |
RA | 826,676 | C→A | 53.6% | A358E (GCG→GAG) | ychP → | predicted invasin |
RA | 826,710 | G→A | 46.0% | Q369Q (CAG→CAA) | ychP → | predicted invasin |
RA | 827,457 | G→A | 27.2% | L18L (CTG→TTG) | narL ← | DNA‑binding response regulator in two‑component regulatory system with NarX (or NarQ) |
RA | 828,872 | G→A | 35.7% | D142D (GAC→GAT) | narX ← | sensory histidine kinase in two‑component regulatory system with NarL |
RA | 831,492 | T→C | 15.1% | intergenic (+465/‑51) | narK → / → narG | nitrate/nitrite transporter/nitrate reductase 1, alpha subunit |
RA | 832,367 | G→A | 48.5% | G275G (GGG→GGA) | narG → | nitrate reductase 1, alpha subunit |
RA | 832,628 | T→G | 18.0% | V362V (GTT→GTG) | narG → | nitrate reductase 1, alpha subunit |
RA | 832,634 | G→A | 22.2% | A364A (GCG→GCA) | narG → | nitrate reductase 1, alpha subunit |
RA | 834,059 | C→T | 51.1% | V839V (GTC→GTT) | narG → | nitrate reductase 1, alpha subunit |
RA | 834,062 | C→T | 51.8% | G840G (GGC→GGT) | narG → | nitrate reductase 1, alpha subunit |
RA | 834,107 | T→C | 57.7% | H855H (CAT→CAC) | narG → | nitrate reductase 1, alpha subunit |
RA | 834,665 | T→C | 43.9% | G1041G (GGT→GGC) | narG → | nitrate reductase 1, alpha subunit |
RA | 834,674 | A→G | 42.8% | Q1044Q (CAA→CAG) | narG → | nitrate reductase 1, alpha subunit |
RA | 834,692 | G→A | 30.8% | Q1050Q (CAG→CAA) | narG → | nitrate reductase 1, alpha subunit |
RA | 835,957 | T→C | 47.0% | T225T (ACT→ACC) | narH → | nitrate reductase 1, beta (Fe‑S) subunit |
RA | 836,119 | T→G | 63.5% | A279A (GCT→GCG) | narH → | nitrate reductase 1, beta (Fe‑S) subunit |
RA | 839,437 | G→C | 100% | intergenic (‑136/+24) | tyrT ← / ← purU | tRNA‑Tyr/formyltetrahydrofolate hydrolase |
RA | 839,914 | A→C | 49.5% | R130R (CGT→CGG) | purU ← | formyltetrahydrofolate hydrolase |
RA | 842,247 | A→G | 27.9% | P109P (CCA→CCG) | rssB → | response regulator of RpoS |
RA | 842,947 | G→A | 36.2% | intergenic (+13/‑189) | rssB → / → galU | response regulator of RpoS/glucose‑1‑phosphate uridylyltransferase |
RA | 843,576 | G→A | 41.4% | L147L (TTG→TTA) | galU → | glucose‑1‑phosphate uridylyltransferase |
RA | 846,580 | G→T | 100% | T340T (ACC→ACA) | cls ← | cardiolipin synthase 1 |
RA | 849,820 | G→A | 100% | intergenic (‑1/‑223) | yciI ← / → tonB | hypothetical protein/membrane spanning protein in TonB‑ExbB‑ExbD complex |
RA | 851,033 | A→G | 26.2% | T56T (ACT→ACC) | yciA ← | predicted hydrolase |
RA | 851,042 | G→A | 50.0% | R53R (CGC→CGT) | yciA ← | predicted hydrolase |
RA | 852,069 | A→T | 43.8% | T183T (ACT→ACA) | yciC ← | predicted inner membrane protein |
RA | 853,846 | G→A | 29.2% | Y111Y (TAC→TAT) | yciE ← | conserved hypothetical protein |
RA | 856,437 | T→C | 39.4% | P311P (CCA→CCG) | trpB ← | tryptophan synthase, beta subunit |
RA | 856,644 | A→T | 56.9% | A242A (GCT→GCA) | trpB ← | tryptophan synthase, beta subunit |
RA | 856,653 | G→A | 52.9% | G239G (GGC→GGT) | trpB ← | tryptophan synthase, beta subunit |
RA | 856,734 | G→C | 32.6% | T212T (ACC→ACG) | trpB ← | tryptophan synthase, beta subunit |
RA | 857,834 | C→T | 54.8% | A302A (GCG→GCA) | trpC ← | fused indole‑3‑glycerolphosphate synthetase and N‑(5‑phosphoribosyl)anthranilate isomerase |
RA | 858,231 | T→A | 52.3% | Q170L (CAG→CTG) | trpC ← | fused indole‑3‑glycerolphosphate synthetase and N‑(5‑phosphoribosyl)anthranilate isomerase |
RA | 860,339 | C→T | 57.6% | *521* (TGA→TAA) | trpE ← | component I of anthranilate synthase |
RA | 860,344 | A→C | 57.6% | T519T (ACT→ACG) | trpE ← | component I of anthranilate synthase |
RA | 860,884 | T→C | 48.3% | S339S (TCA→TCG) | trpE ← | component I of anthranilate synthase |
RA | 860,896 | G→A | 38.3% | R335R (CGC→CGT) | trpE ← | component I of anthranilate synthase |
RA | 860,911 | G→A | 37.7% | R330R (CGC→CGT) | trpE ← | component I of anthranilate synthase |
RA | 863,501 | C→T | 60.4% | S150S (AGC→AGT) | yciO → | conserved hypothetical protein |
RA | 863,516 | G→C | 59.2% | S155S (TCG→TCC) | yciO → | conserved hypothetical protein |
RA | 866,934 | A→G | 62.7% | L126L (CTT→CTC) | btuR ← | cob(I)alamin adenolsyltransferase/cobinamide ATP‑dependent adenolsyltransferase |
RA | 869,449 | T→A | 33.3% | T58T (ACA→ACT) | yciN ← | hypothetical protein |
RA | 870,646 | G→A | 61.7% | V215V (GTG→GTA) | topA → | DNA topoisomerase I, omega subunit |
RA | 871,945 | C→T | 26.3% | G648G (GGC→GGT) | topA → | DNA topoisomerase I, omega subunit |
RA | 871,951 | T→C | 29.7% | D650D (GAT→GAC) | topA → | DNA topoisomerase I, omega subunit |
RA | 872,874 | A→G | 31.0% | T22T (ACA→ACG) | cysB → | DNA‑binding transcriptional dual regulator, O‑acetyl‑L‑serine‑binding |
RA | 874,871 | T→C | 37.3% | A29A (GCT→GCC) | acnA → | aconitate hydratase 1 |
RA | 875,974 | A→G | 17.0% | N397S (AAC→AGC) | acnA → | aconitate hydratase 1 |
RA | 876,010 | A→T | 22.1% | Q409L (CAG→CTG) | acnA → | aconitate hydratase 1 |
RA | 876,263 | G→A | 29.9% | G493G (GGG→GGA) | acnA → | aconitate hydratase 1 |
RA | 876,311 | G→A | 60.9% | G509G (GGG→GGA) | acnA → | aconitate hydratase 1 |
RA | 876,315 | C→T | 60.9% | L511L (CTG→TTG) | acnA → | aconitate hydratase 1 |
RA | 878,242 | G→A | 41.1% | intergenic (‑128/‑42) | ribA ← / → pgpB | GTP cyclohydrolase II/phosphatidylglycerophosphate phosphatase B |
RA | 880,072 | C→T | 59.0% | A187A (GCC→GCT) | yciM → | conserved hypothetical protein |
RA | 880,747 | A→C | 67.7% | intergenic (+66/‑128) | yciM → / → pyrF | conserved hypothetical protein/orotidine‑5'‑phosphate decarboxylase |
RA | 882,776 | T→C | 31.1% | G175G (GGA→GGG) | yciT ← | predicted DNA‑binding transcriptional regulator |
RA | 889,529 | G→A | 28.2% | N155N (AAC→AAT) | fabI ← | enoyl‑[acyl‑carrier‑protein] reductase, NADH‑dependent |
RA | 889,789 | C→T | 49.4% | A69T (GCC→ACC) | fabI ← | enoyl‑[acyl‑carrier‑protein] reductase, NADH‑dependent |
RA | 889,796 | T→G | 47.9% | A66A (GCA→GCC) | fabI ← | enoyl‑[acyl‑carrier‑protein] reductase, NADH‑dependent |
RA | 891,052 | A→G | 42.3% | A179A (GCT→GCC) | sapF ← | predicted antimicrobial peptide transporter subunit |
RA | 891,127 | T→C | 37.3% | G154G (GGA→GGG) | sapF ← | predicted antimicrobial peptide transporter subunit |
RA | 891,136 | C→T | 37.2% | L151L (TTG→TTA) | sapF ← | predicted antimicrobial peptide transporter subunit |
RA | 892,843 | T→G | 21.6% | P210P (CCA→CCC) | sapC ← | predicted antimicrobial peptide transporter subunit |
RA | 893,176 | C→T | 44.0% | V99V (GTG→GTA) | sapC ← | predicted antimicrobial peptide transporter subunit |
RA | 893,899 | T→C | 50.4% | I176V (ATC→GTC) | sapB ← | predicted antimicrobial peptide transporter subunit |
RA | 893,980 | G→A | 56.2% | L149L (CTG→TTG) | sapB ← | predicted antimicrobial peptide transporter subunit |
RA | 893,993 | T→A | 36.5% | S144S (TCA→TCT) | sapB ← | predicted antimicrobial peptide transporter subunit |
RA | 894,163 | C→T | 14.3% | A88T (GCG→ACG) | sapB ← | predicted antimicrobial peptide transporter subunit |
RA | 894,957 | A→C | 35.5% | S370A (TCG→GCG) | sapA ← | predicted antimicrobial peptide transporter subunit |
RA | 899,437 | G→A | 100% | V35V (GTG→GTA) | pspD → | peripheral inner membrane phage‑shock protein |
RA | 899,440 | G→T | 100% | A36A (GCG→GCT) | pspD → | peripheral inner membrane phage‑shock protein |
RA | 900,712 | C→T | 44.1% | T186M (ACG→ATG) | ycjM → | predicted glucosyltransferase |
RA | 900,737 | T→C | 36.0% | S194S (AGT→AGC) | ycjM → | predicted glucosyltransferase |
RA | 901,694 | T→C | 12.0% | C513C (TGT→TGC) | ycjM → | predicted glucosyltransferase |
RA | 901,700 | T→G | 12.1% | T515T (ACT→ACG) | ycjM → | predicted glucosyltransferase |
RA | 901,719 | A→G | 18.6% | K522E (AAA→GAA) | ycjM → | predicted glucosyltransferase |
RA | 901,754 | T→C | 49.2% | H533H (CAT→CAC) | ycjM → | predicted glucosyltransferase |
RA | 904,059 | C→A | 48.0% | R10R (CGC→CGA) | ycjP → | predicted sugar transporter subunit |
RA | 905,536 | A→G | 43.3% | T212A (ACT→GCT) | ycjQ → | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 905,541 | T→C | 52.9% | D213D (GAT→GAC) | ycjQ → | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 906,051 | C→T | 100% | G26G (GGC→GGT) | ycjR → | hypothetical protein |
RA | 906,069 | T→C | 100% | I32I (ATT→ATC) | ycjR → | hypothetical protein |
RA | 906,094 | A→C | 37.5% | I41L (ATC→CTC) | ycjR → | hypothetical protein |
RA | 906,111 | G→A | 48.6% | A46A (GCG→GCA) | ycjR → | hypothetical protein |
RA | 906,114 | G→A | 48.6% | A47A (GCG→GCA) | ycjR → | hypothetical protein |
RA | 908,257 | C→T | 63.8% | S145L (TCA→TTA) | ycjT → | predicted hydrolase |
RA | 910,465 | G→A | 71.5% | A126A (GCG→GCA) | ycjU → | predicted beta‑phosphoglucomutase |
RA | 910,937 | C→T | 25.1% | G59G (GGC→GGT) | ycjV → | predicted sugar transporter subunit |
RA | 912,048 | A→T | 24.9% | S54S (TCA→TCT) | ompG → | outer membrane porin |
RA | 912,291 | C→T | 26.1% | I135I (ATC→ATT) | ompG → | outer membrane porin |
RA | 913,128 | G→A | 31.8% | S258S (AGC→AGT) | ycjW ← | predicted DNA‑binding transcriptional regulator |
RA | 913,152 | G→A | 41.6% | A250A (GCC→GCT) | ycjW ← | predicted DNA‑binding transcriptional regulator |
RA | 913,161 | C→T | 31.8% | A247A (GCG→GCA) | ycjW ← | predicted DNA‑binding transcriptional regulator |
RA | 913,954 | G→C | 41.6% | intergenic (‑53/‑103) | ycjW ← / → ycjX | predicted DNA‑binding transcriptional regulator/conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 915,319 | T→A | 26.4% | P421P (CCT→CCA) | ycjX → | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 915,361 | A→G | 20.4% | A435A (GCA→GCG) | ycjX → | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 915,579 | C→T | 30.8% | D43D (GAC→GAT) | ycjF → | conserved inner membrane protein |
RA | 915,606 | C→T | 28.4% | V52V (GTC→GTT) | ycjF → | conserved inner membrane protein |
RA | 917,203 | T→C | 9.9% | L182L (TTG→CTG) | tyrR → | DNA‑binding transcriptional dual regulator, tyrosine‑binding |
RA | 917,229 | C→T | 100% | R190R (CGC→CGT) | tyrR → | DNA‑binding transcriptional dual regulator, tyrosine‑binding |
RA | 917,710 | A→G | 42.2% | M351V (ATG→GTG) | tyrR → | DNA‑binding transcriptional dual regulator, tyrosine‑binding |
RA | 920,281 | C→T | 47.8% | L106L (TTG→TTA) | mpaA ← | murein peptide amidase A |
RA | 920,323 | A→G | 38.9% | R92R (CGT→CGC) | mpaA ← | murein peptide amidase A |
RA | 920,335 | A→C | 35.9% | P88P (CCT→CCG) | mpaA ← | murein peptide amidase A |
RA | 920,527 | G→A | 100% | T24T (ACC→ACT) | mpaA ← | murein peptide amidase A |
RA | 921,380 | G→A | 35.8% | T142T (ACC→ACT) | ycjY ← | predicted hydrolase |
RA | 923,755 | G→A | 34.5% | G197S (GGT→AGT) | mppA → | murein tripeptide (L‑ala‑gamma‑D‑glutamyl‑meso‑DAP) transporter subunit |
RA | 924,732 | T→C | 14.5% | N522N (AAT→AAC) | mppA → | murein tripeptide (L‑ala‑gamma‑D‑glutamyl‑meso‑DAP) transporter subunit |
RA | 927,449 | C→T | 36.8% | R82H (CGC→CAC) | narZ ← | nitrate reductase 2 (NRZ), alpha subunit |
RA | 931,645 | T→C | 31.1% | I191V (ATA→GTA) | yddG ← | predicted methyl viologen efflux pump |
RA | 931,721 | A→G | 31.5% | N165N (AAT→AAC) | yddG ← | predicted methyl viologen efflux pump |
RA | 931,730 | G→A | 31.9% | R162R (CGC→CGT) | yddG ← | predicted methyl viologen efflux pump |
RA | 932,920 | T→C | 63.7% | A139A (GCT→GCC) | fdnG → | formate dehydrogenase‑N, alpha subunit, nitrate‑inducible |
RA | 934,499 | T→G | 50.6% | S666A (TCC→GCC) | fdnG → | formate dehydrogenase‑N, alpha subunit, nitrate‑inducible |
RA | 934,504 | A→G | 50.6% | E667E (GAA→GAG) | fdnG → | formate dehydrogenase‑N, alpha subunit, nitrate‑inducible |
RA | 935,197 | C→G | 49.5% | T898T (ACC→ACG) | fdnG → | formate dehydrogenase‑N, alpha subunit, nitrate‑inducible |
RA | 936,253 | C→T | 36.1% | H230H (CAC→CAT) | fdnH → | formate dehydrogenase‑N, Fe‑S (beta) subunit, nitrate‑inducible |
RA | 936,797 | G→A | 22.1% | S119S (TCG→TCA) | fdnI → | formate dehydrogenase‑N, cytochrome B556 (gamma) subunit, nitrate‑inducible |
RA | 936,833 | G→A | 34.0% | G131G (GGG→GGA) | fdnI → | formate dehydrogenase‑N, cytochrome B556 (gamma) subunit, nitrate‑inducible |
RA | 937,004 | A→G | 37.5% | V188V (GTA→GTG) | fdnI → | formate dehydrogenase‑N, cytochrome B556 (gamma) subunit, nitrate‑inducible |
RA | 938,456 | C→T | 28.6% | G162G (GGG→GGA) | adhP ← | alcohol dehydrogenase, 1‑propanol preferring |
RA | 940,401 | G→A | 44.6% | G124G (GGC→GGT) | sfcA ← | malate dehydrogenase, NAD‑requiring |
RA | 940,715 | G→A | 39.2% | L20L (CTG→TTG) | sfcA ← | malate dehydrogenase, NAD‑requiring |
RA | 941,252 | A→C | 29.9% | V44V (GTT→GTG) | bdm ← | biofilm‑dependent modulation protein |
RA | 942,074 | G→T | 31.8% | G116V (GGC→GTC) | osmC → | osmotically inducible, stress‑inducible membrane protein |
RA | 942,078 | A→T | 41.0% | I117I (ATA→ATT) | osmC → | osmotically inducible, stress‑inducible membrane protein |
RA | 942,108 | C→T | 33.6% | V127V (GTC→GTT) | osmC → | osmotically inducible, stress‑inducible membrane protein |
RA | 948,926 | C→A | 30.6% | S637S (TCG→TCT) | dos ← | cAMP phosphodiesterase, heme‑regulated |
RA | 948,935 | C→A | 35.3% | V634V (GTG→GTT) | dos ← | cAMP phosphodiesterase, heme‑regulated |
RA | 949,625 | G→C | 30.0% | P404P (CCC→CCG) | dos ← | cAMP phosphodiesterase, heme‑regulated |
RA | 950,075 | A→G | 21.6% | I254I (ATT→ATC) | dos ← | cAMP phosphodiesterase, heme‑regulated |
RA | 950,078 | C→T | 19.0% | Q253Q (CAG→CAA) | dos ← | cAMP phosphodiesterase, heme‑regulated |
RA | 950,083 | G→T | 19.2% | R252R (CGG→AGG) | dos ← | cAMP phosphodiesterase, heme‑regulated |
RA | 950,105 | A→T | 27.0% | T244T (ACT→ACA) | dos ← | cAMP phosphodiesterase, heme‑regulated |
RA | 958,752 | C→A | 60.5% | A518A (GCG→GCT) | pqqL ← | predicted peptidase |
RA | 959,697 | A→G | 35.9% | T203T (ACT→ACC) | pqqL ← | predicted peptidase |
RA | 961,630 | T→A | 44.8% | T365S (ACA→TCA) | yddB ← | predicted porin protein |
RA | 964,104 | C→G | 42.0% | R114R (CGG→CGC) | yddA ← | fused predicted multidrug transporter subunits and membrane component and ATP‑binding component of ABC superfamily |
RA | 974,805 | G→T | 56.2% | intergenic (+557/+435) | lsrB → / ← ydeH | AI2 transporter/conserved hypothetical protein |
RA | 975,534 | C→T | 35.0% | V27V (GTG→GTA) | ydeH ← | conserved hypothetical protein |
RA | 977,104 | T→C | 37.5% | I681V (ATA→GTA) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 977,140 | T→G | 35.9% | K669Q (AAG→CAG) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 977,516 | G→A | 20.6% | N543N (AAC→AAT) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 977,525 | G→A | 18.3% | S540S (AGC→AGT) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 977,549 | C→A | 28.8% | L532L (CTG→CTT) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 978,086 | C→T | 35.8% | E353E (GAG→GAA) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 978,092 | A→G | 35.8% | L351L (CTT→CTC) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 978,098 | A→G | 35.8% | F349F (TTT→TTC) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 978,107 | C→A | 42.3% | R346R (CGG→CGT) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 978,110 | C→T | 42.4% | R345R (CGG→CGA) ‡ | dcp ← | dipeptidyl carboxypeptidase II |
RA | 978,112 | G→T | 42.4% | R345R (CGG→AGG) ‡ | dcp ← | dipeptidyl carboxypeptidase II |
RA | 978,119 | T→C | 56.1% | E342E (GAA→GAG) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 978,122 | C→G | 56.0% | A341A (GCG→GCC) | dcp ← | dipeptidyl carboxypeptidase II |
RA | 984,541 | C→T | 60.5% | S203N (AGT→AAT) | ynfC ← | hypothetical protein |
RA | 984,663 | G→A | 39.1% | D162D (GAC→GAT) | ynfC ← | hypothetical protein |
RA | 984,696 | A→C | 13.1% | G151G (GGT→GGG) | ynfC ← | hypothetical protein |
RA | 985,963 | A→G | 60.7% | L68L (CTA→CTG) | ynfE → | oxidoreductase subunit |
RA | 986,248 | C→T | 38.6% | I163I (ATC→ATT) | ynfE → | oxidoreductase subunit |
RA | 986,275 | G→T | 28.4% | S172S (TCG→TCT) | ynfE → | oxidoreductase subunit |
RA | 986,986 | C→T | 35.9% | G409G (GGC→GGT) | ynfE → | oxidoreductase subunit |
RA | 987,016 | A→C | 42.1% | I419I (ATA→ATC) | ynfE → | oxidoreductase subunit |
RA | 987,023 | C→T | 43.2% | L422L (CTG→TTG) | ynfE → | oxidoreductase subunit |
RA | 992,778 | A→G | 28.2% | L194L (TTA→TTG) | dmsD → | twin‑argninine leader‑binding protein for DmsA and TorA |
RA | 994,037 | C→A | 45.9% | F344L (TTC→TTA) | clcB → | predicted voltage‑gated chloride channel |
RA | 994,058 | A→G | 52.2% | T351T (ACA→ACG) | clcB → | predicted voltage‑gated chloride channel |
RA | 994,518 | T→C | 22.9% | V131V (GTA→GTG) | ynfK ← | predicted dethiobiotin synthetase |
RA | 994,533 | T→C | 24.6% | P126P (CCA→CCG) | ynfK ← | predicted dethiobiotin synthetase |
RA | 995,650 | T→A | 40.0% | A202A (GCA→GCT) | dgsA ← | DNA‑binding transcriptional repressor |
RA | 996,736 | T→C | 42.4% | N183S (AAT→AGT) | ynfL ← | predicted DNA‑binding transcriptional regulator |
RA | 997,014 | A→G | 73.5% | G90G (GGT→GGC) | ynfL ← | predicted DNA‑binding transcriptional regulator |
RA | 997,102 | G→T | 100% | A61E (GCA→GAA) | ynfL ← | predicted DNA‑binding transcriptional regulator |
RA | 997,128 | T→C | 100% | R52R (CGA→CGG) | ynfL ← | predicted DNA‑binding transcriptional regulator |
RA | 997,557 | G→A | 40.1% | Q56Q (CAG→CAA) | ynfM → | predicted transporter |
RA | 997,578 | G→A | 37.9% | S63S (TCG→TCA) | ynfM → | predicted transporter |
RA | 997,581 | G→A | 38.4% | Q64Q (CAG→CAA) | ynfM → | predicted transporter |
RA | 997,596 | C→G | 42.1% | T69T (ACC→ACG) | ynfM → | predicted transporter |
RA | 998,295 | G→A | 49.2% | G302G (GGG→GGA) | ynfM → | predicted transporter |
RA | 998,298 | T→C | 38.3% | R303R (CGT→CGC) | ynfM → | predicted transporter |
RA | 998,304 | A→G | 36.7% | P305P (CCA→CCG) | ynfM → | predicted transporter |
RA | 999,500 | G→T | 31.5% | intergenic (+125/‑151) | asr → / → ydgD | acid shock‑inducible periplasmic protein/predicted peptidase |
RA | 1,000,073 | C→T | 50.0% | A141A (GCC→GCT) | ydgD → | predicted peptidase |
RA | 1,000,091 | A→T | 52.8% | G147G (GGA→GGT) | ydgD → | predicted peptidase |
RA | 1,004,373 | G→A | 100% | L408L (CTG→TTG) | pntA ← | pyridine nucleotide transhydrogenase, alpha subunit |
RA | 1,004,409 | T→C | 57.2% | T396A (ACC→GCC) | pntA ← | pyridine nucleotide transhydrogenase, alpha subunit |
RA | 1,005,190 | G→A | 32.1% | N135N (AAC→AAT) | pntA ← | pyridine nucleotide transhydrogenase, alpha subunit |
RA | 1,006,546 | G→A | 23.2% | A143A (GCG→GCA) | ydgH → | hypothetical protein |
RA | 1,008,927 | T→C | 34.7% | S87S (AGT→AGC) | folM → | dihydrofolate reductase isozyme |
RA | 1,008,951 | T→A | 26.6% | G95G (GGT→GGA) | folM → | dihydrofolate reductase isozyme |
RA | 1,008,961 | G→A | 20.2% | A99T (GCC→ACC) | folM → | dihydrofolate reductase isozyme |
RA | 1,010,065 | T→C | 35.8% | S75S (TCT→TCC) | rstA → | DNA‑bindng response regulator in two‑component regulatory system with RstB |
RA | 1,010,641 | T→C | 43.5% | V23V (GTT→GTC) | rstB → | sensory histidine kinase in two‑component regulatory system with RstA |
RA | 1,011,495 | T→C | 16.5% | V308A (GTG→GCG) | rstB → | sensory histidine kinase in two‑component regulatory system with RstA |
RA | 1,011,820 | C→T | 21.5% | R416R (CGC→CGT) | rstB → | sensory histidine kinase in two‑component regulatory system with RstA |
RA | 1,013,728 | A→G | 37.5% | I184I (ATT→ATC) | fumC ← | fumarate hydratase (fumarase C), aerobic Class II |
RA | 1,015,874 | C→A | 68.8% | A65A (GCG→GCT) | fumA ← | aerobic Class I fumarate hydratase |
RA | 1,015,889 | G→A | 63.3% | F60F (TTC→TTT) | fumA ← | aerobic Class I fumarate hydratase |
RA | 1,015,892 | C→T | 63.3% | S59S (TCG→TCA) | fumA ← | aerobic Class I fumarate hydratase |
RA | 1,016,905 | G→A | 32.3% | P213P (CCG→CCA) | manA → | mannose‑6‑phosphate isomerase |
RA | 1,017,067 | A→G | 71.6% | A267A (GCA→GCG) | manA → | mannose‑6‑phosphate isomerase |
RA | 1,017,320 | T→C | 100% | L352L (TTG→CTG) | manA → | mannose‑6‑phosphate isomerase |
RA | 1,017,325 | G→T | 100% | W353C (TGG→TGT) | manA → | mannose‑6‑phosphate isomerase |
RA | 1,018,961 | T→C | 16.5% | N473N (AAT→AAC) | ydgA → | conserved hypothetical protein |
RA | 1,018,974 | T→C | 28.0% | S478P (TCG→CCG) ‡ | ydgA → | conserved hypothetical protein |
RA | 1,018,976 | G→A | 27.9% | S478S (TCG→TCA) ‡ | ydgA → | conserved hypothetical protein |
RA | 1,018,977 | T→C | 28.0% | L479L (TTA→CTA) ‡ | ydgA → | conserved hypothetical protein |
RA | 1,018,979 | A→G | 29.0% | L479L (TTA→TTG) ‡ | ydgA → | conserved hypothetical protein |
RA | 1,020,036 | A→G | 57.2% | D169D (GAT→GAC) | uidC ← | predicted outer membrane porin protein |
RA | 1,020,048 | T→C | 66.8% | T165T (ACA→ACG) | uidC ← | predicted outer membrane porin protein |
RA | 1,020,061 | T→C | 37.5% | Y161C (TAT→TGT) | uidC ← | predicted outer membrane porin protein |
RA | 1,020,221 | C→T | 50.0% | A108T (GCC→ACC) | uidC ← | predicted outer membrane porin protein |
RA | 1,020,261 | A→G | 30.9% | S94S (AGT→AGC) | uidC ← | predicted outer membrane porin protein |
RA | 1,022,353 | T→A | 50.5% | G470G (GGA→GGT) | uidA ← | beta‑D‑glucuronidase |
RA | 1,023,466 | G→T | 43.2% | V99V (GTC→GTA) | uidA ← | beta‑D‑glucuronidase |
RA | 1,025,024 | C→G | 46.7% | A236A (GCG→GCC) | hdhA ← | 7alpha‑hydroxysteroid dehydrogenase, NAD‑dependent |
RA | 1,025,485 | T→C | 40.9% | I83V (ATC→GTC) | hdhA ← | 7alpha‑hydroxysteroid dehydrogenase, NAD‑dependent |
RA | 1,025,486 | A→G | 40.9% | A82A (GCT→GCC) | hdhA ← | 7alpha‑hydroxysteroid dehydrogenase, NAD‑dependent |
RA | 1,026,083 | G→C | 46.2% | L263L (CTC→CTG) | malI ← | DNA‑binding transcriptional repressor |
RA | 1,028,197 | C→T | 29.6% | F384F (TTC→TTT) | malX → | fused maltose and glucose‑specific PTS enzyme IIBC components |
RA | 1,029,310 | T→G | 62.5% | A221A (GCT→GCG) | malY → | bifunctional beta‑cystathionase, PLP‑dependent and regulator of maltose regulon |
RA | 1,031,911 | T→A | 42.6% | Q30L (CAG→CTG) | ydgJ ← | predicted oxidoreductase |
RA | 1,036,647 | G→A | 35.7% | V680I (GTT→ATT) | rsxC → | fused predicted 4Fe‑4S ferredoxin‑type protein |
RA | 1,036,664 | T→C | 38.0% | A685A (GCT→GCC) | rsxC → | fused predicted 4Fe‑4S ferredoxin‑type protein |
RA | 1,036,685 | A→C | 41.4% | A692A (GCA→GCC) | rsxC → | fused predicted 4Fe‑4S ferredoxin‑type protein |
RA | 1,037,015 | A→C | 29.3% | V61V (GTA→GTC) | rsxD → | predicted inner membrane oxidoreductase |
RA | 1,037,041 | C→T | 10.7% | A70V (GCC→GTC) ‡ | rsxD → | predicted inner membrane oxidoreductase |
RA | 1,037,042 | C→T | 39.5% | A70A (GCC→GCT) ‡ | rsxD → | predicted inner membrane oxidoreductase |
RA | 1,037,993 | G→A | 100% | T33T (ACG→ACA) | rsxG → | predicted oxidoreductase |
RA | 1,039,558 | C→T | 38.7% | P115P (CCC→CCT) | nth → | DNA glycosylase and apyrimidinic (AP) lyase |
RA | 1,039,561 | C→T | 41.2% | G116G (GGC→GGT) | nth → | DNA glycosylase and apyrimidinic (AP) lyase |
RA | 1,041,332 | G→T | 27.7% | L291L (CTG→CTT) | ydgR → | predicted transporter |
RA | 1,041,335 | C→T | 31.3% | Y292Y (TAC→TAT) | ydgR → | predicted transporter |
RA | 1,042,145 | C→G | 64.0% | T26T (ACC→ACG) | gst → | glutathionine S‑transferase |
RA | 1,042,223 | G→A | 100% | V52V (GTG→GTA) | gst → | glutathionine S‑transferase |
RA | 1,042,241 | T→C | 100% | D58D (GAT→GAC) | gst → | glutathionine S‑transferase |
RA | 1,044,247 | G→A | 28.6% | L223L (CTG→TTG) | tyrS ← | tyrosyl‑tRNA synthetase |
RA | 1,045,171 | G→A | 18.1% | S176S (AGC→AGT) | pdxH ← | pyridoxine 5'‑phosphate oxidase |
RA | 1,045,174 | C→T | 18.9% | P175P (CCG→CCA) | pdxH ← | pyridoxine 5'‑phosphate oxidase |
RA | 1,047,977 | G→A | 34.6% | P137P (CCG→CCA) | slyB → | outer membrane lipoprotein |
RA | 1,049,623 | T→G | 33.1% | V223V (GTT→GTG) | ydhJ → | undecaprenyl pyrophosphate phosphatase |
RA | 1,050,528 | G→A | 33.9% | A239A (GCG→GCA) | ydhK → | conserved inner membrane protein |
RA | 1,050,833 | A→G | 55.8% | H341R (CAT→CGT) | ydhK → | conserved inner membrane protein |
RA | 1,050,835 | A→G | 55.8% | T342A (ACC→GCC) | ydhK → | conserved inner membrane protein |
RA | 1,051,975 | A→C | 26.5% | A124A (GCT→GCG) | sodC ← | superoxide dismutase, Cu, Zn |
RA | 1,051,978 | T→C | 25.5% | K123K (AAA→AAG) | sodC ← | superoxide dismutase, Cu, Zn |
RA | 1,052,805 | C→T | 13.6% | P173P (CCG→CCA) | ydhF ← | predicted oxidoreductase |
RA | 1,052,811 | A→G | 13.5% | R171R (CGT→CGC) | ydhF ← | predicted oxidoreductase |
RA | 1,052,826 | G→C | 13.6% | A166A (GCC→GCG) | ydhF ← | predicted oxidoreductase |
RA | 1,052,841 | C→T | 12.5% | T161T (ACG→ACA) | ydhF ← | predicted oxidoreductase |
RA | 1,053,033 | A→G | 27.9% | G97G (GGT→GGC) | ydhF ← | predicted oxidoreductase |
RA | 1,053,053 | G→A | 22.7% | R91C (CGT→TGT) | ydhF ← | predicted oxidoreductase |
RA | 1,053,407 | A→G | 38.5% | S69P (TCA→CCA) | ydhL ← | conserved hypothetical protein |
RA | 1,053,421 | G→A | 44.7% | A64V (GCA→GTA) | ydhL ← | conserved hypothetical protein |
RA | 1,053,423 | G→A | 44.1% | R63R (CGC→CGT) | ydhL ← | conserved hypothetical protein |
RA | 1,053,813 | T→C | 32.7% | L6L (TTA→CTA) ‡ | ydhM → | predicted DNA‑binding transcriptional regulator |
RA | 1,053,815 | A→C | 31.1% | L6F (TTA→TTC) ‡ | ydhM → | predicted DNA‑binding transcriptional regulator |
RA | 1,063,766 | T→C | 29.9% | intergenic (+116/+46) | sodB → / ← ydhP | superoxide dismutase, Fe/predicted transporter |
RA | 1,063,821 | A→G | 32.6% | A387A (GCT→GCC) | ydhP ← | predicted transporter |
RA | 1,065,177 | T→C | 24.2% | intergenic (‑196/‑358) | ydhP ← / → purR | predicted transporter/DNA‑binding transcriptional repressor, hypoxanthine‑binding |
RA | 1,066,835 | C→G | 42.2% | V219L (GTT→CTT) | ydhB ← | predicted DNA‑binding transcriptional regulator |
RA | 1,068,429 | G→A | 55.2% | V276V (GTG→GTA) | ydhC → | predicted transporter |
RA | 1,069,145 | C→T | 29.4% | D14D (GAC→GAT) | cfa → | cyclopropane fatty acyl phospholipid synthase |
RA | 1,071,798 | C→G | 47.2% | S217S (TCC→TCG) | mdtK → | multidrug efflux system transporter |
RA | 1,071,831 | A→G | 54.3% | A228A (GCA→GCG) | mdtK → | multidrug efflux system transporter |
RA | 1,071,834 | A→G | 53.8% | K229K (AAA→AAG) | mdtK → | multidrug efflux system transporter |
RA | 1,074,351 | T→C | 39.1% | intergenic (+68/‑40) | valW → / → ydhR | tRNA‑Val/hypothetical protein |
RA | 1,075,721 | T→C | 49.3% | S300S (AGT→AGC) | ydhS → | conserved hypothetical protein with FAD/NAD(P)‑binding domain |
RA | 1,076,180 | C→T | 29.0% | I453I (ATC→ATT) | ydhS → | conserved hypothetical protein with FAD/NAD(P)‑binding domain |
RA | 1,076,192 | G→A | 29.0% | G457G (GGG→GGA) | ydhS → | conserved hypothetical protein with FAD/NAD(P)‑binding domain |
RA | 1,080,838 | A→G | 28.5% | I228I (ATT→ATC) | ydhV ← | predicted oxidoreductase |
RA | 1,080,862 | A→G | 39.3% | N220N (AAT→AAC) | ydhV ← | predicted oxidoreductase |
RA | 1,082,519 | T→C | 34.6% | intergenic (‑351/+104) | ydhY ← / ← ydhZ | predicted 4Fe‑4S ferridoxin‑type protein/hypothetical protein |
RA | 1,082,530 | G→A | 13.4% | intergenic (‑362/+93) | ydhY ← / ← ydhZ | predicted 4Fe‑4S ferridoxin‑type protein/hypothetical protein |
RA | 1,087,357 | A→G | 47.2% | G286G (GGT→GGC) | sufS ← | selenocysteine lyase, PLP‑dependent |
RA | 1,087,363 | G→A | 54.1% | I284I (ATC→ATT) | sufS ← | selenocysteine lyase, PLP‑dependent |
RA | 1,087,366 | G→A | 54.1% | G283G (GGC→GGT) | sufS ← | selenocysteine lyase, PLP‑dependent |
RA | 1,087,369 | C→T | 51.5% | G282G (GGG→GGA) | sufS ← | selenocysteine lyase, PLP‑dependent |
RA | 1,090,837 | A→G | 45.0% | F288F (TTT→TTC) | sufB ← | component of SufBCD complex |
RA | 1,090,843 | G→A | 45.0% | N286N (AAC→AAT) | sufB ← | component of SufBCD complex |
RA | 1,091,278 | C→T | 33.2% | A141A (GCG→GCA) | sufB ← | component of SufBCD complex |
RA | 1,091,823 | C→A | 38.2% | P85P (CCG→CCT) | sufA ← | Fe‑S cluster assembly protein |
RA | 1,092,045 | T→C | 33.6% | Q11Q (CAA→CAG) | sufA ← | Fe‑S cluster assembly protein |
RA | 1,092,051 | G→A | 33.6% | N9N (AAC→AAT) | sufA ← | Fe‑S cluster assembly protein |
RA | 1,094,838 | G→A | 23.7% | F513F (TTC→TTT) | ydiJ ← | predicted FAD‑linked oxidoreductase |
RA | 1,094,979 | C→T | 60.9% | A466A (GCG→GCA) | ydiJ ← | predicted FAD‑linked oxidoreductase |
RA | 1,096,275 | A→G | 57.0% | S34S (AGT→AGC) | ydiJ ← | predicted FAD‑linked oxidoreductase |
RA | 1,097,286 | T→C | 39.5% | S174S (AGT→AGC) | ydiK → | predicted inner membrane protein |
RA | 1,099,401 | A→T | 51.9% | T214S (ACC→TCC) | ydiM → | predicted transporter |
RA | 1,099,404 | T→C | 48.3% | L215L (TTA→CTA) | ydiM → | predicted transporter |
RA | 1,100,307 | T→C | 51.4% | N35N (AAT→AAC) | ydiN → | predicted transporter |
RA | 1,100,311 | T→A | 47.5% | S37T (TCA→ACA) | ydiN → | predicted transporter |
RA | 1,100,317 | C→T | 49.3% | L39L (CTG→TTG) | ydiN → | predicted transporter |
RA | 1,100,322 | G→A | 50.0% | A40A (GCG→GCA) | ydiN → | predicted transporter |
RA | 1,100,643 | T→C | 20.0% | F147F (TTT→TTC) | ydiN → | predicted transporter |
RA | 1,106,393 | T→C | 63.0% | E200E (GAA→GAG) | ydiP ← | predicted DNA‑binding transcriptional regulator |
RA | 1,112,816 | C→T | 81.3% | R663H (CGT→CAT) | pps ← | phosphoenolpyruvate synthase |
RA | 1,112,827 | T→C | 78.4% | E659E (GAA→GAG) | pps ← | phosphoenolpyruvate synthase |
RA | 1,112,851 | T→A | 68.3% | V651V (GTA→GTT) | pps ← | phosphoenolpyruvate synthase |
RA | 1,113,349 | T→C | 42.5% | K485K (AAA→AAG) | pps ← | phosphoenolpyruvate synthase |
RA | 1,113,361 | A→G | 41.9% | D481D (GAT→GAC) | pps ← | phosphoenolpyruvate synthase |
RA | 1,114,039 | G→A | 51.6% | I255I (ATC→ATT) | pps ← | phosphoenolpyruvate synthase |
RA | 1,114,060 | C→A | 45.7% | L248L (CTG→CTT) | pps ← | phosphoenolpyruvate synthase |
RA | 1,114,225 | T→C | 33.3% | Q193Q (CAA→CAG) | pps ← | phosphoenolpyruvate synthase |
RA | 1,114,246 | C→T | 35.0% | V186V (GTG→GTA) | pps ← | phosphoenolpyruvate synthase |
RA | 1,114,249 | A→G | 35.0% | G185G (GGT→GGC) | pps ← | phosphoenolpyruvate synthase |
RA | 1,114,255 | G→A | 39.1% | H183H (CAC→CAT) | pps ← | phosphoenolpyruvate synthase |
RA | 1,116,827 | C→T | 47.8% | G234G (GGC→GGT) | aroH → | 3‑deoxy‑D‑arabino‑heptulosonate‑7‑phosphate synthase, tryptophan repressible |
RA | 1,117,194 | A→G | 54.8% | intergenic (+22/‑110) | aroH → / → ydiE | 3‑deoxy‑D‑arabino‑heptulosonate‑7‑phosphate synthase, tryptophan repressible/conserved hypothetical protein |
RA | 1,119,187 | G→A | 62.9% | H175H (CAC→CAT) | ydiV ← | conserved hypothetical protein |
RA | 1,119,719 | G→T | 49.1% | intergenic (‑8/+239) | ydiV ← / ← nlpC | conserved hypothetical protein/predicted lipoprotein |
RA | 1,120,174 | T→C | 25.8% | K83K (AAA→AAG) | nlpC ← | predicted lipoprotein |
RA | 1,121,626 | T→C | 58.0% | M59V (ATG→GTG) | btuE ← | predicted glutathione peroxidase |
RA | 1,121,633 | T→A | 47.7% | R56R (CGA→CGT) | btuE ← | predicted glutathione peroxidase |
RA | 1,121,639 | G→A | 47.7% | V54V (GTC→GTT) ‡ | btuE ← | predicted glutathione peroxidase |
RA | 1,121,640 | A→G | 48.4% | V54A (GTC→GCC) ‡ | btuE ← | predicted glutathione peroxidase |
RA | 1,124,414 | G→A | 50.0% | L408L (CTA→TTA) | pheT ← | phenylalanine tRNA synthetase, beta subunit |
RA | 1,125,092 | G→A | 35.5% | L182L (CTG→TTG) | pheT ← | phenylalanine tRNA synthetase, beta subunit |
RA | 1,125,105 | A→G | 54.8% | R177R (CGT→CGC) | pheT ← | phenylalanine tRNA synthetase, beta subunit |
RA | 1,125,241 | C→T | 42.8% | S132N (AGC→AAC) | pheT ← | phenylalanine tRNA synthetase, beta subunit |
RA | 1,125,243 | G→A | 45.6% | H131H (CAC→CAT) | pheT ← | phenylalanine tRNA synthetase, beta subunit |
RA | 1,125,258 | G→T | 46.5% | G126G (GGC→GGA) | pheT ← | phenylalanine tRNA synthetase, beta subunit |
RA | 1,125,264 | T→C | 57.8% | E124E (GAA→GAG) | pheT ← | phenylalanine tRNA synthetase, beta subunit |
RA | 1,125,725 | A→G | 48.9% | T303T (ACT→ACC) | pheS ← | phenylalanine tRNA synthetase, alpha subunit |
RA | 1,126,307 | A→C | 71.5% | V109V (GTT→GTG) | pheS ← | phenylalanine tRNA synthetase, alpha subunit |
RA | 1,126,319 | A→C | 75.7% | G105G (GGT→GGG) | pheS ← | phenylalanine tRNA synthetase, alpha subunit |
RA | 1,126,343 | T→C | 77.7% | P97P (CCA→CCG) | pheS ← | phenylalanine tRNA synthetase, alpha subunit |
RA | 1,126,349 | A→G | 77.6% | S95S (TCT→TCC) | pheS ← | phenylalanine tRNA synthetase, alpha subunit |
RA | 1,126,684 | T→C | 61.7% | intergenic (‑51/+233) | pheS ← / ← pheM | phenylalanine tRNA synthetase, alpha subunit/phenylalanyl‑tRNA synthetase operon leader peptide |
RA | 1,130,079 | G→A | 42.6% | T61T (ACC→ACT) | thrS ← | threonyl‑tRNA synthetase |
RA | 1,130,566 | G→A | 25.2% | intergenic (‑305/‑219) | thrS ← / → arpB | threonyl‑tRNA synthetase/ECK1718:JW5278:b1720; hypothetical protein, N‑ter fragment |
RA | 1,130,923 | G→T | 31.9% | pseudogene (139/474 nt) pseudogene (139/1900 nt) |
arpB → arpB → |
ECK1718:JW5278:b1720; hypothetical protein, N‑ter fragment ECK1718:JW5278+JW1710:b4494; hypothetical protein |
RA | 1,130,925 | C→T | 36.7% | pseudogene (141/474 nt) pseudogene (141/1900 nt) |
arpB → arpB → |
ECK1718:JW5278:b1720; hypothetical protein, N‑ter fragment ECK1718:JW5278+JW1710:b4494; hypothetical protein |
RA | 1,133,307 | T→A | 51.0% | P156P (CCA→CCT) | ydiY ← | conserved hypothetical protein |
RA | 1,133,310 | A→G | 52.2% | G155G (GGT→GGC) | ydiY ← | conserved hypothetical protein |
RA | 1,133,571 | G→A | 28.4% | T68T (ACC→ACT) | ydiY ← | conserved hypothetical protein |
RA | 1,134,852 | G→T | 48.7% | L264L (CTG→CTT) | pfkB → | 6‑phosphofructokinase II |
RA | 1,134,888 | T→C | 40.6% | V276V (GTT→GTC) | pfkB → | 6‑phosphofructokinase II |
RA | 1,134,927 | T→C | 29.1% | N289N (AAT→AAC) | pfkB → | 6‑phosphofructokinase II |
RA | 1,134,939 | T→C | 26.7% | R293R (CGT→CGC) | pfkB → | 6‑phosphofructokinase II |
RA | 1,134,975 | T→G | 50.1% | A305A (GCT→GCG) | pfkB → | 6‑phosphofructokinase II |
RA | 1,135,605 | A→G | 28.9% | H40R (CAT→CGT) | yniA → | predicted phosphotransferase/kinase |
RA | 1,137,810 | T→C | 31.9% | intergenic (+71/‑92) | yniC → / → ydjM | predicted hydrolase/predicted inner membrane protein regulated by LexA |
RA | 1,138,447 | G→A | 36.8% | L182L (TTG→TTA) | ydjM → | predicted inner membrane protein regulated by LexA |
RA | 1,138,871 | T→C | 36.2% | L83L (TTA→CTA) | ydjN → | predicted transporter |
RA | 1,139,074 | T→C | 41.1% | I150I (ATT→ATC) | ydjN → | predicted transporter |
RA | 1,139,906 | T→C | 100% | L428L (TTA→CTA) | ydjN → | predicted transporter |
RA | 1,141,923 | T→C | 50.0% | I122I (ATT→ATC) | katE → | hydroperoxidase HPII(III) |
RA | 1,143,119 | G→A | 39.9% | R521H (CGC→CAC) | katE → | hydroperoxidase HPII(III) |
RA | 1,143,159 | C→A | 24.5% | V534V (GTC→GTA) | katE → | hydroperoxidase HPII(III) |
RA | 1,145,600 | A→G | 36.4% | L198L (TTG→CTG) | chbF ← | cryptic phospho‑beta‑glucosidase, NAD(P)‑binding |
RA | 1,146,056 | G→C | 23.8% | P46A (CCG→GCG) | chbF ← | cryptic phospho‑beta‑glucosidase, NAD(P)‑binding |
RA | 1,149,753 | G→A | 14.4% | R65R (CGC→CGT) | osmE ← | DNA‑binding transcriptional regulator |
RA | 1,153,175 | G→C | 36.0% | Q48E (CAG→GAG) | spy ← | envelope stress induced periplasmic protein |
RA | 1,153,197 | G→A | 42.8% | H40H (CAC→CAT) | spy ← | envelope stress induced periplasmic protein |
RA | 1,153,806 | C→T | 70.1% | S270N (AGT→AAT) | astE ← | succinylglutamate desuccinylase |
RA | 1,154,279 | T→C | 39.2% | L112L (CTA→CTG) | astE ← | succinylglutamate desuccinylase |
RA | 1,154,282 | C→T | 39.1% | Q111Q (CAG→CAA) | astE ← | succinylglutamate desuccinylase |
RA | 1,155,561 | G→A | 52.2% | A130A (GCC→GCT) | astB ← | succinylarginine dihydrolase |
RA | 1,155,567 | G→A | 48.6% | T128T (ACC→ACT) | astB ← | succinylarginine dihydrolase |
RA | 1,156,730 | G→A | 56.8% | L232L (CTC→CTT) | astD ← | succinylglutamic semialdehyde dehydrogenase |
RA | 1,156,744 | A→G | 44.1% | L228L (TTG→CTG) | astD ← | succinylglutamic semialdehyde dehydrogenase |
RA | 1,156,754 | T→G | 40.6% | T224T (ACA→ACC) | astD ← | succinylglutamic semialdehyde dehydrogenase |
RA | 1,156,766 | A→G | 41.9% | G220G (GGT→GGC) | astD ← | succinylglutamic semialdehyde dehydrogenase |
RA | 1,157,473 | G→T | 64.3% | A328A (GCC→GCA) | astA ← | arginine succinyltransferase |
RA | 1,160,787 | C→T | 29.4% | N223N (AAC→AAT) | xthA → | exonuclease III |
RA | 1,160,790 | T→C | 24.9% | R224R (CGT→CGC) | xthA → | exonuclease III |
RA | 1,161,118 | T→A | 32.6% | F9L (TTT→TTA) | ydjX → | predicted inner membrane protein |
RA | 1,161,857 | T→C | 37.5% | C17C (TGT→TGC) | ydjY → | hypothetical protein |
RA | 1,162,506 | T→A | 48.8% | M3K (ATG→AAG) | ydjZ → | conserved inner membrane protein |
RA | 1,162,897 | G→A | 24.2% | V133V (GTG→GTA) | ydjZ → | conserved inner membrane protein |
RA | 1,168,168 | C→A | 26.8% | G337G (GGC→GGA) | ynjE → | predicted thiosulfate sulfur transferase |
RA | 1,168,456 | T→C | 24.2% | S433S (AGT→AGC) | ynjE → | predicted thiosulfate sulfur transferase |
RA | 1,168,459 | C→T | 25.9% | S434S (AGC→AGT) | ynjE → | predicted thiosulfate sulfur transferase |
RA | 1,168,929 | C→T | 47.8% | V56I (GTC→ATC) | ynjF ← | predicted phosphatidyl transferase, inner membrane protein |
RA | 1,170,030 | C→T | 41.9% | intergenic (‑204/‑32) | ynjH ← / → gdhA | hypothetical protein/glutamate dehydrogenase, NADP‑specific |
RA | 1,170,190 | A→C | 30.4% | P43P (CCA→CCC) | gdhA → | glutamate dehydrogenase, NADP‑specific |
RA | 1,170,199 | C→T | 48.5% | R46R (CGC→CGT) | gdhA → | glutamate dehydrogenase, NADP‑specific |
RA | 1,174,382 | C→G | 67.1% | R90R (CGG→CGC) ‡ | topB ← | DNA topoisomerase III |
RA | 1,174,383 | C→T | 67.1% | R90Q (CGG→CAG) ‡ | topB ← | DNA topoisomerase III |
RA | 1,174,394 | G→A | 74.1% | N86N (AAC→AAT) | topB ← | DNA topoisomerase III |
RA | 1,174,406 | G→A | 63.3% | T82T (ACC→ACT) | topB ← | DNA topoisomerase III |
RA | 1,176,179 | T→C | 40.6% | E63E (GAA→GAG) | ydjA ← | predicted oxidoreductase |
RA | 1,176,188 | G→A | 48.4% | A60A (GCC→GCT) | ydjA ← | predicted oxidoreductase |
RA | 1,177,103 | G→A | 50.0% | L192L (TTG→TTA) | sppA → | protease IV |
RA | 1,177,523 | T→C | 19.6% | F332F (TTT→TTC) | sppA → | protease IV |
RA | 1,178,820 | C→T | 50.0% | G90G (GGC→GGT) | ansA → | cytoplasmic L‑asparaginase I |
RA | 1,178,823 | C→A | 45.7% | T91T (ACC→ACA) | ansA → | cytoplasmic L‑asparaginase I |
RA | 1,178,850 | G→A | 47.8% | A100A (GCG→GCA) | ansA → | cytoplasmic L‑asparaginase I |
RA | 1,178,979 | G→T | 32.8% | P143P (CCG→CCT) | ansA → | cytoplasmic L‑asparaginase I |
RA | 1,178,994 | G→T | 31.9% | T148T (ACG→ACT) | ansA → | cytoplasmic L‑asparaginase I |
RA | 1,179,174 | C→G | 56.6% | T208T (ACC→ACG) | ansA → | cytoplasmic L‑asparaginase I |
RA | 1,179,177 | A→G | 74.7% | P209P (CCA→CCG) | ansA → | cytoplasmic L‑asparaginase I |
RA | 1,181,303 | A→G | 46.6% | H109R (CAT→CGT) | yeaD → | conserved hypothetical protein |
RA | 1,182,072 | C→T | 53.6% | V231V (GTG→GTA) | yeaE ← | predicted oxidoreductase |
RA | 1,182,099 | G→A | 56.7% | S222S (AGC→AGT) | yeaE ← | predicted oxidoreductase |
RA | 1,182,950 | T→C | 42.8% | A217A (GCA→GCG) | mipA ← | scaffolding protein for murein synthesizing machinery |
RA | 1,182,954 | G→A | 41.2% | T216I (ACC→ATC) | mipA ← | scaffolding protein for murein synthesizing machinery |
RA | 1,182,974 | G→A | 44.0% | G209G (GGC→GGT) | mipA ← | scaffolding protein for murein synthesizing machinery |
RA | 1,184,938 | A→C | 41.4% | A301A (GCA→GCC) | yeaG → | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,184,950 | G→A | 40.5% | E305E (GAG→GAA) | yeaG → | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,186,871 | A→G | 24.2% | Q263Q (CAA→CAG) | yeaH → | conserved hypothetical protein |
RA | 1,190,401 | G→A | 61.0% | Q411Q (CAG→CAA) | yeaJ → | predicted diguanylate cyclase |
RA | 1,193,222 | T→A | 47.2% | V147V (GTA→GTT) | fadD ← | acyl‑CoA synthetase |
RA | 1,195,439 | T→C | 45.2% | P571P (CCA→CCG) | yoaA ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,195,442 | T→C | 40.0% | L570L (CTA→CTG) | yoaA ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,195,448 | C→T | 30.3% | V568V (GTG→GTA) | yoaA ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,195,481 | A→G | 24.4% | C557C (TGT→TGC) | yoaA ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,195,496 | C→T | 28.6% | A552A (GCG→GCA) | yoaA ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,202,586 | G→A | 51.4% | A82T (GCC→ACC) | yoaD → | predicted phosphodiesterase |
RA | 1,202,612 | G→T | 67.3% | A90A (GCG→GCT) | yoaD → | predicted phosphodiesterase |
RA | 1,203,338 | G→A | 34.9% | L332L (CTG→CTA) | yoaD → | predicted phosphodiesterase |
RA | 1,204,200 | A→G | 30.7% | D434D (GAT→GAC) | yoaE ← | fused predicted membrane proteins |
RA | 1,204,203 | A→G | 30.7% | T433T (ACT→ACC) | yoaE ← | fused predicted membrane proteins |
RA | 1,204,743 | C→G | 55.2% | L253L (CTG→CTC) | yoaE ← | fused predicted membrane proteins |
RA | 1,204,746 | G→A | 58.2% | I252I (ATC→ATT) | yoaE ← | fused predicted membrane proteins |
RA | 1,204,749 | G→C | 58.2% | A251A (GCC→GCG) | yoaE ← | fused predicted membrane proteins |
RA | 1,207,129 | G→C | 39.5% | G44G (GGG→GGC) | manY → | mannose‑specific enzyme IIC component of PTS |
RA | 1,207,231 | T→C | 43.8% | S78S (TCT→TCC) | manY → | mannose‑specific enzyme IIC component of PTS |
RA | 1,207,243 | C→T | 61.6% | T82T (ACC→ACT) | manY → | mannose‑specific enzyme IIC component of PTS |
RA | 1,209,598 | A→G | 41.1% | intergenic (+423/‑6) | yobD → / → yebN | conserved inner membrane protein/conserved inner membrane protein |
RA | 1,211,750 | A→T | 41.5% | intergenic (‑243/+427) | yobF ← / ← yebO | hypothetical protein/hypothetical protein |
RA | 1,214,890 | A→G | 100% | L233L (TTA→TTG) | yebQ → | predicted transporter |
RA | 1,215,319 | A→G | 41.1% | L376L (TTA→TTG) | yebQ → | predicted transporter |
RA | 1,217,488 | G→C | 45.4% | P415P (CCC→CCG) | prc ← | carboxy‑terminal protease for penicillin‑binding protein 3 |
RA | 1,217,491 | A→G | 45.4% | G414G (GGT→GGC) | prc ← | carboxy‑terminal protease for penicillin‑binding protein 3 |
RA | 1,217,494 | C→G | 44.8% | A413A (GCG→GCC) ‡ | prc ← | carboxy‑terminal protease for penicillin‑binding protein 3 |
RA | 1,217,496 | C→A | 44.7% | A413S (GCG→TCG) ‡ | prc ← | carboxy‑terminal protease for penicillin‑binding protein 3 |
RA | 1,217,497 | A→T | 44.8% | P412P (CCT→CCA) | prc ← | carboxy‑terminal protease for penicillin‑binding protein 3 |
RA | 1,217,503 | A→G | 62.1% | F410F (TTT→TTC) | prc ← | carboxy‑terminal protease for penicillin‑binding protein 3 |
RA | 1,217,545 | G→A | 100% | G396G (GGC→GGT) | prc ← | carboxy‑terminal protease for penicillin‑binding protein 3 |
RA | 1,220,477 | G→A | 70.6% | V102I (GTT→ATT) | yebS → | conserved inner membrane protein |
RA | 1,220,863 | T→C | 22.8% | L230L (CTT→CTC) | yebS → | conserved inner membrane protein |
RA | 1,221,439 | C→T | 37.4% | N422N (AAC→AAT) T5M (ACG→ATG) |
yebS → yebT → |
conserved inner membrane protein conserved hypothetical protein |
RA | 1,221,569 | C→T | 44.1% | T48T (ACC→ACT) | yebT → | conserved hypothetical protein |
RA | 1,222,865 | G→A | 42.0% | G480G (GGG→GGA) | yebT → | conserved hypothetical protein |
RA | 1,222,892 | T→C | 43.5% | G489G (GGT→GGC) | yebT → | conserved hypothetical protein |
RA | 1,223,717 | G→A | 31.7% | T764T (ACG→ACA) | yebT → | conserved hypothetical protein |
RA | 1,225,125 | C→T | 63.2% | F329F (TTC→TTT) | yebU → | predicted methyltransferase |
RA | 1,225,149 | T→C | 54.6% | A337A (GCT→GCC) | yebU → | predicted methyltransferase |
RA | 1,225,152 | A→T | 54.6% | G338G (GGA→GGT) | yebU → | predicted methyltransferase |
RA | 1,226,694 | A→G | 43.4% | C64C (TGT→TGC) | pphA ← | serine/threonine‑specific protein phosphatase 1 |
RA | 1,228,040 | A→G | 100% | I156I (ATT→ATC) | yebZ ← | predicted inner membrane protein |
RA | 1,228,052 | C→T | 100% | A152A (GCG→GCA) | yebZ ← | predicted inner membrane protein |
RA | 1,229,092 | C→A | 29.4% | A23A (GCC→GCA) | holE → | DNA polymerase III, theta subunit |
RA | 1,230,359 | T→A | 40.9% | P108P (CCT→CCA) | exoX → | DNA exonuclease X |
RA | 1,230,983 | G→A | 32.7% | Y591Y (TAC→TAT) | ptrB ← | protease II |
RA | 1,230,986 | C→T | 30.3% | E590E (GAG→GAA) | ptrB ← | protease II |
RA | 1,231,268 | T→A | 43.5% | G496G (GGA→GGT) | ptrB ← | protease II |
RA | 1,231,274 | T→C | 37.3% | E494E (GAA→GAG) | ptrB ← | protease II |
RA | 1,231,400 | A→G | 58.0% | Y452Y (TAT→TAC) | ptrB ← | protease II |
RA | 1,231,598 | G→A | 64.7% | D386D (GAC→GAT) | ptrB ← | protease II |
RA | 1,231,607 | A→G | 64.9% | T383T (ACT→ACC) | ptrB ← | protease II |
RA | 1,231,616 | A→C | 55.5% | S380S (TCT→TCG) | ptrB ← | protease II |
RA | 1,235,894 | G→A | 67.8% | V366V (GTG→GTA) | purT → | phosphoribosylglycinamide formyltransferase 2 |
RA | 1,238,257 | T→C | 28.5% | P88P (CCA→CCG) | edd ← | 6‑phosphogluconate dehydratase |
RA | 1,238,281 | C→A | 31.9% | A80A (GCG→GCT) | edd ← | 6‑phosphogluconate dehydratase |
RA | 1,238,425 | A→G | 43.5% | T32T (ACT→ACC) | edd ← | 6‑phosphogluconate dehydratase |
RA | 1,238,977 | C→T | 37.2% | A418A (GCG→GCA) | zwf ← | glucose‑6‑phosphate dehydrogenase |
RA | 1,238,989 | C→T | 29.6% | Q414Q (CAG→CAA) | zwf ← | glucose‑6‑phosphate dehydrogenase |
RA | 1,238,998 | G→A | 32.7% | T411T (ACC→ACT) | zwf ← | glucose‑6‑phosphate dehydrogenase |
RA | 1,239,208 | C→T | 40.6% | L341L (CTG→CTA) | zwf ← | glucose‑6‑phosphate dehydrogenase |
RA | 1,241,927 | C→T | 19.0% | V121V (GTC→GTT) | pykA → | pyruvate kinase II |
RA | 1,242,341 | C→T | 31.1% | D259D (GAC→GAT) | pykA → | pyruvate kinase II |
RA | 1,244,760 | A→T | 41.8% | A264A (GCT→GCA) | yebA ← | predicted peptidase |
RA | 1,246,200 | C→T | 36.7% | K100K (AAG→AAA) | znuA ← | zinc transporter subunit |
RA | 1,246,332 | G→C | 27.7% | G56G (GGC→GGG) | znuA ← | zinc transporter subunit |
RA | 1,246,341 | A→T | 29.4% | L53L (CTT→CTA) | znuA ← | zinc transporter subunit |
RA | 1,246,353 | T→C | 33.3% | T49T (ACA→ACG) | znuA ← | zinc transporter subunit |
RA | 1,246,943 | T→G | 100% | S122S (TCT→TCG) | znuC → | zinc transporter subunit |
RA | 1,246,967 | A→G | 100% | L130L (CTA→CTG) | znuC → | zinc transporter subunit |
RA | 1,247,830 | A→C | 22.3% | R167R (CGA→CGC) | znuB → | zinc transporter subunit |
RA | 1,248,433 | A→C | 67.3% | P280P (CCT→CCG) | ruvB ← | ATP‑dependent DNA helicase, component of RuvABC resolvasome |
RA | 1,248,436 | T→C | 66.1% | G279G (GGA→GGG) | ruvB ← | ATP‑dependent DNA helicase, component of RuvABC resolvasome |
RA | 1,251,077 | T→C | 29.8% | A72A (GCA→GCG) | ruvC ← | component of RuvABC resolvasome, endonuclease |
RA | 1,251,089 | T→C | 24.4% | Q68Q (CAA→CAG) | ruvC ← | component of RuvABC resolvasome, endonuclease |
RA | 1,251,528 | A→G | 35.9% | G180G (GGT→GGC) | yebC ← | conserved hypothetical protein |
RA | 1,251,873 | T→A | 100% | T65T (ACA→ACT) | yebC ← | conserved hypothetical protein |
RA | 1,251,909 | C→A | 56.7% | V53V (GTG→GTT) ‡ | yebC ← | conserved hypothetical protein |
RA | 1,251,911 | C→T | 56.7% | V53M (GTG→ATG) ‡ | yebC ← | conserved hypothetical protein |
RA | 1,251,912 | C→T | 56.7% | A52A (GCG→GCA) | yebC ← | conserved hypothetical protein |
RA | 1,251,915 | C→T | 58.0% | A51A (GCG→GCA) | yebC ← | conserved hypothetical protein |
RA | 1,251,923 | G→A | 56.1% | L49L (CTG→TTG) | yebC ← | conserved hypothetical protein |
RA | 1,253,454 | G→A | 53.2% | L329L (CTG→TTG) | aspS ← | aspartyl‑tRNA synthetase |
RA | 1,253,473 | G→A | 54.1% | R322R (CGC→CGT) | aspS ← | aspartyl‑tRNA synthetase |
RA | 1,253,551 | A→G | 70.7% | A296A (GCT→GCC) | aspS ← | aspartyl‑tRNA synthetase |
RA | 1,253,560 | A→G | 69.4% | T293T (ACT→ACC) | aspS ← | aspartyl‑tRNA synthetase |
RA | 1,255,182 | T→C | 29.1% | L145L (CTT→CTC) | yecD → | predicted hydrolase |
RA | 1,255,185 | C→T | 26.0% | G146G (GGC→GGT) | yecD → | predicted hydrolase |
RA | 1,255,821 | C→T | 31.7% | H171Y (CAC→TAC) | yecE → | conserved hypothetical protein |
RA | 1,257,696 | T→C | 100% | R113R (CGT→CGC) | yecP → | predicted methyltransferase |
RA | 1,257,700 | C→A | 100% | L115M (CTG→ATG) | yecP → | predicted methyltransferase |
RA | 1,257,879 | G→A | 58.2% | A174A (GCG→GCA) | yecP → | predicted methyltransferase |
RA | 1,258,176 | G→A | 65.5% | A273A (GCG→GCA) | yecP → | predicted methyltransferase |
RA | 1,259,087 | C→T | 51.5% | V613I (GTT→ATT) | torZ ← | trimethylamine N‑oxide reductase system III, catalytic subunit |
RA | 1,259,163 | A→C | 54.9% | T587T (ACT→ACG) | torZ ← | trimethylamine N‑oxide reductase system III, catalytic subunit |
RA | 1,259,166 | G→C | 47.9% | V586V (GTC→GTG) | torZ ← | trimethylamine N‑oxide reductase system III, catalytic subunit |
RA | 1,259,181 | G→C | 45.1% | A581A (GCC→GCG) | torZ ← | trimethylamine N‑oxide reductase system III, catalytic subunit |
RA | 1,261,248 | A→C | 54.7% | T267T (ACT→ACG) | torY ← | TMAO reductase III (TorYZ), cytochrome c‑type subunit |
RA | 1,261,251 | G→T | 53.9% | L266L (CTC→CTA) | torY ← | TMAO reductase III (TorYZ), cytochrome c‑type subunit |
RA | 1,261,587 | T→C | 21.9% | A154A (GCA→GCG) | torY ← | TMAO reductase III (TorYZ), cytochrome c‑type subunit |
RA | 1,261,872 | C→T | 48.5% | S59S (TCG→TCA) | torY ← | TMAO reductase III (TorYZ), cytochrome c‑type subunit |
RA | 1,263,009 | A→G | 41.5% | I58I (ATT→ATC) | cutC ← | copper homeostasis protein |
RA | 1,263,012 | T→A | 40.2% | I57I (ATA→ATT) | cutC ← | copper homeostasis protein |
RA | 1,263,024 | A→T | 40.6% | P53P (CCT→CCA) | cutC ← | copper homeostasis protein |
RA | 1,266,325 | A→C | 37.0% | I154L (ATT→CTT) | tyrP → | tyrosine transporter |
RA | 1,266,328 | T→C | 36.2% | S155P (TCT→CCT) | tyrP → | tyrosine transporter |
RA | 1,266,337 | T→A | 37.6% | C158S (TGC→AGC) | tyrP → | tyrosine transporter |
RA | 1,266,364 | T→A | 61.0% | *167R (TGA→AGA) | tyrP → | tyrosine transporter |
RA | 1,266,733 | T→G | 39.3% | intergenic (+54/+8) | tyrP → / ← yecA | tyrosine transporter/conserved metal‑binding protein |
RA | 1,266,736 | G→A | 39.1% | intergenic (+57/+5) | tyrP → / ← yecA | tyrosine transporter/conserved metal‑binding protein |
RA | 1,266,786 | G→A | 45.6% | C207C (TGC→TGT) | yecA ← | conserved metal‑binding protein |
RA | 1,268,188 | T→G | 53.7% | A139A (GCA→GCC) | pgsA ← | phosphatidylglycerophosphate synthetase |
RA | 1,268,191 | C→T | 52.4% | L138L (TTG→TTA) | pgsA ← | phosphatidylglycerophosphate synthetase |
RA | 1,269,009 | G→A | 100% | R148C (CGT→TGT) | uvrC ← | excinuclease UvrABC, endonuclease subunit |
RA | 1,271,105 | A→G | 28.6% | V384V (GTT→GTC) | yedQ ← | predicted diguanylate cyclase |
RA | 1,272,913 | C→T | 55.9% | A231A (GCG→GCA) | yedI ← | conserved inner membrane protein |
RA | 1,274,978 | A→G | 25.8% | T97A (ACA→GCA) | yodA → | conserved metal‑binding protein |
RA | 1,274,991 | A→G | 31.3% | Q101R (CAA→CGA) | yodA → | conserved metal‑binding protein |
RA | 1,279,208 | C→G | 35.5% | H329Q (CAC→CAG) | yeeJ → | adhesin |
RA | 1,279,216 | G→C | 39.3% | G332A (GGT→GCT) ‡ | yeeJ → | adhesin |
RA | 1,279,217 | T→A | 39.3% | G332G (GGT→GGA) ‡ | yeeJ → | adhesin |
RA | 1,279,219 | A→G | 52.4% | K333R (AAA→AGA) ‡ | yeeJ → | adhesin |
RA | 1,279,220 | A→C | 52.4% | K333N (AAA→AAC) ‡ | yeeJ → | adhesin |
RA | 1,279,224 | G→A | 47.8% | V335I (GTC→ATC) ‡ | yeeJ → | adhesin |
RA | 1,279,226 | C→G | 47.8% | V335V (GTC→GTG) ‡ | yeeJ → | adhesin |
RA | 1,282,611 | G→A | 61.1% | A1464T (GCG→ACG) | yeeJ → | adhesin |
RA | 1,283,633 | T→G | 39.0% | V1804V (GTT→GTG) | yeeJ → | adhesin |
RA | 1,283,634 | G→A | 39.7% | A1805T (GCG→ACG) | yeeJ → | adhesin |
RA | 1,283,647 | T→C | 43.2% | V1809A (GTG→GCG) | yeeJ → | adhesin |
RA | 1,283,662 | A→C | 31.5% | E1814A (GAG→GCG) | yeeJ → | adhesin |
RA | 1,283,867 | C→T | 100% | A1882A (GCC→GCT) | yeeJ → | adhesin |
RA | 1,284,101 | A→G | 38.2% | K1960K (AAA→AAG) | yeeJ → | adhesin |
RA | 1,284,104 | C→T | 42.2% | V1961V (GTC→GTT) | yeeJ → | adhesin |
RA | 1,284,114 | T→C | 48.0% | S1965P (TCA→CCA) | yeeJ → | adhesin |
RA | 1,284,125 | C→A | 43.4% | A1968A (GCC→GCA) | yeeJ → | adhesin |
RA | 1,285,590 | T→A | 33.0% | pseudogene (324/327 nt) pseudogene (1050/1053 nt) |
yeeL ← yeeL ← |
ECK1975:JW5325:b1979; hypothetical protein, C‑ter fragment ECK1975:JW1961+JW5325:b4497; hypothetical protein |
RA | 1,285,832 | G→A | 16.0% | pseudogene (82/327 nt) pseudogene (808/1053 nt) |
yeeL ← yeeL ← |
ECK1975:JW5325:b1979; hypothetical protein, C‑ter fragment ECK1975:JW1961+JW5325:b4497; hypothetical protein |
RA | 1,286,261 | A→T | 22.0% | pseudogene (379/1053 nt) pseudogene (379/705 nt) |
yeeL ← yeeL ← |
ECK1975:JW1961+JW5325:b4497; hypothetical protein ECK1975:JW1961:b1980; hypothetical protein, N‑ter fragment |
RA | 1,287,709 | C→T | 36.8% | F252F (TTC→TTT) | shiA → | shikimate transporter |
RA | 1,287,724 | G→A | 39.7% | A257A (GCG→GCA) | shiA → | shikimate transporter |
RA | 1,287,739 | A→G | 41.0% | E262E (GAA→GAG) | shiA → | shikimate transporter |
RA | 1,287,757 | C→T | 14.5% | I268I (ATC→ATT) | shiA → | shikimate transporter |
RA | 1,289,145 | T→C | 33.8% | H258H (CAT→CAC) | amn → | AMP nucleosidase |
RA | 1,289,523 | A→G | 61.0% | E384E (GAA→GAG) | amn → | AMP nucleosidase |
RA | 1,290,390 | C→T | 37.2% | G74G (GGC→GGT) | yeeN → | conserved hypothetical protein |
RA | 1,290,890 | C→A | 55.1% | intergenic (+5/+448) | yeeN → / ← asnW | conserved hypothetical protein/tRNA‑Asn |
RA | 1,290,892 | T→G | 52.5% | intergenic (+7/+446) | yeeN → / ← asnW | conserved hypothetical protein/tRNA‑Asn |
RA | 1,291,652 | A→G | 40.8% | G502G (GGT→GGC) | yeeO ← | predicted multidrug efflux system |
RA | 1,292,843 | A→G | 33.9% | N105N (AAT→AAC) | yeeO ← | predicted multidrug efflux system |
RA | 1,293,306 | C→T | 68.1% | S307N (AGC→AAC) | cbl ← | DNA‑binding transcriptional activator |
RA | 1,293,320 | C→G | 66.7% | R302R (CGG→CGC) | cbl ← | DNA‑binding transcriptional activator |
RA | 1,293,836 | C→T | 43.3% | T130T (ACG→ACA) | cbl ← | DNA‑binding transcriptional activator |
RA | 1,293,839 | C→A | 44.8% | G129G (GGG→GGT) | cbl ← | DNA‑binding transcriptional activator |
RA | 1,293,854 | G→C | 34.6% | L124L (CTC→CTG) | cbl ← | DNA‑binding transcriptional activator |
RA | 1,294,414 | C→T | 35.5% | S277S (TCG→TCA) | nac ← | DNA‑binding transcriptional dual regulator |
RA | 1,294,417 | T→C | 36.4% | L276L (TTA→TTG) | nac ← | DNA‑binding transcriptional dual regulator |
RA | 1,294,423 | C→T | 49.6% | A274A (GCG→GCA) | nac ← | DNA‑binding transcriptional dual regulator |
RA | 1,294,444 | T→G | 47.7% | S267S (TCA→TCC) | nac ← | DNA‑binding transcriptional dual regulator |
RA | 1,294,462 | G→T | 49.1% | S261S (TCC→TCA) | nac ← | DNA‑binding transcriptional dual regulator |
RA | 1,294,615 | T→C | 23.7% | R210R (CGA→CGG) | nac ← | DNA‑binding transcriptional dual regulator |
RA | 1,294,653 | T→C | 31.3% | I198V (ATT→GTT) | nac ← | DNA‑binding transcriptional dual regulator |
RA | 1,294,657 | A→G | 33.5% | S196S (AGT→AGC) | nac ← | DNA‑binding transcriptional dual regulator |
RA | 1,297,593 | C→T | 50.0% | A62A (GCG→GCA) | cobT ← | nicotinate‑nucleotide dimethylbenzimidazole‑P phophoribosyl transferase |
RA | 1,298,836 | A→C | 25.2% | L80L (CTT→CTG) | cobU ← | bifunctional cobinamide kinase and cobinamide phosphate guanylyltransferase |
RA | 1,299,765 | G→A | 37.5% | L66L (CTG→TTG) | yeeX ← | conserved hypothetical protein |
RA | 1,302,292 | A→G | 43.5% | S263S (AGT→AGC) | dacD ← | D‑alanyl‑D‑alanine carboxypeptidase |
RA | 1,302,805 | G→A | 58.4% | R92R (CGC→CGT) | dacD ← | D‑alanyl‑D‑alanine carboxypeptidase |
RA | 1,306,522 | T→A | 44.6% | A358A (GCA→GCT) | yeeF ← | predicted amino‑acid transporter |
RA | 1,307,479 | A→T | 25.2% | T39T (ACT→ACA) | yeeF ← | predicted amino‑acid transporter |
RA | 1,308,306 | T→C | 37.7% | S162S (TCA→TCG) | yeeY ← | predicted DNA‑binding transcriptional regulator |
RA | 1,308,309 | A→G | 37.0% | F161F (TTT→TTC) | yeeY ← | predicted DNA‑binding transcriptional regulator |
RA | 1,309,899 | G→A | 34.4% | R31R (CGC→CGT) | yefM ← | antitoxin of the YoeB‑YefM toxin‑antitoxin system |
RA | 1,309,908 | A→G | 39.6% | L28L (CTT→CTC) | yefM ← | antitoxin of the YoeB‑YefM toxin‑antitoxin system |
RA | 1,310,934 | T→C | 52.3% | V155V (GTT→GTC) | hisG → | ATP phosphoribosyltransferase |
RA | 1,310,940 | C→T | 61.1% | V157V (GTC→GTT) | hisG → | ATP phosphoribosyltransferase |
RA | 1,310,943 | C→G | 61.8% | A158A (GCC→GCG) | hisG → | ATP phosphoribosyltransferase |
RA | 1,312,382 | T→C | 46.6% | R336R (CGT→CGC) | hisD → | bifunctional histidinal dehydrogenase and histidinol dehydrogenase |
RA | 1,312,395 | A→G | 48.9% | S341G (AGC→GGC) | hisD → | bifunctional histidinal dehydrogenase and histidinol dehydrogenase |
RA | 1,312,860 | C→T | 23.4% | A62V (GCG→GTG) | hisC → | histidinol‑phosphate aminotransferase |
RA | 1,314,240 | T→A | 28.7% | R165R (CGT→CGA) | hisB → | fused histidinol‑phosphatase and imidazoleglycerol‑phosphate dehydratase |
RA | 1,314,252 | T→C | 42.5% | A169A (GCT→GCC) | hisB → | fused histidinol‑phosphatase and imidazoleglycerol‑phosphate dehydratase |
RA | 1,314,264 | T→C | 50.6% | R173R (CGT→CGC) | hisB → | fused histidinol‑phosphatase and imidazoleglycerol‑phosphate dehydratase |
RA | 1,314,267 | T→C | 50.7% | N174N (AAT→AAC) | hisB → | fused histidinol‑phosphatase and imidazoleglycerol‑phosphate dehydratase |
RA | 1,314,660 | C→T | 24.6% | L305L (CTC→CTT) | hisB → | fused histidinol‑phosphatase and imidazoleglycerol‑phosphate dehydratase |
RA | 1,315,519 | C→T | 72.3% | A39A (GCC→GCT) | hisA → | N‑(5'‑phospho‑L‑ribosyl‑formimino)‑5‑amino‑1‑ (5'‑phosphoribosyl)‑4‑imidazolecarboxamide isomerase |
RA | 1,315,525 | G→A | 72.3% | Q41Q (CAG→CAA) | hisA → | N‑(5'‑phospho‑L‑ribosyl‑formimino)‑5‑amino‑1‑ (5'‑phosphoribosyl)‑4‑imidazolecarboxamide isomerase |
RA | 1,315,909 | G→A | 22.4% | L169L (CTG→CTA) | hisA → | N‑(5'‑phospho‑L‑ribosyl‑formimino)‑5‑amino‑1‑ (5'‑phosphoribosyl)‑4‑imidazolecarboxamide isomerase |
RA | 1,316,223 | G→A | 24.0% | P34P (CCG→CCA) | hisF → | imidazole glycerol phosphate synthase, catalytic subunit with HisF |
RA | 1,316,241 | T→C | 23.1% | A40A (GCT→GCC) | hisF → | imidazole glycerol phosphate synthase, catalytic subunit with HisF |
RA | 1,318,439 | T→A | 18.4% | G47G (GGA→GGT) | cld ← | regulator of length of O‑antigen component of lipopolysaccharide chains |
RA | 1,319,007 | C→T | 44.3% | K295K (AAG→AAA) | ugd ← | UDP‑glucose 6‑dehydrogenase |
RA | 1,320,248 | A→G | 60.8% | A433A (GCT→GCC) | gnd ← | gluconate‑6‑phosphate dehydrogenase, decarboxylating |
RA | 1,320,260 | G→A | 51.6% | D429D (GAC→GAT) | gnd ← | gluconate‑6‑phosphate dehydrogenase, decarboxylating |
RA | 1,322,814 | A→G | 39.4% | I40I (ATT→ATC) | galF ← | predicted subunit with GalU |
RA | 1,322,844 | T→C | 32.6% | P30P (CCA→CCG) | galF ← | predicted subunit with GalU |
RA | 1,324,798 | A→G | 41.3% | G312G (GGT→GGC) | wcaL ← | predicted glycosyl transferase |
RA | 1,325,781 | T→C | 36.3% | T410T (ACA→ACG) | wcaK ← | predicted pyruvyl transferase |
RA | 1,325,790 | C→T | 35.7% | E407E (GAG→GAA) | wcaK ← | predicted pyruvyl transferase |
RA | 1,325,793 | A→G | 29.9% | R406R (CGT→CGC) | wcaK ← | predicted pyruvyl transferase |
RA | 1,325,802 | G→A | 30.7% | A403A (GCC→GCT) | wcaK ← | predicted pyruvyl transferase |
RA | 1,325,808 | A→G | 23.8% | S401S (AGT→AGC) ‡ | wcaK ← | predicted pyruvyl transferase |
RA | 1,325,809 | C→T | 23.8% | S401N (AGT→AAT) ‡ | wcaK ← | predicted pyruvyl transferase |
RA | 1,325,817 | C→T | 23.8% | A398A (GCG→GCA) | wcaK ← | predicted pyruvyl transferase |
RA | 1,325,820 | A→G | 25.3% | N397N (AAT→AAC) | wcaK ← | predicted pyruvyl transferase |
RA | 1,326,078 | T→C | 39.3% | V311V (GTA→GTG) | wcaK ← | predicted pyruvyl transferase |
RA | 1,327,112 | C→T | 40.6% | intergenic (‑102/+174) | wcaK ← / ← wzxC | predicted pyruvyl transferase/colanic acid exporter |
RA | 1,330,278 | C→T | 45.9% | S436S (TCG→TCA) | cpsG ← | phosphomannomutase |
RA | 1,330,292 | G→A | 47.3% | L432L (CTG→TTG) | cpsG ← | phosphomannomutase |
RA | 1,330,293 | G→C | 47.8% | R431R (CGC→CGG) | cpsG ← | phosphomannomutase |
RA | 1,330,311 | A→G | 61.9% | N425N (AAT→AAC) | cpsG ← | phosphomannomutase |
RA | 1,330,467 | A→G | 48.1% | F373F (TTT→TTC) | cpsG ← | phosphomannomutase |
RA | 1,330,470 | C→T | 48.1% | A372A (GCG→GCA) | cpsG ← | phosphomannomutase |
RA | 1,330,617 | G→A | 21.2% | A323A (GCC→GCT) | cpsG ← | phosphomannomutase |
RA | 1,330,797 | G→A | 35.1% | G263G (GGC→GGT) | cpsG ← | phosphomannomutase |
RA | 1,330,803 | A→G | 36.2% | I261I (ATT→ATC) | cpsG ← | phosphomannomutase |
RA | 1,331,307 | A→G | 68.2% | I93I (ATT→ATC) | cpsG ← | phosphomannomutase |
RA | 1,332,182 | A→G | 44.4% | A315A (GCT→GCC) | cpsB ← | mannose‑1‑phosphate guanyltransferase |
RA | 1,334,062 | C→T | 51.5% | P97P (CCG→CCA) | wcaI ← | predicted glycosyl transferase |
RA | 1,334,438 | A→G | 24.2% | S131P (TCG→CCG) | nudD ← | GDP‑mannose mannosyl hydrolase |
RA | 1,335,308 | C→T | 43.4% | P163P (CCG→CCA) | fcl ← | bifunctional GDP‑fucose synthetase: GDP‑4‑dehydro‑6‑deoxy‑D‑mannose epimerase and GDP‑4‑dehydro‑6‑L‑deoxygalactose reductase |
RA | 1,335,329 | G→C | 30.5% | R156R (CGC→CGG) | fcl ← | bifunctional GDP‑fucose synthetase: GDP‑4‑dehydro‑6‑deoxy‑D‑mannose epimerase and GDP‑4‑dehydro‑6‑L‑deoxygalactose reductase |
RA | 1,335,350 | T→A | 28.7% | S149S (TCA→TCT) | fcl ← | bifunctional GDP‑fucose synthetase: GDP‑4‑dehydro‑6‑deoxy‑D‑mannose epimerase and GDP‑4‑dehydro‑6‑L‑deoxygalactose reductase |
RA | 1,336,186 | C→T | 52.2% | Q245Q (CAG→CAA) | gmd ← | GDP‑D‑mannose dehydratase, NAD(P)‑binding |
RA | 1,336,234 | G→A | 36.1% | H229H (CAC→CAT) | gmd ← | GDP‑D‑mannose dehydratase, NAD(P)‑binding |
RA | 1,336,510 | A→G | 49.4% | Y137Y (TAT→TAC) | gmd ← | GDP‑D‑mannose dehydratase, NAD(P)‑binding |
RA | 1,336,522 | G→A | 54.3% | T133T (ACC→ACT) | gmd ← | GDP‑D‑mannose dehydratase, NAD(P)‑binding |
RA | 1,336,525 | G→A | 49.3% | S132S (TCC→TCT) | gmd ← | GDP‑D‑mannose dehydratase, NAD(P)‑binding |
RA | 1,336,543 | A→G | 32.7% | T126T (ACT→ACC) | gmd ← | GDP‑D‑mannose dehydratase, NAD(P)‑binding |
RA | 1,337,546 | A→C | 65.0% | T237T (ACT→ACG) | wcaE ← | predicted glycosyl transferase |
RA | 1,337,550 | C→T | 65.1% | R236H (CGT→CAT) | wcaE ← | predicted glycosyl transferase |
RA | 1,337,984 | C→T | 22.8% | S91S (TCG→TCA) | wcaE ← | predicted glycosyl transferase |
RA | 1,337,998 | A→G | 21.1% | L87L (TTG→CTG) | wcaE ← | predicted glycosyl transferase |
RA | 1,339,846 | A→G | 36.6% | F277F (TTT→TTC) | wcaC ← | predicted glycosyl transferase |
RA | 1,339,849 | G→A | 36.5% | T276T (ACC→ACT) | wcaC ← | predicted glycosyl transferase |
RA | 1,339,861 | A→G | 30.5% | I272I (ATT→ATC) | wcaC ← | predicted glycosyl transferase |
RA | 1,339,872 | C→T | 25.1% | G269S (GGC→AGC) | wcaC ← | predicted glycosyl transferase |
RA | 1,339,891 | T→C | 23.3% | V262V (GTA→GTG) | wcaC ← | predicted glycosyl transferase |
RA | 1,341,374 | A→G | 22.0% | G210G (GGT→GGC) | wcaA ← | predicted glycosyl transferase |
RA | 1,341,410 | T→C | 22.6% | V198V (GTA→GTG) | wcaA ← | predicted glycosyl transferase |
RA | 1,341,659 | T→A | 100% | T115T (ACA→ACT) | wcaA ← | predicted glycosyl transferase |
RA | 1,341,698 | A→G | 36.9% | R102R (CGT→CGC) | wcaA ← | predicted glycosyl transferase |
RA | 1,343,146 | C→T | 42.5% | E371E (GAG→GAA) | wzc ← | protein‑tyrosine kinase |
RA | 1,343,784 | T→C | 72.0% | N159D (AAC→GAC) | wzc ← | protein‑tyrosine kinase |
RA | 1,343,785 | G→A | 72.0% | D158D (GAC→GAT) | wzc ← | protein‑tyrosine kinase |
RA | 1,343,788 | C→A | 71.1% | L157L (CTG→CTT) | wzc ← | protein‑tyrosine kinase |
RA | 1,344,055 | G→A | 67.8% | S68S (AGC→AGT) | wzc ← | protein‑tyrosine kinase |
RA | 1,344,420 | C→A | 43.5% | P95P (CCG→CCT) | wzb ← | protein‑tyrosine phosphatase |
RA | 1,345,321 | C→T | 36.8% | G177S (GGT→AGT) | wza ← | lipoprotein required for capsular polysaccharide translocation through the outer membrane |
RA | 1,346,921 | T→C | 53.3% | I138I (ATT→ATC) | yegH → | fused predicted membrane proteins |
RA | 1,346,936 | A→G | 46.0% | S143S (TCA→TCG) | yegH → | fused predicted membrane proteins |
RA | 1,347,113 | A→G | 26.8% | A202A (GCA→GCG) | yegH → | fused predicted membrane proteins |
RA | 1,347,872 | G→A | 32.7% | E455E (GAG→GAA) | yegH → | fused predicted membrane proteins |
RA | 1,350,590 | C→T | 24.9% | G78S (GGC→AGC) | dcd ← | 2'‑deoxycytidine 5'‑triphosphate deaminase |
RA | 1,350,591 | C→T | 24.9% | E77E (GAG→GAA) | dcd ← | 2'‑deoxycytidine 5'‑triphosphate deaminase |
RA | 1,350,594 | G→A | 25.2% | D76D (GAC→GAT) | dcd ← | 2'‑deoxycytidine 5'‑triphosphate deaminase |
RA | 1,351,725 | G→A | 56.5% | intergenic (‑171/+202) | udk ← / ← thiD | uridine/cytidine kinase/bifunctional hydroxy‑methylpyrimidine kinase and hydroxy‑phosphomethylpyrimidine kinase |
RA | 1,351,726 | T→C | 54.7% | intergenic (‑172/+201) | udk ← / ← thiD | uridine/cytidine kinase/bifunctional hydroxy‑methylpyrimidine kinase and hydroxy‑phosphomethylpyrimidine kinase |
RA | 1,351,743 | A→T | 38.7% | intergenic (‑189/+184) | udk ← / ← thiD | uridine/cytidine kinase/bifunctional hydroxy‑methylpyrimidine kinase and hydroxy‑phosphomethylpyrimidine kinase |
RA | 1,352,188 | C→A | 50.4% | L180L (CTG→CTT) | thiD ← | bifunctional hydroxy‑methylpyrimidine kinase and hydroxy‑phosphomethylpyrimidine kinase |
RA | 1,353,402 | G→A | 43.9% | T37T (ACC→ACT) | thiM ← | hydoxyethylthiazole kinase |
RA | 1,353,408 | G→A | 36.0% | T35T (ACC→ACT) | thiM ← | hydoxyethylthiazole kinase |
RA | 1,353,423 | A→G | 43.2% | N30N (AAT→AAC) | thiM ← | hydoxyethylthiazole kinase |
RA | 1,353,786 | A→T | 20.4% | R74R (CGT→CGA) | yohL ← | conserved hypothetical protein |
RA | 1,354,874 | C→T | 34.2% | A249A (GCC→GCT) | yohM → | membrane protein conferring nickel and cobalt resistance |
RA | 1,356,770 | A→G | 58.1% | S784S (AGT→AGC) | yehB ← | predicted outer membrane protein |
RA | 1,356,788 | G→A | 41.1% | G778G (GGC→GGT) | yehB ← | predicted outer membrane protein |
RA | 1,357,250 | C→T | 54.0% | L624L (TTG→TTA) | yehB ← | predicted outer membrane protein |
RA | 1,357,304 | A→C | 29.9% | G606G (GGT→GGG) | yehB ← | predicted outer membrane protein |
RA | 1,357,310 | A→G | 28.1% | N604N (AAT→AAC) | yehB ← | predicted outer membrane protein |
RA | 1,357,313 | G→A | 27.6% | F603F (TTC→TTT) | yehB ← | predicted outer membrane protein |
RA | 1,357,325 | A→G | 43.5% | S599S (AGT→AGC) | yehB ← | predicted outer membrane protein |
RA | 1,357,328 | C→T | 43.1% | G598G (GGG→GGA) | yehB ← | predicted outer membrane protein |
RA | 1,357,331 | T→A | 40.4% | V597V (GTA→GTT) | yehB ← | predicted outer membrane protein |
RA | 1,357,334 | T→G | 30.2% | T596T (ACA→ACC) | yehB ← | predicted outer membrane protein |
RA | 1,357,628 | A→G | 64.8% | G498G (GGT→GGC) | yehB ← | predicted outer membrane protein |
RA | 1,357,646 | G→A | 55.7% | S492S (AGC→AGT) | yehB ← | predicted outer membrane protein |
RA | 1,357,658 | G→A | 35.3% | S488S (TCC→TCT) | yehB ← | predicted outer membrane protein |
RA | 1,357,714 | C→T | 34.0% | V470I (GTC→ATC) | yehB ← | predicted outer membrane protein |
RA | 1,357,757 | A→T | 45.7% | V455V (GTT→GTA) | yehB ← | predicted outer membrane protein |
RA | 1,357,820 | C→T | 30.2% | T434T (ACG→ACA) | yehB ← | predicted outer membrane protein |
RA | 1,359,713 | A→G | 34.2% | N48N (AAT→AAC) ‡ | yehC ← | predicted periplasmic pilin chaperone |
RA | 1,359,715 | T→G | 39.8% | N48H (AAT→CAT) ‡ | yehC ← | predicted periplasmic pilin chaperone |
RA | 1,359,716 | T→C | 39.7% | E47E (GAA→GAG) | yehC ← | predicted periplasmic pilin chaperone |
RA | 1,359,734 | G→A | 45.1% | R41R (CGC→CGT) | yehC ← | predicted periplasmic pilin chaperone |
RA | 1,359,914 | C→T | 43.7% | V174I (GTT→ATT) | yehD ← | predicted fimbrial‑like adhesin protein |
RA | 1,359,918 | A→G | 43.7% | S172S (TCT→TCC) | yehD ← | predicted fimbrial‑like adhesin protein |
RA | 1,360,119 | A→T | 58.1% | G105G (GGT→GGA) | yehD ← | predicted fimbrial‑like adhesin protein |
RA | 1,361,205 | T→A | 50.5% | intergenic (‑198/+65) | yehE ← / ← mrp | hypothetical protein/antiporter inner membrane protein |
RA | 1,363,050 | C→T | 46.1% | G180G (GGC→GGT) | metG → | methionyl‑tRNA synthetase |
RA | 1,363,056 | G→C | 47.7% | T182T (ACG→ACC) | metG → | methionyl‑tRNA synthetase |
RA | 1,363,569 | A→C | 25.3% | A353A (GCA→GCC) | metG → | methionyl‑tRNA synthetase |
RA | 1,364,193 | G→A | 14.4% | P561P (CCG→CCA) | metG → | methionyl‑tRNA synthetase |
RA | 1,364,199 | A→T | 15.3% | A563A (GCA→GCT) | metG → | methionyl‑tRNA synthetase |
RA | 1,364,202 | T→C | 18.6% | D564D (GAT→GAC) | metG → | methionyl‑tRNA synthetase |
RA | 1,364,205 | T→C | 18.6% | D565D (GAT→GAC) | metG → | methionyl‑tRNA synthetase |
RA | 1,365,129 | C→T | 47.5% | R100R (CGC→CGT) | yohD → | conserved inner membrane protein |
RA | 1,365,663 | C→T | 57.3% | A213T (GCA→ACA) | yohF ← | predicted oxidoreductase with NAD(P)‑binding Rossmann‑fold domain |
RA | 1,365,673 | C→T | 56.8% | R209R (CGG→CGA) | yohF ← | predicted oxidoreductase with NAD(P)‑binding Rossmann‑fold domain |
RA | 1,367,294 | G→A | 28.6% | A49A (GCC→GCT) | yohG ← | predicted outer membrane protein |
RA | 1,367,302 | C→T | 32.2% | V47I (GTT→ATT) | yohG ← | predicted outer membrane protein |
RA | 1,367,570 | A→G | 42.3% | intergenic (‑130/+8) | yohG ← / ← yohH | predicted outer membrane protein/conserved hypothetical protein |
RA | 1,367,573 | G→A | 42.3% | intergenic (‑133/+5) | yohG ← / ← yohH | predicted outer membrane protein/conserved hypothetical protein |
RA | 1,368,902 | C→T | 59.2% | T171T (ACG→ACA) | dusC ← | tRNA‑dihydrouridine synthase C |
RA | 1,368,914 | C→T | 56.5% | V167V (GTG→GTA) | dusC ← | tRNA‑dihydrouridine synthase C |
RA | 1,368,917 | C→T | 55.7% | V166V (GTG→GTA) | dusC ← | tRNA‑dihydrouridine synthase C |
RA | 1,369,001 | C→T | 52.5% | V138V (GTG→GTA) | dusC ← | tRNA‑dihydrouridine synthase C |
RA | 1,369,010 | G→A | 45.6% | P135P (CCC→CCT) | dusC ← | tRNA‑dihydrouridine synthase C |
RA | 1,369,034 | A→G | 67.9% | R127R (CGT→CGC) | dusC ← | tRNA‑dihydrouridine synthase C |
RA | 1,369,934 | C→T | 30.1% | G94G (GGC→GGT) | yohJ → | conserved inner membrane protein |
RA | 1,369,997 | G→A | 53.1% | S115S (TCG→TCA) | yohJ → | conserved inner membrane protein |
RA | 1,370,006 | A→G | 54.9% | V118V (GTA→GTG) | yohJ → | conserved inner membrane protein |
RA | 1,370,805 | C→T | 33.0% | intergenic (+62/‑68) | yohK → / → cdd | predicted inner membrane protein/cytidine/deoxycytidine deaminase |
RA | 1,370,824 | C→T | 36.9% | intergenic (+81/‑49) | yohK → / → cdd | predicted inner membrane protein/cytidine/deoxycytidine deaminase |
RA | 1,371,319 | G→T | 30.1% | L149L (CTG→CTT) | cdd → | cytidine/deoxycytidine deaminase |
RA | 1,371,325 | C→A | 25.7% | G151G (GGC→GGA) | cdd → | cytidine/deoxycytidine deaminase |
RA | 1,371,355 | G→A | 40.2% | L161L (CTG→CTA) | cdd → | cytidine/deoxycytidine deaminase |
RA | 1,371,358 | A→G | 40.9% | P162P (CCA→CCG) | cdd → | cytidine/deoxycytidine deaminase |
RA | 1,371,806 | C→T | 100% | intergenic (+49/‑101) | cdd → / → sanA | cytidine/deoxycytidine deaminase/hypothetical protein |
RA | 1,374,788 | G→T | 19.9% | R165R (CGG→CGT) | yeiA → | predicted oxidoreductase |
RA | 1,375,750 | C→A | 33.6% | intergenic (+221/+22) | yeiA → / ← mglC | predicted oxidoreductase/methyl‑galactoside transporter subunit |
RA | 1,377,077 | C→T | 32.2% | K414K (AAG→AAA) | mglA ← | fused methyl‑galactoside transporter subunitsl and ATP‑binding components of ABC superfamily |
RA | 1,377,359 | T→A | 24.0% | I320I (ATA→ATT) | mglA ← | fused methyl‑galactoside transporter subunitsl and ATP‑binding components of ABC superfamily |
RA | 1,379,801 | G→A | 43.8% | A299A (GCC→GCT) | galS ← | DNA‑binding transcriptional repressor |
RA | 1,379,810 | C→A | 44.3% | A296A (GCG→GCT) | galS ← | DNA‑binding transcriptional repressor |
RA | 1,379,837 | G→A | 63.8% | T287T (ACC→ACT) | galS ← | DNA‑binding transcriptional repressor |
RA | 1,381,097 | C→T | 24.2% | A300A (GCG→GCA) | yeiB ← | conserved inner membrane protein |
RA | 1,381,100 | A→C | 34.5% | L299L (CTT→CTG) | yeiB ← | conserved inner membrane protein |
RA | 1,381,217 | G→A | 36.3% | R260R (CGC→CGT) | yeiB ← | conserved inner membrane protein |
RA | 1,381,235 | C→T | 35.3% | Q254Q (CAG→CAA) ‡ | yeiB ← | conserved inner membrane protein |
RA | 1,381,236 | T→C | 35.4% | Q254R (CAG→CGG) ‡ | yeiB ← | conserved inner membrane protein |
RA | 1,381,675 | A→G | 55.6% | L108L (TTG→CTG) | yeiB ← | conserved inner membrane protein |
RA | 1,381,717 | A→G | 60.7% | L94L (TTG→CTG) | yeiB ← | conserved inner membrane protein |
RA | 1,383,043 | T→A | 100% | P35P (CCT→CCA) | yeiG → | predicted esterase |
RA | 1,386,629 | C→T | 50.9% | A311A (GCG→GCA) | lysP ← | lysine transporter |
RA | 1,390,648 | C→T | 36.6% | L260L (CTC→CTT) | nfo → | endonuclease IV with intrinsic 3'‑5' exonuclease activity |
RA | 1,393,956 | A→G | 14.2% | G324G (GGT→GGC) | fruB ← | fused fructose‑specific PTS enzyme IIA component and HPr component |
RA | 1,398,612 | C→G | 42.4% | A312A (GCC→GCG) | yeiQ → | predicted dehydrogenase, NAD‑dependent |
RA | 1,398,615 | T→C | 44.2% | H313H (CAT→CAC) | yeiQ → | predicted dehydrogenase, NAD‑dependent |
RA | 1,400,543 | T→A | 54.6% | P86P (CCT→CCA) | yeiU → | undecaprenyl pyrophosphate phosphatase |
RA | 1,402,418 | A→G | 40.6% | A87A (GCA→GCG) | rtn → | conserved hypothetical protein |
RA | 1,402,436 | C→T | 46.9% | V93V (GTC→GTT) | rtn → | conserved hypothetical protein |
RA | 1,402,439 | A→T | 45.2% | R94R (CGA→CGT) | rtn → | conserved hypothetical protein |
RA | 1,402,454 | G→A | 40.3% | V99V (GTG→GTA) | rtn → | conserved hypothetical protein |
RA | 1,402,727 | C→T | 42.6% | G190G (GGC→GGT) | rtn → | conserved hypothetical protein |
RA | 1,403,231 | G→A | 42.8% | P358P (CCG→CCA) | rtn → | conserved hypothetical protein |
RA | 1,403,233 | A→C | 42.9% | D359A (GAC→GCC) | rtn → | conserved hypothetical protein |
RA | 1,403,261 | A→G | 39.5% | A368A (GCA→GCG) | rtn → | conserved hypothetical protein |
RA | 1,404,287 | A→G | 37.2% | A164A (GCA→GCG) | yejA → | predicted oligopeptide transporter subunit |
RA | 1,406,881 | A→G | 100% | L59L (TTA→TTG) | yejE → | predicted oligopeptide transporter subunit |
RA | 1,408,514 | G→A | 52.3% | P261P (CCG→CCA) | yejF → | fused predicted oligopeptide transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,408,517 | A→T | 51.7% | S262S (TCA→TCT) | yejF → | fused predicted oligopeptide transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,408,523 | T→C | 51.8% | D264D (GAT→GAC) | yejF → | fused predicted oligopeptide transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,408,526 | A→G | 46.9% | P265P (CCA→CCG) | yejF → | fused predicted oligopeptide transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,408,532 | G→A | 46.8% | P267P (CCG→CCA) | yejF → | fused predicted oligopeptide transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,408,544 | T→C | 43.5% | P271P (CCT→CCC) | yejF → | fused predicted oligopeptide transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,408,559 | G→A | 42.2% | L276L (CTG→CTA) | yejF → | fused predicted oligopeptide transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,408,853 | G→A | 56.8% | S374S (TCG→TCA) | yejF → | fused predicted oligopeptide transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,410,527 | A→G | 18.8% | S222S (AGT→AGC) | bcr ← | bicyclomycin/multidrug efflux system |
RA | 1,410,533 | A→C | 19.4% | L220L (CTT→CTG) | bcr ← | bicyclomycin/multidrug efflux system |
RA | 1,417,268 | T→G | 22.8% | A487A (GCT→GCG) | yejM → | predicted hydrolase, inner membrane |
RA | 1,417,873 | T→C | 46.4% | intergenic (+154/‑179) | proL → / → narP | tRNA‑Pro/DNA‑binding response regulator in two‑component regulatory system with NarQ or NarX |
RA | 1,419,063 | C→T | 29.4% | A300A (GCG→GCA) | ccmH ← | heme lyase, CcmH subunit |
RA | 1,419,077 | G→A | 33.7% | L296L (CTA→TTA) | ccmH ← | heme lyase, CcmH subunit |
RA | 1,419,735 | T→C | 21.9% | K76K (AAA→AAG) | ccmH ← | heme lyase, CcmH subunit |
RA | 1,419,744 | A→G | 21.9% | G73G (GGT→GGC) | ccmH ← | heme lyase, CcmH subunit |
RA | 1,420,124 | A→G | 72.4% | D131D (GAT→GAC) | ccmG ← | periplasmic thioredoxin of cytochrome c‑type biogenesis |
RA | 1,422,085 | A→G | 62.4% | R124R (CGT→CGC) | ccmF ← | heme lyase, CcmF subunit |
RA | 1,422,091 | C→A | 59.4% | V122V (GTG→GTT) | ccmF ← | heme lyase, CcmF subunit |
RA | 1,422,361 | A→G | 21.3% | D32D (GAT→GAC) | ccmF ← | heme lyase, CcmF subunit |
RA | 1,422,364 | T→C | 21.3% | G31G (GGA→GGG) | ccmF ← | heme lyase, CcmF subunit |
RA | 1,422,660 | C→T | 100% | V91V (GTG→GTA) | ccmE ← | periplasmic heme chaperone |
RA | 1,423,342 | C→A | 56.4% | V177V (GTG→GTT) | ccmC ← | heme exporter subunit |
RA | 1,426,028 | A→G | 44.9% | N81N (AAT→AAC) | napB ← | nitrate reductase, small, cytochrome C550 subunit, periplasmic |
RA | 1,426,109 | A→T | 21.0% | D54E (GAT→GAA) | napB ← | nitrate reductase, small, cytochrome C550 subunit, periplasmic |
RA | 1,427,002 | T→C | 40.8% | P43P (CCA→CCG) | napH ← | ferredoxin‑type protein essential for electron transfer from ubiquinol to periplasmic nitrate reductase (NapAB) |
RA | 1,427,948 | T→C | 31.5% | P786P (CCA→CCG) | napA ← | nitrate reductase, periplasmic, large subunit |
RA | 1,431,974 | T→C | 100% | intergenic (+29/+686) | eco → / ← mqo | ecotin, a serine protease inhibitor/malate dehydrogenase, FAD/NAD(P)‑binding domain |
RA | 1,431,976 | 2 bp→GA | 100% | intergenic (+31/+683) | eco → / ← mqo | ecotin, a serine protease inhibitor/malate dehydrogenase, FAD/NAD(P)‑binding domain |
RA | 1,431,979 | C→T | 100% | intergenic (+34/+681) | eco → / ← mqo | ecotin, a serine protease inhibitor/malate dehydrogenase, FAD/NAD(P)‑binding domain |
RA | 1,433,227 | T→C | 38.1% | L360L (CTA→CTG) | mqo ← | malate dehydrogenase, FAD/NAD(P)‑binding domain |
RA | 1,436,912 | G→A | 40.5% | A349V (GCT→GTT) | ada ← | fused DNA‑binding transcriptional dual regulator and O6‑methylguanine‑DNA methyltransferase |
RA | 1,438,595 | G→A | 42.8% | I164I (ATC→ATT) | yojL ← | predicted thiamine biosynthesis lipoprotein |
RA | 1,439,432 | G→A | 43.3% | F290F (TTC→TTT) | ompC ← | outer membrane porin protein C |
RA | 1,439,903 | A→G | 44.1% | G133G (GGT→GGC) | ompC ← | outer membrane porin protein C |
RA | 1,440,158 | T→C | 41.8% | K48K (AAA→AAG) | ompC ← | outer membrane porin protein C |
RA | 1,441,372 | G→C | 33.1% | A111A (GCG→GCC) | rcsD → | phosphotransfer intermediate protein in two‑component regulatory system with RcsBC |
RA | 1,444,406 | T→C | 34.5% | intergenic (+27/+173) | rcsB → / ← rcsC | DNA‑binding response regulator in two‑component regulatory system with RcsC and YojN/hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,444,430 | C→G | 21.4% | intergenic (+51/+149) | rcsB → / ← rcsC | DNA‑binding response regulator in two‑component regulatory system with RcsC and YojN/hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,445,416 | A→G | 70.7% | D655D (GAT→GAC) | rcsC ← | hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,445,467 | G→A | 52.6% | T638T (ACC→ACT) | rcsC ← | hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,446,895 | G→A | 45.4% | I162I (ATC→ATT) | rcsC ← | hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,446,916 | C→T | 20.2% | L155L (TTG→TTA) ‡ | rcsC ← | hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,446,918 | A→G | 20.9% | L155L (TTG→CTG) ‡ | rcsC ← | hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,447,102 | G→A | 50.0% | S93S (TCC→TCT) | rcsC ← | hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,447,108 | G→A | 50.7% | A91A (GCC→GCT) | rcsC ← | hybrid sensory kinase in two‑component regulatory system with RcsB and YojN |
RA | 1,447,784 | G→A | 38.2% | D64N (GAT→AAT) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,448,005 | G→C | 41.8% | V137V (GTG→GTC) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,448,026 | A→G | 50.0% | L144L (TTA→TTG) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,448,248 | T→A | 14.3% | I218I (ATT→ATA) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,448,281 | A→T | 17.8% | A229A (GCA→GCT) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,448,347 | T→C | 57.7% | N251N (AAT→AAC) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,449,142 | C→T | 54.9% | S516S (AGC→AGT) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,449,160 | C→T | 49.5% | R522R (CGC→CGT) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,449,165 | A→G | 44.2% | Q524R (CAA→CGA) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,449,175 | A→G | 50.0% | Q527Q (CAA→CAG) | atoS → | sensory histidine kinase in two‑component regulatory system with AtoC |
RA | 1,450,176 | A→G | 66.2% | L253L (CTA→CTG) | atoC → | fused response regulator of ato opeon, in two‑component system with AtoS |
RA | 1,450,200 | A→G | 43.3% | L261L (CTA→CTG) | atoC → | fused response regulator of ato opeon, in two‑component system with AtoS |
RA | 1,453,736 | G→A | 48.1% | A26T (GCC→ACC) | atoB → | acetyl‑CoA acetyltransferase |
RA | 1,456,231 | C→T | 100% | T373T (ACG→ACA) | yfaQ ← | hypothetical protein |
RA | 1,456,246 | G→A | 100% | P368P (CCC→CCT) | yfaQ ← | hypothetical protein |
RA | 1,458,271 | C→T | 37.5% | pseudogene (3684/4605 nt) pseudogene (3684/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,458,274 | C→A | 37.6% | pseudogene (3681/4605 nt) pseudogene (3681/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,458,559 | A→G | 27.8% | pseudogene (3396/4605 nt) pseudogene (3396/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,458,571 | A→G | 37.8% | pseudogene (3384/4605 nt) pseudogene (3384/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,458,605 | G→A | 52.2% | pseudogene (3350/4605 nt) pseudogene (3350/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,459,992 | C→A | 50.0% | pseudogene (1963/4605 nt) pseudogene (1963/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,460,020 | A→G | 50.0% | pseudogene (1935/4605 nt) pseudogene (1935/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,460,029 | A→G | 55.4% | pseudogene (1926/4605 nt) pseudogene (1926/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,461,154 | T→G | 100% | pseudogene (801/4605 nt) pseudogene (801/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,461,157 | G→A | 62.5% | pseudogene (798/4605 nt) pseudogene (798/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,461,181 | G→T | 49.2% | pseudogene (774/4605 nt) pseudogene (774/4104 nt) |
yfaS ← yfaS ← |
ECK2220:JW2222+JW2221:b4500; hypothetical protein ECK2220:JW2222:b2228; hypothetical protein, N‑ter fragment |
RA | 1,462,113 | C→T | 20.4% | A133A (GCG→GCA) | yfaT ← | hypothetical protein |
RA | 1,463,378 | C→T | 64.3% | R273R (CGG→CGA) | yfaA ← | hypothetical protein |
RA | 1,463,756 | C→A | 40.6% | L147L (CTG→CTT) | yfaA ← | hypothetical protein |
RA | 1,463,780 | G→A | 32.4% | G139G (GGC→GGT) | yfaA ← | hypothetical protein |
RA | 1,464,254 | T→C | 22.8% | intergenic (‑58/+91) | yfaA ← / ← gyrA | hypothetical protein/DNA gyrase (type II topoisomerase), subunit A |
RA | 1,464,999 | A→G | 47.5% | T658T (ACT→ACC) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,065 | T→C | 100% | P636P (CCA→CCG) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,077 | A→G | 100% | T632T (ACT→ACC) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,344 | G→A | 58.4% | L543L (CTC→CTT) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,350 | C→G | 68.7% | V541V (GTG→GTC) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,353 | G→C | 65.0% | V540V (GTC→GTG) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,518 | G→A | 34.8% | I485I (ATC→ATT) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,692 | A→C | 22.0% | A427A (GCT→GCG) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,701 | G→C | 26.8% | L424L (CTC→CTG) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,465,710 | G→A | 28.8% | A421A (GCC→GCT) | gyrA ← | DNA gyrase (type II topoisomerase), subunit A |
RA | 1,469,153 | A→G | 31.2% | S857P (TCC→CCC) | yfaL ← | adhesin |
RA | 1,469,159 | C→T | 34.9% | V855I (GTT→ATT) | yfaL ← | adhesin |
RA | 1,469,318 | C→T | 38.0% | V802I (GTT→ATT) | yfaL ← | adhesin |
RA | 1,469,411 | T→C | 55.0% | T771A (ACA→GCA) | yfaL ← | adhesin |
RA | 1,469,414 | A→G | 55.1% | L770L (TTG→CTG) | yfaL ← | adhesin |
RA | 1,469,421 | A→G | 61.2% | G767G (GGT→GGC) | yfaL ← | adhesin |
RA | 1,472,815 | C→G | 24.6% | T133T (ACC→ACG) | nrdA → | ribonucleoside diphosphate reductase 1, alpha subunit |
RA | 1,472,914 | T→C | 45.6% | Y166Y (TAT→TAC) | nrdA → | ribonucleoside diphosphate reductase 1, alpha subunit |
RA | 1,472,917 | G→A | 45.6% | E167E (GAG→GAA) | nrdA → | ribonucleoside diphosphate reductase 1, alpha subunit |
RA | 1,473,718 | T→C | 69.7% | R434R (CGT→CGC) | nrdA → | ribonucleoside diphosphate reductase 1, alpha subunit |
RA | 1,474,270 | T→C | 28.2% | A618A (GCT→GCC) | nrdA → | ribonucleoside diphosphate reductase 1, alpha subunit |
RA | 1,474,576 | C→T | 34.3% | T720T (ACC→ACT) | nrdA → | ribonucleoside diphosphate reductase 1, alpha subunit |
RA | 1,475,298 | T→C | 31.4% | R121R (CGT→CGC) | nrdB → | ribonucleoside diphosphate reductase 1, beta subunit, ferritin‑like |
RA | 1,475,307 | T→C | 31.3% | T124T (ACT→ACC) | nrdB → | ribonucleoside diphosphate reductase 1, beta subunit, ferritin‑like |
RA | 1,475,316 | T→C | 21.5% | I127I (ATT→ATC) | nrdB → | ribonucleoside diphosphate reductase 1, beta subunit, ferritin‑like |
RA | 1,475,709 | C→T | 36.3% | D258D (GAC→GAT) | nrdB → | ribonucleoside diphosphate reductase 1, beta subunit, ferritin‑like |
RA | 1,475,715 | T→G | 37.8% | P260P (CCT→CCG) | nrdB → | ribonucleoside diphosphate reductase 1, beta subunit, ferritin‑like |
RA | 1,475,814 | C→T | 19.8% | R293R (CGC→CGT) | nrdB → | ribonucleoside diphosphate reductase 1, beta subunit, ferritin‑like |
RA | 1,475,817 | C→T | 19.5% | D294D (GAC→GAT) | nrdB → | ribonucleoside diphosphate reductase 1, beta subunit, ferritin‑like |
RA | 1,475,847 | T→C | 42.7% | I304I (ATT→ATC) | nrdB → | ribonucleoside diphosphate reductase 1, beta subunit, ferritin‑like |
RA | 1,476,848 | A→G | 29.8% | Y59Y (TAT→TAC) | inaA ← | conserved hypothetical protein |
RA | 1,476,857 | G→A | 29.1% | S56S (TCC→TCT) | inaA ← | conserved hypothetical protein |
RA | 1,477,742 | T→A | 42.5% | A274A (GCA→GCT) | glpQ ← | periplasmic glycerophosphodiester phosphodiesterase |
RA | 1,478,087 | A→G | 46.2% | N159N (AAT→AAC) | glpQ ← | periplasmic glycerophosphodiester phosphodiesterase |
RA | 1,478,321 | G→A | 47.4% | Y81Y (TAC→TAT) | glpQ ← | periplasmic glycerophosphodiester phosphodiesterase |
RA | 1,478,347 | T→G | 34.5% | N73H (AAT→CAT) | glpQ ← | periplasmic glycerophosphodiester phosphodiesterase |
RA | 1,478,949 | A→G | 42.8% | V326V (GTT→GTC) | glpT ← | sn‑glycerol‑3‑phosphate transporter |
RA | 1,478,970 | G→A | 42.2% | G319G (GGC→GGT) | glpT ← | sn‑glycerol‑3‑phosphate transporter |
RA | 1,478,976 | G→A | 41.1% | F317F (TTC→TTT) | glpT ← | sn‑glycerol‑3‑phosphate transporter |
RA | 1,479,278 | A→G | 18.0% | L217L (TTG→CTG) | glpT ← | sn‑glycerol‑3‑phosphate transporter |
RA | 1,479,321 | T→C | 17.8% | L202L (TTA→TTG) ‡ | glpT ← | sn‑glycerol‑3‑phosphate transporter |
RA | 1,479,323 | A→G | 17.7% | L202L (TTA→CTA) ‡ | glpT ← | sn‑glycerol‑3‑phosphate transporter |
RA | 1,480,246 | C→T | 40.5% | G16G (GGC→GGT) | glpA → | sn‑glycerol‑3‑phosphate dehydrogenase (anaerobic), large subunit, FAD/NAD(P)‑binding |
RA | 1,480,522 | T→C | 56.7% | I108I (ATT→ATC) | glpA → | sn‑glycerol‑3‑phosphate dehydrogenase (anaerobic), large subunit, FAD/NAD(P)‑binding |
RA | 1,480,660 | C→A | 32.6% | T154T (ACC→ACA) | glpA → | sn‑glycerol‑3‑phosphate dehydrogenase (anaerobic), large subunit, FAD/NAD(P)‑binding |
RA | 1,481,284 | T→G | 34.2% | A362A (GCT→GCG) | glpA → | sn‑glycerol‑3‑phosphate dehydrogenase (anaerobic), large subunit, FAD/NAD(P)‑binding |
RA | 1,481,302 | G→C | 46.9% | A368A (GCG→GCC) | glpA → | sn‑glycerol‑3‑phosphate dehydrogenase (anaerobic), large subunit, FAD/NAD(P)‑binding |
RA | 1,483,604 | T→C | 38.8% | L178L (TTA→CTA) | glpC → | sn‑glycerol‑3‑phosphate dehydrogenase (anaerobic), small subunit |
RA | 1,483,609 | T→C | 38.1% | G179G (GGT→GGC) | glpC → | sn‑glycerol‑3‑phosphate dehydrogenase (anaerobic), small subunit |
RA | 1,485,543 | A→C | 44.5% | A99A (GCT→GCG) | menF ← | isochorismate synthase 2 |
RA | 1,485,551 | G→A | 41.4% | L97L (CTG→TTG) | menF ← | isochorismate synthase 2 |
RA | 1,485,558 | A→G | 46.6% | I94I (ATT→ATC) | menF ← | isochorismate synthase 2 |
RA | 1,486,136 | C→T | 38.6% | A392A (GCG→GCA) | nuoN ← | NADH:ubiquinone oxidoreductase, membrane subunit N |
RA | 1,486,331 | C→T | 31.6% | P327P (CCG→CCA) | nuoN ← | NADH:ubiquinone oxidoreductase, membrane subunit N |
RA | 1,486,340 | G→A | 40.9% | A324A (GCC→GCT) | nuoN ← | NADH:ubiquinone oxidoreductase, membrane subunit N |
RA | 1,486,500 | G→A | 38.0% | A271V (GCC→GTC) | nuoN ← | NADH:ubiquinone oxidoreductase, membrane subunit N |
RA | 1,486,679 | C→T | 54.9% | V211V (GTG→GTA) | nuoN ← | NADH:ubiquinone oxidoreductase, membrane subunit N |
RA | 1,486,694 | G→A | 66.6% | S206S (AGC→AGT) | nuoN ← | NADH:ubiquinone oxidoreductase, membrane subunit N |
RA | 1,486,715 | G→A | 60.3% | L199L (CTC→CTT) | nuoN ← | NADH:ubiquinone oxidoreductase, membrane subunit N |
RA | 1,486,723 | G→A | 61.9% | L197L (CTG→TTG) | nuoN ← | NADH:ubiquinone oxidoreductase, membrane subunit N |
RA | 1,487,774 | T→G | 53.1% | V418V (GTA→GTC) | nuoM ← | NADH:ubiquinone oxidoreductase, membrane subunit M |
RA | 1,488,467 | A→G | 73.5% | I187I (ATT→ATC) | nuoM ← | NADH:ubiquinone oxidoreductase, membrane subunit M |
RA | 1,488,482 | G→A | 63.7% | G182G (GGC→GGT) | nuoM ← | NADH:ubiquinone oxidoreductase, membrane subunit M |
RA | 1,489,398 | A→G | 100% | Y545Y (TAT→TAC) | nuoL ← | NADH:ubiquinone oxidoreductase, membrane subunit L |
RA | 1,489,413 | T→G | 100% | G540G (GGA→GGC) | nuoL ← | NADH:ubiquinone oxidoreductase, membrane subunit L |
RA | 1,489,437 | G→A | 100% | G532G (GGC→GGT) | nuoL ← | NADH:ubiquinone oxidoreductase, membrane subunit L |
RA | 1,490,568 | C→A | 48.0% | G155G (GGG→GGT) | nuoL ← | NADH:ubiquinone oxidoreductase, membrane subunit L |
RA | 1,492,939 | A→G | 50.8% | L164L (TTG→CTG) | nuoH ← | NADH:ubiquinone oxidoreductase, membrane subunit H |
RA | 1,493,288 | G→A | 63.1% | Y47Y (TAC→TAT) | nuoH ← | NADH:ubiquinone oxidoreductase, membrane subunit H |
RA | 1,493,345 | G→A | 60.8% | C28C (TGC→TGT) | nuoH ← | NADH:ubiquinone oxidoreductase, membrane subunit H |
RA | 1,494,022 | G→A | 60.0% | S712S (AGC→AGT) | nuoG ← | NADH:ubiquinone oxidoreductase, chain G |
RA | 1,494,025 | G→A | 55.1% | Y711Y (TAC→TAT) | nuoG ← | NADH:ubiquinone oxidoreductase, chain G |
RA | 1,494,028 | A→G | 55.2% | R710R (CGT→CGC) | nuoG ← | NADH:ubiquinone oxidoreductase, chain G |
RA | 1,495,138 | G→A | 100% | Y340Y (TAC→TAT) | nuoG ← | NADH:ubiquinone oxidoreductase, chain G |
RA | 1,496,624 | A→G | 41.3% | D306D (GAT→GAC) | nuoF ← | NADH:ubiquinone oxidoreductase, chain F |
RA | 1,497,661 | A→G | 49.5% | F126F (TTT→TTC) | nuoE ← | NADH:ubiquinone oxidoreductase, chain E |
RA | 1,497,667 | G→A | 47.3% | G124G (GGC→GGT) | nuoE ← | NADH:ubiquinone oxidoreductase, chain E |
RA | 1,497,670 | A→G | 47.5% | D123D (GAT→GAC) | nuoE ← | NADH:ubiquinone oxidoreductase, chain E |
RA | 1,498,221 | T→C | 60.9% | K541K (AAA→AAG) | nuoC ← | NADH:ubiquinone oxidoreductase, chain C,D |
RA | 1,500,201 | A→G | 39.5% | G133G (GGT→GGC) | nuoB ← | NADH:ubiquinone oxidoreductase, chain B |
RA | 1,500,204 | A→G | 39.9% | S132S (TCT→TCC) | nuoB ← | NADH:ubiquinone oxidoreductase, chain B |
RA | 1,501,821 | A→G | 42.8% | D269D (GAT→GAC) | lrhA ← | DNA‑binding transcriptional repressor |
RA | 1,502,921 | G→A | 51.6% | intergenic (‑294/‑626) | lrhA ← / → yfbQ | DNA‑binding transcriptional repressor/predicted aminotransferase |
RA | 1,502,952 | C→A | 69.6% | intergenic (‑325/‑595) | lrhA ← / → yfbQ | DNA‑binding transcriptional repressor/predicted aminotransferase |
RA | 1,505,057 | C→T | 65.4% | A70A (GCC→GCT) | yfbR → | deoxyribonucleoside 5'‑monophosphatase |
RA | 1,505,809 | C→A | 12.7% | G510G (GGG→GGT) | yfbS ← | predicted transporter |
RA | 1,505,836 | A→G | 22.6% | G501G (GGT→GGC) | yfbS ← | predicted transporter |
RA | 1,506,571 | G→A | 54.5% | G256G (GGC→GGT) | yfbS ← | predicted transporter |
RA | 1,506,580 | C→T | 54.8% | E253E (GAG→GAA) | yfbS ← | predicted transporter |
RA | 1,506,598 | A→G | 68.5% | D247D (GAT→GAC) | yfbS ← | predicted transporter |
RA | 1,506,604 | C→T | 62.1% | R245R (CGG→CGA) | yfbS ← | predicted transporter |
RA | 1,507,973 | C→A | 100% | A35S (GCG→TCG) | yfbT ← | predicted hydrolase or phosphatase |
RA | 1,508,705 | G→A | 36.1% | R138R (CGC→CGT) | yfbV ← | conserved inner membrane protein |
RA | 1,510,448 | T→C | 48.4% | T331T (ACT→ACC) | ackA → | acetate kinase A and propionate kinase 2 |
RA | 1,511,011 | A→G | 25.8% | A93A (GCA→GCG) | pta → | phosphate acetyltransferase |
RA | 1,511,053 | T→G | 45.9% | V107V (GTT→GTG) | pta → | phosphate acetyltransferase |
RA | 1,513,033 | C→A | 37.5% | intergenic (+156/+276) | pta → / ← ubiX | phosphate acetyltransferase/3‑octaprenyl‑4‑hydroxybenzoate carboxy‑lyase |
RA | 1,513,394 | A→G | 60.1% | V162A (GTG→GCG) | ubiX ← | 3‑octaprenyl‑4‑hydroxybenzoate carboxy‑lyase |
RA | 1,513,411 | C→T | 58.8% | P156P (CCG→CCA) | ubiX ← | 3‑octaprenyl‑4‑hydroxybenzoate carboxy‑lyase |
RA | 1,513,603 | A→C | 43.9% | L92L (CTT→CTG) | ubiX ← | 3‑octaprenyl‑4‑hydroxybenzoate carboxy‑lyase |
RA | 1,513,641 | G→A | 29.0% | L80L (CTG→TTG) | ubiX ← | 3‑octaprenyl‑4‑hydroxybenzoate carboxy‑lyase |
RA | 1,514,048 | C→A | 40.1% | T481T (ACG→ACT) | purF ← | amidophosphoribosyltransferase |
RA | 1,514,054 | G→A | 34.5% | L479L (CTC→CTT) | purF ← | amidophosphoribosyltransferase |
RA | 1,514,474 | G→A | 36.7% | G339G (GGC→GGT) | purF ← | amidophosphoribosyltransferase |
RA | 1,514,486 | A→G | 31.3% | F335F (TTT→TTC) | purF ← | amidophosphoribosyltransferase |
RA | 1,514,504 | G→A | 24.5% | R329R (CGC→CGT) | purF ← | amidophosphoribosyltransferase |
RA | 1,515,074 | C→T | 66.7% | E139E (GAG→GAA) | purF ← | amidophosphoribosyltransferase |
RA | 1,515,080 | G→T | 74.4% | A137A (GCC→GCA) | purF ← | amidophosphoribosyltransferase |
RA | 1,515,086 | G→A | 74.5% | I135I (ATC→ATT) | purF ← | amidophosphoribosyltransferase |
RA | 1,515,092 | A→G | 73.4% | L133L (CTT→CTC) | purF ← | amidophosphoribosyltransferase |
RA | 1,516,229 | G→A | 59.1% | intergenic (‑214/+45) | cvpA ← / ← dedD | membrane protein required for colicin V production/conserved hypothetical protein |
RA | 1,516,230 | T→C | 59.2% | intergenic (‑215/+44) | cvpA ← / ← dedD | membrane protein required for colicin V production/conserved hypothetical protein |
RA | 1,516,244 | C→T | 77.3% | intergenic (‑229/+30) | cvpA ← / ← dedD | membrane protein required for colicin V production/conserved hypothetical protein |
RA | 1,517,661 | A→C | 42.9% | G178G (GGT→GGG) | folC ← | bifunctional folylpolyglutamate synthase and dihydrofolate synthase |
RA | 1,521,023 | A→G | 58.6% | S293S (TCT→TCC) | usg ← | predicted semialdehyde dehydrogenase |
RA | 1,521,041 | C→A | 51.3% | S287S (TCG→TCT) | usg ← | predicted semialdehyde dehydrogenase |
RA | 1,521,050 | A→T | 45.5% | G284G (GGT→GGA) | usg ← | predicted semialdehyde dehydrogenase |
RA | 1,522,711 | C→T | 100% | L131L (TTG→TTA) | pdxB ← | erythronate‑4‑phosphate dehydrogenase |
RA | 1,522,714 | T→A | 100% | R130R (CGA→CGT) | pdxB ← | erythronate‑4‑phosphate dehydrogenase |
RA | 1,522,720 | T→A | 100% | G128G (GGA→GGT) | pdxB ← | erythronate‑4‑phosphate dehydrogenase |
RA | 1,522,738 | C→A | 100% | V122V (GTG→GTT) | pdxB ← | erythronate‑4‑phosphate dehydrogenase |
RA | 1,524,808 | C→A | 52.0% | V189L (GTA→TTA) | yfcJ ← | predicted transporter |
RA | 1,524,816 | A→G | 50.7% | V186A (GTA→GCA) | yfcJ ← | predicted transporter |
RA | 1,525,136 | A→G | 47.7% | G79G (GGT→GGC) | yfcJ ← | predicted transporter |
RA | 1,525,931 | C→T | 84.8% | E309E (GAG→GAA) | fabB ← | 3‑oxoacyl‑[acyl‑carrier‑protein] synthase I |
RA | 1,527,117 | G→A | 39.9% | G34G (GGG→GGA) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,527,855 | G→A | 100% | S280S (TCG→TCA) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,527,870 | G→T | 100% | R285R (CGG→CGT) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,528,294 | T→C | 52.8% | Y427H (TAT→CAT) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,528,303 | T→C | 47.0% | Y430H (TAT→CAT) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,528,315 | A→G | 38.1% | N434D (AAT→GAT) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,528,336 | T→G | 43.7% | C441G (TGT→GGT) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,528,792 | T→C | 43.6% | L593L (TTG→CTG) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,528,801 | C→A | 44.5% | Q596K (CAG→AAG) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,528,812 | G→A | 45.0% | E599E (GAG→GAA) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,528,832 | T→A | 51.9% | F606Y (TTT→TAT) | trmC → | fused 5‑methylaminomethyl‑2‑thiouridine forming enzyme methyltransferase and FAD‑dependent demodification enzyme |
RA | 1,529,221 | A→C | 36.5% | A67A (GCT→GCG) | yfcL ← | hypothetical protein |
RA | 1,529,224 | A→G | 37.9% | G66G (GGT→GGC) | yfcL ← | hypothetical protein |
RA | 1,529,257 | C→T | 50.0% | T55T (ACG→ACA) | yfcL ← | hypothetical protein |
RA | 1,530,159 | C→T | 100% | G218G (GGG→GGA) | yfcA ← | conserved inner membrane protein |
RA | 1,530,162 | C→T | 100% | V217V (GTG→GTA) | yfcA ← | conserved inner membrane protein |
RA | 1,530,167 | G→A | 100% | L216L (CTG→TTG) | yfcA ← | conserved inner membrane protein |
RA | 1,530,171 | G→C | 100% | V214V (GTC→GTG) | yfcA ← | conserved inner membrane protein |
RA | 1,530,177 | G→T | 100% | G212G (GGC→GGA) | yfcA ← | conserved inner membrane protein |
RA | 1,530,201 | G→A | 100% | G204G (GGC→GGT) | yfcA ← | conserved inner membrane protein |
RA | 1,530,282 | A→G | 100% | F177F (TTT→TTC) | yfcA ← | conserved inner membrane protein |
RA | 1,532,228 | A→T | 100% | D166E (GAT→GAA) | aroC ← | chorismate synthase |
RA | 1,532,234 | C→T | 100% | P164P (CCG→CCA) | aroC ← | chorismate synthase |
RA | 1,532,988 | A→G | 49.1% | T235T (ACT→ACC) | prmB ← | N5‑glutamine methyltransferase |
RA | 1,533,003 | G→A | 57.1% | G230G (GGC→GGT) | prmB ← | N5‑glutamine methyltransferase |
RA | 1,533,006 | C→G | 58.0% | L229L (CTG→CTC) | prmB ← | N5‑glutamine methyltransferase |
RA | 1,533,152 | G→A | 36.5% | L181L (CTG→TTG) | prmB ← | N5‑glutamine methyltransferase |
RA | 1,534,034 | C→G | 60.0% | S59S (TCC→TCG) | yfcN → | conserved hypothetical protein |
RA | 1,534,037 | T→C | 62.2% | D60D (GAT→GAC) | yfcN → | conserved hypothetical protein |
RA | 1,534,040 | G→A | 62.1% | E61E (GAG→GAA) | yfcN → | conserved hypothetical protein |
RA | 1,534,049 | G→A | 50.7% | P64P (CCG→CCA) | yfcN → | conserved hypothetical protein |
RA | 1,534,055 | A→G | 55.3% | L66L (TTA→TTG) | yfcN → | conserved hypothetical protein |
RA | 1,534,073 | G→C | 33.3% | V72V (GTG→GTC) | yfcN → | conserved hypothetical protein |
RA | 1,542,008 | G→C | 100% | S19S (TCC→TCG) | sixA ← | phosphohistidine phosphatase |
RA | 1,542,575 | T→G | 46.0% | I613L (ATC→CTC) | yfcX ← | fused enoyl‑CoA hydratase, 3‑hydroxybutyryl‑CoA epimerase, dodecenoyl‑CoA D‑isomerase, and 3‑hydroxyacyl‑CoA dehydrogenase, subunit of anaerobic fatty acid oxidation complex |
RA | 1,542,960 | T→G | 59.4% | P484P (CCA→CCC) | yfcX ← | fused enoyl‑CoA hydratase, 3‑hydroxybutyryl‑CoA epimerase, dodecenoyl‑CoA D‑isomerase, and 3‑hydroxyacyl‑CoA dehydrogenase, subunit of anaerobic fatty acid oxidation complex |
RA | 1,542,969 | A→G | 42.3% | G481G (GGT→GGC) | yfcX ← | fused enoyl‑CoA hydratase, 3‑hydroxybutyryl‑CoA epimerase, dodecenoyl‑CoA D‑isomerase, and 3‑hydroxyacyl‑CoA dehydrogenase, subunit of anaerobic fatty acid oxidation complex |
RA | 1,545,006 | A→G | 100% | V239A (GTC→GCC) | yfcY ← | beta‑ketoacyl‑CoA thiolase, anaerobic, subunit |
RA | 1,550,146 | G→A | 55.8% | T38T (ACC→ACT) | vacJ ← | predicted lipoprotein |
RA | 1,550,155 | G→A | 46.6% | F35F (TTC→TTT) | vacJ ← | predicted lipoprotein |
RA | 1,550,810 | T→C | 38.3% | G86G (GGT→GGC) | yfdC → | predicted inner membrane protein |
RA | 1,551,242 | T→C | 100% | H230H (CAT→CAC) | yfdC → | predicted inner membrane protein |
RA | 1,551,248 | G→T | 48.6% | V232V (GTG→GTT) | yfdC → | predicted inner membrane protein |
RA | 1,552,932 | A→C | 31.9% | T106T (ACT→ACG) | dsdC ← | DNA‑binding transcriptional dual regulator |
RA | 1,553,148 | C→G | 84.4% | L34L (CTG→CTC) | dsdC ← | DNA‑binding transcriptional dual regulator |
RA | 1,553,151 | G→A | 100% | A33A (GCC→GCT) | dsdC ← | DNA‑binding transcriptional dual regulator |
RA | 1,553,364 | A→C | 49.4% | intergenic (‑115/‑103) | dsdC ← / → dsdX | DNA‑binding transcriptional dual regulator/predicted transporter |
RA | 1,553,378 | C→G | 52.7% | intergenic (‑129/‑89) | dsdC ← / → dsdX | DNA‑binding transcriptional dual regulator/predicted transporter |
RA | 1,554,660 | T→G | 37.3% | T398T (ACT→ACG) | dsdX → | predicted transporter |
RA | 1,554,675 | G→A | 30.9% | S403S (TCG→TCA) | dsdX → | predicted transporter |
RA | 1,554,687 | A→G | 34.8% | L407L (CTA→CTG) | dsdX → | predicted transporter |
RA | 1,555,145 | T→C | 79.5% | D108D (GAT→GAC) | dsdA → | D‑serine ammonia‑lyase |
RA | 1,555,181 | C→T | 50.0% | R120R (CGC→CGT) | dsdA → | D‑serine ammonia‑lyase |
RA | 1,555,457 | T→C | 35.2% | Y212Y (TAT→TAC) | dsdA → | D‑serine ammonia‑lyase |
RA | 1,556,173 | A→C | 28.4% | intergenic (+23/+1240) | dsdA → / ← emrY | D‑serine ammonia‑lyase/predicted multidrug efflux system |
RA | 1,556,777 | T→C | 29.3% | intergenic (+627/+636) | dsdA → / ← emrY | D‑serine ammonia‑lyase/predicted multidrug efflux system |
RA | 1,558,506 | T→C | 40.7% | T152A (ACG→GCG) | emrK ← | EmrKY‑TolC multidrug resistance efflux pump, membrane fusion protein component |
RA | 1,558,525 | C→T | 37.2% | Q145Q (CAG→CAA) | emrK ← | EmrKY‑TolC multidrug resistance efflux pump, membrane fusion protein component |
RA | 1,558,537 | C→A | 34.1% | P141P (CCG→CCT) | emrK ← | EmrKY‑TolC multidrug resistance efflux pump, membrane fusion protein component |
RA | 1,560,390 | A→G | 25.9% | N133D (AAT→GAT) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,560,407 | C→T | 24.5% | T138T (ACC→ACT) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,560,410 | A→T | 24.7% | K139N (AAA→AAT) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,560,413 | A→T | 24.6% | P140P (CCA→CCT) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,560,414 | T→C | 23.4% | L141L (TTG→CTG) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,560,500 | G→A | 39.0% | R169R (CGG→CGA) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,561,043 | C→T | 33.2% | H350H (CAC→CAT) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,561,049 | C→T | 36.3% | I352I (ATC→ATT) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,562,111 | A→C | 68.8% | I706I (ATA→ATC) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,562,114 | G→T | 69.8% | K707N (AAG→AAT) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,562,117 | T→A | 56.4% | A708A (GCT→GCA) | evgS → | hybrid sensory histidine kinase in two‑component regulatory system with EvgA |
RA | 1,565,578 | G→T | 29.7% | G156G (GGC→GGA) | glk ← | glucokinase |
RA | 1,565,635 | C→T | 100% | T137T (ACG→ACA) | glk ← | glucokinase |
RA | 1,565,671 | G→T | 45.2% | V125V (GTC→GTA) | glk ← | glucokinase |
RA | 1,566,500 | C→T | 65.8% | D84D (GAC→GAT) | yfeO → | predicted ion channel protein |
RA | 1,566,518 | G→T | 72.5% | L90L (CTG→CTT) | yfeO → | predicted ion channel protein |
RA | 1,566,887 | T→G | 40.2% | A213A (GCT→GCG) | yfeO → | predicted ion channel protein |
RA | 1,567,023 | C→T | 45.9% | L259F (CTC→TTC) | yfeO → | predicted ion channel protein |
RA | 1,567,424 | T→C | 34.5% | L392L (CTT→CTC) | yfeO → | predicted ion channel protein |
RA | 1,568,594 | A→C | 26.7% | T244T (ACT→ACG) | mntH ← | manganese/divalent cation transporter |
RA | 1,569,367 | T→C | 21.5% | intergenic (‑42/‑294) | mntH ← / → nupC | manganese/divalent cation transporter/nucleoside (except guanosine) transporter |
RA | 1,569,369 | C→T | 21.5% | intergenic (‑44/‑292) | mntH ← / → nupC | manganese/divalent cation transporter/nucleoside (except guanosine) transporter |
RA | 1,569,370 | C→T | 21.5% | intergenic (‑45/‑291) | mntH ← / → nupC | manganese/divalent cation transporter/nucleoside (except guanosine) transporter |
RA | 1,569,374 | C→T | 20.2% | intergenic (‑49/‑287) | mntH ← / → nupC | manganese/divalent cation transporter/nucleoside (except guanosine) transporter |
RA | 1,570,332 | C→T | 50.5% | I224I (ATC→ATT) | nupC → | nucleoside (except guanosine) transporter |
RA | 1,570,455 | C→T | 67.4% | A265A (GCC→GCT) | nupC → | nucleoside (except guanosine) transporter |
RA | 1,570,458 | G→A | 67.7% | A266A (GCG→GCA) | nupC → | nucleoside (except guanosine) transporter |
RA | 1,570,467 | A→T | 73.6% | A269A (GCA→GCT) | nupC → | nucleoside (except guanosine) transporter |
RA | 1,570,476 | C→T | 76.8% | A272A (GCC→GCT) | nupC → | nucleoside (except guanosine) transporter |
RA | 1,570,482 | T→G | 64.2% | V274V (GTT→GTG) | nupC → | nucleoside (except guanosine) transporter |
RA | 1,570,677 | T→G | 60.6% | A339A (GCT→GCG) | nupC → | nucleoside (except guanosine) transporter |
RA | 1,571,749 | A→G | 31.3% | V75V (GTA→GTG) | yfeC → | predicted DNA‑binding transcriptional regulator |
RA | 1,573,449 | A→T | 53.3% | T94T (ACT→ACA) | gltX ← | glutamyl‑tRNA synthetase |
RA | 1,576,150 | G→A | 34.7% | F298F (TTC→TTT) | xapB ← | xanthosine transporter |
RA | 1,576,174 | G→C | 68.6% | A290A (GCC→GCG) | xapB ← | xanthosine transporter |
RA | 1,576,207 | G→A | 77.6% | G279G (GGC→GGT) | xapB ← | xanthosine transporter |
RA | 1,576,210 | A→G | 74.0% | F278F (TTT→TTC) | xapB ← | xanthosine transporter |
RA | 1,576,213 | T→A | 72.3% | R277R (CGA→CGT) | xapB ← | xanthosine transporter |
RA | 1,576,219 | T→C | 61.5% | L275L (TTA→TTG) | xapB ← | xanthosine transporter |
RA | 1,576,228 | T→C | 38.4% | P272P (CCA→CCG) | xapB ← | xanthosine transporter |
RA | 1,576,231 | G→T | 38.3% | I271I (ATC→ATA) | xapB ← | xanthosine transporter |
RA | 1,576,234 | A→C | 37.3% | T270T (ACT→ACG) | xapB ← | xanthosine transporter |
RA | 1,577,649 | A→G | 30.2% | I96I (ATT→ATC) | xapA ← | purine nucleoside phosphorylase II |
RA | 1,577,658 | T→C | 32.7% | G93G (GGA→GGG) | xapA ← | purine nucleoside phosphorylase II |
RA | 1,577,897 | T→C | 41.5% | I14V (ATA→GTA) | xapA ← | purine nucleoside phosphorylase II |
RA | 1,577,902 | A→T | 39.1% | F12Y (TTT→TAT) | xapA ← | purine nucleoside phosphorylase II |
RA | 1,577,907 | C→T | 39.6% | P10P (CCG→CCA) | xapA ← | purine nucleoside phosphorylase II |
RA | 1,578,568 | C→T | 12.2% | H128H (CAC→CAT) | yfeN → | conserved outer membrane protein |
RA | 1,581,564 | T→G | 55.4% | A557A (GCA→GCC) | ligA ← | DNA ligase, NAD(+)‑dependent |
RA | 1,581,666 | G→A | 100% | A523A (GCC→GCT) | ligA ← | DNA ligase, NAD(+)‑dependent |
RA | 1,582,181 | G→A | 30.5% | L352L (CTG→TTG) | ligA ← | DNA ligase, NAD(+)‑dependent |
RA | 1,582,188 | T→A | 29.9% | A349A (GCA→GCT) | ligA ← | DNA ligase, NAD(+)‑dependent |
RA | 1,582,830 | G→C | 40.9% | T135T (ACC→ACG) | ligA ← | DNA ligase, NAD(+)‑dependent |
RA | 1,583,611 | A→G | 37.5% | N227N (AAT→AAC) | zipA ← | cell division protein involved in Z ring assembly |
RA | 1,583,785 | G→A | 100% | P169P (CCC→CCT) | zipA ← | cell division protein involved in Z ring assembly |
RA | 1,584,700 | T→G | 35.9% | T60T (ACT→ACG) | cysZ → | predicted inner membrane protein |
RA | 1,584,712 | C→T | 37.8% | Y64Y (TAC→TAT) | cysZ → | predicted inner membrane protein |
RA | 1,584,725 | C→T | 31.8% | L69L (CTA→TTA) | cysZ → | predicted inner membrane protein |
RA | 1,584,739 | T→C | 37.7% | S73S (AGT→AGC) | cysZ → | predicted inner membrane protein |
RA | 1,584,892 | G→A | 100% | G124G (GGG→GGA) | cysZ → | predicted inner membrane protein |
RA | 1,585,072 | C→T | 35.1% | C184C (TGC→TGT) | cysZ → | predicted inner membrane protein |
RA | 1,586,707 | G→A | 63.6% | intergenic (+269/‑115) | cysK → / → ptsH | cysteine synthase A, O‑acetylserine sulfhydrolase A subunit/phosphohistidinoprotein‑hexose phosphotransferase component of PTS system (Hpr) |
RA | 1,588,287 | T→C | 57.4% | I388I (ATT→ATC) | ptsI → | PEP‑protein phosphotransferase of PTS system |
RA | 1,590,071 | G→A | 40.8% | G75G (GGC→GGT) | pdxK ← | pyridoxal‑pyridoxamine kinase/hydroxymethylpyrimidine kinase |
RA | 1,590,086 | G→A | 44.8% | D70D (GAC→GAT) | pdxK ← | pyridoxal‑pyridoxamine kinase/hydroxymethylpyrimidine kinase |
RA | 1,590,191 | G→C | 42.9% | A35A (GCC→GCG) | pdxK ← | pyridoxal‑pyridoxamine kinase/hydroxymethylpyrimidine kinase |
RA | 1,590,206 | C→T | 31.8% | V30V (GTG→GTA) | pdxK ← | pyridoxal‑pyridoxamine kinase/hydroxymethylpyrimidine kinase |
RA | 1,590,559 | T→G | 33.7% | Y54D (TAT→GAT) | yfeK → | hypothetical protein |
RA | 1,593,753 | C→T | 40.3% | G40G (GGG→GGA) | cysA ← | sulfate/thiosulfate transporter subunit |
RA | 1,600,816 | 2 bp→AT | 100% | coding (1086‑1087/1425 nt) | murP → | fused predicted enzyme IIBC components of PTS |
RA | 1,600,831 | A→C | 100% | V367V (GTA→GTC) | murP → | fused predicted enzyme IIBC components of PTS |
RA | 1,600,906 | G→A | 65.3% | K392K (AAG→AAA) | murP → | fused predicted enzyme IIBC components of PTS |
RA | 1,602,797 | G→A | 82.6% | T269T (ACC→ACT) | yfeX ← | conserved hypothetical protein |
RA | 1,602,820 | G→A | 74.9% | L262L (CTG→TTG) | yfeX ← | conserved hypothetical protein |
RA | 1,602,887 | A→G | 45.2% | T239T (ACT→ACC) | yfeX ← | conserved hypothetical protein |
RA | 1,602,908 | G→A | 39.7% | R232R (CGC→CGT) | yfeX ← | conserved hypothetical protein |
RA | 1,602,989 | G→A | 18.2% | I205I (ATC→ATT) | yfeX ← | conserved hypothetical protein |
RA | 1,603,274 | G→A | 61.9% | A110A (GCC→GCT) | yfeX ← | conserved hypothetical protein |
RA | 1,603,289 | T→C | 67.4% | V105V (GTA→GTG) | yfeX ← | conserved hypothetical protein |
RA | 1,603,951 | G→A | 27.6% | D108D (GAC→GAT) | yfeY ← | hypothetical protein |
RA | 1,603,960 | A→G | 35.0% | S105S (AGT→AGC) | yfeY ← | hypothetical protein |
RA | 1,605,751 | T→G | 31.1% | L114L (CTT→CTG) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,605,763 | T→G | 34.7% | V118V (GTT→GTG) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,605,781 | T→C | 18.3% | H124H (CAT→CAC) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,605,790 | T→C | 18.2% | D127D (GAT→GAC) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,605,808 | T→C | 20.6% | H133H (CAT→CAC) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,605,814 | T→C | 23.6% | D135D (GAT→GAC) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,605,817 | C→T | 22.9% | G136G (GGC→GGT) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,606,216 | T→C | 33.3% | A269A (GCT→GCC) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,606,276 | A→G | 47.5% | R289R (CGA→CGG) | amiA → | N‑acetylmuramoyl‑l‑alanine amidase I |
RA | 1,606,282 | T→G | 57.6% | intergenic (+3/‑1) | amiA → / → hemF | N‑acetylmuramoyl‑l‑alanine amidase I/coproporphyrinogen III oxidase |
RA | 1,606,349 | C→T | 30.6% | L23L (CTG→TTG) | hemF → | coproporphyrinogen III oxidase |
RA | 1,606,933 | C→A | 31.0% | V217V (GTC→GTA) | hemF → | coproporphyrinogen III oxidase |
RA | 1,606,942 | G→A | 30.6% | R220R (CGG→CGA) | hemF → | coproporphyrinogen III oxidase |
RA | 1,607,584 | G→C | 58.3% | A219A (GCC→GCG) | yfeG ← | predicted DNA‑binding transcriptional regulator |
RA | 1,609,750 | A→T | 28.5% | V202V (GTT→GTA) | eutC ← | ethanolamine ammonia‑lyase, small subunit (light chain) |
RA | 1,609,762 | T→C | 43.7% | T198T (ACA→ACG) | eutC ← | ethanolamine ammonia‑lyase, small subunit (light chain) |
RA | 1,609,783 | C→T | 34.9% | Q191Q (CAG→CAA) | eutC ← | ethanolamine ammonia‑lyase, small subunit (light chain) |
RA | 1,609,786 | T→C | 45.9% | K190K (AAA→AAG) | eutC ← | ethanolamine ammonia‑lyase, small subunit (light chain) |
RA | 1,610,182 | A→C | 100% | V58V (GTT→GTG) | eutC ← | ethanolamine ammonia‑lyase, small subunit (light chain) |
RA | 1,610,811 | T→C | 75.7% | A309A (GCA→GCG) | eutB ← | ethanolamine ammonia‑lyase, large subunit, heavy chain |
RA | 1,610,862 | A→C | 63.0% | S292S (TCT→TCG) | eutB ← | ethanolamine ammonia‑lyase, large subunit, heavy chain |
RA | 1,610,889 | G→A | 46.5% | C283C (TGC→TGT) | eutB ← | ethanolamine ammonia‑lyase, large subunit, heavy chain |
RA | 1,611,069 | A→G | 100% | C223C (TGT→TGC) | eutB ← | ethanolamine ammonia‑lyase, large subunit, heavy chain |
RA | 1,611,483 | G→A | 47.3% | Y85Y (TAC→TAT) | eutB ← | ethanolamine ammonia‑lyase, large subunit, heavy chain |
RA | 1,611,501 | A→G | 50.8% | D79D (GAT→GAC) | eutB ← | ethanolamine ammonia‑lyase, large subunit, heavy chain |
RA | 1,612,061 | A→G | 36.0% | D364D (GAT→GAC) ‡ | eutA ← | reactivating factor for ethanolamine ammonia lyase |
RA | 1,612,062 | T→C | 36.0% | D364G (GAT→GGT) ‡ | eutA ← | reactivating factor for ethanolamine ammonia lyase |
RA | 1,612,063 | C→A | 36.0% | D364Y (GAT→TAT) ‡ | eutA ← | reactivating factor for ethanolamine ammonia lyase |
RA | 1,612,073 | C→T | 44.1% | Q360Q (CAG→CAA) | eutA ← | reactivating factor for ethanolamine ammonia lyase |
RA | 1,612,166 | A→C | 57.0% | L329L (CTT→CTG) | eutA ← | reactivating factor for ethanolamine ammonia lyase |
RA | 1,612,202 | C→A | 84.0% | A317A (GCG→GCT) | eutA ← | reactivating factor for ethanolamine ammonia lyase |
RA | 1,612,205 | G→A | 84.1% | G316G (GGC→GGT) | eutA ← | reactivating factor for ethanolamine ammonia lyase |
RA | 1,613,635 | C→G | 39.3% | L247L (CTG→CTC) | eutH ← | predicted inner membrane protein |
RA | 1,613,998 | A→G | 48.7% | I126I (ATT→ATC) | eutH ← | predicted inner membrane protein |
RA | 1,614,031 | G→A | 40.6% | G115G (GGC→GGT) | eutH ← | predicted inner membrane protein |
RA | 1,614,100 | C→T | 32.6% | S92S (TCG→TCA) | eutH ← | predicted inner membrane protein |
RA | 1,614,103 | T→C | 32.6% | P91P (CCA→CCG) | eutH ← | predicted inner membrane protein |
RA | 1,614,459 | T→C | 60.6% | intergenic (‑84/+133) | eutH ← / ← eutG | predicted inner membrane protein/predicted alcohol dehydrogenase in ethanolamine utilization |
RA | 1,614,829 | G→C | 54.0% | R317R (CGC→CGG) | eutG ← | predicted alcohol dehydrogenase in ethanolamine utilization |
RA | 1,614,832 | T→A | 57.7% | E316D (GAA→GAT) | eutG ← | predicted alcohol dehydrogenase in ethanolamine utilization |
RA | 1,616,492 | G→A | 65.3% | T38T (ACC→ACT) | eutJ ← | predicted chaperonin, ethanolamine utilization protein |
RA | 1,616,715 | G→C | 100% | T435T (ACC→ACG) | eutE ← | predicted aldehyde dehydrogenase, ethanolamine utilization protein |
RA | 1,616,754 | G→A | 100% | C422C (TGC→TGT) | eutE ← | predicted aldehyde dehydrogenase, ethanolamine utilization protein |
RA | 1,616,820 | G→A | 42.2% | N400N (AAC→AAT) | eutE ← | predicted aldehyde dehydrogenase, ethanolamine utilization protein |
RA | 1,619,764 | C→T | 51.4% | E4K (GAA→AAA) | eutI ← | predicted phosphotransacetylase subunit |
RA | 1,620,888 | A→G | 52.1% | S128S (AGT→AGC) | eutQ ← | conserved hypothetical protein |
RA | 1,620,900 | C→A | 47.4% | V124V (GTG→GTT) | eutQ ← | conserved hypothetical protein |
RA | 1,621,151 | G→A | 75.1% | L41L (CTG→TTG) | eutQ ← | conserved hypothetical protein |
RA | 1,621,152 | T→C | 75.2% | L40L (CTA→CTG) | eutQ ← | conserved hypothetical protein |
RA | 1,621,158 | C→A | 72.4% | A38A (GCG→GCT) | eutQ ← | conserved hypothetical protein |
RA | 1,621,531 | T→C | 60.9% | V65V (GTA→GTG) | eutP ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,622,426 | C→T | 24.2% | V740V (GTG→GTA) | maeB ← | fused malic enzyme predicted oxidoreductase and predicted phosphotransacetylase |
RA | 1,622,669 | T→C | 48.3% | A659A (GCA→GCG) | maeB ← | fused malic enzyme predicted oxidoreductase and predicted phosphotransacetylase |
RA | 1,622,786 | G→A | 23.2% | V620V (GTC→GTT) | maeB ← | fused malic enzyme predicted oxidoreductase and predicted phosphotransacetylase |
RA | 1,622,834 | C→A | 36.7% | P604P (CCG→CCT) | maeB ← | fused malic enzyme predicted oxidoreductase and predicted phosphotransacetylase |
RA | 1,622,837 | T→C | 35.6% | E603E (GAA→GAG) | maeB ← | fused malic enzyme predicted oxidoreductase and predicted phosphotransacetylase |
RA | 1,625,674 | A→G | 38.6% | L247L (TTA→TTG) | talA → | transaldolase A |
RA | 1,625,686 | G→A | 48.9% | L251L (CTG→CTA) | talA → | transaldolase A |
RA | 1,625,936 | C→T | 39.3% | R11R (CGC→CGT) | tktB → | transketolase 2, thiamin‑binding |
RA | 1,625,969 | C→T | 39.3% | N22N (AAC→AAT) | tktB → | transketolase 2, thiamin‑binding |
RA | 1,626,692 | A→G | 40.0% | P263P (CCA→CCG) | tktB → | transketolase 2, thiamin‑binding |
RA | 1,626,710 | G→A | 21.4% | V269V (GTG→GTA) | tktB → | transketolase 2, thiamin‑binding |
RA | 1,626,713 | G→T | 21.9% | A270A (GCG→GCT) | tktB → | transketolase 2, thiamin‑binding |
RA | 1,628,383 | C→T | 64.6% | L221L (TTG→TTA) | ypfG ← | hypothetical protein |
RA | 1,628,386 | T→C | 67.8% | P220P (CCA→CCG) | ypfG ← | hypothetical protein |
RA | 1,628,398 | G→A | 63.0% | C216C (TGC→TGT) | ypfG ← | hypothetical protein |
RA | 1,629,040 | G→T | 49.3% | R2R (CGC→CGA) | ypfG ← | hypothetical protein |
RA | 1,629,190 | G→A | 57.0% | T186M (ACG→ATG) | yffH ← | predicted NUDIX hydrolase |
RA | 1,629,654 | G→A | 37.8% | D31D (GAC→GAT) | yffH ← | predicted NUDIX hydrolase |
RA | 1,630,243 | G→A | 47.9% | R517R (CGC→CGT) | aegA ← | fused predicted FeS binding subunit and predicted NAD/FAD‑binding subunit of oxidoreductase |
RA | 1,631,650 | T→C | 43.5% | Q48Q (CAA→CAG) | aegA ← | fused predicted FeS binding subunit and predicted NAD/FAD‑binding subunit of oxidoreductase |
RA | 1,632,211 | C→T | 42.2% | R71R (CGC→CGT) | narQ → | sensory histidine kinase in two‑component regulatory system with NarP (NarL) |
RA | 1,632,688 | A→G | 31.9% | E230E (GAA→GAG) | narQ → | sensory histidine kinase in two‑component regulatory system with NarP (NarL) |
RA | 1,633,534 | T→C | 45.6% | G512G (GGT→GGC) | narQ → | sensory histidine kinase in two‑component regulatory system with NarP (NarL) |
RA | 1,633,561 | T→C | 60.5% | G521G (GGT→GGC) | narQ → | sensory histidine kinase in two‑component regulatory system with NarP (NarL) |
RA | 1,634,474 | T→C | 41.6% | T204T (ACT→ACC) | acrD → | aminoglycoside/multidrug efflux system |
RA | 1,639,499 | G→A | 53.7% | D180D (GAC→GAT) | ypfH ← | predicted hydrolase |
RA | 1,639,502 | A→G | 53.9% | G179G (GGT→GGC) | ypfH ← | predicted hydrolase |
RA | 1,639,640 | A→G | 60.1% | A133A (GCT→GCC) | ypfH ← | predicted hydrolase |
RA | 1,642,040 | C→G | 31.2% | G30R (GGT→CGT) | ypfI ← | predicted hydrolase |
RA | 1,646,159 | A→G | 53.5% | intergenic (‑131/‑15) | dapA ← / → gcvR | dihydrodipicolinate synthase/DNA‑binding transcriptional repressor, regulatory protein accessory to GcvA |
RA | 1,646,236 | T→A | 40.0% | I21I (ATT→ATA) | gcvR → | DNA‑binding transcriptional repressor, regulatory protein accessory to GcvA |
RA | 1,649,709 | A→G | 43.7% | A310A (GCA→GCG) | yfgC → | predicted peptidase |
RA | 1,649,712 | A→G | 43.7% | A311A (GCA→GCG) | yfgC → | predicted peptidase |
RA | 1,649,829 | T→C | 60.9% | T350T (ACT→ACC) | yfgC → | predicted peptidase |
RA | 1,650,803 | A→G | 100% | R235R (CGT→CGC) | hda ← | ATPase regulatory factor involved in DnaA inactivation |
RA | 1,653,313 | A→C | 100% | G82G (GGT→GGG) | upp ← | uracil phosphoribosyltransferase |
RA | 1,653,633 | C→A | 30.8% | intergenic (‑75/‑250) | upp ← / → purM | uracil phosphoribosyltransferase/phosphoribosylaminoimidazole synthetase |
RA | 1,654,260 | T→C | 51.6% | I126I (ATT→ATC) | purM → | phosphoribosylaminoimidazole synthetase |
RA | 1,654,281 | A→G | 45.5% | S133S (TCA→TCG) | purM → | phosphoribosylaminoimidazole synthetase |
RA | 1,655,091 | G→A | 62.1% | A58T (GCC→ACC) | purN → | phosphoribosylglycinamide formyltransferase 1 |
RA | 1,657,292 | G→A | 45.9% | E521E (GAG→GAA) | ppk → | polyphosphate kinase, component of RNA degradosome |
RA | 1,657,322 | T→C | 72.0% | S531S (AGT→AGC) | ppk → | polyphosphate kinase, component of RNA degradosome |
RA | 1,657,763 | T→C | 33.3% | Y678Y (TAT→TAC) | ppk → | polyphosphate kinase, component of RNA degradosome |
RA | 1,657,788 | C→T | 34.4% | P687S (CCT→TCT) | ppk → | polyphosphate kinase, component of RNA degradosome |
RA | 1,657,998 | A→G | 45.8% | L66L (TTA→TTG) | ppx → | exopolyphosphatase |
RA | 1,658,013 | G→A | 45.8% | L71L (CTG→CTA) | ppx → | exopolyphosphatase |
RA | 1,658,023 | C→A | 38.5% | R75R (CGG→AGG) | ppx → | exopolyphosphatase |
RA | 1,658,583 | G→A | 56.3% | P261P (CCG→CCA) | ppx → | exopolyphosphatase |
RA | 1,660,973 | G→T | 24.9% | L218I (CTC→ATC) | yfgF ← | predicted inner membrane protein |
RA | 1,660,974 | C→T | 24.8% | A217A (GCG→GCA) | yfgF ← | predicted inner membrane protein |
RA | 1,661,722 | T→A | 13.5% | intergenic (‑98/‑254) | yfgF ← / → yfgG | predicted inner membrane protein/hypothetical protein |
RA | 1,661,747 | A→T | 24.6% | intergenic (‑123/‑229) | yfgF ← / → yfgG | predicted inner membrane protein/hypothetical protein |
RA | 1,664,030 | G→A | 57.0% | L398L (CTG→TTG) | guaA ← | GMP synthetase |
RA | 1,664,037 | G→A | 64.5% | Y395Y (TAC→TAT) | guaA ← | GMP synthetase |
RA | 1,664,043 | C→T | 64.5% | L393L (CTG→CTA) | guaA ← | GMP synthetase |
RA | 1,664,496 | T→A | 52.2% | V242V (GTA→GTT) | guaA ← | GMP synthetase |
RA | 1,664,511 | A→G | 44.8% | G237G (GGT→GGC) | guaA ← | GMP synthetase |
RA | 1,665,156 | C→T | 35.6% | L22L (CTG→CTA) | guaA ← | GMP synthetase |
RA | 1,665,980 | T→C | 42.4% | Q259Q (CAA→CAG) | guaB ← | IMP dehydrogenase |
RA | 1,665,986 | T→A | 61.9% | V257V (GTA→GTT) | guaB ← | IMP dehydrogenase |
RA | 1,665,995 | T→A | 44.1% | S254S (TCA→TCT) | guaB ← | IMP dehydrogenase |
RA | 1,669,173 | T→C | 33.7% | L290L (TTA→TTG) | der ← | predicted GTP‑binding protein |
RA | 1,671,075 | A→G | 37.5% | D88D (GAT→GAC) | yfgL ← | protein assembly complex, lipoprotein component |
RA | 1,672,344 | A→C | 49.6% | A306A (GCT→GCG) | hisS ← | histidyl tRNA synthetase |
RA | 1,672,356 | A→T | 49.6% | A302A (GCT→GCA) | hisS ← | histidyl tRNA synthetase |
RA | 1,672,374 | G→A | 42.1% | G296G (GGC→GGT) | hisS ← | histidyl tRNA synthetase |
RA | 1,676,004 | G→A | 59.7% | S322S (AGC→AGT) | yfgB ← | hypothetical protein |
RA | 1,676,325 | T→C | 46.5% | V215V (GTA→GTG) | yfgB ← | hypothetical protein |
RA | 1,677,332 | C→A | 38.7% | V73V (GTG→GTT) | ndk ← | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase |
RA | 1,677,347 | G→A | 39.1% | T68T (ACC→ACT) | ndk ← | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase |
RA | 1,677,486 | T→C | 54.0% | N22S (AAT→AGT) | ndk ← | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase |
RA | 1,677,494 | G→C | 51.9% | V19V (GTC→GTG) | ndk ← | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase |
RA | 1,677,666 | A→C | 24.4% | intergenic (‑116/+33) | ndk ← / ← pbpC | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase/fused transglycosylase and transpeptidase |
RA | 1,677,667 | T→C | 24.3% | intergenic (‑117/+32) | ndk ← / ← pbpC | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase/fused transglycosylase and transpeptidase |
RA | 1,677,668 | G→C | 24.7% | intergenic (‑118/+31) | ndk ← / ← pbpC | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase/fused transglycosylase and transpeptidase |
RA | 1,677,674 | T→A | 28.5% | intergenic (‑124/+25) | ndk ← / ← pbpC | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase/fused transglycosylase and transpeptidase |
RA | 1,677,695 | C→T | 38.4% | intergenic (‑145/+4) | ndk ← / ← pbpC | multifunctional nucleoside diphosphate kinase, apyrimidinic endonuclease, and 3'‑phosphodiesterase/fused transglycosylase and transpeptidase |
RA | 1,678,452 | G→A | 68.0% | D520D (GAC→GAT) | pbpC ← | fused transglycosylase and transpeptidase |
RA | 1,679,130 | C→T | 40.9% | R294R (CGG→CGA) | pbpC ← | fused transglycosylase and transpeptidase |
RA | 1,679,133 | C→T | 39.7% | G293G (GGG→GGA) | pbpC ← | fused transglycosylase and transpeptidase |
RA | 1,679,847 | G→A | 29.9% | R55R (CGC→CGT) | pbpC ← | fused transglycosylase and transpeptidase |
RA | 1,680,201 | A→T | 68.4% | I1591I (ATT→ATA) | yfhM ← | conserved hypothetical protein |
RA | 1,680,429 | A→G | 36.7% | D1515D (GAT→GAC) | yfhM ← | conserved hypothetical protein |
RA | 1,680,438 | A→C | 33.0% | L1512L (CTT→CTG) | yfhM ← | conserved hypothetical protein |
RA | 1,680,453 | G→A | 38.4% | I1507I (ATC→ATT) | yfhM ← | conserved hypothetical protein |
RA | 1,680,469 | T→C | 37.5% | N1502S (AAC→AGC) | yfhM ← | conserved hypothetical protein |
RA | 1,680,544 | C→G | 44.2% | S1477T (AGC→ACC) | yfhM ← | conserved hypothetical protein |
RA | 1,680,559 | A→G | 43.0% | V1472A (GTC→GCC) | yfhM ← | conserved hypothetical protein |
RA | 1,680,919 | G→A | 66.0% | T1352I (ACC→ATC) | yfhM ← | conserved hypothetical protein |
RA | 1,681,250 | G→A | 30.8% | L1242L (CTG→TTG) | yfhM ← | conserved hypothetical protein |
RA | 1,682,040 | G→A | 35.6% | N978N (AAC→AAT) | yfhM ← | conserved hypothetical protein |
RA | 1,682,068 | A→G | 38.1% | V969A (GTG→GCG) | yfhM ← | conserved hypothetical protein |
RA | 1,682,563 | C→G | 64.8% | R804P (CGG→CCG) | yfhM ← | conserved hypothetical protein |
RA | 1,683,045 | G→A | 62.0% | G643G (GGC→GGT) | yfhM ← | conserved hypothetical protein |
RA | 1,683,429 | A→G | 50.0% | G515G (GGT→GGC) | yfhM ← | conserved hypothetical protein |
RA | 1,683,516 | G→A | 16.2% | R486R (CGC→CGT) | yfhM ← | conserved hypothetical protein |
RA | 1,683,719 | T→C | 57.0% | N419D (AAT→GAT) | yfhM ← | conserved hypothetical protein |
RA | 1,683,726 | C→T | 59.4% | A416A (GCG→GCA) | yfhM ← | conserved hypothetical protein |
RA | 1,686,595 | G→A | 39.0% | intergenic (+570/+248) | sseA → / ← sseB | 3‑mercaptopyruvate sulfurtransferase/rhodanase‑like enzyme, sulfur transfer from thiosulfate |
RA | 1,687,119 | C→T | 54.0% | P167P (CCG→CCA) | sseB ← | rhodanase‑like enzyme, sulfur transfer from thiosulfate |
RA | 1,687,227 | G→A | 100% | S131S (AGC→AGT) | sseB ← | rhodanase‑like enzyme, sulfur transfer from thiosulfate |
RA | 1,687,235 | G→A | 100% | P129S (CCG→TCG) | sseB ← | rhodanase‑like enzyme, sulfur transfer from thiosulfate |
RA | 1,687,239 | T→C | 100% | G127G (GGA→GGG) | sseB ← | rhodanase‑like enzyme, sulfur transfer from thiosulfate |
RA | 1,687,242 | C→T | 75.1% | E126E (GAG→GAA) | sseB ← | rhodanase‑like enzyme, sulfur transfer from thiosulfate |
RA | 1,688,153 | T→G | 30.9% | M298L (ATG→CTG) | pepB ← | aminopeptidase B |
RA | 1,688,613 | A→G | 67.6% | Y144Y (TAT→TAC) | pepB ← | aminopeptidase B |
RA | 1,688,631 | C→T | 65.4% | A138A (GCG→GCA) | pepB ← | aminopeptidase B |
RA | 1,688,958 | G→A | 47.6% | D29D (GAC→GAT) | pepB ← | aminopeptidase B |
RA | 1,688,979 | T→C | 25.3% | A22A (GCA→GCG) | pepB ← | aminopeptidase B |
RA | 1,688,994 | G→A | 20.4% | R17R (CGC→CGT) | pepB ← | aminopeptidase B |
RA | 1,688,997 | C→T | 20.3% | A16A (GCG→GCA) | pepB ← | aminopeptidase B |
RA | 1,689,310 | T→G | 47.1% | D38A (GAT→GCT) | yfhJ ← | conserved hypothetical protein |
RA | 1,690,443 | T→C | 37.4% | P393P (CCA→CCG) | hscA ← | DnaK‑like molecular chaperone specific for IscU |
RA | 1,690,455 | A→C | 36.5% | L389L (CTT→CTG) | hscA ← | DnaK‑like molecular chaperone specific for IscU |
RA | 1,690,476 | T→C | 45.8% | P382P (CCA→CCG) | hscA ← | DnaK‑like molecular chaperone specific for IscU |
RA | 1,693,353 | G→A | 26.6% | L289L (CTG→TTG) | iscS ← | cysteine desulfurase (tRNA sulfurtransferase), PLP‑dependent |
RA | 1,695,242 | A→G | 100% | intergenic (‑425/+27) | iscR ← / ← yfhQ | DNA‑binding transcriptional activator/predicted methyltransferase |
RA | 1,695,246 | C→A | 100% | intergenic (‑429/+23) | iscR ← / ← yfhQ | DNA‑binding transcriptional activator/predicted methyltransferase |
RA | 1,695,249 | G→A | 100% | intergenic (‑432/+20) | iscR ← / ← yfhQ | DNA‑binding transcriptional activator/predicted methyltransferase |
RA | 1,696,724 | T→C | 53.7% | R199R (CGT→CGC) | suhB → | inositol monophosphatase |
RA | 1,697,000 | T→C | 24.3% | intergenic (+69/‑49) | suhB → / → yfhR | inositol monophosphatase/predicted peptidase |
RA | 1,697,162 | T→C | 37.2% | V38V (GTT→GTC) | yfhR → | predicted peptidase |
RA | 1,698,218 | T→C | 43.3% | M33T (ATG→ACG) | csiE → | stationary phase inducible protein |
RA | 1,698,225 | C→T | 44.2% | T35T (ACC→ACT) | csiE → | stationary phase inducible protein |
RA | 1,698,435 | A→T | 58.7% | Q105H (CAA→CAT) | csiE → | stationary phase inducible protein |
RA | 1,698,732 | A→G | 41.7% | P204P (CCA→CCG) | csiE → | stationary phase inducible protein |
RA | 1,698,757 | C→T | 39.4% | L213L (CTA→TTA) | csiE → | stationary phase inducible protein |
RA | 1,698,852 | T→C | 25.8% | H244H (CAT→CAC) | csiE → | stationary phase inducible protein |
RA | 1,699,077 | T→C | 38.9% | S319S (AGT→AGC) | csiE → | stationary phase inducible protein |
RA | 1,699,098 | C→T | 36.4% | F326F (TTC→TTT) | csiE → | stationary phase inducible protein |
RA | 1,707,042 | G→A | 15.0% | V111V (GTC→GTT) | yphB ← | conserved hypothetical protein |
RA | 1,707,052 | C→A | 10.8% | R108L (CGC→CTC) | yphB ← | conserved hypothetical protein |
RA | 1,707,075 | A→G | 24.2% | S100S (AGT→AGC) | yphB ← | conserved hypothetical protein |
RA | 1,707,088 | T→C | 24.9% | H96R (CAC→CGC) | yphB ← | conserved hypothetical protein |
RA | 1,707,359 | A→G | 100% | L6L (TTA→CTA) | yphB ← | conserved hypothetical protein |
RA | 1,707,743 | A→T | 40.0% | I235I (ATT→ATA) | yphC ← | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 1,707,754 | G→T | 30.5% | L232M (CTG→ATG) | yphC ← | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 1,709,926 | C→T | 58.0% | V374V (GTG→GTA) | yphE ← | fused predicted sugar transporter subunits and ATP‑binding components of ABC superfamily |
RA | 1,712,949 | G→A | 40.0% | A828V (GCC→GTC) | yphG ← | conserved hypothetical protein |
RA | 1,712,951 | T→A | 37.7% | G827G (GGA→GGT) | yphG ← | conserved hypothetical protein |
RA | 1,712,954 | A→G | 42.6% | S826S (AGT→AGC) | yphG ← | conserved hypothetical protein |
RA | 1,714,265 | A→G | 53.0% | G389G (GGT→GGC) | yphG ← | conserved hypothetical protein |
RA | 1,714,466 | G→A | 32.1% | N322N (AAC→AAT) | yphG ← | conserved hypothetical protein |
RA | 1,714,472 | G→C | 32.0% | A320A (GCC→GCG) | yphG ← | conserved hypothetical protein |
RA | 1,714,688 | A→G | 28.3% | P248P (CCT→CCC) | yphG ← | conserved hypothetical protein |
RA | 1,716,655 | G→A | 19.0% | T369T (ACG→ACA) | yphH → | predicted DNA‑binding transcriptional regulator |
RA | 1,716,658 | A→G | 21.8% | Q370Q (CAA→CAG) | yphH → | predicted DNA‑binding transcriptional regulator |
RA | 1,717,117 | G→A | 37.7% | T359T (ACC→ACT) | glyA ← | serine hydroxymethyltransferase |
RA | 1,717,162 | G→C | 32.1% | V344V (GTC→GTG) | glyA ← | serine hydroxymethyltransferase |
RA | 1,725,308 | G→A | 45.4% | F974F (TTC→TTT) | purL ← | phosphoribosylformyl‑glycineamide synthetase |
RA | 1,726,985 | G→A | 100% | G415G (GGC→GGT) | purL ← | phosphoribosylformyl‑glycineamide synthetase |
RA | 1,727,498 | A→G | 30.8% | T244T (ACT→ACC) | purL ← | phosphoribosylformyl‑glycineamide synthetase |
RA | 1,727,501 | A→G | 30.8% | N243N (AAT→AAC) | purL ← | phosphoribosylformyl‑glycineamide synthetase |
RA | 1,727,747 | A→T | 46.3% | V161V (GTT→GTA) | purL ← | phosphoribosylformyl‑glycineamide synthetase |
RA | 1,727,756 | A→G | 46.4% | V158V (GTT→GTC) | purL ← | phosphoribosylformyl‑glycineamide synthetase |
RA | 1,728,960 | T→C | 66.3% | H112H (CAT→CAC) | yfhD → | predicted transglycosylase |
RA | 1,728,993 | A→C | 45.5% | E123D (GAA→GAC) | yfhD → | predicted transglycosylase |
RA | 1,730,046 | C→T | 36.0% | T177T (ACG→ACA) | tadA ← | tRNA‑specific adenosine deaminase |
RA | 1,732,510 | C→T | 51.7% | C54C (TGC→TGT) | yfhL → | predicted 4Fe‑4S cluster‑containing protein |
RA | 1,732,555 | A→G | 48.9% | T69T (ACA→ACG) | yfhL → | predicted 4Fe‑4S cluster‑containing protein |
RA | 1,733,340 | C→G | 51.4% | R115R (CGG→CGC) | acpS ← | holo‑[acyl‑carrier‑protein] synthase 1 |
RA | 1,733,349 | T→G | 51.5% | A112A (GCA→GCC) | acpS ← | holo‑[acyl‑carrier‑protein] synthase 1 |
RA | 1,733,352 | C→A | 50.9% | L111L (CTG→CTT) | acpS ← | holo‑[acyl‑carrier‑protein] synthase 1 |
RA | 1,733,864 | G→A | 45.9% | S184S (AGC→AGT) | pdxJ ← | pyridoxine 5'‑phosphate synthase |
RA | 1,737,138 | G→A | 100% | G286G (GGC→GGT) | lepB ← | leader peptidase |
RA | 1,737,305 | G→A | 47.4% | L231L (CTG→TTG) | lepB ← | leader peptidase |
RA | 1,738,392 | C→T | 33.2% | K473K (AAG→AAA) | lepA ← | GTP binding membrane protein |
RA | 1,738,596 | C→T | 41.0% | E405E (GAG→GAA) | lepA ← | GTP binding membrane protein |
RA | 1,741,977 | T→C | 36.1% | L38L (TTA→TTG) | rseA ← | anti‑sigma factor |
RA | 1,743,369 | C→T | 32.4% | S88S (AGC→AGT) | nadB → | quinolinate synthase, L‑aspartate oxidase (B protein) subunit |
RA | 1,747,578 | G→C | 38.6% | G143G (GGC→GGG) | yfiE ← | predicted DNA‑binding transcriptional regulator |
RA | 1,747,581 | A→G | 39.2% | V142V (GTT→GTC) | yfiE ← | predicted DNA‑binding transcriptional regulator |
RA | 1,749,239 | A→T | 40.2% | intergenic (‑104/‑201) | yfiD ← / → ung | pyruvate formate lyase subunit/uracil‑DNA‑glycosylase |
RA | 1,750,507 | C→A | 100% | S236S (TCG→TCT) | yfiF ← | predicted methyltransferase |
RA | 1,756,432 | T→C | 53.8% | N340N (AAT→AAC) | pssA → | phosphatidylserine synthase |
RA | 1,756,442 | C→T | 45.1% | L344L (CTA→TTA) | pssA → | phosphatidylserine synthase |
RA | 1,756,447 | G→A | 44.4% | V345V (GTG→GTA) | pssA → | phosphatidylserine synthase |
RA | 1,758,112 | C→T | 28.5% | S107S (TCG→TCA) | kgtP ← | alpha‑ketoglutarate transporter |
RA | 1,758,115 | T→G | 28.0% | G106G (GGA→GGC) | kgtP ← | alpha‑ketoglutarate transporter |
RA | 1,763,556 | T→C | 72.0% | noncoding (288/1542 nt) | rrsG ← | 16S ribosomal RNA |
RA | 1,763,636 | A→G | 36.1% | noncoding (208/1542 nt) | rrsG ← | 16S ribosomal RNA |
RA | 1,764,751 | T→C | 36.8% | Q703Q (CAA→CAG) | clpB ← | protein disaggregation chaperone |
RA | 1,765,891 | A→G | 59.0% | I323I (ATT→ATC) | clpB ← | protein disaggregation chaperone |
RA | 1,766,035 | T→C | 58.1% | L275L (CTA→CTG) | clpB ← | protein disaggregation chaperone |
RA | 1,767,900 | T→C | 30.4% | A266A (GCA→GCG) | rluD ← | 23S rRNA pseudouridine synthase |
RA | 1,768,173 | C→T | 65.9% | A175A (GCG→GCA) | rluD ← | 23S rRNA pseudouridine synthase |
RA | 1,770,511 | A→G | 71.1% | E27E (GAA→GAG) | pheA → | fused chorismate mutase P and prephenate dehydratase |
RA | 1,771,324 | C→G | 33.6% | T298T (ACC→ACG) | pheA → | fused chorismate mutase P and prephenate dehydratase |
RA | 1,771,345 | G→A | 49.5% | G305G (GGG→GGA) | pheA → | fused chorismate mutase P and prephenate dehydratase |
RA | 1,771,354 | C→T | 57.3% | A308A (GCC→GCT) | pheA → | fused chorismate mutase P and prephenate dehydratase |
RA | 1,771,360 | G→A | 48.3% | A310A (GCG→GCA) | pheA → | fused chorismate mutase P and prephenate dehydratase |
RA | 1,771,423 | C→T | 34.9% | R331R (CGC→CGT) | pheA → | fused chorismate mutase P and prephenate dehydratase |
RA | 1,772,153 | A→G | 43.8% | G201G (GGT→GGC) | tyrA ← | fused chorismate mutase T and prephenate dehydrogenase |
RA | 1,772,441 | G→A | 47.4% | G105G (GGC→GGT) | tyrA ← | fused chorismate mutase T and prephenate dehydrogenase |
RA | 1,772,459 | A→G | 39.4% | R99R (CGT→CGC) | tyrA ← | fused chorismate mutase T and prephenate dehydrogenase |
RA | 1,772,477 | T→C | 43.3% | T93T (ACA→ACG) | tyrA ← | fused chorismate mutase T and prephenate dehydrogenase |
RA | 1,775,329 | G→C | 34.5% | G87G (GGG→GGC) | yfiN → | predicted diguanylate cyclase |
RA | 1,775,995 | C→A | 36.7% | I309I (ATC→ATA) | yfiN → | predicted diguanylate cyclase |
RA | 1,776,358 | G→T | 33.3% | L16L (CTG→CTT) | yfiB → | predicted outer membrane lipoprotein |
RA | 1,779,576 | C→T | 55.7% | S302S (TCG→TCA) | ffh ← | Signal Recognition Particle (SRP) component with 4.5S RNA (ffs) |
RA | 1,779,750 | G→A | 64.7% | G244G (GGC→GGT) | ffh ← | Signal Recognition Particle (SRP) component with 4.5S RNA (ffs) |
RA | 1,780,767 | T→C | 41.3% | I65I (ATT→ATC) | ypjD → | predicted inner membrane protein |
RA | 1,781,070 | C→T | 45.4% | A166A (GCC→GCT) | ypjD → | predicted inner membrane protein |
RA | 1,781,672 | C→T | 16.7% | N41N (AAC→AAT) | yfjD → | predicted inner membrane protein |
RA | 1,781,684 | T→C | 19.1% | I45I (ATT→ATC) | yfjD → | predicted inner membrane protein |
RA | 1,781,690 | C→T | 18.6% | A47A (GCC→GCT) | yfjD → | predicted inner membrane protein |
RA | 1,781,696 | G→A | 18.8% | A49A (GCG→GCA) | yfjD → | predicted inner membrane protein |
RA | 1,781,711 | T→C | 15.1% | V54V (GTT→GTC) | yfjD → | predicted inner membrane protein |
RA | 1,781,720 | T→C | 25.6% | R57R (CGT→CGC) | yfjD → | predicted inner membrane protein |
RA | 1,781,726 | C→T | 23.3% | Y59Y (TAC→TAT) | yfjD → | predicted inner membrane protein |
RA | 1,781,735 | G→T | 37.6% | A62A (GCG→GCT) | yfjD → | predicted inner membrane protein |
RA | 1,781,756 | T→C | 45.7% | G69G (GGT→GGC) | yfjD → | predicted inner membrane protein |
RA | 1,781,765 | T→C | 34.4% | T72T (ACT→ACC) | yfjD → | predicted inner membrane protein |
RA | 1,781,768 | T→C | 34.4% | F73F (TTT→TTC) | yfjD → | predicted inner membrane protein |
RA | 1,781,771 | C→A | 33.3% | V74V (GTC→GTA) | yfjD → | predicted inner membrane protein |
RA | 1,781,774 | A→G | 48.4% | V75V (GTA→GTG) | yfjD → | predicted inner membrane protein |
RA | 1,781,789 | G→A | 57.7% | E80E (GAG→GAA) | yfjD → | predicted inner membrane protein |
RA | 1,782,512 | C→T | 44.1% | I321I (ATC→ATT) | yfjD → | predicted inner membrane protein |
RA | 1,782,521 | C→T | 38.9% | T324T (ACC→ACT) | yfjD → | predicted inner membrane protein |
RA | 1,782,942 | C→T | 53.3% | P151P (CCG→CCA) | grpE ← | heat shock protein |
RA | 1,784,663 | C→T | 46.1% | R61R (CGC→CGT) | recN → | recombination and repair protein |
RA | 1,784,666 | T→C | 43.9% | A62A (GCT→GCC) | recN → | recombination and repair protein |
RA | 1,786,533 | A→T | 51.7% | P81P (CCA→CCT) | smpA → | small membrane lipoprotein |
RA | 1,786,551 | T→G | 34.0% | T87T (ACT→ACG) | smpA → | small membrane lipoprotein |
RA | 1,787,112 | A→G | 100% | C113C (TGT→TGC) | yfjG ← | conserved hypothetical protein |
RA | 1,787,118 | C→G | 100% | E111D (GAG→GAC) | yfjG ← | conserved hypothetical protein |
RA | 1,790,943 | C→T | 44.9% | I263I (ATC→ATT) | gabD → | succinate‑semialdehyde dehydrogenase I, NADP‑dependent |
RA | 1,790,961 | C→T | 100% | D269D (GAC→GAT) | gabD → | succinate‑semialdehyde dehydrogenase I, NADP‑dependent |
RA | 1,790,967 | C→T | 100% | D271D (GAC→GAT) | gabD → | succinate‑semialdehyde dehydrogenase I, NADP‑dependent |
RA | 1,792,351 | G→A | 100% | A245A (GCG→GCA) | gabT → | 4‑aminobutyrate aminotransferase, PLP‑dependent |
RA | 1,793,299 | G→A | 41.4% | G55G (GGG→GGA) | gabP → | gamma‑aminobutyrate transporter |
RA | 1,793,300 | C→T | 41.4% | L56L (CTA→TTA) | gabP → | gamma‑aminobutyrate transporter |
RA | 1,793,548 | T→C | 58.8% | T138T (ACT→ACC) | gabP → | gamma‑aminobutyrate transporter |
RA | 1,793,557 | C→T | 37.2% | N141N (AAC→AAT) | gabP → | gamma‑aminobutyrate transporter |
RA | 1,793,884 | A→G | 56.5% | L250L (TTA→TTG) | gabP → | gamma‑aminobutyrate transporter |
RA | 1,794,406 | T→C | 44.6% | R424R (CGT→CGC) | gabP → | gamma‑aminobutyrate transporter |
RA | 1,798,738 | C→T | 9.9% | L253L (CTC→CTT) | proV → | glycine betaine transporter subunit |
RA | 1,798,765 | T→A | 13.5% | R262R (CGT→CGA) | proV → | glycine betaine transporter subunit |
RA | 1,799,411 | C→T | 50.7% | F79F (TTC→TTT) | proW → | glycine betaine transporter subunit |
RA | 1,799,423 | C→T | 45.9% | F83F (TTC→TTT) | proW → | glycine betaine transporter subunit |
RA | 1,799,450 | T→C | 27.6% | Y92Y (TAT→TAC) | proW → | glycine betaine transporter subunit |
RA | 1,800,617 | G→A | 44.4% | G107G (GGG→GGA) | proX → | glycine betaine transporter subunit |
RA | 1,801,836 | G→A | 51.5% | pseudogene (60/882 nt) | ygaY → | ECK2675:JW5428:b2681; predicted transporter |
RA | 1,801,863 | T→C | 74.0% | pseudogene (87/882 nt) | ygaY → | ECK2675:JW5428:b2681; predicted transporter |
RA | 1,802,088 | T→C | 48.4% | pseudogene (312/882 nt) | ygaY → | ECK2675:JW5428:b2681; predicted transporter |
RA | 1,802,101 | G→A | 46.2% | pseudogene (325/882 nt) | ygaY → | ECK2675:JW5428:b2681; predicted transporter |
RA | 1,802,106 | A→G | 52.6% | pseudogene (330/882 nt) | ygaY → | ECK2675:JW5428:b2681; predicted transporter |
RA | 1,802,502 | T→C | 29.3% | pseudogene (726/882 nt) | ygaY → | ECK2675:JW5428:b2681; predicted transporter |
RA | 1,803,541 | A→G | 45.8% | L11L (CTA→CTG) | ygaH → | predicted inner membrane protein |
RA | 1,803,549 | T→C | 51.0% | V14A (GTG→GCG) | ygaH → | predicted inner membrane protein |
RA | 1,803,572 | T→C | 44.3% | L22L (TTG→CTG) | ygaH → | predicted inner membrane protein |
RA | 1,804,090 | G→A | 90.1% | G52G (GGG→GGA) | mprA → | DNA‑binding transcriptional regulator |
RA | 1,806,227 | C→T | 37.8% | V149V (GTC→GTT) | emrB → | multidrug efflux system protein |
RA | 1,806,641 | T→G | 100% | A287A (GCT→GCG) | emrB → | multidrug efflux system protein |
RA | 1,807,019 | C→T | 60.1% | G413G (GGC→GGT) | emrB → | multidrug efflux system protein |
RA | 1,807,025 | G→C | 61.1% | S415S (TCG→TCC) | emrB → | multidrug efflux system protein |
RA | 1,807,031 | C→G | 48.7% | T417T (ACC→ACG) | emrB → | multidrug efflux system protein |
RA | 1,807,037 | C→G | 48.1% | T419T (ACC→ACG) | emrB → | multidrug efflux system protein |
RA | 1,807,046 | C→T | 48.0% | T422T (ACC→ACT) | emrB → | multidrug efflux system protein |
RA | 1,807,070 | G→T | 40.8% | A430A (GCG→GCT) | emrB → | multidrug efflux system protein |
RA | 1,807,079 | T→C | 35.1% | T433T (ACT→ACC) | emrB → | multidrug efflux system protein |
RA | 1,813,536 | C→A | 66.6% | A547A (GCG→GCT) | alaS ← | alanyl‑tRNA synthetase |
RA | 1,813,620 | A→G | 36.9% | F519F (TTT→TTC) | alaS ← | alanyl‑tRNA synthetase |
RA | 1,813,656 | G→A | 38.4% | G507G (GGC→GGT) | alaS ← | alanyl‑tRNA synthetase |
RA | 1,814,214 | A→G | 46.5% | G321G (GGT→GGC) | alaS ← | alanyl‑tRNA synthetase |
RA | 1,814,577 | G→A | 60.8% | S200S (AGC→AGT) | alaS ← | alanyl‑tRNA synthetase |
RA | 1,817,649 | T→C | 34.6% | intergenic (‑138/+7) | ygaD ← / ← mltB | conserved hypothetical protein/membrane‑bound lytic murein transglycosylase B |
RA | 1,817,656 | C→T | 38.7% | *362* (TAG→TAA) | mltB ← | membrane‑bound lytic murein transglycosylase B |
RA | 1,817,662 | T→C | 35.5% | V360V (GTA→GTG) | mltB ← | membrane‑bound lytic murein transglycosylase B |
RA | 1,817,665 | T→G | 34.7% | R359R (CGA→CGC) | mltB ← | membrane‑bound lytic murein transglycosylase B |
RA | 1,820,412 | T→C | 35.7% | L32L (CTA→CTG) | norR ← | DNA‑binding transcriptional activator |
RA | 1,820,972 | A→G | 14.0% | A93A (GCA→GCG) | norV → | flavorubredoxin oxidoreductase |
RA | 1,826,057 | G→A | 40.4% | C89C (TGC→TGT) | hydN ← | formate dehydrogenase‑H, [4Fe‑4S] ferredoxin subunit |
RA | 1,826,895 | C→G | 63.4% | R46R (CGC→CGG) | mutS → | methyl‑directed mismatch repair protein |
RA | 1,827,216 | G→T | 67.8% | G153G (GGG→GGT) | mutS → | methyl‑directed mismatch repair protein |
RA | 1,827,240 | T→G | 55.2% | A161A (GCT→GCG) | mutS → | methyl‑directed mismatch repair protein |
RA | 1,827,435 | C→T | 51.7% | G226G (GGC→GGT) | mutS → | methyl‑directed mismatch repair protein |
RA | 1,827,438 | C→G | 54.5% | V227V (GTC→GTG) | mutS → | methyl‑directed mismatch repair protein |
RA | 1,827,447 | G→A | 58.8% | A230A (GCG→GCA) | mutS → | methyl‑directed mismatch repair protein |
RA | 1,827,450 | G→A | 58.0% | P231P (CCG→CCA) | mutS → | methyl‑directed mismatch repair protein |
RA | 1,829,861 | G→A | 35.8% | S146N (AGT→AAT) ‡ | pphB → | serine/threonine‑specific protein phosphatase 2 |
RA | 1,829,862 | T→G | 35.8% | S146R (AGT→AGG) ‡ | pphB → | serine/threonine‑specific protein phosphatase 2 |
RA | 1,829,865 | A→G | 22.6% | E147E (GAA→GAG) | pphB → | serine/threonine‑specific protein phosphatase 2 |
RA | 1,829,870 | T→A | 17.2% | L149H (CTC→CAC) ‡ | pphB → | serine/threonine‑specific protein phosphatase 2 |
RA | 1,829,871 | C→G | 17.8% | L149L (CTC→CTG) ‡ | pphB → | serine/threonine‑specific protein phosphatase 2 |
RA | 1,829,877 | T→C | 22.5% | G151G (GGT→GGC) | pphB → | serine/threonine‑specific protein phosphatase 2 |
RA | 1,830,537 | T→A | 49.0% | T131T (ACA→ACT) | ygbI ← | predicted DNA‑binding transcriptional regulator |
RA | 1,830,540 | G→A | 49.0% | V130V (GTC→GTT) | ygbI ← | predicted DNA‑binding transcriptional regulator |
RA | 1,830,546 | A→T | 57.8% | T128T (ACT→ACA) | ygbI ← | predicted DNA‑binding transcriptional regulator |
RA | 1,830,549 | C→G | 57.8% | L127L (CTG→CTC) | ygbI ← | predicted DNA‑binding transcriptional regulator |
RA | 1,830,554 | A→G | 50.0% | S126P (TCA→CCA) | ygbI ← | predicted DNA‑binding transcriptional regulator |
RA | 1,830,565 | A→G | 50.8% | I122T (ATT→ACT) | ygbI ← | predicted DNA‑binding transcriptional regulator |
RA | 1,830,579 | T→A | 50.9% | I117I (ATA→ATT) | ygbI ← | predicted DNA‑binding transcriptional regulator |
RA | 1,830,840 | G→A | 53.2% | V30V (GTC→GTT) | ygbI ← | predicted DNA‑binding transcriptional regulator |
RA | 1,830,994 | A→G | 34.0% | intergenic (‑65/‑101) | ygbI ← / → ygbJ | predicted DNA‑binding transcriptional regulator/predicted dehydrogenase, with NAD(P)‑binding Rossmann‑fold domain |
RA | 1,831,018 | A→C | 36.0% | intergenic (‑89/‑77) | ygbI ← / → ygbJ | predicted DNA‑binding transcriptional regulator/predicted dehydrogenase, with NAD(P)‑binding Rossmann‑fold domain |
RA | 1,831,027 | C→T | 44.5% | intergenic (‑98/‑68) | ygbI ← / → ygbJ | predicted DNA‑binding transcriptional regulator/predicted dehydrogenase, with NAD(P)‑binding Rossmann‑fold domain |
RA | 1,831,037 | C→T | 44.4% | intergenic (‑108/‑58) | ygbI ← / → ygbJ | predicted DNA‑binding transcriptional regulator/predicted dehydrogenase, with NAD(P)‑binding Rossmann‑fold domain |
RA | 1,831,039 | A→C | 44.5% | intergenic (‑110/‑56) | ygbI ← / → ygbJ | predicted DNA‑binding transcriptional regulator/predicted dehydrogenase, with NAD(P)‑binding Rossmann‑fold domain |
RA | 1,831,056 | T→C | 25.1% | intergenic (‑127/‑39) | ygbI ← / → ygbJ | predicted DNA‑binding transcriptional regulator/predicted dehydrogenase, with NAD(P)‑binding Rossmann‑fold domain |
RA | 1,833,604 | G→A | 46.8% | S116N (AGC→AAC) ‡ | ygbL → | predicted class II aldolase |
RA | 1,833,605 | C→T | 39.4% | S116S (AGC→AGT) ‡ | ygbL → | predicted class II aldolase |
RA | 1,833,617 | T→G | 39.1% | R120R (CGT→CGG) | ygbL → | predicted class II aldolase |
RA | 1,833,650 | A→T | 48.5% | G131G (GGA→GGT) | ygbL → | predicted class II aldolase |
RA | 1,833,668 | T→C | 39.1% | P137P (CCT→CCC) | ygbL → | predicted class II aldolase |
RA | 1,840,013 | C→T | 56.8% | E319E (GAG→GAA) | truD ← | pseudoruidine synthase |
RA | 1,840,037 | A→G | 62.4% | N311N (AAT→AAC) | truD ← | pseudoruidine synthase |
RA | 1,841,416 | A→G | 40.3% | H10H (CAT→CAC) | ispF ← | 2C‑methyl‑D‑erythritol 2,4‑cyclodiphosphate synthase |
RA | 1,841,484 | C→T | 40.4% | E224E (GAG→GAA) | ispD ← | 4‑diphosphocytidyl‑2C‑methyl‑D‑erythritol synthase |
RA | 1,841,493 | T→C | 42.6% | A221A (GCA→GCG) | ispD ← | 4‑diphosphocytidyl‑2C‑methyl‑D‑erythritol synthase |
RA | 1,841,502 | T→C | 23.6% | E218E (GAA→GAG) | ispD ← | 4‑diphosphocytidyl‑2C‑methyl‑D‑erythritol synthase |
RA | 1,841,514 | G→T | 23.0% | V214V (GTC→GTA) | ispD ← | 4‑diphosphocytidyl‑2C‑methyl‑D‑erythritol synthase |
RA | 1,841,517 | T→C | 26.4% | K213K (AAA→AAG) | ispD ← | 4‑diphosphocytidyl‑2C‑methyl‑D‑erythritol synthase |
RA | 1,841,520 | A→G | 24.8% | I212I (ATT→ATC) | ispD ← | 4‑diphosphocytidyl‑2C‑methyl‑D‑erythritol synthase |
RA | 1,842,330 | T→C | 37.3% | Q52Q (CAA→CAG) | ftsB ← | cell division protein |
RA | 1,843,423 | C→A | 9.2% | D79Y (GAT→TAT) | cysC ← | adenosine 5'‑phosphosulfate kinase |
RA | 1,844,797 | G→A | 59.8% | D96D (GAC→GAT) | cysN ← | sulfate adenylyltransferase, subunit 1 |
RA | 1,844,803 | G→A | 64.9% | T94T (ACC→ACT) | cysN ← | sulfate adenylyltransferase, subunit 1 |
RA | 1,844,848 | A→T | 38.0% | A79A (GCT→GCA) | cysN ← | sulfate adenylyltransferase, subunit 1 |
RA | 1,845,292 | G→A | 51.8% | P235S (CCG→TCG) | cysD ← | sulfate adenylyltransferase, subunit 2 |
RA | 1,845,301 | C→T | 56.3% | D232N (GAC→AAC) | cysD ← | sulfate adenylyltransferase, subunit 2 |
RA | 1,845,328 | A→G | 50.5% | L223L (TTG→CTG) | cysD ← | sulfate adenylyltransferase, subunit 2 |
RA | 1,847,097 | G→C | 24.2% | G284G (GGG→GGC) | iap → | aminopeptidase in alkaline phosphatase isozyme conversion |
RA | 1,847,181 | C→A | 34.9% | H312Q (CAC→CAA) | iap → | aminopeptidase in alkaline phosphatase isozyme conversion |
RA | 1,847,184 | A→G | 38.1% | Q313Q (CAA→CAG) | iap → | aminopeptidase in alkaline phosphatase isozyme conversion |
RA | 1,857,716 | C→G | 29.1% | E27Q (GAA→CAA) | cysH ← | 3'‑phosphoadenosine 5'‑phosphosulfate reductase |
RA | 1,858,220 | A→G | 14.1% | F454F (TTT→TTC) | cysI ← | sulfite reductase, beta subunit, NAD(P)‑binding |
RA | 1,858,283 | A→G | 38.6% | A433A (GCT→GCC) | cysI ← | sulfite reductase, beta subunit, NAD(P)‑binding |
RA | 1,858,289 | C→T | 48.6% | S431S (TCG→TCA) | cysI ← | sulfite reductase, beta subunit, NAD(P)‑binding |
RA | 1,858,373 | T→C | 23.7% | V403V (GTA→GTG) | cysI ← | sulfite reductase, beta subunit, NAD(P)‑binding |
RA | 1,858,376 | A→T | 24.7% | G402G (GGT→GGA) | cysI ← | sulfite reductase, beta subunit, NAD(P)‑binding |
RA | 1,859,000 | G→A | 56.9% | D194D (GAC→GAT) | cysI ← | sulfite reductase, beta subunit, NAD(P)‑binding |
RA | 1,862,621 | T→G | 53.9% | A161A (GCT→GCG) | ygcN → | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
RA | 1,862,627 | T→C | 59.6% | R163R (CGT→CGC) | ygcN → | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
RA | 1,863,770 | A→G | 27.2% | Q31Q (CAA→CAG) | ygcP → | predicted anti‑terminator regulatory protein |
RA | 1,864,367 | G→C | 38.3% | intergenic (+114/+34) | ygcP → / ← ygcQ | predicted anti‑terminator regulatory protein/predicted flavoprotein |
RA | 1,864,396 | A→G | 53.5% | intergenic (+143/+5) | ygcP → / ← ygcQ | predicted anti‑terminator regulatory protein/predicted flavoprotein |
RA | 1,866,972 | T→G | 55.9% | V127V (GTA→GTC) | ygcS ← | predicted transporter |
RA | 1,866,978 | A→G | 58.6% | Y125Y (TAT→TAC) | ygcS ← | predicted transporter |
RA | 1,867,002 | A→G | 52.2% | I117I (ATT→ATC) | ygcS ← | predicted transporter |
RA | 1,867,296 | G→T | 71.0% | R19R (CGC→CGA) | ygcS ← | predicted transporter |
RA | 1,867,299 | G→A | 71.1% | C18C (TGC→TGT) | ygcS ← | predicted transporter |
RA | 1,868,106 | G→A | 35.0% | D265D (GAC→GAT) | ygcU ← | predicted FAD containing dehydrogenase |
RA | 1,868,121 | G→A | 32.2% | I260I (ATC→ATT) | ygcU ← | predicted FAD containing dehydrogenase |
RA | 1,868,124 | T→C | 31.9% | S259S (TCA→TCG) | ygcU ← | predicted FAD containing dehydrogenase |
RA | 1,869,681 | A→G | 23.9% | G25G (GGT→GGC) | ygcW ← | predicted deoxygluconate dehydrogenase |
RA | 1,869,696 | G→T | 33.8% | T20T (ACC→ACA) | ygcW ← | predicted deoxygluconate dehydrogenase |
RA | 1,870,835 | G→A | 55.2% | S254S (TCG→TCA) | yqcE → | predicted transporter |
RA | 1,870,877 | A→C | 20.0% | I268I (ATA→ATC) | yqcE → | predicted transporter |
RA | 1,871,049 | C→T | 42.0% | L326L (CTG→TTG) ‡ | yqcE → | predicted transporter |
RA | 1,871,051 | G→A | 42.0% | L326L (CTG→CTA) ‡ | yqcE → | predicted transporter |
RA | 1,871,189 | A→G | 14.1% | P372P (CCA→CCG) | yqcE → | predicted transporter |
RA | 1,872,394 | C→T | 21.5% | S339S (AGC→AGT) | ygcE → | predicted kinase |
RA | 1,872,656 | G→A | 19.2% | A427T (GCA→ACA) | ygcE → | predicted kinase |
RA | 1,872,673 | C→A | 33.1% | N432K (AAC→AAA) | ygcE → | predicted kinase |
RA | 1,872,697 | T→C | 35.1% | F440F (TTT→TTC) | ygcE → | predicted kinase |
RA | 1,874,126 | C→T | 29.6% | intergenic (+1270/+103) | ygcE → / ← ygcF | predicted kinase/conserved hypothetical protein |
RA | 1,874,129 | T→A | 28.0% | intergenic (+1273/+100) | ygcE → / ← ygcF | predicted kinase/conserved hypothetical protein |
RA | 1,874,131 | G→A | 30.7% | intergenic (+1275/+98) | ygcE → / ← ygcF | predicted kinase/conserved hypothetical protein |
RA | 1,874,640 | C→A | 31.6% | R87R (CGG→CGT) | ygcF ← | conserved hypothetical protein |
RA | 1,874,658 | G→A | 36.2% | R81R (CGC→CGT) | ygcF ← | conserved hypothetical protein |
RA | 1,874,661 | A→G | 39.9% | G80G (GGT→GGC) | ygcF ← | conserved hypothetical protein |
RA | 1,876,236 | A→G | 62.2% | S396S (TCT→TCC) | eno ← | enolase |
RA | 1,876,242 | A→C | 62.2% | T394T (ACT→ACG) | eno ← | enolase |
RA | 1,876,341 | A→G | 66.4% | D361D (GAT→GAC) | eno ← | enolase |
RA | 1,876,356 | G→A | 31.5% | I356I (ATC→ATT) | eno ← | enolase |
RA | 1,876,359 | T→A | 31.6% | A355A (GCA→GCT) | eno ← | enolase |
RA | 1,876,368 | A→G | 27.0% | T352T (ACT→ACC) | eno ← | enolase |
RA | 1,876,422 | A→G | 41.1% | G334G (GGT→GGC) | eno ← | enolase |
RA | 1,876,560 | A→G | 44.0% | S288S (TCT→TCC) | eno ← | enolase |
RA | 1,879,631 | T→C | 37.6% | E179E (GAA→GAG) | mazG ← | nucleoside triphosphate pyrophosphohydrolase |
RA | 1,879,862 | A→G | 42.5% | D102D (GAT→GAC) | mazG ← | nucleoside triphosphate pyrophosphohydrolase |
RA | 1,881,919 | C→T | 45.5% | R405R (CGG→CGA) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,378 | A→T | 17.7% | R252R (CGT→CGA) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,393 | C→A | 19.3% | A247A (GCG→GCT) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,402 | G→A | 30.7% | G244G (GGC→GGT) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,471 | C→G | 41.4% | R221R (CGG→CGC) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,489 | G→T | 53.5% | A215A (GCC→GCA) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,492 | A→G | 52.4% | I214I (ATT→ATC) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,495 | T→G | 52.2% | R213R (CGA→CGC) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,510 | T→C | 39.6% | P208P (CCA→CCG) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,513 | A→G | 39.1% | H207H (CAT→CAC) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,516 | G→C | 39.2% | L206L (CTC→CTG) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,519 | G→A | 38.7% | Y205Y (TAC→TAT) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,543 | T→C | 35.8% | E197E (GAA→GAG) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,657 | A→G | 52.2% | H159H (CAT→CAC) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,882,687 | T→C | 31.6% | V149V (GTA→GTG) | relA ← | (p)ppGpp synthetase I/GTP pyrophosphokinase |
RA | 1,883,630 | G→C | 41.1% | Q285E (CAA→GAA) | rumA ← | 23S rRNA (uracil‑5)‑methyltransferase |
RA | 1,883,667 | T→C | 35.8% | Q272Q (CAA→CAG) | rumA ← | 23S rRNA (uracil‑5)‑methyltransferase |
RA | 1,884,080 | G→A | 11.9% | L135L (CTG→TTG) | rumA ← | 23S rRNA (uracil‑5)‑methyltransferase |
RA | 1,884,138 | A→T | 35.8% | D115E (GAT→GAA) | rumA ← | 23S rRNA (uracil‑5)‑methyltransferase |
RA | 1,885,303 | G→A | 54.0% | Q255Q (CAG→CAA) | barA → | hybrid sensory histidine kinase, in two‑component regulatory system with UvrY |
RA | 1,886,458 | A→G | 33.3% | T640T (ACA→ACG) | barA → | hybrid sensory histidine kinase, in two‑component regulatory system with UvrY |
RA | 1,886,479 | G→A | 42.8% | T647T (ACG→ACA) | barA → | hybrid sensory histidine kinase, in two‑component regulatory system with UvrY |
RA | 1,886,680 | G→A | 16.9% | L714L (TTG→TTA) | barA → | hybrid sensory histidine kinase, in two‑component regulatory system with UvrY |
RA | 1,887,935 | C→A | 37.1% | L311L (CTG→CTT) | gudD ← | (D)‑glucarate dehydratase 1 |
RA | 1,888,190 | G→A | 62.0% | R226R (CGC→CGT) | gudD ← | (D)‑glucarate dehydratase 1 |
RA | 1,888,954 | A→G | 30.5% | G425G (GGT→GGC) | gudX ← | predicted glucarate dehydratase |
RA | 1,889,568 | C→T | 45.4% | A221T (GCA→ACA) | gudX ← | predicted glucarate dehydratase |
RA | 1,889,608 | G→A | 57.3% | G207G (GGC→GGT) | gudX ← | predicted glucarate dehydratase |
RA | 1,889,980 | G→A | 24.4% | V83V (GTC→GTT) | gudX ← | predicted glucarate dehydratase |
RA | 1,891,013 | C→G | 48.8% | G190G (GGG→GGC) | gudP ← | predicted D‑glucarate transporter |
RA | 1,891,538 | T→C | 40.8% | T15T (ACA→ACG) | gudP ← | predicted D‑glucarate transporter |
RA | 1,891,664 | Δ1 bp | 100% | intergenic (‑82/+409) | gudP ← / ← ygdL | predicted D‑glucarate transporter/conserved hypothetical protein |
RA | 1,892,019:1 | +GC | 100% | intergenic (‑437/+54) | gudP ← / ← ygdL | predicted D‑glucarate transporter/conserved hypothetical protein |
RA | 1,892,351 | G→A | 100% | L177L (CTG→TTG) | ygdL ← | conserved hypothetical protein |
RA | 1,892,400 | A→G | 100% | D160D (GAT→GAC) | ygdL ← | conserved hypothetical protein |
RA | 1,892,496 | G→A | 29.5% | A128A (GCC→GCT) | ygdL ← | conserved hypothetical protein |
RA | 1,893,820 | G→A | 18.7% | R132R (CGC→CGT) | mltA ← | membrane‑bound lytic murein transglycosylase A |
RA | 1,893,856 | A→G | 32.3% | G120G (GGT→GGC) | mltA ← | membrane‑bound lytic murein transglycosylase A |
RA | 1,893,859 | G→T | 31.4% | T119T (ACC→ACA) | mltA ← | membrane‑bound lytic murein transglycosylase A |
RA | 1,896,246 | C→A | 40.9% | intergenic (‑199/‑33) | amiC ← / → argA | N‑acetylmuramoyl‑L‑alanine amidase/fused acetylglutamate kinase homolog (inactive) and amino acid N‑acetyltransferase |
RA | 1,896,276 | G→A | 54.0% | intergenic (‑229/‑3) | amiC ← / → argA | N‑acetylmuramoyl‑L‑alanine amidase/fused acetylglutamate kinase homolog (inactive) and amino acid N‑acetyltransferase |
RA | 1,896,815 | A→G | 38.5% | S179S (TCA→TCG) | argA → | fused acetylglutamate kinase homolog (inactive) and amino acid N‑acetyltransferase |
RA | 1,897,196 | T→C | 30.9% | I306I (ATT→ATC) | argA → | fused acetylglutamate kinase homolog (inactive) and amino acid N‑acetyltransferase |
RA | 1,897,223 | A→G | 29.4% | P315P (CCA→CCG) | argA → | fused acetylglutamate kinase homolog (inactive) and amino acid N‑acetyltransferase |
RA | 1,898,833 | C→T | 60.7% | Q222Q (CAG→CAA) | recD ← | exonuclease V (RecBCD complex), alpha chain |
RA | 1,900,206 | A→G | 59.3% | F945F (TTT→TTC) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,900,215 | T→C | 58.2% | P942P (CCA→CCG) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,901,157 | G→A | 35.8% | I628I (ATC→ATT) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,901,169 | G→A | 56.4% | N624N (AAC→AAT) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,901,202 | A→G | 48.4% | R613R (CGT→CGC) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,901,226 | C→T | 24.4% | T605T (ACG→ACA) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,902,495 | G→C | 34.1% | V182V (GTC→GTG) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,902,504 | T→A | 30.4% | I179I (ATA→ATT) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,902,939 | C→T | 41.8% | A34A (GCG→GCA) | recB ← | exonuclease V (RecBCD complex), beta subunit |
RA | 1,903,767 | C→G | 43.8% | D719H (GAT→CAT) | ptr ← | protease III |
RA | 1,903,827 | G→T | 57.3% | R699R (CGA→AGA) | ptr ← | protease III |
RA | 1,903,969 | A→G | 37.3% | G651G (GGT→GGC) | ptr ← | protease III |
RA | 1,904,593 | C→T | 27.7% | K443K (AAG→AAA) | ptr ← | protease III |
RA | 1,904,641 | C→T | 50.0% | T427T (ACG→ACA) | ptr ← | protease III |
RA | 1,904,674 | T→A | 50.2% | A416A (GCA→GCT) | ptr ← | protease III |
RA | 1,904,710 | C→T | 40.6% | S404S (TCG→TCA) | ptr ← | protease III |
RA | 1,904,833 | A→C | 25.2% | A363A (GCT→GCG) | ptr ← | protease III |
RA | 1,904,839 | G→A | 26.3% | G361G (GGC→GGT) | ptr ← | protease III |
RA | 1,905,025 | G→A | 17.2% | N299N (AAC→AAT) | ptr ← | protease III |
RA | 1,905,908 | G→A | 40.8% | T5I (ACC→ATC) | ptr ← | protease III |
RA | 1,906,192 | T→G | 36.4% | R1092R (AGG→CGG) | recC ← | exonuclease V (RecBCD complex), gamma chain |
RA | 1,906,806 | G→A | 43.6% | A887V (GCA→GTA) | recC ← | exonuclease V (RecBCD complex), gamma chain |
RA | 1,906,811 | C→T | 44.4% | L885L (TTG→TTA) | recC ← | exonuclease V (RecBCD complex), gamma chain |
RA | 1,906,823 | A→G | 38.0% | N881N (AAT→AAC) | recC ← | exonuclease V (RecBCD complex), gamma chain |
RA | 1,908,113 | C→A | 46.4% | L451L (CTG→CTT) | recC ← | exonuclease V (RecBCD complex), gamma chain |
RA | 1,908,119 | C→A | 41.9% | P449P (CCG→CCT) | recC ← | exonuclease V (RecBCD complex), gamma chain |
RA | 1,910,142 | C→T | 58.9% | V18I (GTT→ATT) | ygdB ← | hypothetical protein |
RA | 1,910,924 | T→C | 42.5% | P97P (CCA→CCG) | ppdA ← | conserved hypothetical protein |
RA | 1,911,643 | A→G | 57.4% | L184L (TTG→CTG) | thyA ← | thymidylate synthetase |
RA | 1,914,053 | G→A | 28.0% | F473F (TTC→TTT) | ptsP ← | fused PEP‑protein phosphotransferase (enzyme I) of PTS system |
RA | 1,914,338 | C→T | 51.8% | V378V (GTG→GTA) | ptsP ← | fused PEP‑protein phosphotransferase (enzyme I) of PTS system |
RA | 1,914,374 | G→T | 73.1% | I366I (ATC→ATA) | ptsP ← | fused PEP‑protein phosphotransferase (enzyme I) of PTS system |
RA | 1,914,611 | A→G | 34.4% | S287S (AGT→AGC) | ptsP ← | fused PEP‑protein phosphotransferase (enzyme I) of PTS system |
RA | 1,916,684 | T→C | 34.8% | intergenic (‑670/‑15) | nudH ← / → mutH | nucleotide hydrolase/methyl‑directed mismatch repair protein |
RA | 1,920,405 | G→A | 28.1% | V165V (GTC→GTT) | ygeD ← | predicted inner membrane protein |
RA | 1,920,408 | G→C | 28.0% | L164L (CTC→CTG) | ygeD ← | predicted inner membrane protein |
RA | 1,920,411 | G→A | 27.3% | V163V (GTC→GTT) ‡ | ygeD ← | predicted inner membrane protein |
RA | 1,920,413 | C→T | 26.5% | V163I (GTC→ATC) ‡ | ygeD ← | predicted inner membrane protein |
RA | 1,920,429 | C→A | 35.3% | V157V (GTG→GTT) | ygeD ← | predicted inner membrane protein |
RA | 1,920,438 | G→A | 31.4% | A154A (GCC→GCT) | ygeD ← | predicted inner membrane protein |
RA | 1,922,014 | T→C | 47.5% | V346V (GTA→GTG) | aas ← | fused 2‑acylglycerophospho‑ethanolamine acyl transferase and acyl‑acyl carrier protein synthetase |
RA | 1,923,899 | C→T | 48.2% | T88T (ACC→ACT) | galR → | DNA‑binding transcriptional repressor |
RA | 1,924,613 | T→C | 24.9% | R326R (CGT→CGC) | galR → | DNA‑binding transcriptional repressor |
RA | 1,924,968 | A→C | 35.2% | D323E (GAT→GAG) | lysA ← | diaminopimelate decarboxylase, PLP‑binding |
RA | 1,926,217 | G→A | 62.8% | V54I (GTA→ATA) | lysR → | DNA‑binding transcriptional dual regulator |
RA | 1,926,225 | G→A | 65.6% | G56G (GGG→GGA) | lysR → | DNA‑binding transcriptional dual regulator |
RA | 1,927,349 | G→A | 60.8% | T108T (ACC→ACT) | ygeA ← | predicted racemase |
RA | 1,927,361 | A→T | 54.0% | I104I (ATT→ATA) | ygeA ← | predicted racemase |
RA | 1,927,381 | T→A | 47.4% | T98S (ACT→TCT) | ygeA ← | predicted racemase |
RA | 1,927,388 | T→A | 41.9% | S95S (TCA→TCT) | ygeA ← | predicted racemase |
RA | 1,929,007 | A→G | 45.6% | G71G (GGT→GGC) | araE ← | arabinose transporter |
RA | 1,930,883 | G→A | 27.6% | G93G (GGC→GGT) | kduI ← | predicted 5‑keto 4‑deoxyuronate isomerase |
RA | 1,932,006 | C→T | 30.7% | G208G (GGG→GGA) | yqeF ← | predicted acyltransferase |
RA | 1,932,021 | C→T | 37.2% | M203I (ATG→ATA) | yqeF ← | predicted acyltransferase |
RA | 1,932,207 | G→A | 31.1% | D141D (GAC→GAT) | yqeF ← | predicted acyltransferase |
RA | 1,932,405 | C→A | 27.5% | L75L (CTG→CTT) | yqeF ← | predicted acyltransferase |
RA | 1,933,099 | G→A | 58.9% | D448D (GAC→GAT) | lysS ← | lysine tRNA synthetase, constitutive |
RA | 1,933,915 | G→A | 60.0% | S176S (TCC→TCT) | lysS ← | lysine tRNA synthetase, constitutive |
RA | 1,933,927 | G→C | 39.2% | L172L (CTC→CTG) | lysS ← | lysine tRNA synthetase, constitutive |
RA | 1,934,611 | G→A | 41.5% | N288N (AAC→AAT) | prfB ← | peptide chain release factor RF‑2 |
RA | 1,934,614 | A→G | 55.7% | D287D (GAT→GAC) | prfB ← | peptide chain release factor RF‑2 |
RA | 1,936,148 | A→G | 26.6% | R409R (CGT→CGC) | recJ ← | ssDNA exonuclease, 5' ‑‑> 3'‑specific |
RA | 1,936,247 | G→A | 58.7% | R376R (CGC→CGT) | recJ ← | ssDNA exonuclease, 5' ‑‑> 3'‑specific |
RA | 1,937,926 | G→A | 38.3% | G55G (GGC→GGT) | dsbC ← | protein disulfide isomerase II |
RA | 1,938,229 | T→C | 32.7% | L261L (TTA→TTG) | xerD ← | site‑specific tyrosine recombinase |
RA | 1,938,253 | A→G | 44.1% | H253H (CAT→CAC) | xerD ← | site‑specific tyrosine recombinase |
RA | 1,939,711 | A→T | 30.5% | I127I (ATT→ATA) | ygfX ← | hypothetical protein |
RA | 1,939,735 | A→G | 31.6% | A119A (GCT→GCC) | ygfX ← | hypothetical protein |
RA | 1,939,987 | T→C | 100% | P35P (CCA→CCG) | ygfX ← | hypothetical protein |
RA | 1,940,706 | G→A | 27.8% | Q42Q (CAG→CAA) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,940,709 | T→C | 27.8% | G43G (GGT→GGC) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,940,737 | G→A | 33.7% | A53T (GCA→ACA) ‡ | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,940,739 | A→T | 34.3% | A53A (GCA→GCT) ‡ | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,941,264 | T→C | 54.7% | C228C (TGT→TGC) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,941,417 | A→G | 62.4% | V279V (GTA→GTG) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,941,424 | G→A | 58.2% | A282T (GCG→ACG) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,941,429 | A→C | 45.0% | V283V (GTA→GTC) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,941,450 | C→T | 47.7% | V290V (GTC→GTT) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,941,456 | A→G | 38.0% | V292V (GTA→GTG) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,941,462 | C→T | 13.6% | V294V (GTC→GTT) | ygfZ → | predicted folate‑dependent regulatory protein |
RA | 1,942,643 | T→C | 14.4% | K83K (AAA→AAG) | yqfB ← | conserved hypothetical protein |
RA | 1,943,994 | A→G | 45.5% | P355P (CCA→CCG) | bglA → | 6‑phospho‑beta‑glucosidase A |
RA | 1,943,997 | A→T | 45.5% | V356V (GTA→GTT) | bglA → | 6‑phospho‑beta‑glucosidase A |
RA | 1,944,009 | T→C | 32.4% | Y360Y (TAT→TAC) | bglA → | 6‑phospho‑beta‑glucosidase A |
RA | 1,945,691 | G→A | 57.8% | D873D (GAC→GAT) | gcvP ← | glycine decarboxylase, PLP‑dependent, subunit (protein P) of glycine cleavage complex |
RA | 1,948,611 | G→A | 31.5% | D69D (GAC→GAT) | gcvH ← | glycine cleavage complex lipoylprotein |
RA | 1,948,808 | C→T | 61.7% | V4I (GTA→ATA) | gcvH ← | glycine cleavage complex lipoylprotein |
RA | 1,950,925 | G→A | 56.9% | H221Y (CAT→TAT) | visC ← | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
RA | 1,951,476 | T→G | 54.1% | Q37P (CAG→CCG) | visC ← | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
RA | 1,951,514 | C→A | 74.0% | G24G (GGG→GGT) | visC ← | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
RA | 1,951,544 | C→G | 75.0% | V14V (GTG→GTC) | visC ← | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
RA | 1,953,017 | C→A | 69.7% | V364V (GTG→GTT) | pepP ← | proline aminopeptidase P II |
RA | 1,953,026 | G→A | 71.0% | V361V (GTC→GTT) | pepP ← | proline aminopeptidase P II |
RA | 1,953,119 | G→A | 36.2% | G330G (GGC→GGT) | pepP ← | proline aminopeptidase P II |
RA | 1,953,382 | G→A | 46.9% | L243L (CTG→TTG) | pepP ← | proline aminopeptidase P II |
RA | 1,953,425 | C→A | 47.5% | P228P (CCG→CCT) | pepP ← | proline aminopeptidase P II |
RA | 1,953,428 | A→G | 47.5% | Y227Y (TAT→TAC) | pepP ← | proline aminopeptidase P II |
RA | 1,956,137 | C→T | 42.4% | intergenic (+80/+309) | ygfA → / ← serA | predicted ligase/D‑3‑phosphoglycerate dehydrogenase |
RA | 1,956,148 | A→T | 47.4% | intergenic (+91/+298) | ygfA → / ← serA | predicted ligase/D‑3‑phosphoglycerate dehydrogenase |
RA | 1,956,167 | G→T | 38.3% | intergenic (+110/+279) | ygfA → / ← serA | predicted ligase/D‑3‑phosphoglycerate dehydrogenase |
RA | 1,956,168 | C→G | 37.5% | intergenic (+111/+278) | ygfA → / ← serA | predicted ligase/D‑3‑phosphoglycerate dehydrogenase |
RA | 1,956,169 | T→G | 38.4% | intergenic (+112/+277) | ygfA → / ← serA | predicted ligase/D‑3‑phosphoglycerate dehydrogenase |
RA | 1,956,370 | C→T | 39.0% | intergenic (+313/+76) | ygfA → / ← serA | predicted ligase/D‑3‑phosphoglycerate dehydrogenase |
RA | 1,959,153 | C→T | 57.5% | A306A (GCG→GCA) ‡ | fbaA ← | fructose‑bisphosphate aldolase, class II |
RA | 1,959,154 | G→T | 57.5% | A306E (GCG→GAG) ‡ | fbaA ← | fructose‑bisphosphate aldolase, class II |
RA | 1,959,174 | G→A | 100% | G299G (GGC→GGT) | fbaA ← | fructose‑bisphosphate aldolase, class II |
RA | 1,959,701 | A→G | 58.3% | L124L (TTG→CTG) | fbaA ← | fructose‑bisphosphate aldolase, class II |
RA | 1,960,780 | C→T | 76.1% | A223A (GCG→GCA) | pgk ← | phosphoglycerate kinase |
RA | 1,960,798 | G→A | 70.5% | I217I (ATC→ATT) | pgk ← | phosphoglycerate kinase |
RA | 1,960,813 | A→G | 36.3% | I212I (ATT→ATC) | pgk ← | phosphoglycerate kinase |
RA | 1,963,098 | A→G | 31.3% | L140L (TTG→CTG) | yggC ← | conserved hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 1,963,872 | C→G | 49.1% | V50V (GTG→GTC) | yggD ← | predicted DNA‑binding transcriptional regulator |
RA | 1,966,797 | T→C | 40.9% | V611V (GTA→GTG) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,966,800 | A→C | 41.0% | A610A (GCT→GCG) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,966,806 | G→A | 42.0% | R608R (CGC→CGT) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,966,809 | T→A | 37.2% | A607A (GCA→GCT) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,966,812 | A→G | 38.4% | T606T (ACT→ACC) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,112 | A→G | 48.1% | G506G (GGT→GGC) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,127 | G→T | 78.1% | V501V (GTC→GTA) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,130 | C→T | 81.0% | A500A (GCG→GCA) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,301 | G→A | 20.8% | N443N (AAC→AAT) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,334 | G→T | 27.2% | S432S (TCC→TCA) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,340 | G→A | 44.2% | Y430Y (TAC→TAT) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,352 | G→A | 42.9% | G426G (GGC→GGT) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,397 | C→T | 61.2% | E411E (GAG→GAA) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,400 | G→A | 51.9% | R410R (CGC→CGT) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,967,403 | A→T | 51.9% | V409V (GTT→GTA) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,968,090 | T→C | 28.3% | A180A (GCA→GCG) | tktA ← | transketolase 1, thiamin‑binding |
RA | 1,968,732 | G→T | 54.6% | intergenic (‑103/‑175) | tktA ← / → yggG | transketolase 1, thiamin‑binding/predicted peptidase |
RA | 1,969,046 | C→A | 52.4% | T47N (ACC→AAC) ‡ | yggG → | predicted peptidase |
RA | 1,969,047 | C→A | 52.4% | T47T (ACC→ACA) ‡ | yggG → | predicted peptidase |
RA | 1,969,065 | T→C | 45.2% | C53C (TGT→TGC) | yggG → | predicted peptidase |
RA | 1,969,083 | G→A | 36.1% | K59K (AAG→AAA) | yggG → | predicted peptidase |
RA | 1,969,173 | A→G | 19.7% | V89V (GTA→GTG) | yggG → | predicted peptidase |
RA | 1,970,324 | C→A | 40.3% | A156A (GCG→GCT) | speB ← | agmatinase |
RA | 1,970,327 | A→G | 40.3% | Y155Y (TAT→TAC) | speB ← | agmatinase |
RA | 1,970,345 | G→A | 34.6% | D149D (GAC→GAT) | speB ← | agmatinase |
RA | 1,970,359 | G→A | 51.0% | L145L (CTG→TTG) | speB ← | agmatinase |
RA | 1,971,130 | G→A | 42.8% | D592D (GAC→GAT) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,971,412 | T→C | 70.6% | A498A (GCA→GCG) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,971,415 | G→A | 74.3% | D497D (GAC→GAT) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,971,856 | G→A | 20.7% | N350N (AAC→AAT) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,971,874 | G→A | 47.2% | G344G (GGC→GGT) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,971,889 | A→G | 73.7% | I339I (ATT→ATC) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,971,922 | C→T | 52.2% | V328V (GTG→GTA) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,971,934 | G→A | 41.2% | S324S (TCC→TCT) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,971,940 | C→A | 39.5% | S322S (TCG→TCT) | speA ← | biosynthetic arginine decarboxylase, PLP‑binding |
RA | 1,973,145 | A→G | 26.4% | intergenic (‑85/‑36) | yqgB ← / → yqgC | hypothetical protein/hypothetical protein |
RA | 1,973,768 | T→C | 28.6% | I23I (ATT→ATC) | metK → | methionine adenosyltransferase 1 |
RA | 1,973,851 | T→C | 44.8% | V51A (GTT→GCT) | metK → | methionine adenosyltransferase 1 |
RA | 1,974,119 | C→T | 64.0% | T140T (ACC→ACT) | metK → | methionine adenosyltransferase 1 |
RA | 1,974,440 | T→C | 44.3% | I247I (ATT→ATC) | metK → | methionine adenosyltransferase 1 |
RA | 1,974,473 | C→T | 46.1% | H258H (CAC→CAT) | metK → | methionine adenosyltransferase 1 |
RA | 1,974,485 | A→G | 30.2% | A262A (GCA→GCG) | metK → | methionine adenosyltransferase 1 |
RA | 1,974,491 | T→C | 29.2% | S264S (TCT→TCC) | metK → | methionine adenosyltransferase 1 |
RA | 1,974,967 | G→C | 45.1% | intergenic (+113/‑311) | metK → / → galP | methionine adenosyltransferase 1/D‑galactose transporter |
RA | 1,974,969 | T→A | 46.4% | intergenic (+115/‑309) | metK → / → galP | methionine adenosyltransferase 1/D‑galactose transporter |
RA | 1,974,977 | C→T | 40.5% | intergenic (+123/‑301) | metK → / → galP | methionine adenosyltransferase 1/D‑galactose transporter |
RA | 1,974,984 | G→A | 44.0% | intergenic (+130/‑294) | metK → / → galP | methionine adenosyltransferase 1/D‑galactose transporter |
RA | 1,974,996 | A→T | 47.3% | intergenic (+142/‑282) | metK → / → galP | methionine adenosyltransferase 1/D‑galactose transporter |
RA | 1,976,012 | C→T | 34.8% | N245N (AAC→AAT) | galP → | D‑galactose transporter |
RA | 1,976,135 | T→C | 59.7% | T286T (ACT→ACC) | galP → | D‑galactose transporter |
RA | 1,976,156 | C→A | 63.9% | T293T (ACC→ACA) | galP → | D‑galactose transporter |
RA | 1,976,678 | C→T | 28.0% | intergenic (+6/‑71) | galP → / → sprT | D‑galactose transporter/conserved hypothetical protein |
RA | 1,976,681 | A→G | 27.3% | intergenic (+9/‑68) | galP → / → sprT | D‑galactose transporter/conserved hypothetical protein |
RA | 1,976,695 | G→A | 36.3% | intergenic (+23/‑54) | galP → / → sprT | D‑galactose transporter/conserved hypothetical protein |
RA | 1,976,696 | C→T | 36.3% | intergenic (+24/‑53) | galP → / → sprT | D‑galactose transporter/conserved hypothetical protein |
RA | 1,977,299 | G→A | 53.2% | intergenic (+53/‑42) | sprT → / → endA | conserved hypothetical protein/DNA‑specific endonuclease I |
RA | 1,977,610 | G→A | 53.8% | Q90Q (CAG→CAA) | endA → | DNA‑specific endonuclease I |
RA | 1,977,655 | C→T | 41.9% | N105N (AAC→AAT) | endA → | DNA‑specific endonuclease I |
RA | 1,977,661 | T→C | 37.3% | A107A (GCT→GCC) | endA → | DNA‑specific endonuclease I |
RA | 1,980,200 | C→T | 55.3% | P90P (CCC→CCT) | yqgE → | hypothetical protein |
RA | 1,980,799 | A→G | 51.4% | E102E (GAA→GAG) | yqgF → | predicted Holliday junction resolvase |
RA | 1,980,802 | C→A | 50.6% | A103A (GCC→GCA) | yqgF → | predicted Holliday junction resolvase |
RA | 1,981,406 | T→C | 24.9% | A223A (GCA→GCG) | yggR ← | predicted transporter |
RA | 1,981,463 | G→A | 33.2% | D204D (GAC→GAT) | yggR ← | predicted transporter |
RA | 1,981,950 | G→A | 39.9% | P42L (CCG→CTG) | yggR ← | predicted transporter |
RA | 1,981,954 | T→C | 40.0% | T41A (ACG→GCG) | yggR ← | predicted transporter |
RA | 1,982,466 | T→A | 43.9% | V125V (GTT→GTA) | yggS → | hypothetical protein |
RA | 1,984,551 | T→G | 100% | T97T (ACT→ACG) | yggW → | predicted oxidoreductase |
RA | 1,984,563 | C→T | 68.5% | N101N (AAC→AAT) | yggW → | predicted oxidoreductase |
RA | 1,984,569 | C→T | 68.5% | G103G (GGC→GGT) | yggW → | predicted oxidoreductase |
RA | 1,984,575 | A→T | 59.1% | V105V (GTA→GTT) | yggW → | predicted oxidoreductase |
RA | 1,985,612 | T→C | 28.6% | Q316Q (CAA→CAG) | yggM ← | conserved hypothetical protein |
RA | 1,986,041 | C→T | 66.7% | V173V (GTG→GTA) | yggM ← | conserved hypothetical protein |
RA | 1,986,044 | T→A | 66.7% | E172D (GAA→GAT) | yggM ← | conserved hypothetical protein |
RA | 1,986,052 | C→T | 62.5% | E170K (GAA→AAA) | yggM ← | conserved hypothetical protein |
RA | 1,987,051 | T→C | 30.9% | P224P (CCA→CCG) | ansB ← | periplasmic L‑asparaginase II |
RA | 1,987,066 | A→G | 38.0% | H219H (CAT→CAC) | ansB ← | periplasmic L‑asparaginase II |
RA | 1,987,087 | C→T | 39.0% | Q212Q (CAG→CAA) | ansB ← | periplasmic L‑asparaginase II |
RA | 1,987,156 | G→A | 30.8% | D189D (GAC→GAT) | ansB ← | periplasmic L‑asparaginase II |
RA | 1,987,180 | G→A | 40.5% | D181D (GAC→GAT) | ansB ← | periplasmic L‑asparaginase II |
RA | 1,987,528 | T→C | 26.0% | K65K (AAA→AAG) | ansB ← | periplasmic L‑asparaginase II |
RA | 1,987,531 | T→C | 26.0% | L64L (CTA→CTG) | ansB ← | periplasmic L‑asparaginase II |
RA | 1,988,027 | C→G | 65.7% | G197G (GGG→GGC) | yggN ← | hypothetical protein |
RA | 1,988,030 | C→G | 65.7% | G196G (GGG→GGC) | yggN ← | hypothetical protein |
RA | 1,988,048 | A→G | 100% | N190N (AAT→AAC) | yggN ← | hypothetical protein |
RA | 1,990,804 | C→T | 60.0% | D266D (GAC→GAT) | mutY → | adenine DNA glycosylase |
RA | 1,990,864 | A→G | 69.9% | Q286Q (CAA→CAG) | mutY → | adenine DNA glycosylase |
RA | 1,992,977 | G→T | 36.9% | T90T (ACG→ACT) | nupG → | nucleoside transporter |
RA | 1,992,980 | A→G | 36.9% | T91T (ACA→ACG) | nupG → | nucleoside transporter |
RA | 1,992,986 | A→G | 33.3% | E93E (GAA→GAG) | nupG → | nucleoside transporter |
RA | 1,993,595 | G→T | 31.3% | A296A (GCG→GCT) | nupG → | nucleoside transporter |
RA | 1,993,811 | T→G | 30.0% | V368V (GTT→GTG) | nupG → | nucleoside transporter |
RA | 1,993,837 | T→C | 46.9% | I377T (ATT→ACT) | nupG → | nucleoside transporter |
RA | 1,993,886 | T→G | 27.3% | V393V (GTT→GTG) | nupG → | nucleoside transporter |
RA | 1,994,046 | C→T | 67.9% | V702M (GTG→ATG) | speC ← | ornithine decarboxylase, constitutive |
RA | 1,995,805 | G→A | 51.9% | N115N (AAC→AAT) | speC ← | ornithine decarboxylase, constitutive |
RA | 1,995,808 | G→A | 53.5% | G114G (GGC→GGT) | speC ← | ornithine decarboxylase, constitutive |
RA | 1,996,903 | G→A | 23.1% | G119G (GGG→GGA) | yqgA → | predicted inner membrane protein |
RA | 1,997,980 | C→T | 43.8% | V384V (GTG→GTA) | pitB ← | phosphate transporter |
RA | 1,998,490 | C→G | 39.5% | L214L (CTG→CTC) | pitB ← | phosphate transporter |
RA | 1,998,493 | C→G | 44.7% | A213A (GCG→GCC) | pitB ← | phosphate transporter |
RA | 2,000,404 | G→A | 43.6% | I293I (ATC→ATT) | gss ← | fused glutathionylspermidine amidase and glutathionylspermidine synthetase |
RA | 2,000,410 | G→A | 36.3% | F291F (TTC→TTT) | gss ← | fused glutathionylspermidine amidase and glutathionylspermidine synthetase |
RA | 2,000,536 | A→C | 48.0% | P249P (CCT→CCG) | gss ← | fused glutathionylspermidine amidase and glutathionylspermidine synthetase |
RA | 2,000,557 | A→G | 15.9% | G242G (GGT→GGC) | gss ← | fused glutathionylspermidine amidase and glutathionylspermidine synthetase |
RA | 2,001,010 | T→A | 16.2% | R91R (CGA→CGT) | gss ← | fused glutathionylspermidine amidase and glutathionylspermidine synthetase |
RA | 2,001,040 | C→T | 25.8% | A81A (GCG→GCA) | gss ← | fused glutathionylspermidine amidase and glutathionylspermidine synthetase |
RA | 2,001,058 | A→G | 44.4% | F75F (TTT→TTC) | gss ← | fused glutathionylspermidine amidase and glutathionylspermidine synthetase |
RA | 2,002,536 | A→G | 43.9% | D63D (GAT→GAC) | hybG ← | hydrogenase 2 accessory protein |
RA | 2,002,542 | G→A | 40.9% | D61D (GAC→GAT) | hybG ← | hydrogenase 2 accessory protein |
RA | 2,002,548 | G→A | 39.9% | I59I (ATC→ATT) | hybG ← | hydrogenase 2 accessory protein |
RA | 2,002,578 | C→T | 24.2% | V49V (GTG→GTA) | hybG ← | hydrogenase 2 accessory protein |
RA | 2,002,764 | C→T | 27.0% | L105L (CTG→CTA) | hybF ← | protein involved with the maturation of hydrogenases 1 and 2 |
RA | 2,003,978 | G→A | 34.1% | V23V (GTC→GTT) | hybD ← | predicted maturation element for hydrogenase 2 |
RA | 2,004,772 | G→T | 36.4% | G326G (GGC→GGA) | hybC ← | hydrogenase 2, large subunit |
RA | 2,004,952 | G→A | 26.3% | A266A (GCC→GCT) | hybC ← | hydrogenase 2, large subunit |
RA | 2,004,955 | A→G | 26.0% | I265I (ATT→ATC) | hybC ← | hydrogenase 2, large subunit |
RA | 2,004,964 | G→A | 26.7% | T262T (ACC→ACT) | hybC ← | hydrogenase 2, large subunit |
RA | 2,005,051 | G→A | 64.4% | G233G (GGC→GGT) | hybC ← | hydrogenase 2, large subunit |
RA | 2,005,056 | A→G | 69.2% | L232L (TTG→CTG) | hybC ← | hydrogenase 2, large subunit |
RA | 2,005,368 | T→C | 23.9% | T128A (ACC→GCC) | hybC ← | hydrogenase 2, large subunit |
RA | 2,005,372 | G→A | 27.4% | D126D (GAC→GAT) | hybC ← | hydrogenase 2, large subunit |
RA | 2,006,358 | C→T | 57.7% | G189G (GGG→GGA) | hybB ← | predicted hydrogenase 2 cytochrome b type component |
RA | 2,006,379 | G→A | 39.4% | T182T (ACC→ACT) | hybB ← | predicted hydrogenase 2 cytochrome b type component |
RA | 2,006,382 | C→T | 35.5% | P181P (CCG→CCA) | hybB ← | predicted hydrogenase 2 cytochrome b type component |
RA | 2,007,034 | A→G | 31.5% | I289I (ATT→ATC) ‡ | hybA ← | hydrogenase 2 4Fe‑4S ferredoxin‑type component |
RA | 2,007,036 | T→C | 31.5% | I289V (ATT→GTT) ‡ | hybA ← | hydrogenase 2 4Fe‑4S ferredoxin‑type component |
RA | 2,007,039 | T→G | 29.7% | N288H (AAT→CAT) | hybA ← | hydrogenase 2 4Fe‑4S ferredoxin‑type component |
RA | 2,008,176 | A→G | 46.8% | G282G (GGT→GGC) | hybO ← | hydrogenase 2, small subunit |
RA | 2,008,326 | G→A | 100% | C232C (TGC→TGT) | hybO ← | hydrogenase 2, small subunit |
RA | 2,008,479 | T→C | 51.8% | P181P (CCA→CCG) | hybO ← | hydrogenase 2, small subunit |
RA | 2,008,482 | C→T | 51.8% | L180L (CTG→CTA) | hybO ← | hydrogenase 2, small subunit |
RA | 2,009,730 | G→T | 61.2% | pseudogene (297/411 nt) | yghX ← | ECK2993:JW5926:b2999; predicted hydrolase |
RA | 2,009,916 | A→T | 43.5% | pseudogene (111/411 nt) | yghX ← | ECK2993:JW5926:b2999; predicted hydrolase |
RA | 2,009,919 | C→T | 50.0% | pseudogene (108/411 nt) | yghX ← | ECK2993:JW5926:b2999; predicted hydrolase |
RA | 2,010,544 | A→G | 13.6% | intergenic (‑165/‑113) | yghY ← / → yghZ | ECK2994:JW5496:b3000; predicted dienlactone hydrolase/aldo‑keto reductase |
RA | 2,010,698 | A→G | 50.0% | Q14Q (CAA→CAG) | yghZ → | aldo‑keto reductase |
RA | 2,011,421 | A→G | 35.4% | T255T (ACA→ACG) | yghZ → | aldo‑keto reductase |
RA | 2,011,433 | T→C | 33.0% | L259L (CTT→CTC) | yghZ → | aldo‑keto reductase |
RA | 2,012,911 | C→T | 33.6% | L164L (CTG→TTG) | yghA → | predicted glutathionylspermidine synthase, with NAD(P)‑binding Rossmann‑fold domain |
RA | 2,013,916 | G→A | 37.9% | L30L (CTG→TTG) | exbD ← | membrane spanning protein in TonB‑ExbB‑ExbD complex |
RA | 2,013,998 | T→C | 51.8% | A2A (GCA→GCG) | exbD ← | membrane spanning protein in TonB‑ExbB‑ExbD complex |
RA | 2,014,008 | T→C | 54.2% | intergenic (‑5/+2) | exbD ← / ← exbB | membrane spanning protein in TonB‑ExbB‑ExbD complex/membrane spanning protein in TonB‑ExbB‑ExbD complex |
RA | 2,014,019 | G→A | 48.2% | R242R (CGC→CGT) | exbB ← | membrane spanning protein in TonB‑ExbB‑ExbD complex |
RA | 2,014,583 | G→A | 43.2% | R54R (CGC→CGT) | exbB ← | membrane spanning protein in TonB‑ExbB‑ExbD complex |
RA | 2,014,607 | T→C | 52.4% | V46V (GTA→GTG) | exbB ← | membrane spanning protein in TonB‑ExbB‑ExbD complex |
RA | 2,015,613 | A→G | 37.9% | Q206Q (CAA→CAG) | metC → | cystathionine beta‑lyase, PLP‑dependent |
RA | 2,015,787 | T→C | 35.8% | R264R (CGT→CGC) | metC → | cystathionine beta‑lyase, PLP‑dependent |
RA | 2,015,838 | G→C | 24.8% | P281P (CCG→CCC) | metC → | cystathionine beta‑lyase, PLP‑dependent |
RA | 2,015,844 | T→A | 24.6% | V283V (GTT→GTA) | metC → | cystathionine beta‑lyase, PLP‑dependent |
RA | 2,019,133 | C→T | 35.6% | P340L (CCG→CTG) | yqhD → | alcohol dehydrogenase, NAD(P)‑dependent |
RA | 2,020,144 | C→T | 47.1% | L254L (CTC→CTT) | dkgA → | 2,5‑diketo‑D‑gluconate reductase A |
RA | 2,021,226 | G→A | 40.2% | V273I (GTT→ATT) | yqhG → | conserved hypothetical protein |
RA | 2,021,534 | C→T | 31.8% | L50L (CTA→TTA) | yqhH → | predicted outer membrane lipoprotein |
RA | 2,022,917 | G→A | 30.3% | H330H (CAC→CAT) | ygiQ ← | conserved hypothetical protein |
RA | 2,022,941 | A→G | 38.3% | C322C (TGT→TGC) | ygiQ ← | conserved hypothetical protein |
RA | 2,023,139 | A→G | 35.5% | G256G (GGT→GGC) | ygiQ ← | conserved hypothetical protein |
RA | 2,023,169 | T→C | 28.5% | G246G (GGA→GGG) | ygiQ ← | conserved hypothetical protein |
RA | 2,023,172 | A→T | 25.8% | P245P (CCT→CCA) | ygiQ ← | conserved hypothetical protein |
RA | 2,023,923 | A→G | 45.0% | intergenic (‑17/+94) | ygiQ ← / ← sufI | conserved hypothetical protein/repressor protein for FtsI |
RA | 2,026,074 | A→G | 18.2% | R56R (CGT→CGC) | plsC ← | 1‑acyl‑sn‑glycerol‑3‑phosphate acyltransferase |
RA | 2,026,083 | A→C | 23.5% | V53V (GTT→GTG) | plsC ← | 1‑acyl‑sn‑glycerol‑3‑phosphate acyltransferase |
RA | 2,028,140 | C→T | 60.2% | Q198Q (CAG→CAA) | parC ← | DNA topoisomerase IV, subunit A |
RA | 2,028,605 | G→C | 22.3% | R43R (CGC→CGG) | parC ← | DNA topoisomerase IV, subunit A |
RA | 2,028,614 | A→G | 21.6% | P40P (CCT→CCC) | parC ← | DNA topoisomerase IV, subunit A |
RA | 2,029,444 | C→A | 31.6% | A467A (GCG→GCT) | parE ← | DNA topoisomerase IV, subunit B |
RA | 2,031,571 | A→G | 59.4% | D237D (GAT→GAC) | cpdA ← | cyclic 3',5'‑adenosine monophosphate phosphodiesterase |
RA | 2,031,586 | G→A | 43.0% | S232S (TCC→TCT) | cpdA ← | cyclic 3',5'‑adenosine monophosphate phosphodiesterase |
RA | 2,034,921 | A→C | 34.0% | A453A (GCA→GCC) | tolC → | transport channel |
RA | 2,036,328 | C→T | 46.8% | L154L (CTG→TTG) | ygiC → | hypothetical protein |
RA | 2,036,339 | A→G | 41.1% | K157K (AAA→AAG) | ygiC → | hypothetical protein |
RA | 2,036,471 | T→C | 35.1% | I201I (ATT→ATC) | ygiC → | hypothetical protein |
RA | 2,036,477 | T→C | 41.3% | T203T (ACT→ACC) | ygiC → | hypothetical protein |
RA | 2,036,495 | T→C | 34.1% | D209D (GAT→GAC) | ygiC → | hypothetical protein |
RA | 2,039,441 | A→G | 27.1% | I158I (ATT→ATC) | ribB ← | 3,4 dihydroxy‑2‑butanone‑4‑phosphate synthase |
RA | 2,039,447 | T→C | 39.8% | A156A (GCA→GCG) | ribB ← | 3,4 dihydroxy‑2‑butanone‑4‑phosphate synthase |
RA | 2,039,489 | A→C | 60.6% | A142A (GCT→GCG) | ribB ← | 3,4 dihydroxy‑2‑butanone‑4‑phosphate synthase |
RA | 2,039,492 | G→A | 60.5% | R141R (CGC→CGT) | ribB ← | 3,4 dihydroxy‑2‑butanone‑4‑phosphate synthase |
RA | 2,044,257 | A→G | 100% | V227V (GTA→GTG) | yqiK → | conserved hypothetical protein |
RA | 2,044,263 | T→C | 57.0% | V229V (GTT→GTC) | yqiK → | conserved hypothetical protein |
RA | 2,044,266 | G→A | 56.3% | A230A (GCG→GCA) | yqiK → | conserved hypothetical protein |
RA | 2,044,275 | A→G | 56.3% | E233E (GAA→GAG) | yqiK → | conserved hypothetical protein |
RA | 2,044,281 | T→C | 56.3% | N235N (AAT→AAC) | yqiK → | conserved hypothetical protein |
RA | 2,044,284 | C→T | 42.0% | R236R (CGC→CGT) | yqiK → | conserved hypothetical protein |
RA | 2,044,290 | G→A | 42.0% | A238A (GCG→GCA) | yqiK → | conserved hypothetical protein |
RA | 2,044,293 | A→T | 36.4% | L239L (CTA→CTT) | yqiK → | conserved hypothetical protein |
RA | 2,048,393 | T→A | 57.4% | I654I (ATA→ATT) | glnE ← | fused deadenylyltransferase and adenylyltransferase for glutamine synthetase |
RA | 2,048,405 | C→T | 48.8% | A650A (GCG→GCA) | glnE ← | fused deadenylyltransferase and adenylyltransferase for glutamine synthetase |
RA | 2,048,438 | C→T | 45.6% | V639V (GTG→GTA) | glnE ← | fused deadenylyltransferase and adenylyltransferase for glutamine synthetase |
RA | 2,049,641 | G→A | 18.5% | S238S (AGC→AGT) | glnE ← | fused deadenylyltransferase and adenylyltransferase for glutamine synthetase |
RA | 2,051,274 | A→G | 38.8% | G135G (GGT→GGC) | ygiF ← | predicted adenylate cyclase |
RA | 2,052,180 | T→G | 44.2% | T87T (ACT→ACG) | htrG → | predicted signal transduction protein |
RA | 2,052,195 | C→T | 46.9% | R92R (CGC→CGT) | htrG → | predicted signal transduction protein |
RA | 2,053,383 | G→A | 43.7% | G260G (GGG→GGA) | cca → | fused tRNA nucleotidyl transferase and 2'3'‑cyclic phosphodiesterase/2'nucleotidase/phosphatase |
RA | 2,053,401 | C→T | 50.7% | L266L (CTC→CTT) | cca → | fused tRNA nucleotidyl transferase and 2'3'‑cyclic phosphodiesterase/2'nucleotidase/phosphatase |
RA | 2,053,407 | G→A | 52.1% | P268P (CCG→CCA) | cca → | fused tRNA nucleotidyl transferase and 2'3'‑cyclic phosphodiesterase/2'nucleotidase/phosphatase |
RA | 2,055,817 | C→T | 34.7% | S137S (AGC→AGT) | ygiH → | conserved inner membrane protein |
RA | 2,055,820 | A→T | 36.3% | G138G (GGA→GGT) | ygiH → | conserved inner membrane protein |
RA | 2,056,976 | T→A | 42.6% | intergenic (‑7/‑200) | ygiP ← / → ttdA | predicted DNA‑binding transcriptional regulator/L‑tartrate dehydratase, alpha subunit |
RA | 2,056,988 | G→T | 43.2% | intergenic (‑19/‑188) | ygiP ← / → ttdA | predicted DNA‑binding transcriptional regulator/L‑tartrate dehydratase, alpha subunit |
RA | 2,057,310 | G→A | 35.6% | T45T (ACG→ACA) | ttdA → | L‑tartrate dehydratase, alpha subunit |
RA | 2,057,322 | G→A | 29.3% | G49G (GGG→GGA) | ttdA → | L‑tartrate dehydratase, alpha subunit |
RA | 2,057,328 | T→C | 23.7% | I51I (ATT→ATC) | ttdA → | L‑tartrate dehydratase, alpha subunit |
RA | 2,057,337 | T→C | 23.4% | H54H (CAT→CAC) | ttdA → | L‑tartrate dehydratase, alpha subunit |
RA | 2,057,922 | C→T | 32.2% | T249T (ACC→ACT) | ttdA → | L‑tartrate dehydratase, alpha subunit |
RA | 2,057,946 | A→G | 47.8% | V257V (GTA→GTG) | ttdA → | L‑tartrate dehydratase, alpha subunit |
RA | 2,057,964 | C→T | 36.0% | A263A (GCC→GCT) | ttdA → | L‑tartrate dehydratase, alpha subunit |
RA | 2,058,356 | T→C | 56.9% | I91I (ATT→ATC) | ttdB → | L‑tartrate dehydratase, beta subunit |
RA | 2,058,584 | T→A | 37.2% | I167I (ATT→ATA) | ttdB → | L‑tartrate dehydratase, beta subunit |
RA | 2,060,531 | C→T | 53.3% | A242A (GCG→GCA) | ygjD ← | predicted peptidase |
RA | 2,062,527 | A→G | 61.4% | T236T (ACA→ACG) | dnaG → | DNA primase |
RA | 2,066,109 | A→C | 38.6% | T26T (ACT→ACG) | ygjF ← | G/U mismatch‑specific DNA glycosylase |
RA | 2,067,040 | T→C | 29.0% | K55K (AAA→AAG) | yqjH ← | predicted siderophore interacting protein |
RA | 2,067,061 | A→G | 38.2% | R48R (CGT→CGC) | yqjH ← | predicted siderophore interacting protein |
RA | 2,070,061 | A→G | 38.6% | intergenic (‑272/‑119) | aer ← / → ygjG | fused signal transducer for aerotaxis sensory component and methyl accepting chemotaxis component/putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,070,071 | A→G | 43.7% | intergenic (‑282/‑109) | aer ← / → ygjG | fused signal transducer for aerotaxis sensory component and methyl accepting chemotaxis component/putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,070,074 | G→A | 51.6% | intergenic (‑285/‑106) | aer ← / → ygjG | fused signal transducer for aerotaxis sensory component and methyl accepting chemotaxis component/putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,070,092 | A→G | 47.1% | intergenic (‑303/‑88) | aer ← / → ygjG | fused signal transducer for aerotaxis sensory component and methyl accepting chemotaxis component/putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,070,105 | G→A | 72.9% | intergenic (‑316/‑75) | aer ← / → ygjG | fused signal transducer for aerotaxis sensory component and methyl accepting chemotaxis component/putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,070,106 | A→C | 72.1% | intergenic (‑317/‑74) | aer ← / → ygjG | fused signal transducer for aerotaxis sensory component and methyl accepting chemotaxis component/putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,070,836 | G→A | 31.9% | V219V (GTG→GTA) | ygjG → | putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,070,862 | G→T | 22.5% | R228L (CGC→CTC) | ygjG → | putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,070,902 | G→T | 35.2% | V241V (GTG→GTT) | ygjG → | putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,071,466 | T→C | 32.7% | N429N (AAT→AAC) | ygjG → | putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,071,472 | C→T | 29.4% | A431A (GCC→GCT) | ygjG → | putrescine:2‑oxoglutaric acid aminotransferase, PLP‑dependent |
RA | 2,071,675 | G→A | 58.6% | L96L (CTG→TTG) | ygjH ← | conserved hypothetical protein |
RA | 2,073,249 | C→T | 18.0% | intergenic (+87/‑97) | ebgR → / → ebgA | DNA‑binding transcriptional repressor/cryptic beta‑D‑galactosidase, alpha subunit |
RA | 2,073,250 | T→C | 18.3% | intergenic (+88/‑96) | ebgR → / → ebgA | DNA‑binding transcriptional repressor/cryptic beta‑D‑galactosidase, alpha subunit |
RA | 2,073,927 | A→G | 46.3% | S194S (TCA→TCG) | ebgA → | cryptic beta‑D‑galactosidase, alpha subunit |
RA | 2,078,055 | A→G | 67.6% | T154T (ACT→ACC) | uxaA ← | altronate hydrolase |
RA | 2,078,064 | G→A | 44.9% | A151A (GCC→GCT) | uxaA ← | altronate hydrolase |
RA | 2,078,085 | A→G | 39.3% | F144F (TTT→TTC) | uxaA ← | altronate hydrolase |
RA | 2,078,091 | G→A | 47.3% | N142N (AAC→AAT) | uxaA ← | altronate hydrolase |
RA | 2,078,094 | C→T | 47.3% | Q141Q (CAG→CAA) | uxaA ← | altronate hydrolase |
RA | 2,080,902 | A→G | 40.5% | V199V (GTA→GTG) | exuT → | hexuronate transporter |
RA | 2,080,941 | A→G | 50.6% | A212A (GCA→GCG) | exuT → | hexuronate transporter |
RA | 2,081,478 | C→T | 27.6% | S391S (TCC→TCT) | exuT → | hexuronate transporter |
RA | 2,081,481 | T→C | 27.4% | D392D (GAT→GAC) | exuT → | hexuronate transporter |
RA | 2,081,487 | T→C | 27.2% | F394F (TTT→TTC) | exuT → | hexuronate transporter |
RA | 2,082,240 | A→G | 42.0% | E129E (GAA→GAG) | exuR → | DNA‑binding transcriptional repressor |
RA | 2,082,246 | G→A | 48.9% | A131A (GCG→GCA) | exuR → | DNA‑binding transcriptional repressor |
RA | 2,082,252 | C→T | 48.9% | G133G (GGC→GGT) | exuR → | DNA‑binding transcriptional repressor |
RA | 2,082,342 | G→T | 27.9% | V163V (GTG→GTT) | exuR → | DNA‑binding transcriptional repressor |
RA | 2,082,504 | T→C | 34.5% | H217H (CAT→CAC) | exuR → | DNA‑binding transcriptional repressor |
RA | 2,083,454 | C→T | 37.8% | S160S (AGC→AGT) | yqjA → | conserved inner membrane protein |
RA | 2,084,365 | G→A | 45.9% | Q65Q (CAG→CAA) | yqjC → | conserved hypothetical protein |
RA | 2,086,423 | G→A | 20.1% | A66A (GCG→GCA) | yqjG → | predicted S‑transferase |
RA | 2,086,444 | C→T | 18.5% | R73R (CGC→CGT) | yqjG → | predicted S‑transferase |
RA | 2,086,447 | A→G | 20.4% | K74K (AAA→AAG) | yqjG → | predicted S‑transferase |
RA | 2,086,684 | C→A | 57.7% | I153I (ATC→ATA) | yqjG → | predicted S‑transferase |
RA | 2,086,717 | C→T | 80.8% | G164G (GGC→GGT) | yqjG → | predicted S‑transferase |
RA | 2,086,868 | G→A | 52.3% | E215K (GAA→AAA) | yqjG → | predicted S‑transferase |
RA | 2,086,879 | A→G | 47.3% | A218A (GCA→GCG) | yqjG → | predicted S‑transferase |
RA | 2,086,888 | G→A | 35.6% | E221E (GAG→GAA) | yqjG → | predicted S‑transferase |
RA | 2,086,900 | C→T | 43.0% | G225G (GGC→GGT) | yqjG → | predicted S‑transferase |
RA | 2,086,906 | T→C | 57.9% | H227H (CAT→CAC) | yqjG → | predicted S‑transferase |
RA | 2,086,957 | T→C | 28.3% | T244T (ACT→ACC) | yqjG → | predicted S‑transferase |
RA | 2,087,622 | G→A | 43.3% | L39L (CTG→CTA) | yhaH → | predicted inner membrane protein |
RA | 2,087,649 | C→T | 42.4% | R48R (CGC→CGT) | yhaH → | predicted inner membrane protein |
RA | 2,087,652 | T→C | 44.7% | A49A (GCT→GCC) | yhaH → | predicted inner membrane protein |
RA | 2,087,781 | T→C | 33.9% | F92F (TTT→TTC) | yhaH → | predicted inner membrane protein |
RA | 2,088,530 | T→C | 34.7% | N296S (AAC→AGC) | yhaJ ← | predicted DNA‑binding transcriptional regulator |
RA | 2,088,571 | T→C | 34.4% | E282E (GAA→GAG) | yhaJ ← | predicted DNA‑binding transcriptional regulator |
RA | 2,089,147 | A→G | 47.8% | A90A (GCT→GCC) | yhaJ ← | predicted DNA‑binding transcriptional regulator |
RA | 2,092,496 | A→G | 31.0% | S218S (AGT→AGC) | yhaO ← | predicted transporter |
RA | 2,094,183 | C→T | 49.3% | G223G (GGG→GGA) | tdcG ← | L‑serine dehydratase 3 |
RA | 2,094,432 | A→G | 41.2% | S140S (AGT→AGC) | tdcG ← | L‑serine dehydratase 3 |
RA | 2,095,825 | A→G | 37.2% | L372L (TTG→CTG) | garK ← | glycerate kinase I |
RA | 2,097,921 | C→T | 67.3% | V242I (GTC→ATC) | garL ← | alpha‑dehydro‑beta‑deoxy‑D‑glucarate aldolase |
RA | 2,099,098 | A→G | 39.8% | G299G (GGT→GGC) | garP ← | predicted (D)‑galactarate transporter |
RA | 2,099,110 | T→C | 50.0% | P295P (CCA→CCG) | garP ← | predicted (D)‑galactarate transporter |
RA | 2,101,280 | C→G | 26.2% | G304G (GGC→GGG) | garD → | (D)‑galactarate dehydrogenase |
RA | 2,101,296 | C→T | 16.6% | L310L (CTG→TTG) | garD → | (D)‑galactarate dehydrogenase |
RA | 2,101,487 | A→G | 29.7% | K373K (AAA→AAG) | garD → | (D)‑galactarate dehydrogenase |
RA | 2,101,493 | T→C | 29.7% | G375G (GGT→GGC) | garD → | (D)‑galactarate dehydrogenase |
RA | 2,101,496 | G→C | 29.8% | L376L (CTG→CTC) | garD → | (D)‑galactarate dehydrogenase |
RA | 2,101,499 | A→C | 31.1% | A377A (GCA→GCC) | garD → | (D)‑galactarate dehydrogenase |
RA | 2,103,141 | A→G | 32.8% | A204A (GCT→GCC) | agaR ← | DNA‑binding transcriptional dual regulator |
RA | 2,103,159 | T→C | 31.2% | T198T (ACA→ACG) | agaR ← | DNA‑binding transcriptional dual regulator |
RA | 2,103,167 | C→T | 24.1% | V196I (GTC→ATC) | agaR ← | DNA‑binding transcriptional dual regulator |
RA | 2,103,173 | G→A | 24.1% | R194C (CGC→TGC) | agaR ← | DNA‑binding transcriptional dual regulator |
RA | 2,103,531 | C→T | 46.3% | T74T (ACG→ACA) | agaR ← | DNA‑binding transcriptional dual regulator |
RA | 2,103,973 | A→G | 26.6% | intergenic (‑221/‑28) | agaR ← / → kbaZ | DNA‑binding transcriptional dual regulator/tagatose 6‑phosphate aldolase 1, kbaZ subunit |
RA | 2,103,985 | T→G | 32.2% | intergenic (‑233/‑16) | agaR ← / → kbaZ | DNA‑binding transcriptional dual regulator/tagatose 6‑phosphate aldolase 1, kbaZ subunit |
RA | 2,103,998 | A→C | 31.7% | intergenic (‑246/‑3) | agaR ← / → kbaZ | DNA‑binding transcriptional dual regulator/tagatose 6‑phosphate aldolase 1, kbaZ subunit |
RA | 2,104,372 | C→T | 14.0% | I124I (ATC→ATT) | kbaZ → | tagatose 6‑phosphate aldolase 1, kbaZ subunit |
RA | 2,105,113 | A→T | 35.3% | V371V (GTA→GTT) | kbaZ → | tagatose 6‑phosphate aldolase 1, kbaZ subunit |
RA | 2,105,324 | C→T | 49.4% | S7S (AGC→AGT) | agaV → | N‑acetylgalactosamine‑specific enzyme IIB component of PTS |
RA | 2,105,863 | C→T | 40.6% | pseudogene (76/402 nt) | agaW → | ECK3122:JW3103:b3134; N‑acetylgalactosamine‑specific enzyme IIC component of PTS, fragment |
RA | 2,106,450 | A→G | 31.7% | H81R (CAC→CGC) | agaA → | predicted truncated N‑acetylgalactosamine‑6‑phosphate deacetylase |
RA | 2,106,475 | T→C | 40.9% | S89S (TCT→TCC) | agaA → | predicted truncated N‑acetylgalactosamine‑6‑phosphate deacetylase |
RA | 2,107,455 | G→A | 60.0% | P131P (CCG→CCA) | agaS → | tagatose‑6‑phosphate ketose/aldose isomerase |
RA | 2,108,247 | T→C | 33.6% | T6T (ACT→ACC) | kbaY → | tagatose 6‑phosphate aldolase 1, kbaY subunit |
RA | 2,108,643 | G→C | 36.5% | L138L (CTG→CTC) | kbaY → | tagatose 6‑phosphate aldolase 1, kbaY subunit |
RA | 2,108,982 | G→T | 49.9% | P251P (CCG→CCT) | kbaY → | tagatose 6‑phosphate aldolase 1, kbaY subunit |
RA | 2,109,346 | A→G | 28.0% | A30A (GCA→GCG) | agaB → | N‑acetylgalactosamine‑specific enzyme IIB component of PTS |
RA | 2,109,353 | C→T | 36.1% | L33L (CTG→TTG) | agaB → | N‑acetylgalactosamine‑specific enzyme IIB component of PTS |
RA | 2,117,769 | C→T | 38.2% | K218K (AAG→AAA) | yraL ← | predicted methyltransferase |
RA | 2,121,861 | A→G | 17.0% | A122A (GCA→GCG) | yraP → | hypothetical protein |
RA | 2,122,104 | C→A | 28.5% | intergenic (+33/+81) | yraP → / ← yraQ | hypothetical protein/predicted permease |
RA | 2,122,416 | T→C | 31.2% | A270A (GCA→GCG) | yraQ ← | predicted permease |
RA | 2,125,198 | T→C | 62.5% | V49A (GTG→GCG) | yhbQ → | predicted endonuclease |
RA | 2,125,208 | G→A | 61.9% | A52A (GCG→GCA) | yhbQ → | predicted endonuclease |
RA | 2,128,106 | C→T | 35.0% | S177S (TCC→TCT) | yhbV → | predicted protease |
RA | 2,128,109 | C→T | 35.0% | A178A (GCC→GCT) | yhbV → | predicted protease |
RA | 2,129,062 | C→T | 21.5% | S176S (AGC→AGT) | yhbW → | hypothetical protein |
RA | 2,129,065 | G→A | 21.5% | A177A (GCG→GCA) | yhbW → | hypothetical protein |
RA | 2,130,221 | A→G | 15.9% | C228C (TGT→TGC) | mtr ← | tryptophan transporter of high affinity |
RA | 2,130,401 | A→G | 41.5% | F168F (TTT→TTC) | mtr ← | tryptophan transporter of high affinity |
RA | 2,130,596 | G→A | 16.2% | T103T (ACC→ACT) | mtr ← | tryptophan transporter of high affinity |
RA | 2,131,391 | A→G | 43.2% | I519I (ATT→ATC) | deaD ← | ATP‑dependent RNA helicase |
RA | 2,131,478 | G→A | 39.2% | R490R (CGC→CGT) | deaD ← | ATP‑dependent RNA helicase |
RA | 2,131,486 | G→A | 42.4% | L488L (CTG→TTG) | deaD ← | ATP‑dependent RNA helicase |
RA | 2,131,514 | A→G | 54.8% | R478R (CGT→CGC) | deaD ← | ATP‑dependent RNA helicase |
RA | 2,131,628 | T→A | 37.8% | V440V (GTA→GTT) | deaD ← | ATP‑dependent RNA helicase |
RA | 2,131,631 | G→A | 34.2% | I439I (ATC→ATT) | deaD ← | ATP‑dependent RNA helicase |
RA | 2,135,716 | A→T | 22.4% | T205T (ACT→ACA) | pnp ← | polynucleotide phosphorylase/polyadenylase |
RA | 2,135,734 | A→G | 28.7% | D199D (GAT→GAC) | pnp ← | polynucleotide phosphorylase/polyadenylase |
RA | 2,135,755 | C→T | 14.3% | E192E (GAG→GAA) | pnp ← | polynucleotide phosphorylase/polyadenylase |
RA | 2,137,295 | G→A | 47.2% | G192G (GGC→GGT) | truB ← | tRNA pseudouridine synthase |
RA | 2,137,307 | A→G | 55.8% | G188G (GGT→GGC) | truB ← | tRNA pseudouridine synthase |
RA | 2,137,310 | C→G | 57.7% | L187L (CTG→CTC) | truB ← | tRNA pseudouridine synthase |
RA | 2,137,313 | G→A | 56.7% | D186D (GAC→GAT) | truB ← | tRNA pseudouridine synthase |
RA | 2,137,316 | A→G | 49.2% | D185D (GAT→GAC) | truB ← | tRNA pseudouridine synthase |
RA | 2,137,325 | G→A | 49.2% | T182T (ACC→ACT) | truB ← | tRNA pseudouridine synthase |
RA | 2,137,703 | C→T | 44.7% | P56P (CCG→CCA) | truB ← | tRNA pseudouridine synthase |
RA | 2,138,498 | G→A | 59.7% | D870D (GAC→GAT) | infB ← | fused protein chain initiation factor 2, IF2 |
RA | 2,138,570 | G→T | 36.9% | R846R (CGC→CGA) | infB ← | fused protein chain initiation factor 2, IF2 |
RA | 2,139,470 | G→A | 58.1% | D546D (GAC→GAT) | infB ← | fused protein chain initiation factor 2, IF2 |
RA | 2,139,485 | G→A | 35.3% | I541I (ATC→ATT) | infB ← | fused protein chain initiation factor 2, IF2 |
RA | 2,139,593 | A→G | 62.0% | A505A (GCT→GCC) | infB ← | fused protein chain initiation factor 2, IF2 |
RA | 2,139,611 | C→T | 39.6% | K499K (AAG→AAA) | infB ← | fused protein chain initiation factor 2, IF2 |
RA | 2,139,620 | T→A | 41.6% | A496A (GCA→GCT) | infB ← | fused protein chain initiation factor 2, IF2 |
RA | 2,141,978 | T→C | 27.2% | P214P (CCA→CCG) | nusA ← | transcription termination/antitermination L factor |
RA | 2,142,023 | A→G | 19.0% | R199R (CGT→CGC) | nusA ← | transcription termination/antitermination L factor |
RA | 2,142,026 | A→G | 19.0% | T198T (ACT→ACC) | nusA ← | transcription termination/antitermination L factor |
RA | 2,143,681 | G→A | 21.7% | intergenic (‑299/‑49) | metY ← / → argG | tRNA‑Met/argininosuccinate synthetase |
RA | 2,143,685 | G→A | 21.5% | intergenic (‑303/‑45) | metY ← / → argG | tRNA‑Met/argininosuccinate synthetase |
RA | 2,144,059 | T→C | 42.6% | T110T (ACT→ACC) | argG → | argininosuccinate synthetase |
RA | 2,144,062 | T→C | 43.4% | G111G (GGT→GGC) | argG → | argininosuccinate synthetase |
RA | 2,144,080 | G→T | 39.0% | A117A (GCG→GCT) | argG → | argininosuccinate synthetase |
RA | 2,144,401 | A→G | 48.3% | K224K (AAA→AAG) | argG → | argininosuccinate synthetase |
RA | 2,144,404 | C→T | 41.1% | F225F (TTC→TTT) | argG → | argininosuccinate synthetase |
RA | 2,144,422 | G→A | 32.1% | K231K (AAG→AAA) | argG → | argininosuccinate synthetase |
RA | 2,145,423 | A→G | 58.9% | R428R (CGT→CGC) | yhbX ← | predicted hydrolase, inner membrane |
RA | 2,145,954 | A→G | 54.2% | V251V (GTT→GTC) | yhbX ← | predicted hydrolase, inner membrane |
RA | 2,146,494 | A→T | 47.9% | T71T (ACT→ACA) | yhbX ← | predicted hydrolase, inner membrane |
RA | 2,146,514 | C→T | 40.4% | A65T (GCA→ACA) | yhbX ← | predicted hydrolase, inner membrane |
RA | 2,147,953 | T→C | 50.0% | N404S (AAC→AGC) | glmM ← | phosphoglucosamine mutase |
RA | 2,151,144 | G→A | 51.9% | A295A (GCC→GCT) | ftsH ← | protease, ATP‑dependent zinc‑metallo |
RA | 2,151,174 | G→A | 48.6% | F285F (TTC→TTT) | ftsH ← | protease, ATP‑dependent zinc‑metallo |
RA | 2,151,177 | G→A | 51.4% | G284G (GGC→GGT) | ftsH ← | protease, ATP‑dependent zinc‑metallo |
RA | 2,156,251 | A→G | 38.8% | G199G (GGT→GGC) | obgE ← | GTPase involved in cell partioning and DNA repair |
RA | 2,156,416 | G→A | 42.1% | G144G (GGC→GGT) | obgE ← | GTPase involved in cell partioning and DNA repair |
RA | 2,156,422 | G→A | 45.0% | T142T (ACC→ACT) | obgE ← | GTPase involved in cell partioning and DNA repair |
RA | 2,156,434 | C→T | 39.6% | P138P (CCG→CCA) | obgE ← | GTPase involved in cell partioning and DNA repair |
RA | 2,156,449 | G→T | 52.9% | S133S (TCC→TCA) | obgE ← | GTPase involved in cell partioning and DNA repair |
RA | 2,156,455 | T→C | 53.0% | K131K (AAA→AAG) | obgE ← | GTPase involved in cell partioning and DNA repair |
RA | 2,156,629 | G→A | 71.1% | G73G (GGC→GGT) | obgE ← | GTPase involved in cell partioning and DNA repair |
RA | 2,156,632 | A→G | 71.2% | N72N (AAT→AAC) | obgE ← | GTPase involved in cell partioning and DNA repair |
RA | 2,159,306 | T→C | 53.4% | Y168Y (TAT→TAC) | ispB → | octaprenyl diphosphate synthase |
RA | 2,159,312 | A→G | 53.8% | K170K (AAA→AAG) | ispB → | octaprenyl diphosphate synthase |
RA | 2,159,315 | C→T | 49.8% | T171T (ACC→ACT) | ispB → | octaprenyl diphosphate synthase |
RA | 2,160,046 | G→A | 21.1% | A15A (GCG→GCA) | sfsB → | DNA‑binding transcriptional regulator |
RA | 2,160,326 | G→A | 100% | intergenic (+46/+2) | sfsB → / ← murA | DNA‑binding transcriptional regulator/UDP‑N‑acetylglucosamine 1‑carboxyvinyltransferase |
RA | 2,160,331 | T→C | 100% | E419E (GAA→GAG) | murA ← | UDP‑N‑acetylglucosamine 1‑carboxyvinyltransferase |
RA | 2,160,370 | C→T | 62.8% | L406L (CTG→CTA) | murA ← | UDP‑N‑acetylglucosamine 1‑carboxyvinyltransferase |
RA | 2,161,129 | A→G | 51.1% | G153G (GGT→GGC) | murA ← | UDP‑N‑acetylglucosamine 1‑carboxyvinyltransferase |
RA | 2,165,946 | G→A | 42.6% | V193V (GTG→GTA) | yrbG → | predicted calcium/sodium:proton antiporter |
RA | 2,167,425 | A→G | 41.5% | I20M (ATA→ATG) | kdsC → | 3‑deoxy‑D‑manno‑octulosonate 8‑phosphate phosphatase |
RA | 2,170,169 | G→A | 61.2% | L120L (TTG→TTA) | rpoN → | RNA polymerase, sigma 54 (sigma N) factor |
RA | 2,171,234 | A→G | 45.1% | Q475Q (CAA→CAG) | rpoN → | RNA polymerase, sigma 54 (sigma N) factor |
RA | 2,172,453 | C→A | 56.6% | L82L (CTC→CTA) | yhbJ → | hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 2,173,038 | T→G | 25.8% | R277R (CGT→CGG) | yhbJ → | hypothetical protein with nucleoside triphosphate hydrolase domain |
RA | 2,173,752 | G→A | 24.8% | V70I (GTT→ATT) | yrbL → | hypothetical protein |
RA | 2,175,971 | T→C | 54.8% | G716G (GGA→GGG) | arcB ← | hybrid sensory histidine kinase in two‑component regulatory system with ArcA |
RA | 2,177,633 | A→G | 42.4% | D162D (GAT→GAC) | arcB ← | hybrid sensory histidine kinase in two‑component regulatory system with ArcA |
RA | 2,179,432 | A→G | 65.4% | intergenic (‑289/‑293) | yhcC ← / → gltB | predicted Fe‑S oxidoreductase/glutamate synthase, large subunit |
RA | 2,179,450 | A→T | 55.5% | intergenic (‑307/‑275) | yhcC ← / → gltB | predicted Fe‑S oxidoreductase/glutamate synthase, large subunit |
RA | 2,179,455 | A→G | 56.3% | intergenic (‑312/‑270) | yhcC ← / → gltB | predicted Fe‑S oxidoreductase/glutamate synthase, large subunit |
RA | 2,182,550 | T→G | 56.3% | A942A (GCT→GCG) | gltB → | glutamate synthase, large subunit |
RA | 2,183,120 | C→T | 30.0% | G1132G (GGC→GGT) | gltB → | glutamate synthase, large subunit |
RA | 2,183,132 | A→G | 30.8% | L1136L (CTA→CTG) | gltB → | glutamate synthase, large subunit |
RA | 2,183,135 | T→A | 30.9% | R1137R (CGT→CGA) | gltB → | glutamate synthase, large subunit |
RA | 2,183,144 | T→C | 24.9% | H1140H (CAT→CAC) | gltB → | glutamate synthase, large subunit |
RA | 2,183,240 | G→A | 46.1% | E1172E (GAG→GAA) | gltB → | glutamate synthase, large subunit |
RA | 2,183,279 | T→G | 37.6% | L1185L (CTT→CTG) | gltB → | glutamate synthase, large subunit |
RA | 2,183,384 | G→A | 20.3% | E1220E (GAG→GAA) | gltB → | glutamate synthase, large subunit |
RA | 2,183,393 | A→G | 37.8% | E1223E (GAA→GAG) | gltB → | glutamate synthase, large subunit |
RA | 2,183,396 | G→A | 37.1% | P1224P (CCG→CCA) | gltB → | glutamate synthase, large subunit |
RA | 2,183,400 | C→G | 40.2% | P1226A (CCA→GCA) | gltB → | glutamate synthase, large subunit |
RA | 2,183,420 | C→T | 50.6% | C1232C (TGC→TGT) | gltB → | glutamate synthase, large subunit |
RA | 2,183,528 | T→C | 63.2% | I1268I (ATT→ATC) | gltB → | glutamate synthase, large subunit |
RA | 2,183,975 | T→C | 22.3% | G1417G (GGT→GGC) | gltB → | glutamate synthase, large subunit |
RA | 2,183,990 | C→T | 40.2% | G1422G (GGC→GGT) | gltB → | glutamate synthase, large subunit |
RA | 2,183,993 | T→C | 35.9% | G1423G (GGT→GGC) | gltB → | glutamate synthase, large subunit |
RA | 2,185,556 | C→T | 48.4% | I422I (ATC→ATT) | gltD → | glutamate synthase, 4Fe‑4S protein, small subunit |
RA | 2,186,816 | G→A | 79.1% | S347S (AGC→AGT) | nanT ← | sialic acid transporter |
RA | 2,187,412 | A→G | 30.3% | L149L (TTG→CTG) | nanT ← | sialic acid transporter |
RA | 2,187,440 | T→C | 32.5% | K139K (AAA→AAG) | nanT ← | sialic acid transporter |
RA | 2,187,797 | G→C | 27.2% | R20R (CGC→CGG) | nanT ← | sialic acid transporter |
RA | 2,187,809 | A→G | 35.9% | R16R (CGT→CGC) | nanT ← | sialic acid transporter |
RA | 2,187,815 | G→A | 51.4% | L14L (CTC→CTT) | nanT ← | sialic acid transporter |
RA | 2,188,466 | A→C | 44.8% | G131G (GGT→GGG) | nanA ← | N‑acetylneuraminate lyase |
RA | 2,188,658 | G→A | 76.0% | A67A (GCC→GCT) | nanA ← | N‑acetylneuraminate lyase |
RA | 2,188,733 | T→C | 46.2% | L42L (TTA→TTG) | nanA ← | N‑acetylneuraminate lyase |
RA | 2,189,346 | A→G | 32.3% | H142H (CAT→CAC) | nanR ← | DNA‑binding transcriptional dual regulator |
RA | 2,195,634 | C→T | 44.7% | S54S (AGC→AGT) | yhcB → | conserved hypothetical protein |
RA | 2,196,732 | C→A | 32.4% | G236G (GGC→GGA) | degQ → | serine endoprotease, periplasmic |
RA | 2,196,738 | G→T | 32.4% | G238G (GGG→GGT) | degQ → | serine endoprotease, periplasmic |
RA | 2,198,000 | T→C | 40.5% | I173I (ATT→ATC) | degS → | serine endoprotease, periplasmic |
RA | 2,198,231 | C→T | 32.9% | R250R (CGC→CGT) | degS → | serine endoprotease, periplasmic |
RA | 2,198,237 | T→C | 32.2% | G252G (GGT→GGC) | degS → | serine endoprotease, periplasmic |
RA | 2,198,240 | C→T | 34.8% | R253R (CGC→CGT) | degS → | serine endoprotease, periplasmic |
RA | 2,198,249 | C→T | 41.6% | R256R (CGC→CGT) | degS → | serine endoprotease, periplasmic |
RA | 2,200,293 | C→T | 53.7% | G103G (GGC→GGT) | argR → | DNA‑binding transcriptional dual regulator, L‑arginine‑binding |
RA | 2,200,383 | C→T | 36.5% | T133T (ACC→ACT) | argR → | DNA‑binding transcriptional dual regulator, L‑arginine‑binding |
RA | 2,200,404 | A→C | 25.8% | T140T (ACA→ACC) | argR → | DNA‑binding transcriptional dual regulator, L‑arginine‑binding |
RA | 2,200,413 | C→G | 30.0% | D143E (GAC→GAG) | argR → | DNA‑binding transcriptional dual regulator, L‑arginine‑binding |
RA | 2,200,724 | C→T | 39.2% | intergenic (+269/‑96) | argR → / → yhcN | DNA‑binding transcriptional dual regulator, L‑arginine‑binding/conserved hypothetical protein |
RA | 2,202,379 | G→A | 25.2% | S364S (TCC→TCT) | aaeB ← | p‑hydroxybenzoic acid efflux system component |
RA | 2,203,776 | T→C | 73.2% | A211A (GCA→GCG) | aaeA ← | p‑hydroxybenzoic acid efflux system component |
RA | 2,203,788 | C→A | 81.7% | P207P (CCG→CCT) | aaeA ← | p‑hydroxybenzoic acid efflux system component |
RA | 2,203,791 | A→G | 75.5% | R206R (CGT→CGC) | aaeA ← | p‑hydroxybenzoic acid efflux system component |
RA | 2,205,665 | G→A | 60.3% | L288L (CTG→CTA) | aaeR → | predicted DNA‑binding transcriptional regulator, efflux system |
RA | 2,206,243 | G→A | 29.7% | A356A (GCC→GCT) | tldD ← | predicted peptidase |
RA | 2,209,246 | C→T | 58.2% | L765L (TTG→TTA) | yhdP ← | conserved membrane protein, predicted transporter |
RA | 2,209,265 | T→G | 45.9% | E759A (GAA→GCA) | yhdP ← | conserved membrane protein, predicted transporter |
RA | 2,209,600 | A→G | 34.7% | S647S (TCT→TCC) | yhdP ← | conserved membrane protein, predicted transporter |
RA | 2,210,179 | A→C | 29.6% | T454T (ACT→ACG) | yhdP ← | conserved membrane protein, predicted transporter |
RA | 2,212,202 | G→C | 41.2% | L292L (CTC→CTG) | rng ← | ribonuclease G |
RA | 2,212,787 | A→G | 35.7% | V97V (GTT→GTC) | rng ← | ribonuclease G |
RA | 2,214,266 | G→A | 58.1% | A332V (GCT→GTT) | mreC ← | cell wall structural complex MreBCD transmembrane component MreC |
RA | 2,217,619 | A→G | 54.3% | V332V (GTT→GTC) | yhdA ← | conserved inner membrane protein |
RA | 2,218,436 | A→G | 45.1% | V60A (GTA→GCA) ‡ | yhdA ← | conserved inner membrane protein |
RA | 2,218,437 | C→T | 45.0% | V60I (GTA→ATA) ‡ | yhdA ← | conserved inner membrane protein |
RA | 2,218,861 | C→T | 37.3% | V32V (GTC→GTT) | yhdH → | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 2,219,341 | T→C | 37.0% | A192A (GCT→GCC) | yhdH → | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 2,219,348 | G→A | 34.4% | V195I (GTT→ATT) | yhdH → | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 2,219,353 | C→T | 33.8% | L196L (CTC→CTT) | yhdH → | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 2,219,359 | T→C | 41.6% | R198R (CGT→CGC) | yhdH → | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding |
RA | 2,220,128 | A→T | 44.5% | intergenic (+388/‑590) | yhdH → / → accB | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding/acetyl CoA carboxylase, BCCP subunit |
RA | 2,220,132 | A→G | 37.6% | intergenic (+392/‑586) | yhdH → / → accB | predicted oxidoreductase, Zn‑dependent and NAD(P)‑binding/acetyl CoA carboxylase, BCCP subunit |
RA | 2,220,870 | A→T | 31.3% | P51P (CCA→CCT) | accB → | acetyl CoA carboxylase, BCCP subunit |
RA | 2,221,351 | T→C | 34.7% | I51I (ATT→ATC) | accC → | acetyl‑CoA carboxylase, biotin carboxylase subunit |
RA | 2,222,098 | A→T | 20.3% | T300T (ACA→ACT) | accC → | acetyl‑CoA carboxylase, biotin carboxylase subunit |
RA | 2,223,383 | T→C | 35.1% | F165F (TTT→TTC) | panF → | pantothenate:sodium symporter |
RA | 2,223,401 | A→G | 21.5% | L171L (TTA→TTG) | panF → | pantothenate:sodium symporter |
RA | 2,224,699 | T→A | 100% | P116P (CCT→CCA) | prmA → | methylase for 50S ribosomal subunit protein L11 |
RA | 2,224,918 | C→T | 42.7% | I189I (ATC→ATT) | prmA → | methylase for 50S ribosomal subunit protein L11 |
RA | 2,224,948 | T→C | 57.4% | D199D (GAT→GAC) | prmA → | methylase for 50S ribosomal subunit protein L11 |
RA | 2,224,954 | C→T | 49.4% | A201A (GCC→GCT) | prmA → | methylase for 50S ribosomal subunit protein L11 |
RA | 2,225,948 | G→C | 40.7% | V129V (GTG→GTC) | dusB → | tRNA‑dihydrouridine synthase B |
RA | 2,225,978 | G→A | 45.9% | K139K (AAG→AAA) | dusB → | tRNA‑dihydrouridine synthase B |
RA | 2,225,987 | C→T | 43.8% | T142T (ACC→ACT) | dusB → | tRNA‑dihydrouridine synthase B |
RA | 2,227,641 | T→C | 58.4% | G238G (GGT→GGC) | yhdY → | predicted amino‑acid transporter subunit |
RA | 2,228,311 | T→G | 46.2% | V105V (GTT→GTG) | yhdZ → | predicted amino‑acid transporter subunit |
RA | 2,228,314 | A→G | 45.2% | L106L (TTA→TTG) | yhdZ → | predicted amino‑acid transporter subunit |
RA | 2,228,356 | T→A | 30.5% | P120P (CCT→CCA) | yhdZ → | predicted amino‑acid transporter subunit |
RA | 2,234,608 | G→C | 30.5% | intergenic (‑368/‑247) | rrsD ← / → purH | 16S ribosomal RNA/fused IMP cyclohydrolase and phosphoribosylaminoimidazolecarboxamide formyltransferase |
RA | 2,235,108 | A→T | 44.8% | Q85L (CAG→CTG) | purH → | fused IMP cyclohydrolase and phosphoribosylaminoimidazolecarboxamide formyltransferase |
RA | 2,237,256 | C→T | 48.1% | T267T (ACC→ACT) | purD → | phosphoribosylglycinamide synthetase phosphoribosylamine‑glycine ligase |
RA | 2,237,404 | A→G | 40.2% | S317G (AGC→GGC) | purD → | phosphoribosylglycinamide synthetase phosphoribosylamine‑glycine ligase |
RA | 2,237,409 | A→G | 40.0% | K318K (AAA→AAG) | purD → | phosphoribosylglycinamide synthetase phosphoribosylamine‑glycine ligase |
RA | 2,239,232 | A→G | 27.4% | T410T (ACT→ACC) | zraS ← | sensory histidine kinase in two‑component regulatory system with ZraR |
RA | 2,239,244 | A→T | 28.3% | D406E (GAT→GAA) | zraS ← | sensory histidine kinase in two‑component regulatory system with ZraR |
RA | 2,239,256 | T→C | 38.1% | A402A (GCA→GCG) | zraS ← | sensory histidine kinase in two‑component regulatory system with ZraR |
RA | 2,239,637 | A→T | 53.3% | P275P (CCT→CCA) | zraS ← | sensory histidine kinase in two‑component regulatory system with ZraR |
RA | 2,243,208 | C→T | 37.0% | V130V (GTG→GTA) | nfi ← | endonuclease V |
RA | 2,243,253 | G→T | 20.4% | V115V (GTC→GTA) | nfi ← | endonuclease V |
RA | 2,243,361 | G→C | 25.3% | S79S (TCC→TCG) | nfi ← | endonuclease V |
RA | 2,243,364 | A→G | 31.6% | L78L (CTT→CTC) | nfi ← | endonuclease V |
RA | 2,243,565 | G→A | 16.5% | I11I (ATC→ATT) | nfi ← | endonuclease V |
RA | 2,243,810 | A→G | 43.8% | L288L (TTG→CTG) | hemE ← | uroporphyrinogen decarboxylase |
RA | 2,243,829 | A→G | 47.1% | R281R (CGT→CGC) | hemE ← | uroporphyrinogen decarboxylase |
RA | 2,243,832 | G→A | 45.7% | R280R (CGC→CGT) | hemE ← | uroporphyrinogen decarboxylase |
RA | 2,243,898 | G→C | 46.1% | A258A (GCC→GCG) | hemE ← | uroporphyrinogen decarboxylase |
RA | 2,243,916 | G→A | 42.8% | G252G (GGC→GGT) | hemE ← | uroporphyrinogen decarboxylase |
RA | 2,243,925 | G→A | 38.0% | T249T (ACC→ACT) | hemE ← | uroporphyrinogen decarboxylase |
RA | 2,245,543 | T→A | 15.3% | intergenic (‑59/‑36) | nudC ← / → rsd | NADH pyrophosphatase/stationary phase protein, binds sigma 70 RNA polymerase subunit |
RA | 2,245,839 | G→A | 30.6% | A87A (GCG→GCA) | rsd → | stationary phase protein, binds sigma 70 RNA polymerase subunit |
RA | 2,245,860 | G→A | 26.9% | P94P (CCG→CCA) | rsd → | stationary phase protein, binds sigma 70 RNA polymerase subunit |
RA | 2,246,389 | T→C | 21.5% | Y34Y (TAT→TAC) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,246,455 | T→C | 36.6% | I56I (ATT→ATC) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,246,521 | C→T | 33.8% | G78G (GGC→GGT) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,246,530 | T→C | 29.3% | G81G (GGT→GGC) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,246,542 | T→C | 20.9% | I85I (ATT→ATC) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,246,725 | T→C | 49.2% | R146R (CGT→CGC) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,247,184 | G→A | 78.7% | A299A (GCG→GCA) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,247,196 | T→G | 80.5% | V303V (GTT→GTG) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,247,208 | C→T | 65.3% | A307A (GCC→GCT) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,247,796 | T→C | 51.0% | G503G (GGT→GGC) | thiC → | thiamin (pyrimidine moiety) biosynthesis protein |
RA | 2,248,786 | T→C | 27.7% | L202L (TTG→CTG) | thiE → | thiamin phosphate synthase |
RA | 2,250,566 | C→T | 54.5% | I16I (ATC→ATT) | thiH → | thiamin biosynthesis ThiGH complex subunit |
RA | 2,251,037 | T→A | 51.8% | L173L (CTT→CTA) | thiH → | thiamin biosynthesis ThiGH complex subunit |
RA | 2,251,646 | A→G | 28.1% | R376R (AGA→AGG) | thiH → | thiamin biosynthesis ThiGH complex subunit |
RA | 2,251,648 | T→C | 27.3% | L377P (CTA→CCA) | thiH → | thiamin biosynthesis ThiGH complex subunit |
RA | 2,251,656 | G→A | 25.5% | intergenic (+4/+406) | thiH → / ← htrC | thiamin biosynthesis ThiGH complex subunit/heat shock protein |
RA | 2,251,686 | C→A | 23.0% | intergenic (+34/+376) | thiH → / ← htrC | thiamin biosynthesis ThiGH complex subunit/heat shock protein |
RA | 2,251,690 | A→C | 22.6% | intergenic (+38/+372) | thiH → / ← htrC | thiamin biosynthesis ThiGH complex subunit/heat shock protein |
RA | 2,253,207 | G→A | 43.2% | G1277G (GGC→GGT) | rpoC ← | RNA polymerase, beta prime subunit |
RA | 2,253,228 | A→G | 29.3% | G1270G (GGT→GGC) | rpoC ← | RNA polymerase, beta prime subunit |
RA | 2,254,185 | T→C | 29.3% | Q951Q (CAA→CAG) | rpoC ← | RNA polymerase, beta prime subunit |
RA | 2,255,856 | A→G | 36.5% | I394I (ATT→ATC) | rpoC ← | RNA polymerase, beta prime subunit |
RA | 2,258,470 | A→G | 50.9% | G891G (GGT→GGC) | rpoB ← | RNA polymerase, beta subunit |
RA | 2,259,276 | A→G | 27.7% | L623L (TTG→CTG) | rpoB ← | RNA polymerase, beta subunit |
RA | 2,259,421 | A→G | 8.2% | S574S (TCT→TCC) | rpoB ← | RNA polymerase, beta subunit |
RA | 2,260,039 | G→A | 50.8% | R368R (CGC→CGT) | rpoB ← | RNA polymerase, beta subunit |
RA | 2,260,636 | T→C | 26.7% | K169K (AAA→AAG) | rpoB ← | RNA polymerase, beta subunit |
RA | 2,263,269 | T→C | 44.9% | Q80Q (CAA→CAG) | rplA ← | 50S ribosomal subunit protein L1 |
RA | 2,269,117 | A→T | 25.7% | P63P (CCT→CCA) | birA ← | bifunctional biotin‑[acetylCoA carboxylase] holoenzyme synthetase and DNA‑binding transcriptional repressor, bio‑5'‑AMP‑binding |
RA | 2,269,123 | A→G | 24.7% | P61P (CCT→CCC) | birA ← | bifunctional biotin‑[acetylCoA carboxylase] holoenzyme synthetase and DNA‑binding transcriptional repressor, bio‑5'‑AMP‑binding |
RA | 2,269,128 | G→A | 24.6% | L60L (CTG→TTG) | birA ← | bifunctional biotin‑[acetylCoA carboxylase] holoenzyme synthetase and DNA‑binding transcriptional repressor, bio‑5'‑AMP‑binding |
RA | 2,269,150 | G→A | 27.7% | T52T (ACC→ACT) | birA ← | bifunctional biotin‑[acetylCoA carboxylase] holoenzyme synthetase and DNA‑binding transcriptional repressor, bio‑5'‑AMP‑binding |
RA | 2,269,255 | A→G | 21.7% | G17G (GGT→GGC) | birA ← | bifunctional biotin‑[acetylCoA carboxylase] holoenzyme synthetase and DNA‑binding transcriptional repressor, bio‑5'‑AMP‑binding |
RA | 2,269,258 | G→A | 21.9% | N16N (AAC→AAT) | birA ← | bifunctional biotin‑[acetylCoA carboxylase] holoenzyme synthetase and DNA‑binding transcriptional repressor, bio‑5'‑AMP‑binding |
RA | 2,269,273 | A→G | 45.8% | I11I (ATT→ATC) | birA ← | bifunctional biotin‑[acetylCoA carboxylase] holoenzyme synthetase and DNA‑binding transcriptional repressor, bio‑5'‑AMP‑binding |
RA | 2,276,970 | A→G | 21.1% | Y593Y (TAT→TAC) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,216 | G→A | 26.8% | T511T (ACC→ACT) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,534 | G→A | 23.7% | F405F (TTC→TTT) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,555 | T→C | 26.2% | E398E (GAA→GAG) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,600 | T→A | 47.5% | S383S (TCA→TCT) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,603 | G→A | 42.6% | N382N (AAC→AAT) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,612 | A→G | 46.7% | S379S (AGT→AGC) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,619 | G→C | 23.8% | A377G (GCA→GGA) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,633 | G→A | 20.1% | T372T (ACC→ACT) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,277,651 | T→C | 17.4% | Q366Q (CAA→CAG) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,278,398 | G→A | 28.5% | S117S (AGC→AGT) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,278,404 | G→A | 33.7% | D115D (GAC→GAT) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,278,407 | G→A | 34.7% | A114A (GCC→GCT) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,278,430 | G→A | 39.7% | L107L (CTG→TTG) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,278,440 | T→G | 41.9% | V103V (GTA→GTC) | btuB ← | vitamin B12/cobalamin outer membrane transporter |
RA | 2,279,636 | G→A | 29.2% | V174I (GTC→ATC) | trmA → | tRNA (uracil‑5‑)‑methyltransferase |
RA | 2,279,641 | A→G | 28.3% | A175A (GCA→GCG) | trmA → | tRNA (uracil‑5‑)‑methyltransferase |
RA | 2,279,686 | G→A | 25.6% | Q190Q (CAG→CAA) | trmA → | tRNA (uracil‑5‑)‑methyltransferase |
RA | 2,280,578 | C→T | 48.6% | L13L (CTG→CTA) | yijD ← | conserved inner membrane protein |
RA | 2,281,039 | G→A | 31.1% | R94R (CGC→CGT) | fabR ← | DNA‑binding transcriptional repressor |
RA | 2,281,141 | C→T | 34.3% | A60A (GCG→GCA) | fabR ← | DNA‑binding transcriptional repressor |
RA | 2,281,147 | A→T | 36.0% | R58R (CGT→CGA) | fabR ← | DNA‑binding transcriptional repressor |
RA | 2,281,150 | C→T | 37.1% | A57A (GCG→GCA) | fabR ← | DNA‑binding transcriptional repressor |
RA | 2,281,337 | A→G | 36.2% | intergenic (‑17/‑260) | fabR ← / → sthA | DNA‑binding transcriptional repressor/pyridine nucleotide transhydrogenase, soluble |
RA | 2,282,340 | T→C | 35.1% | D248D (GAT→GAC) | sthA → | pyridine nucleotide transhydrogenase, soluble |
RA | 2,282,451 | A→G | 24.0% | L285L (CTA→CTG) | sthA → | pyridine nucleotide transhydrogenase, soluble |
RA | 2,282,463 | C→T | 24.8% | S289S (AGC→AGT) | sthA → | pyridine nucleotide transhydrogenase, soluble |
RA | 2,283,154 | C→T | 30.8% | E248E (GAG→GAA) | oxyR ← | DNA‑binding transcriptional dual regulator |
RA | 2,283,685 | C→T | 39.9% | V71V (GTG→GTA) | oxyR ← | DNA‑binding transcriptional dual regulator |
RA | 2,284,209 | C→T | 100% | Q443Q (CAG→CAA) | argH ← | argininosuccinate lyase |
RA | 2,284,434 | G→A | 43.5% | T368T (ACC→ACT) | argH ← | argininosuccinate lyase |
RA | 2,284,437 | G→A | 50.0% | A367A (GCC→GCT) | argH ← | argininosuccinate lyase |
RA | 2,284,647 | G→A | 75.2% | G297G (GGC→GGT) | argH ← | argininosuccinate lyase |
RA | 2,285,082 | T→C | 33.6% | P152P (CCA→CCG) | argH ← | argininosuccinate lyase |
RA | 2,285,088 | T→C | 32.9% | V150V (GTA→GTG) | argH ← | argininosuccinate lyase |
RA | 2,285,268 | G→A | 41.5% | G90G (GGC→GGT) | argH ← | argininosuccinate lyase |
RA | 2,286,015 | A→G | 37.3% | G119G (GGT→GGC) | argB ← | acetylglutamate kinase |
RA | 2,286,511 | C→A | 53.9% | G292G (GGG→GGT) | argC ← | N‑acetyl‑gamma‑glutamylphosphate reductase, NAD(P)‑binding |
RA | 2,286,523 | A→G | 47.9% | F288F (TTT→TTC) | argC ← | N‑acetyl‑gamma‑glutamylphosphate reductase, NAD(P)‑binding |
RA | 2,286,913 | C→T | 68.6% | A158A (GCG→GCA) | argC ← | N‑acetyl‑gamma‑glutamylphosphate reductase, NAD(P)‑binding |
RA | 2,286,931 | C→T | 62.8% | P152P (CCG→CCA) | argC ← | N‑acetyl‑gamma‑glutamylphosphate reductase, NAD(P)‑binding |
RA | 2,286,937 | C→G | 66.1% | A150A (GCG→GCC) | argC ← | N‑acetyl‑gamma‑glutamylphosphate reductase, NAD(P)‑binding |
RA | 2,287,806 | T→A | 49.5% | G89G (GGT→GGA) | argE → | acetylornithine deacetylase |
RA | 2,287,824 | G→A | 40.9% | P95P (CCG→CCA) | argE → | acetylornithine deacetylase |
RA | 2,287,830 | A→G | 41.6% | T97T (ACA→ACG) | argE → | acetylornithine deacetylase |
RA | 2,287,831 | C→T | 41.6% | L98L (CTG→TTG) | argE → | acetylornithine deacetylase |
RA | 2,287,932 | A→G | 65.8% | K131K (AAA→AAG) | argE → | acetylornithine deacetylase |
RA | 2,290,461 | C→G | 38.3% | V391V (GTC→GTG) | ppc → | phosphoenolpyruvate carboxylase |
RA | 2,290,611 | G→A | 54.4% | L441L (CTG→CTA) | ppc → | phosphoenolpyruvate carboxylase |
RA | 2,290,614 | G→A | 54.6% | P442P (CCG→CCA) | ppc → | phosphoenolpyruvate carboxylase |
RA | 2,290,737 | A→G | 46.0% | V483V (GTA→GTG) | ppc → | phosphoenolpyruvate carboxylase |
RA | 2,290,935 | A→C | 20.0% | G549G (GGA→GGC) | ppc → | phosphoenolpyruvate carboxylase |
RA | 2,291,520 | C→T | 31.0% | D744D (GAC→GAT) | ppc → | phosphoenolpyruvate carboxylase |
RA | 2,292,688 | A→T | 58.2% | intergenic (+239/‑182) | fsaB → / → gldA | fructose‑6‑phosphate aldolase 2/glycerol dehydrogenase, NAD |
RA | 2,292,920 | G→A | 36.4% | V17V (GTG→GTA) | gldA → | glycerol dehydrogenase, NAD |
RA | 2,292,938 | A→G | 39.4% | E23E (GAA→GAG) | gldA → | glycerol dehydrogenase, NAD |
RA | 2,292,950 | G→A | 39.0% | P27P (CCG→CCA) | gldA → | glycerol dehydrogenase, NAD |
RA | 2,292,956 | A→G | 50.8% | A29A (GCA→GCG) | gldA → | glycerol dehydrogenase, NAD |
RA | 2,293,682 | C→T | 37.4% | H271H (CAC→CAT) | gldA → | glycerol dehydrogenase, NAD |
RA | 2,295,597 | T→C | 19.7% | T67T (ACA→ACG) | yijE ← | predicted permease |
RA | 2,296,088 | C→T | 48.0% | E661E (GAG→GAA) | katG ← | catalase/hydroperoxidase HPI(I) |
RA | 2,296,406 | A→G | 31.9% | G555G (GGT→GGC) | katG ← | catalase/hydroperoxidase HPI(I) |
RA | 2,298,204 | T→G | 52.1% | intergenic (‑134/+195) | katG ← / ← metF | catalase/hydroperoxidase HPI(I)/5,10‑methylenetetrahydrofolate reductase |
RA | 2,298,214 | T→C | 36.9% | intergenic (‑144/+185) | katG ← / ← metF | catalase/hydroperoxidase HPI(I)/5,10‑methylenetetrahydrofolate reductase |
RA | 2,298,218 | T→A | 36.6% | intergenic (‑148/+181) | katG ← / ← metF | catalase/hydroperoxidase HPI(I)/5,10‑methylenetetrahydrofolate reductase |
RA | 2,298,777 | G→T | 40.5% | R171R (CGC→CGA) | metF ← | 5,10‑methylenetetrahydrofolate reductase |
RA | 2,298,781 | T→C | 40.5% | K170R (AAA→AGA) | metF ← | 5,10‑methylenetetrahydrofolate reductase |
RA | 2,298,786 | A→G | 29.9% | N168N (AAT→AAC) | metF ← | 5,10‑methylenetetrahydrofolate reductase |
RA | 2,298,789 | A→G | 29.9% | L167L (CTT→CTC) | metF ← | 5,10‑methylenetetrahydrofolate reductase |
RA | 2,299,044 | A→G | 21.3% | G82G (GGT→GGC) | metF ← | 5,10‑methylenetetrahydrofolate reductase |
RA | 2,299,047 | A→G | 21.0% | T81T (ACT→ACC) | metF ← | 5,10‑methylenetetrahydrofolate reductase |
RA | 2,301,360 | A→G | 37.5% | S237S (AGT→AGC) | metL ← | fused aspartokinase II and homoserine dehydrogenase II |
RA | 2,301,363 | G→A | 47.0% | Y236Y (TAC→TAT) | metL ← | fused aspartokinase II and homoserine dehydrogenase II |
RA | 2,301,381 | G→A | 37.8% | S230S (AGC→AGT) | metL ← | fused aspartokinase II and homoserine dehydrogenase II |
RA | 2,301,387 | G→A | 43.0% | I228I (ATC→ATT) | metL ← | fused aspartokinase II and homoserine dehydrogenase II |
RA | 2,301,495 | T→C | 61.9% | G192G (GGA→GGG) | metL ← | fused aspartokinase II and homoserine dehydrogenase II |
RA | 2,301,534 | C→T | 100% | L179L (CTG→CTA) | metL ← | fused aspartokinase II and homoserine dehydrogenase II |
RA | 2,302,032 | C→T | 53.8% | Q13Q (CAG→CAA) | metL ← | fused aspartokinase II and homoserine dehydrogenase II |
RA | 2,302,610 | G→T | 55.0% | A208A (GCC→GCA) | metB ← | cystathionine gamma‑synthase, PLP‑dependent |
RA | 2,302,616 | T→C | 46.2% | V206V (GTA→GTG) | metB ← | cystathionine gamma‑synthase, PLP‑dependent |
RA | 2,302,622 | T→A | 43.1% | S204S (TCA→TCT) | metB ← | cystathionine gamma‑synthase, PLP‑dependent |
RA | 2,305,340 | A→C | 34.5% | L82L (CTA→CTC) | priA → | primosome factor n' |
RA | 2,305,466 | C→T | 48.0% | G124G (GGC→GGT) | priA → | primosome factor n' |
RA | 2,305,496 | C→T | 62.1% | R134R (CGC→CGT) | priA → | primosome factor n' |
RA | 2,306,411 | T→C | 19.9% | C439C (TGT→TGC) | priA → | primosome factor n' |
RA | 2,309,857 | A→G | 23.7% | A80A (GCA→GCG) | hslV → | peptidase component of the HslUV protease |
RA | 2,312,371 | G→C | 36.9% | R272R (CGG→CGC) | menA → | 1,4‑dihydroxy‑2‑naphthoate octaprenyltransferase |
RA | 2,312,410 | T→C | 29.5% | R285R (CGT→CGC) | menA → | 1,4‑dihydroxy‑2‑naphthoate octaprenyltransferase |
RA | 2,316,170 | G→A | 32.1% | A496A (GCG→GCA) | glpK → | glycerol kinase |
RA | 2,316,188 | A→G | 37.1% | E502E (GAA→GAG) | glpK → | glycerol kinase |
RA | 2,317,228 | G→C | 45.5% | A301A (GCG→GCC) | glpX → | fructose 1,6‑bisphosphatase II |
RA | 2,317,231 | T→C | 45.5% | T302T (ACT→ACC) | glpX → | fructose 1,6‑bisphosphatase II |
RA | 2,317,252 | C→T | 30.5% | R309R (CGC→CGT) | glpX → | fructose 1,6‑bisphosphatase II |
RA | 2,317,255 | C→T | 30.2% | G310G (GGC→GGT) | glpX → | fructose 1,6‑bisphosphatase II |
RA | 2,317,510 | C→T | 59.7% | A26A (GCC→GCT) | fpr → | ferredoxin‑NADP reductase |
RA | 2,317,540 | T→C | 57.2% | F36F (TTT→TTC) | fpr → | ferredoxin‑NADP reductase |
RA | 2,317,732 | C→G | 37.1% | L100L (CTC→CTG) | fpr → | ferredoxin‑NADP reductase |
RA | 2,317,741 | G→A | 32.7% | V103V (GTG→GTA) | fpr → | ferredoxin‑NADP reductase |
RA | 2,317,744 | G→A | 32.3% | P104P (CCG→CCA) | fpr → | ferredoxin‑NADP reductase |
RA | 2,317,745 | C→G | 32.4% | H105D (CAC→GAC) ‡ | fpr → | ferredoxin‑NADP reductase |
RA | 2,317,747 | C→T | 35.8% | H105H (CAC→CAT) ‡ | fpr → | ferredoxin‑NADP reductase |
RA | 2,317,828 | T→A | 36.3% | D132E (GAT→GAA) | fpr → | ferredoxin‑NADP reductase |
RA | 2,318,190 | A→G | 33.3% | D141D (GAT→GAC) | yiiT ← | stress‑induced protein |
RA | 2,318,208 | G→C | 33.1% | L135L (CTC→CTG) ‡ | yiiT ← | stress‑induced protein |
RA | 2,318,210 | G→A | 33.0% | L135F (CTC→TTC) ‡ | yiiT ← | stress‑induced protein |
RA | 2,318,211 | C→G | 33.1% | L134F (TTG→TTC) ‡ | yiiT ← | stress‑induced protein |
RA | 2,318,213 | A→G | 33.0% | L134L (TTG→CTG) ‡ | yiiT ← | stress‑induced protein |
RA | 2,318,225 | T→A | 25.0% | M130L (ATG→TTG) | yiiT ← | stress‑induced protein |
RA | 2,321,351 | G→T | 42.0% | R209S (CGC→AGC) | cdh ← | CDP‑diacylglycerol phosphotidylhydrolase |
RA | 2,321,376 | T→C | 34.6% | V200V (GTA→GTG) | cdh ← | CDP‑diacylglycerol phosphotidylhydrolase |
RA | 2,321,385 | T→C | 40.3% | A197A (GCA→GCG) | cdh ← | CDP‑diacylglycerol phosphotidylhydrolase |
RA | 2,322,183 | G→A | 69.6% | L297L (CTG→TTG) | sbp ← | sulfate transporter subunit |
RA | 2,322,184 | C→T | 69.6% | K296K (AAG→AAA) | sbp ← | sulfate transporter subunit |
RA | 2,322,829 | C→A | 48.4% | T81T (ACG→ACT) | sbp ← | sulfate transporter subunit |
RA | 2,323,123 | A→G | 13.3% | intergenic (‑52/+268) | sbp ← / ← pfkA | sulfate transporter subunit/6‑phosphofructokinase I |
RA | 2,323,249 | G→A | 57.4% | intergenic (‑178/+142) | sbp ← / ← pfkA | sulfate transporter subunit/6‑phosphofructokinase I |
RA | 2,323,251 | G→A | 57.4% | intergenic (‑180/+140) | sbp ← / ← pfkA | sulfate transporter subunit/6‑phosphofructokinase I |
RA | 2,323,502 | A→G | 60.8% | C284C (TGT→TGC) | pfkA ← | 6‑phosphofructokinase I |
RA | 2,323,511 | G→A | 53.3% | G281G (GGC→GGT) | pfkA ← | 6‑phosphofructokinase I |
RA | 2,323,532 | A→C | 49.4% | D274E (GAT→GAG) | pfkA ← | 6‑phosphofructokinase I |
RA | 2,323,988 | A→G | 42.8% | G122G (GGT→GGC) | pfkA ← | 6‑phosphofructokinase I |
RA | 2,325,765 | A→T | 27.1% | I107I (ATT→ATA) | cpxP ← | periplasmic protein combats stress |
RA | 2,326,771 | A→G | 36.3% | E179E (GAA→GAG) | cpxR → | DNA‑binding response regulator in two‑component regulatory system with CpxA |
RA | 2,330,847 | G→A | 100% | S83S (AGC→AGT) | sodA ← | superoxide dismutase, Mn |
RA | 2,330,865 | G→A | 100% | G77G (GGC→GGT) | sodA ← | superoxide dismutase, Mn |
RA | 2,330,874 | G→A | 71.9% | N74N (AAC→AAT) | sodA ← | superoxide dismutase, Mn |
RA | 2,331,109 | A→G | 47.8% | intergenic (‑14/+416) | sodA ← / ← fdhD | superoxide dismutase, Mn/formate dehydrogenase formation protein |
RA | 2,331,252 | A→C | 28.4% | intergenic (‑157/+273) | sodA ← / ← fdhD | superoxide dismutase, Mn/formate dehydrogenase formation protein |
RA | 2,331,283 | A→G | 38.9% | intergenic (‑188/+242) | sodA ← / ← fdhD | superoxide dismutase, Mn/formate dehydrogenase formation protein |
RA | 2,332,248 | G→C | 32.2% | V37V (GTC→GTG) | fdhD ← | formate dehydrogenase formation protein |
RA | 2,334,282 | G→A | 28.1% | K577K (AAG→AAA) | fdoG → | formate dehydrogenase‑O, large subunit |
RA | 2,334,291 | C→G | 30.6% | V580V (GTC→GTG) | fdoG → | formate dehydrogenase‑O, large subunit |
RA | 2,334,294 | C→T | 30.5% | T581T (ACC→ACT) | fdoG → | formate dehydrogenase‑O, large subunit |
RA | 2,335,299 | G→A | 49.3% | Q916Q (CAG→CAA) | fdoG → | formate dehydrogenase‑O, large subunit |
RA | 2,336,397 | G→A | 60.8% | A261A (GCG→GCA) | fdoH → | formate dehydrogenase‑O, Fe‑S subunit |
RA | 2,336,421 | T→C | 56.2% | F269F (TTT→TTC) | fdoH → | formate dehydrogenase‑O, Fe‑S subunit |
RA | 2,336,424 | G→A | 57.5% | A270A (GCG→GCA) | fdoH → | formate dehydrogenase‑O, Fe‑S subunit |
RA | 2,336,882 | T→C | 37.9% | V123V (GTT→GTC) | fdoI → | formate dehydrogenase‑O, cytochrome b556 subunit |
RA | 2,336,886 | C→T | 43.0% | L125L (CTG→TTG) | fdoI → | formate dehydrogenase‑O, cytochrome b556 subunit |
RA | 2,337,184 | A→G | 39.6% | S13S (TCA→TCG) | fdhE → | formate dehydrogenase formation protein |
RA | 2,337,772 | G→T | 29.8% | G209G (GGG→GGT) | fdhE → | formate dehydrogenase formation protein |
RA | 2,340,553 | C→A | 30.2% | intergenic (‑347/‑26) | bipA ← / → glnA | GTP‑binding protein/glutamine synthetase |
RA | 2,340,899 | C→T | 49.6% | S107S (TCC→TCT) | glnA → | glutamine synthetase |
RA | 2,340,914 | C→T | 25.6% | A112A (GCC→GCT) | glnA → | glutamine synthetase |
RA | 2,341,007 | A→G | 14.8% | S143S (TCA→TCG) | glnA → | glutamine synthetase |
RA | 2,341,463 | G→A | 33.6% | A295A (GCG→GCA) | glnA → | glutamine synthetase |
RA | 2,342,351 | C→T | 27.5% | N26N (AAC→AAT) | glnL → | sensory kinase in two‑component regulatory system with GlnG |
RA | 2,342,948 | T→C | 33.3% | D225D (GAT→GAC) | glnL → | sensory kinase in two‑component regulatory system with GlnG |
RA | 2,342,957 | A→G | 43.3% | L228L (CTA→CTG) | glnL → | sensory kinase in two‑component regulatory system with GlnG |
RA | 2,343,955 | A→C | 21.5% | S207S (TCA→TCC) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,343,967 | C→T | 26.8% | G211G (GGC→GGT) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,343,982 | G→A | 29.9% | A216A (GCG→GCA) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,343,988 | T→C | 31.0% | T218T (ACT→ACC) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,344,243 | T→C | 27.6% | V303V (GTT→GTC) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,344,609 | G→A | 65.4% | A425A (GCG→GCA) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,344,624 | G→A | 63.0% | E430E (GAG→GAA) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,344,639 | G→C | 82.0% | T435T (ACG→ACC) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,344,646 | T→C | 70.5% | L438L (TTG→CTG) | glnG → | fused DNA‑binding response regulator in two‑component regulatory system with GlnL, nitrogen regulator I (NRI) |
RA | 2,349,443 | C→A | 45.7% | R735R (CGG→CGT) | polA ← | fused DNA polymerase I 5'‑>3' exonuclease, 3'‑>5' polymerase and 3'‑>5' exonuclease |
RA | 2,353,113 | A→C | 17.8% | F434L (TTT→TTG) | yihF ← | conserved hypothetical protein |
RA | 2,353,879 | C→T | 19.2% | G179D (GGT→GAT) | yihF ← | conserved hypothetical protein |
RA | 2,355,004 | A→G | 32.8% | N64N (AAT→AAC) | dsbA ← | periplasmic protein disulfide isomerase I |
RA | 2,356,630 | C→T | 22.3% | T6M (ACG→ATG) | mobA → | molybdopterin‑guanine dinucleotide synthase |
RA | 2,356,754 | C→T | 40.5% | L47L (CTC→CTT) | mobA → | molybdopterin‑guanine dinucleotide synthase |
RA | 2,359,222 | C→G | 35.1% | noncoding (1873/2905 nt) | rrlA ← | 23S ribosomal RNA |
RA | 2,359,225 | G→A | 28.1% | noncoding (1870/2905 nt) | rrlA ← | 23S ribosomal RNA |
RA | 2,359,227 | G→C | 35.9% | noncoding (1868/2905 nt) | rrlA ← | 23S ribosomal RNA |
RA | 2,359,866 | T→A | 40.3% | noncoding (1229/2905 nt) | rrlA ← | 23S ribosomal RNA |
RA | 2,359,867 | G→C | 44.0% | noncoding (1228/2905 nt) | rrlA ← | 23S ribosomal RNA |
RA | 2,359,876 | C→G | 41.6% | noncoding (1219/2905 nt) | rrlA ← | 23S ribosomal RNA |
RA | 2,359,877 | A→C | 39.1% | noncoding (1218/2905 nt) | rrlA ← | 23S ribosomal RNA |
RA | 2,366,241 | C→T | 37.6% | K404K (AAG→AAA) | pepQ ← | proline dipeptidase |
RA | 2,366,274 | T→A | 43.7% | L393L (CTA→CTT) | pepQ ← | proline dipeptidase |
RA | 2,366,613 | T→C | 51.5% | E280E (GAA→GAG) | pepQ ← | proline dipeptidase |
RA | 2,366,622 | A→T | 47.6% | V277V (GTT→GTA) | pepQ ← | proline dipeptidase |
RA | 2,366,628 | C→T | 43.9% | K275K (AAG→AAA) | pepQ ← | proline dipeptidase |
RA | 2,366,640 | C→T | 43.3% | A271A (GCG→GCA) | pepQ ← | proline dipeptidase |
RA | 2,366,910 | G→A | 51.5% | H181H (CAC→CAT) | pepQ ← | proline dipeptidase |
RA | 2,367,123 | C→T | 31.8% | P110P (CCG→CCA) | pepQ ← | proline dipeptidase |
RA | 2,368,784 | C→T | 77.3% | I381I (ATC→ATT) | fadB → | fused 3‑hydroxybutyryl‑CoA epimerase/delta(3)‑cis‑delta(2)‑trans‑enoyl‑CoA isomerase/enoyl‑CoA hydratase and 3‑hydroxyacyl‑CoA dehydrogenase |
RA | 2,368,808 | A→G | 63.9% | G389G (GGA→GGG) | fadB → | fused 3‑hydroxybutyryl‑CoA epimerase/delta(3)‑cis‑delta(2)‑trans‑enoyl‑CoA isomerase/enoyl‑CoA hydratase and 3‑hydroxyacyl‑CoA dehydrogenase |
RA | 2,369,021 | G→A | 76.8% | L460L (TTG→TTA) | fadB → | fused 3‑hydroxybutyryl‑CoA epimerase/delta(3)‑cis‑delta(2)‑trans‑enoyl‑CoA isomerase/enoyl‑CoA hydratase and 3‑hydroxyacyl‑CoA dehydrogenase |
RA | 2,369,345 | C→T | 41.0% | Y568Y (TAC→TAT) | fadB → | fused 3‑hydroxybutyryl‑CoA epimerase/delta(3)‑cis‑delta(2)‑trans‑enoyl‑CoA isomerase/enoyl‑CoA hydratase and 3‑hydroxyacyl‑CoA dehydrogenase |
RA | 2,369,370 | G→A | 52.8% | D577N (GAT→AAT) | fadB → | fused 3‑hydroxybutyryl‑CoA epimerase/delta(3)‑cis‑delta(2)‑trans‑enoyl‑CoA isomerase/enoyl‑CoA hydratase and 3‑hydroxyacyl‑CoA dehydrogenase |
RA | 2,377,653 | G→A | 20.7% | R245R (CGC→CGT) | ubiB ← | 2‑octaprenylphenol hydroxylase |
RA | 2,378,139 | T→C | 41.9% | P83P (CCA→CCG) | ubiB ← | 2‑octaprenylphenol hydroxylase |
RA | 2,384,433 | G→A | 62.4% | A376A (GCC→GCT) | metE ← | 5‑methyltetrahydropteroyltriglutamate‑ homocysteine S‑methyltransferase |
RA | 2,384,460 | G→A | 61.1% | D367D (GAC→GAT) | metE ← | 5‑methyltetrahydropteroyltriglutamate‑ homocysteine S‑methyltransferase |
RA | 2,384,474 | G→A | 64.1% | L363L (CTG→TTG) | metE ← | 5‑methyltetrahydropteroyltriglutamate‑ homocysteine S‑methyltransferase |
RA | 2,384,489 | G→A | 57.3% | L358L (CTG→TTG) | metE ← | 5‑methyltetrahydropteroyltriglutamate‑ homocysteine S‑methyltransferase |
RA | 2,385,126 | G→C | 30.9% | D145E (GAC→GAG) | metE ← | 5‑methyltetrahydropteroyltriglutamate‑ homocysteine S‑methyltransferase |
RA | 2,386,995 | A→G | 33.4% | F181F (TTT→TTC) | yigM ← | predicted inner membrane protein |
RA | 2,387,114 | G→A | 34.6% | L142L (CTG→TTG) | yigM ← | predicted inner membrane protein |
RA | 2,387,115 | C→T | 32.8% | L141L (TTG→TTA) | yigM ← | predicted inner membrane protein |
RA | 2,387,276 | G→A | 100% | L88L (CTG→TTG) | yigM ← | predicted inner membrane protein |
RA | 2,387,937 | C→T | 30.6% | P159P (CCG→CCA) | yigL ← | predicted hydrolase |
RA | 2,387,943 | C→A | 32.1% | L157L (CTG→CTT) | yigL ← | predicted hydrolase |
RA | 2,388,186 | A→G | 41.2% | N76N (AAT→AAC) | yigL ← | predicted hydrolase |
RA | 2,388,189 | A→G | 46.4% | G75G (GGT→GGC) | yigL ← | predicted hydrolase |
RA | 2,388,213 | A→G | 35.1% | G67G (GGT→GGC) | yigL ← | predicted hydrolase |
RA | 2,388,775 | G→A | 50.0% | R223R (CGC→CGT) | pldB ← | lysophospholipase L(2) |
RA | 2,388,901 | G→A | 34.9% | L181L (CTC→CTT) | pldB ← | lysophospholipase L(2) |
RA | 2,389,219 | A→G | 32.8% | Y75Y (TAT→TAC) | pldB ← | lysophospholipase L(2) |
RA | 2,390,458 | G→A | 26.1% | G133G (GGC→GGT) | rhtC ← | threonine efflux system |
RA | 2,390,479 | C→A | 28.2% | P126P (CCG→CCT) | rhtC ← | threonine efflux system |
RA | 2,390,482 | A→G | 28.8% | N125N (AAT→AAC) | rhtC ← | threonine efflux system |
RA | 2,390,485 | A→C | 29.2% | A124A (GCT→GCG) | rhtC ← | threonine efflux system |
RA | 2,390,896 | A→C | 41.1% | intergenic (‑40/+24) | rhtC ← / ← recQ | threonine efflux system/ATP‑dependent DNA helicase |
RA | 2,392,399 | A→G | 42.3% | R117R (CGT→CGC) | recQ ← | ATP‑dependent DNA helicase |
RA | 2,392,402 | A→G | 42.3% | I116I (ATT→ATC) | recQ ← | ATP‑dependent DNA helicase |
RA | 2,392,429 | C→T | 38.5% | V107V (GTG→GTA) | recQ ← | ATP‑dependent DNA helicase |
RA | 2,393,272 | A→G | 100% | Y160Y (TAT→TAC) | pldA ← | outer membrane phospholipase A |
RA | 2,393,275 | C→G | 100% | G159G (GGG→GGC) | pldA ← | outer membrane phospholipase A |
RA | 2,393,281 | C→T | 100% | E157E (GAG→GAA) | pldA ← | outer membrane phospholipase A |
RA | 2,394,275 | T→C | 100% | T120T (ACT→ACC) | yigI → | conserved hypothetical protein |
RA | 2,396,732 | A→G | 58.6% | Y152Y (TAT→TAC) | corA ← | magnesium/nickel/cobalt transporter |
RA | 2,397,994 | C→T | 34.0% | F146F (TTC→TTT) | yigE → | hypothetical protein |
RA | 2,399,890 | A→G | 47.4% | G247G (GGT→GGC) | uvrD ← | DNA‑dependent ATPase I and helicase II |
RA | 2,399,893 | G→A | 48.2% | V246V (GTC→GTT) | uvrD ← | DNA‑dependent ATPase I and helicase II |
RA | 2,399,911 | G→A | 55.1% | T240T (ACC→ACT) | uvrD ← | DNA‑dependent ATPase I and helicase II |
RA | 2,399,914 | G→A | 52.1% | D239D (GAC→GAT) | uvrD ← | DNA‑dependent ATPase I and helicase II |
RA | 2,400,903 | G→A | 50.5% | L176L (CTC→CTT) | yigB ← | predicted hydrolase |
RA | 2,400,915 | A→C | 51.7% | A172A (GCT→GCG) | yigB ← | predicted hydrolase |
RA | 2,401,943 | A→G | 31.2% | N128N (AAT→AAC) | xerC ← | site‑specific tyrosine recombinase |
RA | 2,402,395 | T→C | 40.8% | Q212Q (CAA→CAG) | yigA ← | conserved hypothetical protein |
RA | 2,402,524 | T→C | 47.5% | P169P (CCA→CCG) | yigA ← | conserved hypothetical protein |
RA | 2,403,432 | A→G | 63.6% | I140I (ATT→ATC) | dapF ← | diaminopimelate epimerase |
RA | 2,403,448 | G→A | 52.6% | A135V (GCG→GTG) | dapF ← | diaminopimelate epimerase |
RA | 2,404,592 | C→G | 45.0% | E58Q (GAG→CAG) L13L (CTC→CTG) |
yzcX ← cyaY → |
hypothetical protein frataxin, iron‑binding and oxidizing protein |
RA | 2,404,986 | T→G | 25.2% | T825T (ACA→ACC) | cyaA ← | adenylate cyclase |
RA | 2,404,992 | G→A | 26.9% | F823F (TTC→TTT) | cyaA ← | adenylate cyclase |
RA | 2,405,511 | A→G | 39.2% | I650I (ATT→ATC) | cyaA ← | adenylate cyclase |
RA | 2,405,535 | A→G | 37.7% | Y642Y (TAT→TAC) | cyaA ← | adenylate cyclase |
RA | 2,405,538 | A→G | 37.7% | C641C (TGT→TGC) | cyaA ← | adenylate cyclase |
RA | 2,406,099 | C→T | 26.5% | V454V (GTG→GTA) | cyaA ← | adenylate cyclase |
RA | 2,407,197 | C→T | 38.9% | P88P (CCG→CCA) | cyaA ← | adenylate cyclase |
RA | 2,407,200 | A→G | 37.9% | D87D (GAT→GAC) | cyaA ← | adenylate cyclase |
RA | 2,408,020 | A→G | 35.5% | G58G (GGA→GGG) | hemC → | hydroxymethylbilane synthase |
RA | 2,408,035 | A→G | 32.7% | V63V (GTA→GTG) | hemC → | hydroxymethylbilane synthase |
RA | 2,409,214 | A→T | 35.8% | T144S (ACC→TCC) | hemD → | uroporphyrinogen III synthase |
RA | 2,409,828 | T→C | 57.2% | I94I (ATT→ATC) | hemX → | uroporphyrinogen III methylase |
RA | 2,409,850 | A→G | 43.4% | K102E (AAG→GAG) | hemX → | uroporphyrinogen III methylase |
RA | 2,410,191 | C→T | 28.5% | N215N (AAC→AAT) | hemX → | uroporphyrinogen III methylase |
RA | 2,411,465 | C→T | 25.9% | S245S (AGC→AGT) | hemY → | predicted protoheme IX synthesis protein |
RA | 2,412,631 | G→T | 27.8% | R9L (CGT→CTT) | aslA → | acrylsulfatase‑like enzyme |
RA | 2,412,668 | G→A | 31.8% | M21I (ATG→ATA) | aslA → | acrylsulfatase‑like enzyme |
RA | 2,413,154 | T→C | 100% | T183T (ACT→ACC) | aslA → | acrylsulfatase‑like enzyme |
RA | 2,413,160 | C→T | 100% | A185A (GCC→GCT) | aslA → | acrylsulfatase‑like enzyme |
RA | 2,413,166 | A→G | 100% | G187G (GGA→GGG) | aslA → | acrylsulfatase‑like enzyme |
RA | 2,413,415 | T→C | 30.7% | D270D (GAT→GAC) | aslA → | acrylsulfatase‑like enzyme |
RA | 2,413,436 | C→A | 23.2% | D277E (GAC→GAA) | aslA → | acrylsulfatase‑like enzyme |
RA | 2,416,365 | C→A | 43.8% | G454G (GGG→GGT) | yifK ← | predicted transporter |
RA | 2,416,428 | A→G | 40.5% | V433V (GTT→GTC) | yifK ← | predicted transporter |
RA | 2,417,935 | G→A | 35.2% | H241H (CAC→CAT) | rffM ← | UDP‑N‑acetyl‑D‑mannosaminuronic acid transferase |
RA | 2,418,505 | A→G | 22.0% | T51T (ACT→ACC) | rffM ← | UDP‑N‑acetyl‑D‑mannosaminuronic acid transferase |
RA | 2,418,565 | A→G | 50.0% | F31F (TTT→TTC) | rffM ← | UDP‑N‑acetyl‑D‑mannosaminuronic acid transferase |
RA | 2,418,583 | G→A | 65.7% | H25H (CAC→CAT) | rffM ← | UDP‑N‑acetyl‑D‑mannosaminuronic acid transferase |
RA | 2,418,849 | A→G | 38.6% | F388F (TTT→TTC) | wzyE ← | predicted Wzy protein involved in ECA polysaccharide chain elongation |
RA | 2,418,876 | T→C | 24.2% | K379K (AAA→AAG) | wzyE ← | predicted Wzy protein involved in ECA polysaccharide chain elongation |
RA | 2,418,890 | G→T | 47.2% | P375T (CCT→ACT) | wzyE ← | predicted Wzy protein involved in ECA polysaccharide chain elongation |
RA | 2,419,494 | G→A | 40.3% | Y173Y (TAC→TAT) | wzyE ← | predicted Wzy protein involved in ECA polysaccharide chain elongation |
RA | 2,419,497 | G→A | 40.9% | V172V (GTC→GTT) | wzyE ← | predicted Wzy protein involved in ECA polysaccharide chain elongation |
RA | 2,419,779 | C→T | 30.0% | A78A (GCG→GCA) | wzyE ← | predicted Wzy protein involved in ECA polysaccharide chain elongation |
RA | 2,420,823 | G→T | 34.7% | T89K (ACA→AAA) | rffT ← | TDP‑Fuc4NAc:lipidII transferase |
RA | 2,420,852 | A→T | 54.5% | R79R (CGT→CGA) | rffT ← | TDP‑Fuc4NAc:lipidII transferase |
RA | 2,422,099 | C→T | 19.3% | V79V (GTG→GTA) | wzxE ← | O‑antigen translocase |
RA | 2,423,039 | T→C | 30.2% | K143K (AAA→AAG) | rffA ← | TDP‑4‑oxo‑6‑deoxy‑D‑glucose transaminase |
RA | 2,423,180 | A→G | 31.2% | V96V (GTT→GTC) | rffA ← | TDP‑4‑oxo‑6‑deoxy‑D‑glucose transaminase |
RA | 2,423,908 | G→A | 25.1% | A37V (GCC→GTC) | rffC ← | TDP‑fucosamine acetyltransferase |
RA | 2,425,192 | A→G | 54.3% | R300R (CGT→CGC) | rffG ← | dTDP‑glucose 4,6‑dehydratase |
RA | 2,425,195 | C→T | 46.2% | L299L (CTG→CTA) | rffG ← | dTDP‑glucose 4,6‑dehydratase |
RA | 2,425,198 | A→G | 47.3% | D298D (GAT→GAC) | rffG ← | dTDP‑glucose 4,6‑dehydratase |
RA | 2,425,207 | C→T | 39.3% | P295P (CCG→CCA) | rffG ← | dTDP‑glucose 4,6‑dehydratase |
RA | 2,425,234 | G→A | 27.6% | D286D (GAC→GAT) | rffG ← | dTDP‑glucose 4,6‑dehydratase |
RA | 2,425,237 | A→G | 25.9% | R285R (CGT→CGC) | rffG ← | dTDP‑glucose 4,6‑dehydratase |
RA | 2,426,748 | G→T | 53.7% | V202V (GTC→GTA) | rffD ← | UDP‑N‑acetyl‑D‑mannosaminuronic acid dehydrogenase |
RA | 2,428,430 | C→T | 35.8% | A17A (GCG→GCA) | rffE ← | UDP‑N‑acetyl glucosamine‑2‑epimerase |
RA | 2,431,447 | G→C | 49.3% | A250A (GCC→GCG) | rho ← | transcription termination factor |
RA | 2,433,207 | T→C | 35.3% | P75P (CCT→CCC) | rhlB → | ATP‑dependent RNA helicase |
RA | 2,434,314 | A→C | 37.6% | intergenic (+66/‑70) | rhlB → / → gpp | ATP‑dependent RNA helicase/guanosine pentaphosphatase/exopolyphosphatase |
RA | 2,434,324 | A→C | 39.9% | intergenic (+76/‑60) | rhlB → / → gpp | ATP‑dependent RNA helicase/guanosine pentaphosphatase/exopolyphosphatase |
RA | 2,434,343 | A→G | 38.8% | intergenic (+95/‑41) | rhlB → / → gpp | ATP‑dependent RNA helicase/guanosine pentaphosphatase/exopolyphosphatase |
RA | 2,434,641 | G→A | 39.7% | T86T (ACG→ACA) | gpp → | guanosine pentaphosphatase/exopolyphosphatase |
RA | 2,435,202 | C→A | 40.6% | I273I (ATC→ATA) | gpp → | guanosine pentaphosphatase/exopolyphosphatase |
RA | 2,439,549 | C→T | 44.8% | V365V (GTG→GTA) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,439,558 | A→G | 60.5% | I362I (ATT→ATC) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,439,591 | C→T | 75.1% | E351E (GAG→GAA) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,439,594 | G→A | 73.4% | G350G (GGC→GGT) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,439,852 | T→C | 18.4% | A264A (GCA→GCG) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,439,903 | T→C | 25.4% | P247P (CCA→CCG) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,440,065 | G→T | 48.3% | A193A (GCC→GCA) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,440,071 | G→A | 51.3% | A191A (GCC→GCT) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,440,074 | A→G | 50.9% | I190I (ATT→ATC) | ilvC ← | ketol‑acid reductoisomerase, NAD(P)‑binding |
RA | 2,440,779 | C→T | 41.1% | intergenic (‑136/‑14) | ilvC ← / → ilvY | ketol‑acid reductoisomerase, NAD(P)‑binding/DNA‑binding transcriptional dual regulator |
RA | 2,440,780 | G→A | 41.6% | intergenic (‑137/‑13) | ilvC ← / → ilvY | ketol‑acid reductoisomerase, NAD(P)‑binding/DNA‑binding transcriptional dual regulator |
RA | 2,440,788 | T→C | 40.0% | intergenic (‑145/‑5) | ilvC ← / → ilvY | ketol‑acid reductoisomerase, NAD(P)‑binding/DNA‑binding transcriptional dual regulator |
RA | 2,440,789 | C→G | 44.4% | intergenic (‑146/‑4) | ilvC ← / → ilvY | ketol‑acid reductoisomerase, NAD(P)‑binding/DNA‑binding transcriptional dual regulator |
RA | 2,440,792 | T→A | 43.7% | intergenic (‑149/‑1) | ilvC ← / → ilvY | ketol‑acid reductoisomerase, NAD(P)‑binding/DNA‑binding transcriptional dual regulator |
RA | 2,440,793 | G→T | 43.7% | V1M (GTG→TTG) † | ilvY → | DNA‑binding transcriptional dual regulator |
RA | 2,441,545 | C→G | 40.7% | P251P (CCC→CCG) | ilvY → | DNA‑binding transcriptional dual regulator |
RA | 2,441,954 | T→C | 22.6% | S443S (TCA→TCG) | ilvA ← | threonine deaminase |
RA | 2,443,474 | A→T | 49.1% | R554R (CGT→CGA) | ilvD ← | dihydroxyacid dehydratase |
RA | 2,443,483 | G→A | 51.9% | I551I (ATC→ATT) | ilvD ← | dihydroxyacid dehydratase |
RA | 2,443,486 | G→A | 61.4% | D550D (GAC→GAT) | ilvD ← | dihydroxyacid dehydratase |
RA | 2,444,281 | C→T | 23.5% | L285L (CTG→CTA) | ilvD ← | dihydroxyacid dehydratase |
RA | 2,444,290 | T→A | 23.3% | V282V (GTA→GTT) | ilvD ← | dihydroxyacid dehydratase |
RA | 2,444,536 | G→A | 47.1% | T200T (ACC→ACT) | ilvD ← | dihydroxyacid dehydratase |
RA | 2,444,608 | T→A | 40.0% | V176V (GTA→GTT) | ilvD ← | dihydroxyacid dehydratase |
RA | 2,447,222 | G→A | 54.2% | pseudogene (834/1647 nt) | ilvG ← | Mutation in protein compared to W3110: p.Glu327_Ilefs*223 Restoration of IlvG found in MG1655 (548 amino acids), fusion of N‑ter and C‑ter fragments ECK3760:JW3740+JW3741:b4488; large subunit of acetolactate synthase II |
RA | 2,447,246 | A→G | 42.7% | pseudogene (810/1647 nt) | ilvG ← | Mutation in protein compared to W3110: p.Glu327_Ilefs*223 Restoration of IlvG found in MG1655 (548 amino acids), fusion of N‑ter and C‑ter fragments ECK3760:JW3740+JW3741:b4488; large subunit of acetolactate synthase II |
RA | 2,447,261 | C→T | 50.6% | pseudogene (795/1647 nt) | ilvG ← | Mutation in protein compared to W3110: p.Glu327_Ilefs*223 Restoration of IlvG found in MG1655 (548 amino acids), fusion of N‑ter and C‑ter fragments ECK3760:JW3740+JW3741:b4488; large subunit of acetolactate synthase II |
RA | 2,447,263 | A→G | 48.1% | pseudogene (793/1647 nt) | ilvG ← | Mutation in protein compared to W3110: p.Glu327_Ilefs*223 Restoration of IlvG found in MG1655 (548 amino acids), fusion of N‑ter and C‑ter fragments ECK3760:JW3740+JW3741:b4488; large subunit of acetolactate synthase II |
RA | 2,447,264 | G→A | 48.1% | pseudogene (792/1647 nt) | ilvG ← | Mutation in protein compared to W3110: p.Glu327_Ilefs*223 Restoration of IlvG found in MG1655 (548 amino acids), fusion of N‑ter and C‑ter fragments ECK3760:JW3740+JW3741:b4488; large subunit of acetolactate synthase II |
RA | 2,447,486 | G→A | 58.7% | pseudogene (570/1647 nt) | ilvG ← | Mutation in protein compared to W3110: p.Glu327_Ilefs*223 Restoration of IlvG found in MG1655 (548 amino acids), fusion of N‑ter and C‑ter fragments ECK3760:JW3740+JW3741:b4488; large subunit of acetolactate synthase II |
RA | 2,447,498 | A→G | 57.6% | pseudogene (558/1647 nt) | ilvG ← | Mutation in protein compared to W3110: p.Glu327_Ilefs*223 Restoration of IlvG found in MG1655 (548 amino acids), fusion of N‑ter and C‑ter fragments ECK3760:JW3740+JW3741:b4488; large subunit of acetolactate synthase II |
RA | 2,449,128 | A→G | 51.2% | Q171Q (CAA→CAG) | yifB → | predicted bifunctional protein, enzyme and transcriptional regulator |
RA | 2,449,137 | T→C | 54.4% | C174C (TGT→TGC) | yifB → | predicted bifunctional protein, enzyme and transcriptional regulator |
RA | 2,449,169 | G→A | 29.3% | R185H (CGC→CAC) | yifB → | predicted bifunctional protein, enzyme and transcriptional regulator |
RA | 2,449,183 | G→A | 14.1% | D190N (GAT→AAT) | yifB → | predicted bifunctional protein, enzyme and transcriptional regulator |
RA | 2,449,225 | A→G | 19.6% | I204V (ATC→GTC) | yifB → | predicted bifunctional protein, enzyme and transcriptional regulator |
RA | 2,449,236 | A→G | 17.4% | E207E (GAA→GAG) | yifB → | predicted bifunctional protein, enzyme and transcriptional regulator |
RA | 2,451,169 | A→T | 53.0% | S174S (TCA→TCT) | hdfR → | DNA‑binding transcriptional regulator |
RA | 2,451,190 | T→C | 47.2% | N181N (AAT→AAC) | hdfR → | DNA‑binding transcriptional regulator |
RA | 2,451,340 | C→T | 37.5% | S231S (AGC→AGT) | hdfR → | DNA‑binding transcriptional regulator |
RA | 2,451,346 | G→A | 27.5% | A233A (GCG→GCA) | hdfR → | DNA‑binding transcriptional regulator |
RA | 2,457,681 | A→G | 30.3% | K131K (AAA→AAG) | yieP → | predicted transcriptional regulator |
RA | 2,458,264 | A→G | 35.1% | T87T (ACA→ACG) | hsrA → | predicted multidrug or homocysteine efflux system |
RA | 2,459,646 | C→T | 15.8% | L86L (CTG→TTG) | asnC → | DNA‑binding transcriptional dual regulator |
RA | 2,459,805 | T→C | 45.0% | L139L (TTG→CTG) | asnC → | DNA‑binding transcriptional dual regulator |
RA | 2,460,061 | A→G | 45.7% | L41L (TTA→TTG) | mioC → | FMN‑binding protein MioC |
RA | 2,460,071 | C→T | 43.5% | P45S (CCT→TCT) | mioC → | FMN‑binding protein MioC |
RA | 2,460,079 | A→G | 37.6% | S47S (TCA→TCG) | mioC → | FMN‑binding protein MioC |
RA | 2,461,663 | A→G | 50.0% | G301G (GGA→GGG) | gidA → | glucose‑inhibited cell‑division protein |
RA | 2,461,675 | T→C | 57.0% | N305N (AAT→AAC) | gidA → | glucose‑inhibited cell‑division protein |
RA | 2,461,741 | T→C | 100% | S327S (TCT→TCC) | gidA → | glucose‑inhibited cell‑division protein |
RA | 2,461,810 | T→A | 100% | P350P (CCT→CCA) | gidA → | glucose‑inhibited cell‑division protein |
RA | 2,463,067 | A→G | 31.7% | E118E (GAA→GAG) | gidB → | methyltransferase, glucose‑inhibited cell‑division protein |
RA | 2,464,528 | C→T | 37.4% | S62S (AGC→AGT) | atpB → | F0 sector of membrane‑bound ATP synthase, subunit a |
RA | 2,464,543 | G→A | 66.0% | A67A (GCG→GCA) | atpB → | F0 sector of membrane‑bound ATP synthase, subunit a |
RA | 2,464,552 | T→C | 100% | G70G (GGT→GGC) | atpB → | F0 sector of membrane‑bound ATP synthase, subunit a |
RA | 2,464,777 | G→T | 53.2% | A145A (GCG→GCT) | atpB → | F0 sector of membrane‑bound ATP synthase, subunit a |
RA | 2,467,055 | A→C | 47.3% | T173T (ACA→ACC) | atpA → | F1 sector of membrane‑bound ATP synthase, alpha subunit |
RA | 2,469,732 | T→A | 56.6% | V238V (GTT→GTA) | atpD → | F1 sector of membrane‑bound ATP synthase, beta subunit |
RA | 2,469,733 | C→T | 52.0% | L239L (CTG→TTG) | atpD → | F1 sector of membrane‑bound ATP synthase, beta subunit |
RA | 2,469,744 | T→C | 51.5% | V242V (GTT→GTC) | atpD → | F1 sector of membrane‑bound ATP synthase, beta subunit |
RA | 2,469,747 | C→T | 61.2% | D243D (GAC→GAT) | atpD → | F1 sector of membrane‑bound ATP synthase, beta subunit |
RA | 2,472,750 | G→A | 8.7% | A9T (GCG→ACG) | glmS → | L‑glutamine:D‑fructose‑6‑phosphate aminotransferase |
RA | 2,472,815 | C→T | 17.2% | D30D (GAC→GAT) | glmS → | L‑glutamine:D‑fructose‑6‑phosphate aminotransferase |
RA | 2,473,223 | C→T | 39.3% | H166H (CAC→CAT) | glmS → | L‑glutamine:D‑fructose‑6‑phosphate aminotransferase |
RA | 2,473,322 | G→A | 42.1% | P199P (CCG→CCA) | glmS → | L‑glutamine:D‑fructose‑6‑phosphate aminotransferase |
RA | 2,474,447 | G→A | 31.9% | P574P (CCG→CCA) | glmS → | L‑glutamine:D‑fructose‑6‑phosphate aminotransferase |
RA | 2,474,471 | G→A | 31.9% | Q582Q (CAG→CAA) | glmS → | L‑glutamine:D‑fructose‑6‑phosphate aminotransferase |
RA | 2,474,474 | G→A | 31.9% | L583L (CTG→CTA) | glmS → | L‑glutamine:D‑fructose‑6‑phosphate aminotransferase |
RA | 2,474,925 | T→C | 57.9% | S19S (AGT→AGC) | pstS → | phosphate transporter subunit |
RA | 2,475,514 | A→G | 18.2% | I216V (ATT→GTT) | pstS → | phosphate transporter subunit |
RA | 2,475,522 | T→C | 21.3% | Y218Y (TAT→TAC) | pstS → | phosphate transporter subunit |
RA | 2,475,894 | T→C | 38.6% | G342G (GGT→GGC) | pstS → | phosphate transporter subunit |
RA | 2,476,277 | C→T | 20.8% | F94F (TTC→TTT) | pstC → | phosphate transporter subunit |
RA | 2,476,553 | G→A | 32.9% | A186A (GCG→GCA) | pstC → | phosphate transporter subunit |
RA | 2,478,336 | T→C | 31.5% | F103F (TTT→TTC) | pstB → | phosphate transporter subunit |
RA | 2,478,339 | G→A | 31.2% | P104P (CCG→CCA) | pstB → | phosphate transporter subunit |
RA | 2,479,154 | G→A | 23.8% | A113A (GCG→GCA) | phoU → | DNA‑binding transcriptional regulator |
RA | 2,479,184 | G→A | 27.3% | P123P (CCG→CCA) | phoU → | DNA‑binding transcriptional regulator |
RA | 2,479,644 | T→C | 25.2% | intergenic (+103/+204) | phoU → / ← yieE | DNA‑binding transcriptional regulator/predicted phosphopantetheinyl transferase |
RA | 2,479,651 | C→A | 30.0% | intergenic (+110/+197) | phoU → / ← yieE | DNA‑binding transcriptional regulator/predicted phosphopantetheinyl transferase |
RA | 2,479,657 | C→A | 36.7% | intergenic (+116/+191) | phoU → / ← yieE | DNA‑binding transcriptional regulator/predicted phosphopantetheinyl transferase |
RA | 2,480,719 | T→C | 35.3% | intergenic (‑110/+35) | yieE ← / ← yidZ | predicted phosphopantetheinyl transferase/predicted DNA‑binding transcriptional regulator |
RA | 2,480,838 | C→A | 18.8% | L292L (CTG→CTT) | yidZ ← | predicted DNA‑binding transcriptional regulator |
RA | 2,481,036 | T→C | 37.1% | G226G (GGA→GGG) | yidZ ← | predicted DNA‑binding transcriptional regulator |
RA | 2,481,132 | C→T | 27.4% | T194T (ACG→ACA) ‡ | yidZ ← | predicted DNA‑binding transcriptional regulator |
RA | 2,481,134 | T→C | 27.5% | T194A (ACG→GCG) ‡ | yidZ ← | predicted DNA‑binding transcriptional regulator |
RA | 2,481,137 | G→C | 25.1% | Q193E (CAA→GAA) | yidZ ← | predicted DNA‑binding transcriptional regulator |
RA | 2,482,012 | A→G | 35.2% | T284T (ACT→ACC) | mdtL ← | multidrug efflux system protein |
RA | 2,482,042 | C→T | 31.5% | S274S (TCG→TCA) | mdtL ← | multidrug efflux system protein |
RA | 2,482,186 | C→T | 49.0% | P226P (CCG→CCA) | mdtL ← | multidrug efflux system protein |
RA | 2,482,189 | T→C | 45.5% | S225S (TCA→TCG) | mdtL ← | multidrug efflux system protein |
RA | 2,482,204 | A→G | 52.1% | T220T (ACT→ACC) | mdtL ← | multidrug efflux system protein |
RA | 2,482,270 | C→T | 27.4% | S198S (TCG→TCA) | mdtL ← | multidrug efflux system protein |
RA | 2,483,170 | C→T | 21.1% | L442L (CTG→CTA) | trmE ← | GTPase |
RA | 2,483,563 | C→A | 64.3% | V311V (GTG→GTT) | trmE ← | GTPase |
RA | 2,483,575 | T→C | 69.3% | T307T (ACA→ACG) | trmE ← | GTPase |
RA | 2,483,746 | A→G | 50.0% | T250T (ACT→ACC) | trmE ← | GTPase |
RA | 2,484,871 | C→A | 46.4% | S459S (TCG→TCT) | yidC ← | cytoplasmic insertase into membrane protein, Sec system |
RA | 2,485,588 | G→A | 37.6% | G220G (GGC→GGT) | yidC ← | cytoplasmic insertase into membrane protein, Sec system |
RA | 2,485,672 | C→G | 17.7% | S192S (TCG→TCC) ‡ | yidC ← | cytoplasmic insertase into membrane protein, Sec system |
RA | 2,485,674 | A→T | 17.5% | S192T (TCG→ACG) ‡ | yidC ← | cytoplasmic insertase into membrane protein, Sec system |
RA | 2,489,400 | A→G | 53.7% | A133A (GCA→GCG) | dnaN → | DNA polymerase III, beta subunit |
RA | 2,489,649 | A→G | 19.5% | V216V (GTA→GTG) | dnaN → | DNA polymerase III, beta subunit |
RA | 2,489,703 | C→G | 26.6% | S234S (TCC→TCG) | dnaN → | DNA polymerase III, beta subunit |
RA | 2,492,469 | G→T | 100% | L422L (CTG→CTT) | gyrB → | DNA gyrase, subunit B |
RA | 2,492,925 | A→G | 25.7% | A574A (GCA→GCG) | gyrB → | DNA gyrase, subunit B |
RA | 2,492,926 | T→C | 25.7% | L575L (TTG→CTG) | gyrB → | DNA gyrase, subunit B |
RA | 2,492,955 | A→G | 18.9% | V584V (GTA→GTG) | gyrB → | DNA gyrase, subunit B |
RA | 2,494,331 | A→G | 100% | V113V (GTA→GTG) | ibpA → | heat shock chaperone |
RA | 2,494,338 | T→C | 100% | L116L (TTG→CTG) | ibpA → | heat shock chaperone |
RA | 2,494,791 | C→T | 34.5% | P92S (CCA→TCA) ‡ | ibpB → | heat shock chaperone |
RA | 2,494,793 | A→T | 29.9% | P92P (CCA→CCT) ‡ | ibpB → | heat shock chaperone |
RA | 2,495,796 | G→A | 48.0% | T176T (ACC→ACT) | emrD ← | multidrug efflux system protein |
RA | 2,495,805 | A→G | 46.7% | A173A (GCT→GCC) | emrD ← | multidrug efflux system protein |
RA | 2,496,207 | G→A | 45.2% | N39N (AAC→AAT) | emrD ← | multidrug efflux system protein |
RA | 2,497,255 | C→T | 44.2% | intergenic (‑932/‑2) | emrD ← / → ivbL | multidrug efflux system protein/ilvB operon leader peptide |
RA | 2,497,272 | C→T | 42.4% | L6F (CTC→TTC) | ivbL → | ilvB operon leader peptide |
RA | 2,498,633 | T→G | 34.3% | V391V (GTT→GTG) | ilvB → | acetolactate synthase I, large subunit |
RA | 2,498,663 | T→C | 42.6% | A401A (GCT→GCC) | ilvB → | acetolactate synthase I, large subunit |
RA | 2,499,173 | C→T | 60.8% | D7D (GAC→GAT) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,179 | A→G | 64.0% | V9V (GTA→GTG) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,188 | G→A | 52.5% | E12E (GAG→GAA) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,275 | T→C | 100% | C41C (TGT→TGC) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,305 | T→C | 60.4% | H51H (CAT→CAC) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,356 | A→G | 32.8% | Q68Q (CAA→CAG) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,359 | C→A | 33.7% | I69I (ATC→ATA) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,362 | T→C | 33.7% | D70D (GAT→GAC) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,377 | C→G | 37.7% | V75V (GTC→GTG) | ilvN → | acetolactate synthase I, small subunit |
RA | 2,499,803 | A→G | 28.5% | A95A (GCA→GCG) | uhpA → | DNA‑binding response regulator in two‑component regulatory system wtih UhpB |
RA | 2,499,815 | T→C | 34.2% | L99L (CTT→CTC) | uhpA → | DNA‑binding response regulator in two‑component regulatory system wtih UhpB |
RA | 2,503,335 | C→T | 18.9% | S86S (TCC→TCT) | uhpT → | hexose phosphate transporter |
RA | 2,503,875 | C→T | 23.0% | F266F (TTC→TTT) | uhpT → | hexose phosphate transporter |
RA | 2,503,899 | A→G | 46.7% | V274V (GTA→GTG) | uhpT → | hexose phosphate transporter |
RA | 2,503,968 | G→A | 50.0% | A297A (GCG→GCA) | uhpT → | hexose phosphate transporter |
RA | 2,505,679 | T→A | 54.5% | G45G (GGT→GGA) | yicJ → | predicted transporter |
RA | 2,505,784 | T→G | 45.1% | R80R (CGT→CGG) | yicJ → | predicted transporter |
RA | 2,505,793 | A→G | 45.0% | V83V (GTA→GTG) | yicJ → | predicted transporter |
RA | 2,505,865 | C→A | 8.6% | G107G (GGC→GGA) | yicJ → | predicted transporter |
RA | 2,505,874 | C→T | 11.2% | I110I (ATC→ATT) | yicJ → | predicted transporter |
RA | 2,506,486 | C→T | 32.4% | P314P (CCC→CCT) | yicJ → | predicted transporter |
RA | 2,507,099 | T→C | 28.5% | L55L (TTG→CTG) | yicI → | predicted alpha‑glucosidase |
RA | 2,507,263 | C→T | 32.2% | S109S (AGC→AGT) | yicI → | predicted alpha‑glucosidase |
RA | 2,507,377 | C→A | 16.3% | R147R (CGC→CGA) | yicI → | predicted alpha‑glucosidase |
RA | 2,507,398 | T→G | 22.4% | L154L (CTT→CTG) | yicI → | predicted alpha‑glucosidase |
RA | 2,508,933 | A→G | 55.1% | N666S (AAC→AGC) | yicI → | predicted alpha‑glucosidase |
RA | 2,508,937 | T→C | 52.0% | T667T (ACT→ACC) | yicI → | predicted alpha‑glucosidase |
RA | 2,508,978 | T→C | 24.7% | V681A (GTG→GCG) | yicI → | predicted alpha‑glucosidase |
RA | 2,508,991 | C→T | 22.7% | G685G (GGC→GGT) | yicI → | predicted alpha‑glucosidase |
RA | 2,509,118 | G→A | 74.4% | A728T (GCG→ACG) | yicI → | predicted alpha‑glucosidase |
RA | 2,509,148 | C→T | 66.3% | L738L (CTG→TTG) | yicI → | predicted alpha‑glucosidase |
RA | 2,509,560 | T→G | 18.8% | T486T (ACA→ACC) | yicH ← | conserved hypothetical protein |
RA | 2,509,926 | C→T | 51.1% | P364P (CCG→CCA) | yicH ← | conserved hypothetical protein |
RA | 2,512,485 | C→T | 60.5% | A15A (GCG→GCA) | yicE ← | predicted transporter |
RA | 2,514,597 | G→A | 41.3% | G556G (GGC→GGT) | recG ← | ATP‑dependent DNA helicase |
RA | 2,514,636 | C→T | 54.3% | E543E (GAG→GAA) | recG ← | ATP‑dependent DNA helicase |
RA | 2,515,737 | G→T | 42.8% | T176T (ACC→ACA) | recG ← | ATP‑dependent DNA helicase |
RA | 2,517,413 | G→A | 54.0% | S554S (AGC→AGT) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,517,491 | T→G | 67.9% | G528G (GGA→GGC) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,517,725 | G→A | 64.3% | G450G (GGC→GGT) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,517,731 | A→T | 64.4% | A448A (GCT→GCA) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,517,761 | G→A | 61.4% | T438T (ACC→ACT) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,517,962 | A→G | 33.9% | S371S (AGT→AGC) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,518,142 | G→A | 41.0% | I311I (ATC→ATT) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,518,676 | G→A | 61.0% | I133I (ATC→ATT) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,518,697 | C→A | 26.3% | M126I (ATG→ATT) | spoT ← | bifunctional (p)ppGpp synthetase II and guanosine‑3',5'‑bis pyrophosphate 3'‑pyrophosphohydrolase |
RA | 2,520,256 | C→T | 28.3% | intergenic (‑210/‑48) | gmk ← / → ligB | guanylate kinase/DNA ligase, NAD(+)‑dependent |
RA | 2,520,257 | T→C | 28.4% | intergenic (‑211/‑47) | gmk ← / → ligB | guanylate kinase/DNA ligase, NAD(+)‑dependent |
RA | 2,522,082 | T→C | 65.2% | V173V (GTA→GTG) | yicG ← | conserved inner membrane protein |
RA | 2,522,085 | C→A | 66.1% | V172V (GTG→GTT) | yicG ← | conserved inner membrane protein |
RA | 2,522,265 | C→T | 36.9% | G112G (GGG→GGA) | yicG ← | conserved inner membrane protein |
RA | 2,522,289 | C→G | 23.6% | G104G (GGG→GGC) | yicG ← | conserved inner membrane protein |
RA | 2,522,857 | G→A | 22.6% | intergenic (‑257/+33) | yicG ← / ← dinD | conserved inner membrane protein/DNA‑damage‑inducible protein |
RA | 2,524,241 | G→T | 39.3% | V186V (GTC→GTA) ‡ | yicC ← | conserved hypothetical protein |
RA | 2,524,243 | C→T | 37.6% | V186I (GTC→ATC) ‡ | yicC ← | conserved hypothetical protein |
RA | 2,524,331 | G→A | 66.7% | I156I (ATC→ATT) | yicC ← | conserved hypothetical protein |
RA | 2,524,337 | T→C | 65.0% | A154A (GCA→GCG) ‡ | yicC ← | conserved hypothetical protein |
RA | 2,524,338 | G→A | 65.0% | A154V (GCA→GTA) ‡ | yicC ← | conserved hypothetical protein |
RA | 2,525,308 | G→T | 65.1% | pseudogene (384/688 nt) | rph → | Mutation in protein compared to W3110: p.Val138Ala; p.Val172Ile; p.Ile216Thr; p.Glu224_Glyfs*16 ECK3633:JW3618:b3643; ribonuclease PH |
RA | 2,525,940 | G→C | 54.2% | A78A (GCG→GCC) | pyrE → | orotate phosphoribosyltransferase |
RA | 2,526,697 | A→G | 48.2% | L95L (CTT→CTC) | ttk ← | division inhibitor |
RA | 2,526,702 | G→A | 48.5% | L94L (CTG→TTG) | ttk ← | division inhibitor |
RA | 2,526,709 | A→G | 48.5% | I91I (ATT→ATC) | ttk ← | division inhibitor |
RA | 2,526,757 | G→A | 27.4% | N75N (AAC→AAT) | ttk ← | division inhibitor |
RA | 2,530,970 | G→T | 48.9% | T216T (ACG→ACT) | mutM → | formamidopyrimidine/5‑formyluracil/ 5‑hydroxymethyluracil DNA glycosylase |
RA | 2,531,297 | C→A | 17.8% | L118L (CTG→CTT) | coaD ← | pantetheine‑phosphate adenylyltransferase |
RA | 2,534,716 | C→T | 30.2% | Y103Y (TAC→TAT) | rfaG → | glucosyltransferase I |
RA | 2,534,728 | T→A | 32.1% | V107V (GTT→GTA) | rfaG → | glucosyltransferase I |
RA | 2,534,734 | A→G | 31.4% | Q109Q (CAA→CAG) | rfaG → | glucosyltransferase I |
RA | 2,546,268 | A→G | 39.5% | S93S (TCT→TCC) | rfaF ← | ADP‑heptose:LPS heptosyltransferase II |
RA | 2,546,283 | G→A | 34.7% | P88P (CCC→CCT) | rfaF ← | ADP‑heptose:LPS heptosyltransferase II |
RA | 2,546,910 | G→A | 34.6% | N193N (AAC→AAT) | rfaD ← | ADP‑L‑glycero‑D‑mannoheptose‑6‑epimerase, NAD(P)‑binding |
RA | 2,547,132 | G→A | 71.5% | T119T (ACC→ACT) | rfaD ← | ADP‑L‑glycero‑D‑mannoheptose‑6‑epimerase, NAD(P)‑binding |
RA | 2,547,147 | A→G | 68.3% | A114A (GCT→GCC) | rfaD ← | ADP‑L‑glycero‑D‑mannoheptose‑6‑epimerase, NAD(P)‑binding |
RA | 2,547,150 | G→A | 66.7% | Y113Y (TAC→TAT) | rfaD ← | ADP‑L‑glycero‑D‑mannoheptose‑6‑epimerase, NAD(P)‑binding |
RA | 2,547,168 | A→G | 51.8% | R107R (CGT→CGC) | rfaD ← | ADP‑L‑glycero‑D‑mannoheptose‑6‑epimerase, NAD(P)‑binding |
RA | 2,547,177 | G→A | 49.1% | C104C (TGC→TGT) | rfaD ← | ADP‑L‑glycero‑D‑mannoheptose‑6‑epimerase, NAD(P)‑binding |
RA | 2,551,684 | A→G | 51.2% | E97E (GAA→GAG) | yibD → | predicted glycosyl transferase |
RA | 2,552,329 | C→G | 31.5% | V312V (GTC→GTG) | yibD → | predicted glycosyl transferase |
RA | 2,554,362 | G→C | 52.7% | L92L (CTC→CTG) | envC ← | protease with a role in cell division |
RA | 2,554,371 | G→A | 53.8% | L89L (CTC→CTT) | envC ← | protease with a role in cell division |
RA | 2,555,847 | G→A | 31.6% | G123G (GGC→GGT) | gpmI ← | phosphoglycero mutase III, cofactor‑independent |
RA | 2,555,850 | G→A | 31.6% | G122G (GGC→GGT) | gpmI ← | phosphoglycero mutase III, cofactor‑independent |
RA | 2,555,880 | C→T | 53.6% | A112A (GCG→GCA) | gpmI ← | phosphoglycero mutase III, cofactor‑independent |
RA | 2,556,062 | G→A | 27.9% | L52L (CTG→TTG) | gpmI ← | phosphoglycero mutase III, cofactor‑independent |
RA | 2,556,078 | T→C | 26.8% | L46L (CTA→CTG) | gpmI ← | phosphoglycero mutase III, cofactor‑independent |
RA | 2,557,493 | C→T | 48.5% | S49S (TCC→TCT) | secB → | protein export chaperone |
RA | 2,557,631 | G→A | 18.6% | A95A (GCG→GCA) | secB → | protein export chaperone |
RA | 2,557,643 | A→C | 14.3% | G99G (GGA→GGC) | secB → | protein export chaperone |
RA | 2,558,404 | T→C | 66.8% | V197V (GTT→GTC) | gpsA → | glycerol‑3‑phosphate dehydrogenase (NAD+) |
RA | 2,558,416 | T→C | 59.2% | G201G (GGT→GGC) | gpsA → | glycerol‑3‑phosphate dehydrogenase (NAD+) |
RA | 2,558,446 | T→C | 40.0% | G211G (GGT→GGC) | gpsA → | glycerol‑3‑phosphate dehydrogenase (NAD+) |
RA | 2,558,488 | A→G | 32.0% | E225E (GAA→GAG) | gpsA → | glycerol‑3‑phosphate dehydrogenase (NAD+) |
RA | 2,559,844 | T→C | 31.6% | V139V (GTA→GTG) | yibK ← | predicted rRNA methylase |
RA | 2,561,280 | T→C | 32.7% | P123P (CCA→CCG) | lldD ← | L‑lactate dehydrogenase, FMN‑linked |
RA | 2,561,283 | G→A | 32.3% | R122R (CGC→CGT) | lldD ← | L‑lactate dehydrogenase, FMN‑linked |
RA | 2,561,286 | C→T | 32.3% | K121K (AAG→AAA) | lldD ← | L‑lactate dehydrogenase, FMN‑linked |
RA | 2,561,292 | G→A | 31.8% | A119A (GCC→GCT) | lldD ← | L‑lactate dehydrogenase, FMN‑linked |
RA | 2,561,295 | T→C | 31.9% | P118P (CCA→CCG) | lldD ← | L‑lactate dehydrogenase, FMN‑linked |
RA | 2,561,298 | C→A | 31.9% | A117A (GCG→GCT) | lldD ← | L‑lactate dehydrogenase, FMN‑linked |
RA | 2,561,301 | G→C | 31.9% | V116V (GTC→GTG) | lldD ← | L‑lactate dehydrogenase, FMN‑linked |
RA | 2,561,935 | G→A | 56.5% | L163L (CTG→TTG) | lldR ← | DNA‑binding transcriptional repressor |
RA | 2,561,939 | G→A | 66.3% | I161I (ATC→ATT) | lldR ← | DNA‑binding transcriptional repressor |
RA | 2,561,951 | G→A | 65.4% | A157A (GCC→GCT) | lldR ← | DNA‑binding transcriptional repressor |
RA | 2,562,227 | G→A | 61.9% | R65R (CGC→CGT) | lldR ← | DNA‑binding transcriptional repressor |
RA | 2,562,245 | G→A | 41.7% | G59G (GGC→GGT) | lldR ← | DNA‑binding transcriptional repressor |
RA | 2,562,251 | A→G | 41.1% | S57S (AGT→AGC) | lldR ← | DNA‑binding transcriptional repressor |
RA | 2,562,254 | C→T | 41.1% | V56V (GTG→GTA) | lldR ← | DNA‑binding transcriptional repressor |
RA | 2,562,263 | T→C | 44.0% | A53A (GCA→GCG) | lldR ← | DNA‑binding transcriptional repressor |
RA | 2,563,066 | A→G | 19.9% | N337N (AAT→AAC) | lldP ← | L‑lactate permease |
RA | 2,563,090 | G→A | 18.2% | G329G (GGC→GGT) | lldP ← | L‑lactate permease |
RA | 2,563,093 | A→G | 18.3% | G328G (GGT→GGC) | lldP ← | L‑lactate permease |
RA | 2,563,096 | C→T | 19.4% | S327S (TCG→TCA) | lldP ← | L‑lactate permease |
RA | 2,563,099 | T→A | 22.3% | A326A (GCA→GCT) | lldP ← | L‑lactate permease |
RA | 2,563,240 | A→G | 53.2% | D279D (GAT→GAC) | lldP ← | L‑lactate permease |
RA | 2,563,246 | A→G | 45.2% | F277F (TTT→TTC) | lldP ← | L‑lactate permease |
RA | 2,563,249 | A→G | 45.2% | R276R (CGT→CGC) | lldP ← | L‑lactate permease |
RA | 2,563,258 | A→G | 52.9% | R273R (CGT→CGC) | lldP ← | L‑lactate permease |
RA | 2,566,476 | T→C | 40.7% | A192A (GCA→GCG) | mtlD ← | mannitol‑1‑phosphate dehydrogenase, NAD(P)‑binding |
RA | 2,566,491 | C→G | 28.9% | T187T (ACG→ACC) | mtlD ← | mannitol‑1‑phosphate dehydrogenase, NAD(P)‑binding |
RA | 2,569,387 | C→T | 36.0% | intergenic (‑193/‑344) | mtlA ← / → yibI | fused mannitol‑specific PTS enzyme IIABC components/predicted inner membrane protein |
RA | 2,569,389 | T→C | 35.1% | intergenic (‑195/‑342) | mtlA ← / → yibI | fused mannitol‑specific PTS enzyme IIABC components/predicted inner membrane protein |
RA | 2,569,401 | C→T | 27.2% | intergenic (‑207/‑330) | mtlA ← / → yibI | fused mannitol‑specific PTS enzyme IIABC components/predicted inner membrane protein |
RA | 2,571,096 | A→C | 63.4% | D334A (GAT→GCT) | yibH → | hypothetical protein |
RA | 2,574,961 | T→C | 58.4% | R212R (CGT→CGC) | glyS → | glycine tRNA synthetase, beta subunit |
RA | 2,575,573 | T→C | 44.3% | Y416Y (TAT→TAC) | glyS → | glycine tRNA synthetase, beta subunit |
RA | 2,575,876 | T→C | 59.1% | N517N (AAT→AAC) | glyS → | glycine tRNA synthetase, beta subunit |
RA | 2,575,885 | A→G | 43.8% | V520V (GTA→GTG) | glyS → | glycine tRNA synthetase, beta subunit |
RA | 2,576,572 | T→C | 59.0% | E509E (GAA→GAG) | treF ← | cytoplasmic trehalase |
RA | 2,582,329 | T→C | 24.6% | V150V (GTT→GTC) | gadX → | DNA‑binding transcriptional dual regulator |
RA | 2,582,398 | T→C | 16.6% | S173S (AGT→AGC) | gadX → | DNA‑binding transcriptional dual regulator |
RA | 2,582,427 | A→G | 39.2% | E183G (GAG→GGG) ‡ | gadX → | DNA‑binding transcriptional dual regulator |
RA | 2,582,428 | G→T | 39.6% | E183D (GAG→GAT) ‡ | gadX → | DNA‑binding transcriptional dual regulator |
RA | 2,582,431 | A→G | 44.4% | T184T (ACA→ACG) | gadX → | DNA‑binding transcriptional dual regulator |
RA | 2,582,461 | A→G | 44.6% | R194R (AGA→AGG) | gadX → | DNA‑binding transcriptional dual regulator |
RA | 2,582,467 | A→G | 51.0% | Q196Q (CAA→CAG) | gadX → | DNA‑binding transcriptional dual regulator |
RA | 2,583,233 | T→A | 44.8% | D54E (GAT→GAA) | gadW → | DNA‑binding transcriptional activator |
RA | 2,583,273 | C→T | 35.0% | L68L (CTA→TTA) ‡ | gadW → | DNA‑binding transcriptional activator |
RA | 2,583,275 | A→G | 37.7% | L68L (CTA→CTG) ‡ | gadW → | DNA‑binding transcriptional activator |
RA | 2,584,463 | T→C | 45.6% | K938K (AAA→AAG) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,584,697 | T→C | 40.8% | L860L (CTA→CTG) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,585,609 | G→A | 70.3% | R556R (CGC→CGT) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,585,696 | A→G | 46.6% | D527D (GAT→GAC) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,585,708 | T→C | 50.1% | Q523Q (CAA→CAG) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,586,227 | T→G | 77.7% | L350L (CTA→CTC) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,586,248 | T→C | 52.7% | T343T (ACA→ACG) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,587,031 | A→G | 24.9% | S82S (AGT→AGC) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,587,208 | A→G | 22.6% | G23G (GGT→GGC) | mdtF ← | multidrug transporter, RpoS‑dependent |
RA | 2,587,673 | T→C | 58.5% | T262T (ACA→ACG) | mdtE ← | multidrug resistance efflux transporter |
RA | 2,587,708 | T→C | 46.2% | S251G (AGC→GGC) | mdtE ← | multidrug resistance efflux transporter |
RA | 2,587,712 | G→A | 45.4% | R249R (CGC→CGT) | mdtE ← | multidrug resistance efflux transporter |
RA | 2,588,902 | A→G | 30.1% | N141N (AAT→AAC) | gadE ← | DNA‑binding transcriptional activator |
RA | 2,588,911 | C→T | 16.3% | S138S (TCG→TCA) | gadE ← | DNA‑binding transcriptional activator |
RA | 2,589,911 | T→C | 29.0% | intergenic (‑587/+212) | gadE ← / ← hdeD | DNA‑binding transcriptional activator/acid‑resistance membrane protein |
RA | 2,591,000 | T→A | 36.0% | V17V (GTT→GTA) | hdeA → | stress response protein acid‑resistance protein |
RA | 2,591,021 | G→A | 47.0% | A24A (GCG→GCA) | hdeA → | stress response protein acid‑resistance protein |
RA | 2,591,550 | C→A | 46.7% | T51T (ACC→ACA) | hdeB → | acid‑resistance protein |
RA | 2,591,553 | G→A | 47.9% | P52P (CCG→CCA) | hdeB → | acid‑resistance protein |
RA | 2,591,559 | A→G | 61.2% | A54A (GCA→GCG) | hdeB → | acid‑resistance protein |
RA | 2,593,801 | T→C | 31.3% | intergenic (‑72/+1069) | slp ← / ← arsC | outer membrane lipoprotein/arsenate reductase |
RA | 2,599,311 | C→T | 58.2% | P279P (CCG→CCA) | yhiR ← | predicted DNA (exogenous) processing protein |
RA | 2,600,955 | C→T | 50.0% | A202A (GCC→GCT) | prlC → | oligopeptidase A |
RA | 2,601,306 | T→C | 26.1% | F319F (TTT→TTC) | prlC → | oligopeptidase A |
RA | 2,601,336 | G→A | 39.9% | L329L (TTG→TTA) | prlC → | oligopeptidase A |
RA | 2,601,339 | G→A | 41.4% | Q330Q (CAG→CAA) | prlC → | oligopeptidase A |
RA | 2,601,372 | A→G | 40.6% | Q341Q (CAA→CAG) | prlC → | oligopeptidase A |
RA | 2,601,906 | T→C | 100% | S519S (TCT→TCC) | prlC → | oligopeptidase A |
RA | 2,604,020 | C→T | 37.4% | V217V (GTG→GTA) | yhiP ← | predicted transporter |
RA | 2,604,035 | G→A | 40.4% | S212S (AGC→AGT) | yhiP ← | predicted transporter |
RA | 2,604,047 | T→C | 50.0% | P208P (CCA→CCG) | yhiP ← | predicted transporter |
RA | 2,604,413 | A→G | 53.9% | L86L (CTT→CTC) | yhiP ← | predicted transporter |
RA | 2,604,434 | C→T | 55.3% | G79G (GGG→GGA) | yhiP ← | predicted transporter |
RA | 2,605,106 | A→G | 34.5% | L106L (TTG→CTG) | uspA ← | universal stress global response regulator |
RA | 2,605,140 | A→T | 57.1% | V94V (GTT→GTA) | uspA ← | universal stress global response regulator |
RA | 2,605,152 | G→A | 44.0% | D90D (GAC→GAT) | uspA ← | universal stress global response regulator |
RA | 2,606,682 | G→A | 32.8% | R403R (CGC→CGT) | pitA ← | phosphate transporter, low‑affinity |
RA | 2,606,922 | G→A | 23.9% | T323T (ACC→ACT) | pitA ← | phosphate transporter, low‑affinity |
RA | 2,606,931 | A→G | 38.8% | G320G (GGT→GGC) | pitA ← | phosphate transporter, low‑affinity |
RA | 2,608,347 | C→A | 32.5% | T85T (ACG→ACT) | nikR ← | DNA‑binding transcriptional regulator, Ni‑binding |
RA | 2,608,350 | G→A | 32.7% | A84A (GCC→GCT) | nikR ← | DNA‑binding transcriptional regulator, Ni‑binding |
RA | 2,608,353 | G→A | 32.7% | V83V (GTC→GTT) | nikR ← | DNA‑binding transcriptional regulator, Ni‑binding |
RA | 2,608,356 | G→T | 31.4% | S82S (TCC→TCA) | nikR ← | DNA‑binding transcriptional regulator, Ni‑binding |
RA | 2,608,362 | G→A | 30.3% | D80D (GAC→GAT) | nikR ← | DNA‑binding transcriptional regulator, Ni‑binding |
RA | 2,609,041 | A→C | 51.3% | S125A (TCC→GCC) | nikE ← | nickel transporter subunit |
RA | 2,609,051 | T→C | 53.9% | S121S (TCA→TCG) | nikE ← | nickel transporter subunit |
RA | 2,609,188 | G→A | 43.1% | L76L (CTG→TTG) | nikE ← | nickel transporter subunit |
RA | 2,609,767 | C→G | 35.7% | L136L (CTG→CTC) | nikD ← | nickel transporter subunit |
RA | 2,612,173 | T→C | 47.3% | K450K (AAA→AAG) | nikA ← | nickel transporter subunit |
RA | 2,612,185 | T→A | 45.6% | G446G (GGA→GGT) | nikA ← | nickel transporter subunit |
RA | 2,612,212 | T→C | 30.8% | S437S (TCA→TCG) | nikA ← | nickel transporter subunit |
RA | 2,612,473 | C→T | 50.0% | A350A (GCG→GCA) | nikA ← | nickel transporter subunit |
RA | 2,612,535 | T→G | 68.2% | S330R (AGC→CGC) | nikA ← | nickel transporter subunit |
RA | 2,612,737 | G→A | 69.2% | T262T (ACC→ACT) | nikA ← | nickel transporter subunit |
RA | 2,612,752 | A→G | 58.4% | N257N (AAT→AAC) | nikA ← | nickel transporter subunit |
RA | 2,613,717 | A→T | 67.4% | L168L (CTT→CTA) | acpT ← | holo‑(acyl carrier protein) synthase 2 |
RA | 2,613,749 | G→T | 73.1% | H158N (CAC→AAC) | acpT ← | holo‑(acyl carrier protein) synthase 2 |
RA | 2,613,876 | A→G | 25.9% | A115A (GCT→GCC) | acpT ← | holo‑(acyl carrier protein) synthase 2 |
RA | 2,614,173 | T→A | 44.9% | P16P (CCA→CCT) | acpT ← | holo‑(acyl carrier protein) synthase 2 |
RA | 2,615,623 | A→G | 57.2% | G56G (GGA→GGG) | yhhS → | predicted transporter |
RA | 2,615,665 | C→T | 58.5% | R70R (CGC→CGT) | yhhS → | predicted transporter |
RA | 2,615,866 | A→G | 19.5% | L137L (CTA→CTG) | yhhS → | predicted transporter |
RA | 2,615,872 | C→T | 18.3% | G139G (GGC→GGT) | yhhS → | predicted transporter |
RA | 2,615,887 | C→T | 13.8% | G144G (GGC→GGT) | yhhS → | predicted transporter |
RA | 2,616,025 | G→A | 100% | A190A (GCG→GCA) | yhhS → | predicted transporter |
RA | 2,616,163 | C→T | 37.0% | V236V (GTC→GTT) | yhhS → | predicted transporter |
RA | 2,617,685 | C→T | 35.1% | Q96Q (CAG→CAA) | yhhQ ← | conserved inner membrane protein |
RA | 2,617,691 | G→T | 32.0% | S94S (TCC→TCA) | yhhQ ← | conserved inner membrane protein |
RA | 2,617,694 | A→C | 31.7% | G93G (GGT→GGG) | yhhQ ← | conserved inner membrane protein |
RA | 2,619,653 | A→G | 50.7% | A362A (GCT→GCC) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,619,671 | G→T | 57.8% | P356P (CCC→CCA) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,619,677 | A→G | 57.9% | Y354Y (TAT→TAC) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,619,680 | G→A | 39.7% | I353I (ATC→ATT) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,619,848 | T→C | 23.6% | A297A (GCA→GCG) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,619,860 | C→A | 30.5% | P293P (CCG→CCT) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,619,872 | G→T | 49.2% | G289G (GGC→GGA) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,619,884 | G→A | 61.8% | S285S (AGC→AGT) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,620,337 | T→A | 35.7% | L134L (CTA→CTT) | zntA ← | zinc, cobalt and lead efflux system |
RA | 2,623,335 | T→C | 50.7% | A130A (GCT→GCC) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,623,632 | G→A | 48.0% | E229E (GAG→GAA) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,623,644 | G→A | 42.9% | E233E (GAG→GAA) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,623,650 | T→G | 41.2% | L235L (CTT→CTG) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,623,815 | C→T | 76.0% | G290G (GGC→GGT) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,623,819 | G→A | 77.4% | A292T (GCG→ACG) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,623,827 | T→C | 100% | F294F (TTT→TTC) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,624,094 | A→C | 42.6% | T383T (ACA→ACC) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,624,109 | G→A | 32.7% | Q388Q (CAG→CAA) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,624,178 | G→T | 47.2% | A411A (GCG→GCT) | ftsY → | fused Signal Recognition Particle (SRP) receptor |
RA | 2,625,741 | T→C | 61.4% | R213R (CGT→CGC) | ftsX → | predicted transporter subunit |
RA | 2,627,107 | A→G | 35.7% | E234E (GAA→GAG) | rpoH → | RNA polymerase, sigma 32 (sigma H) factor |
RA | 2,627,110 | C→T | 37.4% | R235R (CGC→CGT) | rpoH → | RNA polymerase, sigma 32 (sigma H) factor |
RA | 2,627,113 | C→T | 38.4% | S236S (AGC→AGT) | rpoH → | RNA polymerase, sigma 32 (sigma H) factor |
RA | 2,627,453 | T→C | 31.7% | intergenic (+193/‑78) | rpoH → / → livJ | RNA polymerase, sigma 32 (sigma H) factor/leucine/isoleucine/valine transporter subunit |
RA | 2,627,454 | C→T | 32.1% | intergenic (+194/‑77) | rpoH → / → livJ | RNA polymerase, sigma 32 (sigma H) factor/leucine/isoleucine/valine transporter subunit |
RA | 2,627,456 | T→C | 30.0% | intergenic (+196/‑75) | rpoH → / → livJ | RNA polymerase, sigma 32 (sigma H) factor/leucine/isoleucine/valine transporter subunit |
RA | 2,627,458 | C→T | 30.6% | intergenic (+198/‑73) | rpoH → / → livJ | RNA polymerase, sigma 32 (sigma H) factor/leucine/isoleucine/valine transporter subunit |
RA | 2,627,701 | C→T | 35.2% | N57N (AAC→AAT) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,627,710 | C→T | 31.4% | G60G (GGC→GGT) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,627,713 | C→T | 31.4% | G61G (GGC→GGT) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,627,716 | T→C | 27.3% | I62I (ATT→ATC) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,241 | C→T | 100% | R237R (CGC→CGT) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,259 | T→C | 100% | T243T (ACT→ACC) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,280 | T→C | 73.3% | G250G (GGT→GGC) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,292 | T→C | 63.8% | V254V (GTT→GTC) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,493 | T→G | 21.7% | A321A (GCT→GCG) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,496 | A→G | 21.6% | E322E (GAA→GAG) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,502 | C→T | 19.8% | A324A (GCC→GCT) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,523 | C→G | 30.6% | S331S (TCC→TCG) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,526 | G→T | 30.1% | V332V (GTG→GTT) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,532 | C→G | 24.2% | T334T (ACC→ACG) | livJ → | leucine/isoleucine/valine transporter subunit |
RA | 2,628,858 | C→T | 53.6% | G116G (GGG→GGA) | yhhK ← | conserved hypothetical protein |
RA | 2,628,867 | C→T | 51.7% | Q113Q (CAG→CAA) ‡ | yhhK ← | conserved hypothetical protein |
RA | 2,628,868 | T→C | 47.7% | Q113R (CAG→CGG) ‡ | yhhK ← | conserved hypothetical protein |
RA | 2,628,879 | C→T | 33.2% | T109T (ACG→ACA) | yhhK ← | conserved hypothetical protein |
RA | 2,630,947 | A→C | 25.5% | S54S (TCA→TCC) | livH → | leucine/isoleucine/valine transporter subunit |
RA | 2,630,965 | G→A | 26.0% | A60A (GCG→GCA) | livH → | leucine/isoleucine/valine transporter subunit |
RA | 2,631,436 | G→A | 59.0% | A217A (GCG→GCA) | livH → | leucine/isoleucine/valine transporter subunit |
RA | 2,631,652 | T→C | 38.8% | I289I (ATT→ATC) | livH → | leucine/isoleucine/valine transporter subunit |
RA | 2,631,750 | G→T | 26.4% | A14A (GCG→GCT) | livM → | leucine/isoleucine/valine transporter subunit |
RA | 2,633,582 | C→T | 57.2% | R200R (CGC→CGT) | livG → | leucine/isoleucine/valine transporter subunit |
RA | 2,633,585 | T→C | 59.7% | N201N (AAT→AAC) | livG → | leucine/isoleucine/valine transporter subunit |
RA | 2,634,911 | G→T | 31.4% | A16A (GCG→GCT) | ugpB → | glycerol‑3‑phosphate transporter subunit |
RA | 2,634,919 | G→C | 53.1% | G19A (GGG→GCG) ‡ | ugpB → | glycerol‑3‑phosphate transporter subunit |
RA | 2,634,920 | G→A | 53.1% | G19G (GGG→GGA) ‡ | ugpB → | glycerol‑3‑phosphate transporter subunit |
RA | 2,635,184 | G→A | 44.4% | V107V (GTG→GTA) | ugpB → | glycerol‑3‑phosphate transporter subunit |
RA | 2,635,532 | G→T | 61.3% | L223L (CTG→CTT) | ugpB → | glycerol‑3‑phosphate transporter subunit |
RA | 2,635,541 | T→C | 64.4% | N226N (AAT→AAC) | ugpB → | glycerol‑3‑phosphate transporter subunit |
RA | 2,636,862 | C→T | 73.7% | D195D (GAC→GAT) | ugpA → | glycerol‑3‑phosphate transporter subunit |
RA | 2,636,865 | T→G | 45.2% | G196G (GGT→GGG) | ugpA → | glycerol‑3‑phosphate transporter subunit |
RA | 2,636,937 | A→G | 60.8% | V220V (GTA→GTG) | ugpA → | glycerol‑3‑phosphate transporter subunit |
RA | 2,637,188 | G→A | 68.1% | T9T (ACG→ACA) | ugpE → | glycerol‑3‑phosphate transporter subunit |
RA | 2,638,461 | C→T | 54.8% | R151R (CGC→CGT) | ugpC → | glycerol‑3‑phosphate transporter subunit |
RA | 2,638,464 | T→G | 60.7% | D152E (GAT→GAG) | ugpC → | glycerol‑3‑phosphate transporter subunit |
RA | 2,638,470 | G→A | 67.8% | A154A (GCG→GCA) | ugpC → | glycerol‑3‑phosphate transporter subunit |
RA | 2,638,599 | A→G | 18.3% | E197E (GAA→GAG) | ugpC → | glycerol‑3‑phosphate transporter subunit |
RA | 2,639,432 | C→T | 33.9% | T119T (ACC→ACT) | ugpQ → | glycerophosphodiester phosphodiesterase, cytosolic |
RA | 2,639,637 | A→C | 68.8% | I188L (ATT→CTT) | ugpQ → | glycerophosphodiester phosphodiesterase, cytosolic |
RA | 2,640,057 | A→G | 18.3% | L64L (TTG→CTG) | yhhA ← | conserved hypothetical protein |
RA | 2,640,061 | A→C | 17.6% | T62T (ACT→ACG) | yhhA ← | conserved hypothetical protein |
RA | 2,640,112 | A→C | 24.4% | T45T (ACT→ACG) | yhhA ← | conserved hypothetical protein |
RA | 2,640,121 | C→T | 36.1% | Q42Q (CAG→CAA) | yhhA ← | conserved hypothetical protein |
RA | 2,640,124 | G→A | 35.1% | T41T (ACC→ACT) | yhhA ← | conserved hypothetical protein |
RA | 2,640,148 | T→G | 24.3% | I33I (ATA→ATC) | yhhA ← | conserved hypothetical protein |
RA | 2,641,322 | C→T | 50.7% | S319S (AGC→AGT) | ggt → | gamma‑glutamyltranspeptidase |
RA | 2,641,712 | T→C | 68.1% | G449G (GGT→GGC) | ggt → | gamma‑glutamyltranspeptidase |
RA | 2,641,871 | C→A | 78.6% | G502G (GGC→GGA) | ggt → | gamma‑glutamyltranspeptidase |
RA | 2,641,872 | T→A | 78.6% | L503M (TTG→ATG) | ggt → | gamma‑glutamyltranspeptidase |
RA | 2,642,037 | G→A | 25.5% | V558I (GTT→ATT) | ggt → | gamma‑glutamyltranspeptidase |
RA | 2,642,043 | C→T | 58.2% | P560S (CCG→TCG) | ggt → | gamma‑glutamyltranspeptidase |
RA | 2,642,048 | C→T | 64.0% | D561D (GAC→GAT) | ggt → | gamma‑glutamyltranspeptidase |
RA | 2,642,710 | C→A | 42.8% | S114S (TCC→TCA) | gntR → | DNA‑binding transcriptional repressor |
RA | 2,642,719 | C→A | 28.1% | S117S (TCC→TCA) | gntR → | DNA‑binding transcriptional repressor |
RA | 2,643,149 | C→T | 34.7% | L261L (CTG→TTG) | gntR → | DNA‑binding transcriptional repressor |
RA | 2,643,157 | A→G | 27.5% | L263L (TTA→TTG) | gntR → | DNA‑binding transcriptional repressor |
RA | 2,643,235 | C→T | 23.5% | S289S (AGC→AGT) | gntR → | DNA‑binding transcriptional repressor |
RA | 2,645,851 | A→G | 35.4% | G58G (GGT→GGC) | yhgN ← | predicted antibiotic transporter |
RA | 2,645,878 | C→A | 29.2% | L49L (CTG→CTT) | yhgN ← | predicted antibiotic transporter |
RA | 2,646,646 | T→C | 35.0% | L144L (TTG→CTG) | asd → | aspartate‑semialdehyde dehydrogenase, NAD(P)‑binding |
RA | 2,647,443 | T→G | 15.0% | intergenic (+123/‑150) | asd → / → glgB | aspartate‑semialdehyde dehydrogenase, NAD(P)‑binding/1,4‑alpha‑glucan branching enzyme |
RA | 2,647,451 | T→C | 16.2% | intergenic (+131/‑142) | asd → / → glgB | aspartate‑semialdehyde dehydrogenase, NAD(P)‑binding/1,4‑alpha‑glucan branching enzyme |
RA | 2,647,670 | A→G | 48.9% | G26G (GGA→GGG) | glgB → | 1,4‑alpha‑glucan branching enzyme |
RA | 2,647,949 | G→A | 55.8% | L119L (CTG→CTA) | glgB → | 1,4‑alpha‑glucan branching enzyme |
RA | 2,647,952 | C→T | 55.8% | R120R (CGC→CGT) | glgB → | 1,4‑alpha‑glucan branching enzyme |
RA | 2,648,012 | C→T | 100% | F140F (TTC→TTT) | glgB → | 1,4‑alpha‑glucan branching enzyme |
RA | 2,648,441 | C→T | 18.6% | H283H (CAC→CAT) | glgB → | 1,4‑alpha‑glucan branching enzyme |
RA | 2,648,447 | A→G | 33.3% | E285E (GAA→GAG) | glgB → | 1,4‑alpha‑glucan branching enzyme |
RA | 2,648,456 | C→T | 43.5% | P288P (CCC→CCT) | glgB → | 1,4‑alpha‑glucan branching enzyme |
RA | 2,649,084 | G→A | 36.6% | V498I (GTT→ATT) | glgB → | 1,4‑alpha‑glucan branching enzyme |
RA | 2,652,018 | T→C | 56.1% | I84I (ATT→ATC) | glgC → | glucose‑1‑phosphate adenylyltransferase |
RA | 2,654,894 | A→C | 54.4% | G127G (GGA→GGC) | glgP → | glycogen phosphorylase |
RA | 2,654,915 | T→C | 44.4% | L134L (CTT→CTC) | glgP → | glycogen phosphorylase |
RA | 2,656,058 | T→G | 38.8% | A515A (GCT→GCG) | glgP → | glycogen phosphorylase |
RA | 2,656,097 | A→G | 37.8% | A528A (GCA→GCG) | glgP → | glycogen phosphorylase |
RA | 2,656,205 | T→C | 47.9% | H564H (CAT→CAC) | glgP → | glycogen phosphorylase |
RA | 2,656,211 | T→C | 46.0% | I566I (ATT→ATC) | glgP → | glycogen phosphorylase |
RA | 2,658,048 | T→G | 78.9% | A345A (GCA→GCC) | glpD ← | sn‑glycerol‑3‑phosphate dehydrogenase, aerobic, FAD/NAD(P)‑binding |
RA | 2,658,057 | A→G | 79.0% | N342N (AAT→AAC) ‡ | glpD ← | sn‑glycerol‑3‑phosphate dehydrogenase, aerobic, FAD/NAD(P)‑binding |
RA | 2,658,059 | T→C | 79.0% | N342D (AAT→GAT) ‡ | glpD ← | sn‑glycerol‑3‑phosphate dehydrogenase, aerobic, FAD/NAD(P)‑binding |
RA | 2,659,376 | A→G | 18.4% | G35G (GGA→GGG) | glpE → | thiosulfate:cyanide sulfurtransferase |
RA | 2,660,342 | C→T | 37.8% | L234L (CTG→TTG) | glpG → | predicted intramembrane serine protease |
RA | 2,660,954 | G→A | 48.5% | A155A (GCG→GCA) | glpR → | DNA‑binding transcriptional repressor |
RA | 2,661,032 | G→A | 70.6% | L181L (CTG→CTA) | glpR → | DNA‑binding transcriptional repressor |
RA | 2,662,258 | G→A | 100% | P191S (CCC→TCC) | rtcR ← | sigma 54‑dependent transcriptional regulator of rtcBA expression |
RA | 2,662,691 | C→T | 39.7% | L46L (TTG→TTA) | rtcR ← | sigma 54‑dependent transcriptional regulator of rtcBA expression |
RA | 2,662,700 | T→C | 32.5% | R43R (CGA→CGG) | rtcR ← | sigma 54‑dependent transcriptional regulator of rtcBA expression |
RA | 2,662,709 | G→A | 32.0% | V40V (GTC→GTT) | rtcR ← | sigma 54‑dependent transcriptional regulator of rtcBA expression |
RA | 2,663,379 | T→C | 48.3% | G121G (GGT→GGC) | rtcB → | conserved hypothetical protein |
RA | 2,663,382 | C→A | 45.8% | A122A (GCC→GCA) | rtcB → | conserved hypothetical protein |
RA | 2,663,394 | A→G | 62.3% | P126P (CCA→CCG) | rtcB → | conserved hypothetical protein |
RA | 2,663,412 | T→G | 52.3% | A132A (GCT→GCG) | rtcB → | conserved hypothetical protein |
RA | 2,663,427 | T→G | 47.2% | L137L (CTT→CTG) | rtcB → | conserved hypothetical protein |
RA | 2,663,430 | A→G | 38.1% | E138E (GAA→GAG) | rtcB → | conserved hypothetical protein |
RA | 2,664,111 | A→G | 26.8% | E365E (GAA→GAG) | rtcB → | conserved hypothetical protein |
RA | 2,664,129 | A→G | 29.4% | E371E (GAA→GAG) | rtcB → | conserved hypothetical protein |
RA | 2,664,355 | A→G | 100% | S37G (AGC→GGC) | rtcA → | RNA 3'‑terminal phosphate cyclase |
RA | 2,665,357 | A→G | 24.9% | D885D (GAT→GAC) ‡ | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,665,358 | T→G | 25.0% | D885A (GAT→GCT) ‡ | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,665,363 | G→A | 24.6% | R883R (CGC→CGT) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,665,366 | A→G | 15.6% | H882H (CAT→CAC) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,665,372 | C→G | 15.4% | V880V (GTG→GTC) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,665,375 | G→A | 14.8% | G879G (GGC→GGT) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,665,387 | A→G | 14.6% | Y875Y (TAT→TAC) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,665,537 | A→C | 31.2% | P825P (CCT→CCG) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,665,765 | G→A | 29.8% | R749R (CGC→CGT) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,666,038 | A→C | 36.1% | I658M (ATT→ATG) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,666,200 | C→T | 43.0% | Q604Q (CAG→CAA) | malT ← | DNA‑binding transcriptional activator, maltotriose‑ATP‑binding |
RA | 2,668,916 | T→C | 46.4% | N98N (AAT→AAC) | malP → | maltodextrin phosphorylase |
RA | 2,668,922 | G→T | 35.3% | T100T (ACG→ACT) | malP → | maltodextrin phosphorylase |
RA | 2,668,929 | C→T | 34.4% | L103L (CTG→TTG) | malP → | maltodextrin phosphorylase |
RA | 2,668,958 | T→G | 51.5% | G112G (GGT→GGG) | malP → | maltodextrin phosphorylase |
RA | 2,669,963 | C→T | 36.2% | N447N (AAC→AAT) | malP → | maltodextrin phosphorylase |
RA | 2,670,042 | C→A | 54.5% | Q474K (CAA→AAA) | malP → | maltodextrin phosphorylase |
RA | 2,670,071 | G→A | 43.2% | Q483Q (CAG→CAA) | malP → | maltodextrin phosphorylase |
RA | 2,671,600 | C→T | 72.0% | P192L (CCG→CTG) | malQ → | 4‑alpha‑glucanotransferase |
RA | 2,671,959 | C→T | 28.6% | R312C (CGC→TGC) | malQ → | 4‑alpha‑glucanotransferase |
RA | 2,671,973 | T→A | 21.2% | P316P (CCT→CCA) | malQ → | 4‑alpha‑glucanotransferase |
RA | 2,674,145 | A→G | 25.5% | S131S (TCT→TCC) | gntT ← | gluconate transporter, high‑affinity GNT I system |
RA | 2,674,370 | C→T | 44.0% | G56G (GGG→GGA) | gntT ← | gluconate transporter, high‑affinity GNT I system |
RA | 2,675,191 | C→A | 45.5% | P94P (CCG→CCT) | gntY ← | predicted gluconate transport associated protein |
RA | 2,675,194 | G→C | 45.6% | A93A (GCC→GCG) | gntY ← | predicted gluconate transport associated protein |
RA | 2,675,206 | T→C | 51.5% | L89L (TTA→TTG) ‡ | gntY ← | predicted gluconate transport associated protein |
RA | 2,675,208 | A→G | 55.4% | L89L (TTA→CTA) ‡ | gntY ← | predicted gluconate transport associated protein |
RA | 2,675,212 | G→C | 52.9% | S87S (TCC→TCG) | gntY ← | predicted gluconate transport associated protein |
RA | 2,676,470 | T→A | 83.4% | P73P (CCT→CCA) | bioH → | carboxylesterase of pimeloyl‑CoA synthesis |
RA | 2,676,545 | T→G | 51.9% | R98R (CGT→CGG) | bioH → | carboxylesterase of pimeloyl‑CoA synthesis |
RA | 2,676,550 | A→T | 61.4% | Q100L (CAG→CTG) | bioH → | carboxylesterase of pimeloyl‑CoA synthesis |
RA | 2,676,992 | C→T | 20.9% | H247H (CAC→CAT) | bioH → | carboxylesterase of pimeloyl‑CoA synthesis |
RA | 2,677,313 | T→C | 42.8% | D206G (GAC→GGC) | yhgA ← | predicted transposase |
RA | 2,677,405 | C→T | 47.4% | L175L (CTG→CTA) | yhgA ← | predicted transposase |
RA | 2,677,424 | T→A | 35.3% | Q169L (CAG→CTG) | yhgA ← | predicted transposase |
RA | 2,677,561 | G→A | 24.8% | Y123Y (TAC→TAT) | yhgA ← | predicted transposase |
RA | 2,678,154 | C→T | 32.4% | R72H (CGC→CAC) | yhgG ← | predicted DNA‑binding transcriptional regulator |
RA | 2,678,500 | C→T | 24.6% | A730A (GCG→GCA) | feoB ← | fused ferrous iron transporter, protein B |
RA | 2,678,841 | T→C | 36.6% | I617V (ATA→GTA) | feoB ← | fused ferrous iron transporter, protein B |
RA | 2,678,875 | T→C | 23.9% | A605A (GCA→GCG) | feoB ← | fused ferrous iron transporter, protein B |
RA | 2,679,505 | C→T | 24.3% | V395V (GTG→GTA) | feoB ← | fused ferrous iron transporter, protein B |
RA | 2,679,577 | C→G | 29.5% | G371G (GGG→GGC) | feoB ← | fused ferrous iron transporter, protein B |
RA | 2,679,619 | A→G | 44.8% | I357I (ATT→ATC) | feoB ← | fused ferrous iron transporter, protein B |
RA | 2,680,432 | G→T | 26.2% | A86A (GCC→GCA) | feoB ← | fused ferrous iron transporter, protein B |
RA | 2,684,679 | A→G | 61.7% | L56L (TTA→TTG) | ompR → | DNA‑binding response regulator in two‑component regulatory system with EnvZ |
RA | 2,684,790 | A→T | 23.9% | V93V (GTA→GTT) | ompR → | DNA‑binding response regulator in two‑component regulatory system with EnvZ |
RA | 2,687,100 | A→C | 54.9% | G393G (GGT→GGG) | pck ← | phosphoenolpyruvate carboxykinase |
RA | 2,687,910 | A→G | 50.6% | A123A (GCT→GCC) | pck ← | phosphoenolpyruvate carboxykinase |
RA | 2,690,326 | C→T | 67.3% | A557V (GCG→GTG) | yhgE → | predicted inner membrane protein |
RA | 2,690,717 | G→A | 32.1% | T202T (ACC→ACT) | hslO ← | heat shock protein Hsp33 |
RA | 2,693,488 | G→A | 55.6% | T380T (ACC→ACT) | yrfF ← | predicted inner membrane protein |
RA | 2,694,016 | A→G | 31.7% | R204R (CGT→CGC) | yrfF ← | predicted inner membrane protein |
RA | 2,694,489 | G→A | 25.5% | P47S (CCT→TCT) | yrfF ← | predicted inner membrane protein |
RA | 2,695,607 | Δ1 bp | 61.5% | intergenic (+100/+66) | nudE → / ← mrcA | ADP‑ribose diphosphatase/fused penicillin‑binding protein 1a murein transglycosylase and murein transpeptidase |
RA | 2,695,611 | T→C | 64.2% | intergenic (+104/+62) | nudE → / ← mrcA | ADP‑ribose diphosphatase/fused penicillin‑binding protein 1a murein transglycosylase and murein transpeptidase |
RA | 2,695,615 | C→T | 55.6% | intergenic (+108/+58) | nudE → / ← mrcA | ADP‑ribose diphosphatase/fused penicillin‑binding protein 1a murein transglycosylase and murein transpeptidase |
RA | 2,696,690 | A→G | 31.0% | A512A (GCT→GCC) | mrcA ← | fused penicillin‑binding protein 1a murein transglycosylase and murein transpeptidase |
RA | 2,696,696 | C→T | 31.6% | Q510Q (CAG→CAA) | mrcA ← | fused penicillin‑binding protein 1a murein transglycosylase and murein transpeptidase |
RA | 2,697,431 | G→A | 43.2% | S265S (AGC→AGT) | mrcA ← | fused penicillin‑binding protein 1a murein transglycosylase and murein transpeptidase |
RA | 2,697,440 | C→T | 35.5% | P262P (CCG→CCA) | mrcA ← | fused penicillin‑binding protein 1a murein transglycosylase and murein transpeptidase |
RA | 2,698,806 | G→T | 41.5% | V154V (GTG→GTT) | yrfD → | predicted pilus assembly protein |
RA | 2,698,818 | C→T | 54.2% | T158T (ACC→ACT) | yrfD → | predicted pilus assembly protein |
RA | 2,699,330 | G→A | 100% | K69K (AAG→AAA) | yrfC → | predicted fimbrial assembly protein |
RA | 2,700,539 | C→G | 33.6% | V49V (GTC→GTG) | hofQ → | predicted fimbrial transporter |
RA | 2,700,542 | G→T | 36.3% | V50V (GTG→GTT) | hofQ → | predicted fimbrial transporter |
RA | 2,700,761 | C→T | 27.6% | T123T (ACC→ACT) | hofQ → | predicted fimbrial transporter |
RA | 2,700,779 | G→C | 29.0% | A129A (GCG→GCC) | hofQ → | predicted fimbrial transporter |
RA | 2,700,785 | A→G | 28.9% | E131E (GAA→GAG) | hofQ → | predicted fimbrial transporter |
RA | 2,700,888 | G→A | 29.5% | A166T (GCG→ACG) | hofQ → | predicted fimbrial transporter |
RA | 2,700,906 | G→T | 36.9% | A172S (GCG→TCG) | hofQ → | predicted fimbrial transporter |
RA | 2,703,017 | T→C | 70.0% | D136D (GAT→GAC) | aroB → | 3‑dehydroquinate synthase |
RA | 2,704,968 | C→T | 24.1% | Y393Y (TAC→TAT) | damX → | hypothetical protein |
RA | 2,705,113 | A→C | 25.5% | intergenic (+37/‑70) | damX → / → dam | hypothetical protein/DNA adenine methylase |
RA | 2,705,446 | C→T | 6.5% | A88A (GCC→GCT) | dam → | DNA adenine methylase |
RA | 2,706,462 | C→T | 32.3% | N142N (AAC→AAT) | rpe → | D‑ribulose‑5‑phosphate 3‑epimerase |
RA | 2,712,432 | A→T | 68.4% | G643G (GGT→GGA) | nirB ← | nitrite reductase, large subunit, NAD(P)H‑binding |
RA | 2,713,305 | A→G | 39.8% | S352S (AGT→AGC) | nirB ← | nitrite reductase, large subunit, NAD(P)H‑binding |
RA | 2,713,566 | A→T | 29.7% | I265I (ATT→ATA) | nirB ← | nitrite reductase, large subunit, NAD(P)H‑binding |
RA | 2,713,572 | A→G | 30.4% | I263I (ATT→ATC) | nirB ← | nitrite reductase, large subunit, NAD(P)H‑binding |
RA | 2,713,857 | A→G | 70.3% | G168G (GGT→GGC) | nirB ← | nitrite reductase, large subunit, NAD(P)H‑binding |
RA | 2,718,421 | C→T | 14.1% | I77I (ATC→ATT) | argD → | bifunctional acetylornithine aminotransferase and succinyldiaminopimelate aminotransferase |
RA | 2,719,154 | C→T | 38.1% | L322L (CTG→TTG) | argD → | bifunctional acetylornithine aminotransferase and succinyldiaminopimelate aminotransferase |
RA | 2,719,183 | A→G | 41.4% | V331V (GTA→GTG) | argD → | bifunctional acetylornithine aminotransferase and succinyldiaminopimelate aminotransferase |
RA | 2,719,476 | C→T | 46.6% | intergenic (+65/+2) | argD → / ← yhfK | bifunctional acetylornithine aminotransferase and succinyldiaminopimelate aminotransferase/conserved inner membrane protein |
RA | 2,720,333 | C→T | 31.8% | V416V (GTG→GTA) | yhfK ← | conserved inner membrane protein |
RA | 2,720,384 | C→T | 57.2% | T399T (ACG→ACA) | yhfK ← | conserved inner membrane protein |
RA | 2,720,417 | C→A | 61.5% | L388L (CTG→CTT) | yhfK ← | conserved inner membrane protein |
RA | 2,721,260 | C→T | 51.5% | E107E (GAG→GAA) | yhfK ← | conserved inner membrane protein |
RA | 2,721,332 | T→C | 55.0% | L83L (CTA→CTG) ‡ | yhfK ← | conserved inner membrane protein |
RA | 2,721,334 | G→C | 54.9% | L83V (CTA→GTA) ‡ | yhfK ← | conserved inner membrane protein |
RA | 2,722,373 | A→G | 59.4% | intergenic (‑122/‑180) | crp ← / → yhfA | DNA‑binding transcriptional dual regulator/conserved hypothetical protein |
RA | 2,722,403 | G→A | 65.9% | intergenic (‑152/‑150) | crp ← / → yhfA | DNA‑binding transcriptional dual regulator/conserved hypothetical protein |
RA | 2,723,207 | G→C | 43.7% | L225L (CTC→CTG) | prkB ← | predicted phosphoribulokinase |
RA | 2,724,675 | C→T | 73.4% | K165K (AAG→AAA) | yheT ← | predicted hydrolase |
RA | 2,725,134 | G→A | 51.3% | F12F (TTC→TTT) | yheT ← | predicted hydrolase |
RA | 2,725,155 | C→T | 47.5% | T5T (ACG→ACA) | yheT ← | predicted hydrolase |
RA | 2,725,709 | A→G | 68.2% | T458T (ACT→ACC) | yheS ← | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 2,726,336 | G→A | 48.9% | Y249Y (TAC→TAT) | yheS ← | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 2,727,579 | C→T | 44.9% | L124L (CTG→TTG) | kefG → | component of potassium effux complex with KefB |
RA | 2,727,775 | C→T | 35.3% | S4S (TCC→TCT) | kefB → | potassium:proton antiporter |
RA | 2,729,065 | C→T | 60.6% | S434S (AGC→AGT) | kefB → | potassium:proton antiporter |
RA | 2,729,737 | T→C | 38.7% | V53V (GTT→GTC) | yheV → | hypothetical protein |
RA | 2,729,758 | C→T | 49.4% | I60I (ATC→ATT) | yheV → | hypothetical protein |
RA | 2,732,515 | G→A | 30.3% | L195L (CTG→CTA) | yheO → | predicted DNA‑binding transcriptional regulator |
RA | 2,732,551 | T→C | 40.4% | D207D (GAT→GAC) | yheO → | predicted DNA‑binding transcriptional regulator |
RA | 2,732,733 | G→A | 47.8% | L27L (CTG→CTA) | yheN → | predicted intracellular sulfur oxidation protein |
RA | 2,732,742 | T→A | 54.3% | D30E (GAT→GAA) | yheN → | predicted intracellular sulfur oxidation protein |
RA | 2,733,426 | C→T | 32.4% | R7R (CGC→CGT) | yheL → | predicted intracellular sulfur oxidation protein |
RA | 2,733,525 | T→C | 33.7% | G40G (GGT→GGC) | yheL → | predicted intracellular sulfur oxidation protein |
RA | 2,733,673 | C→T | 31.5% | P90S (CCC→TCC) | yheL → | predicted intracellular sulfur oxidation protein |
RA | 2,736,005 | T→A | 51.0% | A383A (GCT→GCA) | fusA → | protein chain elongation factor EF‑G |
RA | 2,736,011 | T→A | 50.9% | A385A (GCT→GCA) | fusA → | protein chain elongation factor EF‑G |
RA | 2,736,887 | T→C | 52.3% | R677R (CGT→CGC) | fusA → | protein chain elongation factor EF‑G |
RA | 2,752,749 | C→T | 23.7% | H78H (CAC→CAT) | yhdN → | conserved hypothetical protein |
RA | 2,752,776 | C→T | 24.8% | S87S (AGC→AGT) | yhdN → | conserved hypothetical protein |
RA | 2,753,807 | C→T | 71.2% | Q65Q (CAG→CAA) | mscL ← | mechanosensitive channel |
RA | 2,753,810 | C→G | 60.6% | A64A (GCG→GCC) | mscL ← | mechanosensitive channel |
RA | 2,753,813 | A→C | 57.2% | D63E (GAT→GAG) | mscL ← | mechanosensitive channel |
RA | 2,753,843 | A→G | 35.2% | D53D (GAT→GAC) | mscL ← | mechanosensitive channel |
RA | 2,753,942 | C→T | 55.0% | A20A (GCG→GCA) | mscL ← | mechanosensitive channel |
RA | 2,755,814 | T→C | 25.3% | P335P (CCA→CCG) | rsmB ← | 16S rRNA m5C967 methyltransferase, S‑adenosyl‑L‑methionine‑dependent |
RA | 2,756,156 | A→G | 35.5% | P221P (CCT→CCC) | rsmB ← | 16S rRNA m5C967 methyltransferase, S‑adenosyl‑L‑methionine‑dependent |
RA | 2,756,429 | T→A | 54.3% | E130D (GAA→GAT) | rsmB ← | 16S rRNA m5C967 methyltransferase, S‑adenosyl‑L‑methionine‑dependent |
RA | 2,756,450 | G→A | 48.1% | R123R (CGC→CGT) | rsmB ← | 16S rRNA m5C967 methyltransferase, S‑adenosyl‑L‑methionine‑dependent |
RA | 2,756,465 | T→A | 33.7% | I118I (ATA→ATT) | rsmB ← | 16S rRNA m5C967 methyltransferase, S‑adenosyl‑L‑methionine‑dependent |
RA | 2,758,108 | T→C | 23.0% | P76P (CCA→CCG) | def ← | peptide deformylase |
RA | 2,758,998 | T→C | 34.8% | R178R (CGT→CGC) | smf → | conserved hypothetical protein |
RA | 2,759,004 | C→T | 33.7% | A180A (GCC→GCT) | smf → | conserved hypothetical protein |
RA | 2,759,006 | G→C | 32.8% | R181P (CGA→CCA) | smf → | conserved hypothetical protein |
RA | 2,759,842 | G→A | 26.4% | Q94Q (CAG→CAA) | smg → | conserved hypothetical protein |
RA | 2,759,854 | C→T | 21.9% | L98L (CTC→CTT) | smg → | conserved hypothetical protein |
RA | 2,759,866 | T→C | 20.6% | T102T (ACT→ACC) | smg → | conserved hypothetical protein |
RA | 2,760,795 | A→G | 52.1% | A62A (GCA→GCG) | yrdC → | dsRNA‑binding protein |
RA | 2,760,838 | T→C | 65.3% | L77L (TTG→CTG) | yrdC → | dsRNA‑binding protein |
RA | 2,760,848 | T→C | 67.6% | V80A (GTG→GCG) | yrdC → | dsRNA‑binding protein |
RA | 2,761,693 | G→C | 90.4% | Q169H (CAG→CAC) | aroE → | dehydroshikimate reductase, NAD(P)‑binding |
RA | 2,761,700 | A→G | 100% | S172G (AGT→GGT) | aroE → | dehydroshikimate reductase, NAD(P)‑binding |
RA | 2,761,918 | G→A | 62.3% | Q244Q (CAG→CAA) | aroE → | dehydroshikimate reductase, NAD(P)‑binding |
RA | 2,770,615 | A→C | 33.7% | intergenic (+208/‑61) | metA → / → aceB | homoserine transsuccinylase/malate synthase A |
RA | 2,771,782 | A→G | 36.6% | P369P (CCA→CCG) | aceB → | malate synthase A |
RA | 2,771,983 | C→T | 20.3% | N436N (AAC→AAT) | aceB → | malate synthase A |
RA | 2,773,593 | T→C | 23.8% | T429T (ACT→ACC) | aceA → | isocitrate lyase |
RA | 2,774,792 | G→A | 28.0% | R333R (CGG→CGA) | aceK → | isocitrate dehydrogenase kinase/phosphatase |
RA | 2,775,059 | C→T | 77.7% | L422L (CTC→CTT) | aceK → | isocitrate dehydrogenase kinase/phosphatase |
RA | 2,775,071 | G→T | 73.1% | L426L (CTG→CTT) | aceK → | isocitrate dehydrogenase kinase/phosphatase |
RA | 2,775,074 | A→G | 68.0% | E427E (GAA→GAG) | aceK → | isocitrate dehydrogenase kinase/phosphatase |
RA | 2,775,080 | G→T | 59.3% | V429V (GTG→GTT) | aceK → | isocitrate dehydrogenase kinase/phosphatase |
RA | 2,775,083 | A→G | 60.4% | E430E (GAA→GAG) | aceK → | isocitrate dehydrogenase kinase/phosphatase |
RA | 2,775,086 | T→G | 62.0% | G431G (GGT→GGG) | aceK → | isocitrate dehydrogenase kinase/phosphatase |
RA | 2,778,392 | T→A | 100% | R145R (CGA→CGT) | iclR ← | DNA‑binding transcriptional repressor |
RA | 2,778,401 | A→G | 58.9% | H142H (CAT→CAC) | iclR ← | DNA‑binding transcriptional repressor |
RA | 2,778,404 | C→A | 58.8% | T141T (ACG→ACT) | iclR ← | DNA‑binding transcriptional repressor |
RA | 2,778,442 | C→T | 17.9% | D129N (GAT→AAT) | iclR ← | DNA‑binding transcriptional repressor |
RA | 2,778,836 | T→C | 47.9% | intergenic (‑10/‑190) | iclR ← / → metH | DNA‑binding transcriptional repressor/homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,779,382 | C→T | 100% | T119T (ACC→ACT) | metH → | homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,779,385 | G→C | 100% | A120A (GCG→GCC) | metH → | homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,780,693 | G→A | 26.8% | A556A (GCG→GCA) | metH → | homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,780,711 | A→T | 20.0% | V562V (GTA→GTT) | metH → | homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,780,768 | A→G | 22.3% | A581A (GCA→GCG) | metH → | homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,781,284 | C→A | 38.7% | T753T (ACC→ACA) | metH → | homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,781,293 | C→T | 43.1% | G756G (GGC→GGT) | metH → | homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,781,296 | C→T | 43.1% | D757D (GAC→GAT) | metH → | homocysteine‑N5‑methyltetrahydrofolate transmethylase, B12‑dependent |
RA | 2,783,591 | T→C | 40.7% | G221G (GGT→GGC) | yjbB → | predicted transporter |
RA | 2,783,600 | A→G | 47.8% | A224A (GCA→GCG) | yjbB → | predicted transporter |
RA | 2,783,748 | C→T | 50.4% | L274L (CTG→TTG) | yjbB → | predicted transporter |
RA | 2,783,786 | T→C | 53.0% | R286R (CGT→CGC) | yjbB → | predicted transporter |
RA | 2,784,005 | T→C | 46.4% | G359G (GGT→GGC) | yjbB → | predicted transporter |
RA | 2,784,296 | G→A | 19.6% | K456K (AAG→AAA) | yjbB → | predicted transporter |
RA | 2,784,311 | G→T | 17.1% | V461V (GTG→GTT) | yjbB → | predicted transporter |
RA | 2,784,954 | A→G | 78.3% | T129T (ACT→ACC) | pepE ← | (alpha)‑aspartyl dipeptidase |
RA | 2,785,095 | G→A | 50.0% | I82I (ATC→ATT) | pepE ← | (alpha)‑aspartyl dipeptidase |
RA | 2,785,098 | C→T | 50.0% | E81E (GAG→GAA) | pepE ← | (alpha)‑aspartyl dipeptidase |
RA | 2,785,101 | A→C | 50.0% | A80A (GCT→GCG) | pepE ← | (alpha)‑aspartyl dipeptidase |
RA | 2,785,363 | T→A | 34.4% | intergenic (‑23/‑189) | pepE ← / → yjbC | (alpha)‑aspartyl dipeptidase/23S rRNA pseudouridine synthase |
RA | 2,785,369 | G→A | 36.1% | intergenic (‑29/‑183) | pepE ← / → yjbC | (alpha)‑aspartyl dipeptidase/23S rRNA pseudouridine synthase |
RA | 2,785,373 | C→A | 41.2% | intergenic (‑33/‑179) | pepE ← / → yjbC | (alpha)‑aspartyl dipeptidase/23S rRNA pseudouridine synthase |
RA | 2,785,788 | A→C | 32.9% | V79V (GTA→GTC) | yjbC → | 23S rRNA pseudouridine synthase |
RA | 2,786,713 | G→A | 30.2% | T39T (ACC→ACT) | yjbD ← | conserved hypothetical protein |
RA | 2,787,280 | T→C | 18.1% | E384E (GAA→GAG) | lysC ← | aspartokinase III |
RA | 2,787,739 | T→C | 33.9% | P231P (CCA→CCG) | lysC ← | aspartokinase III |
RA | 2,790,053 | C→G | 22.5% | N366K (AAC→AAG) | pgi → | glucosephosphate isomerase |
RA | 2,790,341 | A→G | 22.1% | V462V (GTA→GTG) | pgi → | glucosephosphate isomerase |
RA | 2,790,362 | C→T | 45.4% | T469T (ACC→ACT) | pgi → | glucosephosphate isomerase |
RA | 2,791,709 | G→A | 40.2% | L110L (TTG→TTA) | ubiC → | chorismate pyruvate lyase |
RA | 2,794,549 | A→G | 24.9% | I264I (ATT→ATC) | plsB ← | glycerol‑3‑phosphate O‑acyltransferase |
RA | 2,794,591 | T→C | 36.7% | A250A (GCA→GCG) | plsB ← | glycerol‑3‑phosphate O‑acyltransferase |
RA | 2,795,002 | A→G | 37.2% | R113R (CGT→CGC) | plsB ← | glycerol‑3‑phosphate O‑acyltransferase |
RA | 2,795,792 | A→T | 40.3% | A94A (GCA→GCT) | dgkA → | diacylglycerol kinase |
RA | 2,795,807 | C→T | 40.4% | S99S (TCC→TCT) | dgkA → | diacylglycerol kinase |
RA | 2,795,810 | T→C | 40.5% | A100A (GCT→GCC) | dgkA → | diacylglycerol kinase |
RA | 2,795,813 | G→A | 40.8% | A101A (GCG→GCA) | dgkA → | diacylglycerol kinase |
RA | 2,796,501 | T→C | 40.0% | N171N (AAT→AAC) | lexA → | DNA‑binding transcriptional repressor |
RA | 2,797,892 | C→G | 38.6% | A426G (GCT→GGT) | dinF → | DNA‑damage‑inducible SOS response protein |
RA | 2,797,905 | A→G | 44.7% | A430A (GCA→GCG) | dinF → | DNA‑damage‑inducible SOS response protein |
RA | 2,798,470 | C→A | 35.5% | V136V (GTG→GTT) | zur ← | DNA‑binding transcriptional activator, Zn(II)‑binding |
RA | 2,801,019 | C→T | 57.2% | D159D (GAC→GAT) | yjbN → | tRNA‑dihydrouridine synthase A |
RA | 2,801,022 | C→T | 49.2% | D160D (GAC→GAT) | yjbN → | tRNA‑dihydrouridine synthase A |
RA | 2,801,058 | T→C | 30.9% | N172N (AAT→AAC) | yjbN → | tRNA‑dihydrouridine synthase A |
RA | 2,801,121 | G→T | 33.8% | S193S (TCG→TCT) | yjbN → | tRNA‑dihydrouridine synthase A |
RA | 2,801,130 | C→T | 25.4% | S196S (AGC→AGT) | yjbN → | tRNA‑dihydrouridine synthase A |
RA | 2,801,244 | G→A | 41.2% | E234E (GAG→GAA) | yjbN → | tRNA‑dihydrouridine synthase A |
RA | 2,801,633 | C→T | 43.4% | intergenic (+53/‑81) | yjbN → / → yjbO | tRNA‑dihydrouridine synthase A/phage shock protein G |
RA | 2,802,488 | G→A | 62.1% | G206G (GGC→GGT) | qor ← | quinone oxidoreductase, NADPH‑dependent |
RA | 2,803,427 | C→T | 54.1% | S80S (AGC→AGT) | dnaB → | replicative DNA helicase |
RA | 2,803,445 | T→C | 45.6% | T86T (ACT→ACC) | dnaB → | replicative DNA helicase |
RA | 2,805,450 | C→T | 40.4% | T265T (ACC→ACT) | alr → | alanine racemase 1, PLP‑binding, biosynthetic |
RA | 2,806,425 | T→C | 37.4% | S146S (AGT→AGC) | tyrB → | tyrosine aminotransferase, tyrosine‑repressible, PLP‑dependent |
RA | 2,809,462 | T→C | 42.5% | I117I (ATT→ATC) | yjbQ → | conserved hypothetical protein |
RA | 2,810,964 | G→A | 63.0% | G594G (GGC→GGT) | uvrA ← | ATPase and DNA damage recognition protein of nucleotide excision repair excinuclease UvrABC |
RA | 2,810,979 | C→T | 70.3% | G589G (GGG→GGA) | uvrA ← | ATPase and DNA damage recognition protein of nucleotide excision repair excinuclease UvrABC |
RA | 2,811,009 | C→T | 31.8% | A579A (GCG→GCA) | uvrA ← | ATPase and DNA damage recognition protein of nucleotide excision repair excinuclease UvrABC |
RA | 2,811,018 | C→T | 24.0% | P576P (CCG→CCA) | uvrA ← | ATPase and DNA damage recognition protein of nucleotide excision repair excinuclease UvrABC |
RA | 2,811,027 | T→C | 25.3% | A573A (GCA→GCG) | uvrA ← | ATPase and DNA damage recognition protein of nucleotide excision repair excinuclease UvrABC |
RA | 2,811,594 | G→A | 43.6% | R384R (CGC→CGT) | uvrA ← | ATPase and DNA damage recognition protein of nucleotide excision repair excinuclease UvrABC |
RA | 2,811,609 | A→G | 43.1% | H379H (CAT→CAC) | uvrA ← | ATPase and DNA damage recognition protein of nucleotide excision repair excinuclease UvrABC |
RA | 2,814,290 | C→G | 59.7% | intergenic (‑375/‑55) | yjcB ← / → yjcC | predicted inner membrane protein/predicted signal transduction protein |
RA | 2,814,312 | G→A | 38.4% | intergenic (‑397/‑33) | yjcB ← / → yjcC | predicted inner membrane protein/predicted signal transduction protein |
RA | 2,814,313 | G→A | 38.3% | intergenic (‑398/‑32) | yjcB ← / → yjcC | predicted inner membrane protein/predicted signal transduction protein |
RA | 2,814,333 | A→G | 31.7% | intergenic (‑418/‑12) | yjcB ← / → yjcC | predicted inner membrane protein/predicted signal transduction protein |
RA | 2,815,784 | C→T | 49.3% | G480G (GGC→GGT) | yjcC → | predicted signal transduction protein |
RA | 2,816,585 | C→A | 34.0% | P81P (CCC→CCA) | soxR → | DNA‑binding transcriptional dual regulator, Fe‑S center for redox‑sensing |
RA | 2,817,164 | T→C | 20.7% | A95A (GCT→GCC) | nrfA → | nitrite reductase, formate‑dependent, cytochrome |
RA | 2,819,774 | G→T | 26.1% | P61P (CCG→CCT) | nrfD → | formate‑dependent nitrite reductase, membrane subunit |
RA | 2,820,792 | G→C | 51.2% | A55A (GCG→GCC) | nrfE → | heme lyase (NrfEFG) for insertion of heme into c552, subunit NrfE |
RA | 2,824,650 | A→G | 37.5% | Y107Y (TAT→TAC) | yjdC ← | predicted transcriptional regulator |
RA | 2,824,674 | T→C | 54.2% | L99L (CTA→CTG) | yjdC ← | predicted transcriptional regulator |
RA | 2,825,787 | G→A | 36.0% | T306T (ACC→ACT) | dipZ ← | fused thiol:disulfide interchange protein |
RA | 2,827,078 | G→A | 28.2% | intergenic (‑60/+56) | cutA ← / ← dcuA | copper binding protein, copper sensitivity/C4‑dicarboxylate antiporter |
RA | 2,827,128 | T→G | 48.0% | intergenic (‑110/+6) | cutA ← / ← dcuA | copper binding protein, copper sensitivity/C4‑dicarboxylate antiporter |
RA | 2,827,130 | A→G | 52.2% | intergenic (‑112/+4) | cutA ← / ← dcuA | copper binding protein, copper sensitivity/C4‑dicarboxylate antiporter |
RA | 2,829,174 | A→G | 26.0% | S272S (TCT→TCC) | aspA ← | aspartate ammonia‑lyase |
RA | 2,829,222 | A→G | 31.0% | V256V (GTT→GTC) | aspA ← | aspartate ammonia‑lyase |
RA | 2,831,766 | T→C | 15.4% | A103A (GCA→GCG) | yjeH ← | predicted transporter |
RA | 2,832,168 | T→A | 47.5% | intergenic (‑94/‑182) | yjeH ← / → groS | predicted transporter/Cpn10 chaperonin GroES, small subunit of GroESL |
RA | 2,833,787 | A→G | 64.5% | E367E (GAA→GAG) | groL → | Cpn60 chaperonin GroEL, large subunit of GroESL |
RA | 2,835,320 | C→T | 20.7% | D193N (GAC→AAC) | yjeJ ← | hypothetical protein |
RA | 2,835,378 | G→T | 27.1% | D173E (GAC→GAA) | yjeJ ← | hypothetical protein |
RA | 2,835,651 | G→A | 22.7% | N82N (AAC→AAT) | yjeJ ← | hypothetical protein |
RA | 2,835,770 | G→A | 35.1% | L43L (CTG→TTG) | yjeJ ← | hypothetical protein |
RA | 2,835,778 | A→G | 40.8% | V40A (GTC→GCC) | yjeJ ← | hypothetical protein |
RA | 2,836,483 | T→C | 66.2% | V279V (GTA→GTG) | yjeK ← | predicted lysine aminomutase |
RA | 2,836,489 | G→C | 67.5% | A277A (GCC→GCG) | yjeK ← | predicted lysine aminomutase |
RA | 2,839,277 | G→A | 44.1% | A36A (GCC→GCT) | blc ← | outer membrane lipoprotein |
RA | 2,839,488 | A→G | 41.4% | L373L (CTT→CTC) | ampC ← | beta‑lactamase/D‑alanine carboxypeptidase |
RA | 2,839,507 | T→G | 38.7% | D367A (GAC→GCC) | ampC ← | beta‑lactamase/D‑alanine carboxypeptidase |
RA | 2,839,818 | C→T | 34.5% | T263T (ACG→ACA) | ampC ← | beta‑lactamase/D‑alanine carboxypeptidase |
RA | 2,839,920 | A→T | 40.0% | P229P (CCT→CCA) | ampC ← | beta‑lactamase/D‑alanine carboxypeptidase |
RA | 2,841,988 | A→G | 70.0% | G64G (GGT→GGC) | frdB ← | fumarate reductase (anaerobic), Fe‑S subunit |
RA | 2,842,244 | G→A | 73.1% | R579R (CGC→CGT) | frdA ← | fumarate reductase (anaerobic) catalytic and NAD/flavoprotein subunit |
RA | 2,843,402 | A→G | 24.4% | T193T (ACT→ACC) | frdA ← | fumarate reductase (anaerobic) catalytic and NAD/flavoprotein subunit |
RA | 2,845,845 | T→C | 33.8% | Y115Y (TAT→TAC) | yjeM → | predicted transporter |
RA | 2,845,871 | G→A | 28.8% | R124H (CGT→CAT) | yjeM → | predicted transporter |
RA | 2,846,388 | T→C | 25.5% | N296N (AAT→AAC) | yjeM → | predicted transporter |
RA | 2,846,814 | A→G | 55.5% | T438T (ACA→ACG) | yjeM → | predicted transporter |
RA | 2,848,531 | C→T | 45.3% | V834V (GTG→GTA) | yjeP ← | predicted mechanosensitive channel |
RA | 2,848,549 | T→C | 24.9% | P828P (CCA→CCG) | yjeP ← | predicted mechanosensitive channel |
RA | 2,849,359 | A→G | 100% | G558G (GGT→GGC) | yjeP ← | predicted mechanosensitive channel |
RA | 2,849,365 | G→A | 100% | G556G (GGC→GGT) | yjeP ← | predicted mechanosensitive channel |
RA | 2,849,434 | C→A | 61.1% | P533P (CCG→CCT) | yjeP ← | predicted mechanosensitive channel |
RA | 2,849,437 | T→C | 61.2% | L532L (TTA→TTG) ‡ | yjeP ← | predicted mechanosensitive channel |
RA | 2,849,439 | A→G | 61.2% | L532L (TTA→CTA) ‡ | yjeP ← | predicted mechanosensitive channel |
RA | 2,849,476 | C→T | 71.5% | L519L (TTG→TTA) | yjeP ← | predicted mechanosensitive channel |
RA | 2,851,132 | A→T | 41.0% | P297P (CCT→CCA) | psd ← | phosphatidylserine decarboxylase |
RA | 2,854,647 | C→T | 38.4% | L361L (TTG→TTA) | yjeS ← | predicted Fe‑S electron transport protein |
RA | 2,854,662 | T→C | 64.6% | I356M (ATA→ATG) ‡ | yjeS ← | predicted Fe‑S electron transport protein |
RA | 2,854,664 | T→C | 63.6% | I356V (ATA→GTA) ‡ | yjeS ← | predicted Fe‑S electron transport protein |
RA | 2,854,677 | T→C | 52.7% | R351R (AGA→AGG) | yjeS ← | predicted Fe‑S electron transport protein |
RA | 2,854,683 | T→G | 52.8% | I349I (ATA→ATC) | yjeS ← | predicted Fe‑S electron transport protein |
RA | 2,855,148 | G→A | 27.1% | G194G (GGC→GGT) | yjeS ← | predicted Fe‑S electron transport protein |
RA | 2,855,562 | T→C | 51.3% | A56A (GCA→GCG) | yjeS ← | predicted Fe‑S electron transport protein |
RA | 2,856,246 | G→T | 18.4% | L173L (CTG→CTT) | yjeF → | predicted carbohydrate kinase |
RA | 2,856,258 | T→C | 20.2% | T177T (ACT→ACC) | yjeF → | predicted carbohydrate kinase |
RA | 2,856,279 | G→A | 28.1% | V184V (GTG→GTA) | yjeF → | predicted carbohydrate kinase |
RA | 2,858,650 | G→A | 100% | L308L (CTG→CTA) | amiB → | N‑acetylmuramoyl‑l‑alanine amidase II |
RA | 2,858,656 | T→C | 100% | G310G (GGT→GGC) | amiB → | N‑acetylmuramoyl‑l‑alanine amidase II |
RA | 2,858,659 | G→A | 100% | G311G (GGG→GGA) | amiB → | N‑acetylmuramoyl‑l‑alanine amidase II |
RA | 2,859,346 | C→T | 40.6% | S91S (AGC→AGT) | mutL → | methyl‑directed mismatch repair protein |
RA | 2,860,420 | G→T | 42.1% | L449L (CTG→CTT) | mutL → | methyl‑directed mismatch repair protein |
RA | 2,860,429 | C→T | 44.7% | D452D (GAC→GAT) | mutL → | methyl‑directed mismatch repair protein |
RA | 2,861,639 | C→T | 67.5% | D242D (GAC→GAT) | miaA → | delta(2)‑isopentenylpyrophosphate tRNA‑adenosine transferase |
RA | 2,863,452 | A→G | 29.6% | P373P (CCA→CCG) | hflX → | predicted GTPase |
RA | 2,863,467 | T→C | 26.3% | R378R (CGT→CGC) | hflX → | predicted GTPase |
RA | 2,864,086 | C→T | 32.8% | I129I (ATC→ATT) | hflK → | modulator for HflB protease specific for phage lambda cII repressor |
RA | 2,865,711 | C→T | 43.4% | R250R (CGC→CGT) | hflC → | modulator for HflB protease specific for phage lambda cII repressor |
RA | 2,865,714 | G→A | 37.9% | A251A (GCG→GCA) | hflC → | modulator for HflB protease specific for phage lambda cII repressor |
RA | 2,869,590 | T→C | 39.3% | G425G (GGT→GGC) | rnr → | exoribonuclease R, RNase R |
RA | 2,869,908 | T→C | 51.3% | D531D (GAT→GAC) | rnr → | exoribonuclease R, RNase R |
RA | 2,872,269 | T→C | 77.1% | S174P (TCA→CCA) | ulaF → | L‑ribulose 5‑phosphate 4‑epimerase |
RA | 2,872,275 | T→C | 77.9% | C176R (TGC→CGC) | ulaF → | L‑ribulose 5‑phosphate 4‑epimerase |
RA | 2,872,329 | C→G | 28.2% | P194A (CCG→GCG) | ulaF → | L‑ribulose 5‑phosphate 4‑epimerase |
RA | 2,872,332 | C→T | 28.1% | R195W (CGG→TGG) ‡ | ulaF → | L‑ribulose 5‑phosphate 4‑epimerase |
RA | 2,872,333 | G→A | 28.1% | R195Q (CGG→CAG) ‡ | ulaF → | L‑ribulose 5‑phosphate 4‑epimerase |
RA | 2,872,335 | C→T | 26.9% | H196Y (CAT→TAT) | ulaF → | L‑ribulose 5‑phosphate 4‑epimerase |
RA | 2,872,350 | C→G | 22.2% | Q201E (CAA→GAA) | ulaF → | L‑ribulose 5‑phosphate 4‑epimerase |
RA | 2,872,654 | T→C | 29.7% | E60E (GAA→GAG) | yjfY ← | hypothetical protein |
RA | 2,872,681 | G→A | 25.1% | S51S (AGC→AGT) | yjfY ← | hypothetical protein |
RA | 2,872,684 | T→C | 19.4% | E50E (GAA→GAG) | yjfY ← | hypothetical protein |
RA | 2,872,696 | A→G | 17.5% | N46N (AAT→AAC) | yjfY ← | hypothetical protein |
RA | 2,878,535 | T→C | 35.3% | G210G (GGT→GGC) | cycA → | D‑alanine/D‑serine/glycine transporter |
RA | 2,879,384 | T→C | 21.1% | P214P (CCA→CCG) | ytfE ← | predicted regulator of cell morphogenesis and cell wall metabolism |
RA | 2,879,390 | C→T | 18.7% | L212L (CTG→CTA) | ytfE ← | predicted regulator of cell morphogenesis and cell wall metabolism |
RA | 2,879,765 | G→A | 25.1% | H87H (CAC→CAT) | ytfE ← | predicted regulator of cell morphogenesis and cell wall metabolism |
RA | 2,879,768 | A→G | 29.5% | R86R (CGT→CGC) | ytfE ← | predicted regulator of cell morphogenesis and cell wall metabolism |
RA | 2,879,777 | G→A | 30.3% | Y83Y (TAC→TAT) | ytfE ← | predicted regulator of cell morphogenesis and cell wall metabolism |
RA | 2,879,786 | G→A | 48.0% | I80I (ATC→ATT) | ytfE ← | predicted regulator of cell morphogenesis and cell wall metabolism |
RA | 2,879,789 | G→A | 48.0% | I79I (ATC→ATT) | ytfE ← | predicted regulator of cell morphogenesis and cell wall metabolism |
RA | 2,879,792 | A→G | 47.1% | H78H (CAT→CAC) | ytfE ← | predicted regulator of cell morphogenesis and cell wall metabolism |
RA | 2,881,261 | T→C | 44.1% | H269R (CAC→CGC) | ytfG ← | NAD(P)H:quinone oxidoreductase |
RA | 2,881,281 | T→C | 41.4% | T262T (ACA→ACG) | ytfG ← | NAD(P)H:quinone oxidoreductase |
RA | 2,883,501 | C→A | 52.7% | L369L (CTG→CTT) | cpdB ← | 2':3'‑cyclic‑nucleotide 2'‑phosphodiesterase |
RA | 2,883,780 | G→C | 44.4% | A276A (GCC→GCG) | cpdB ← | 2':3'‑cyclic‑nucleotide 2'‑phosphodiesterase |
RA | 2,884,215 | T→C | 25.6% | A131A (GCA→GCG) | cpdB ← | 2':3'‑cyclic‑nucleotide 2'‑phosphodiesterase |
RA | 2,884,233 | G→A | 30.7% | Y125Y (TAC→TAT) | cpdB ← | 2':3'‑cyclic‑nucleotide 2'‑phosphodiesterase |
RA | 2,884,356 | G→T | 15.3% | A84A (GCC→GCA) | cpdB ← | 2':3'‑cyclic‑nucleotide 2'‑phosphodiesterase |
RA | 2,885,111 | T→C | 28.1% | I105I (ATT→ATC) | cysQ → | PAPS (adenosine 3'‑phosphate 5'‑phosphosulfate) 3'(2'),5'‑bisphosphate nucleotidase |
RA | 2,891,498 | G→A | 100% | K51K (AAG→AAA) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,504 | A→T | 100% | G53G (GGA→GGT) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,510 | G→A | 72.2% | T55T (ACG→ACA) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,511 | T→C | 73.2% | L56L (TTG→CTG) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,666 | A→C | 43.9% | V107V (GTA→GTC) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,675 | C→T | 26.7% | L110L (CTC→CTT) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,678 | T→C | 27.0% | D111D (GAT→GAC) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,687 | T→C | 31.7% | I114I (ATT→ATC) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,872 | A→G | 19.4% | K176R (AAG→AGG) | ytfQ → | predicted sugar transporter subunit |
RA | 2,891,894 | C→T | 28.4% | I183I (ATC→ATT) | ytfQ → | predicted sugar transporter subunit |
RA | 2,892,465 | G→A | 100% | E8E (GAG→GAA) | ytfR → | predicted sugar transporter subunit |
RA | 2,892,609 | T→C | 26.8% | T56T (ACT→ACC) | ytfR → | predicted sugar transporter subunit |
RA | 2,893,065 | C→T | 41.7% | V208V (GTC→GTT) | ytfR → | predicted sugar transporter subunit |
RA | 2,893,074 | C→T | 45.8% | V211V (GTC→GTT) | ytfR → | predicted sugar transporter subunit |
RA | 2,893,110 | C→T | 44.6% | F223F (TTC→TTT) | ytfR → | predicted sugar transporter subunit |
RA | 2,893,824 | A→G | 73.1% | E461E (GAA→GAG) | ytfR → | predicted sugar transporter subunit |
RA | 2,894,122 | C→T | 42.6% | P55P (CCC→CCT) | ytfT → | predicted sugar transporter subunit |
RA | 2,894,125 | A→C | 45.3% | I56I (ATA→ATC) | ytfT → | predicted sugar transporter subunit |
RA | 2,894,374 | T→C | 27.6% | T139T (ACT→ACC) | ytfT → | predicted sugar transporter subunit |
RA | 2,894,425 | G→A | 46.1% | G156G (GGG→GGA) | ytfT → | predicted sugar transporter subunit |
RA | 2,894,437 | G→A | 39.9% | T160T (ACG→ACA) | ytfT → | predicted sugar transporter subunit |
RA | 2,894,506 | C→T | 17.7% | I183I (ATC→ATT) | ytfT → | predicted sugar transporter subunit |
RA | 2,894,522 | A→C | 26.6% | I189L (ATC→CTC) | ytfT → | predicted sugar transporter subunit |
RA | 2,894,752 | C→T | 37.2% | L265L (CTC→CTT) | ytfT → | predicted sugar transporter subunit |
RA | 2,894,755 | G→A | 48.9% | A266A (GCG→GCA) | ytfT → | predicted sugar transporter subunit |
RA | 2,895,140 | A→C | 21.3% | S58S (TCA→TCC) | yjfF → | predicted sugar transporter subunit |
RA | 2,895,563 | G→A | 19.2% | A199A (GCG→GCA) | yjfF → | predicted sugar transporter subunit |
RA | 2,895,566 | T→C | 28.2% | N200N (AAT→AAC) | yjfF → | predicted sugar transporter subunit |
RA | 2,895,585 | C→T | 25.6% | R207C (CGC→TGC) | yjfF → | predicted sugar transporter subunit |
RA | 2,895,677 | G→A | 29.9% | A237A (GCG→GCA) | yjfF → | predicted sugar transporter subunit |
RA | 2,897,573 | A→G | 27.9% | V135V (GTA→GTG) | mpl → | UDP‑N‑acetylmuramate:L‑alanyl‑gamma‑D‑glutamyl‑ meso‑diaminopimelate ligase |
RA | 2,902,131 | A→G | 31.7% | N638N (AAT→AAC) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,902,620 | A→G | 33.3% | D475D (GAT→GAC) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,902,623 | A→G | 33.3% | D474D (GAT→GAC) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,902,635 | G→C | 28.1% | L470L (CTC→CTG) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,903,226 | T→C | 53.2% | S273S (TCA→TCG) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,903,259 | T→A | 46.3% | R262R (CGA→CGT) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,903,574 | G→A | 32.6% | G157G (GGC→GGT) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,903,580 | C→T | 34.3% | E155E (GAG→GAA) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,903,583 | A→G | 35.5% | H154H (CAT→CAC) | nrdD ← | anaerobic ribonucleoside‑triphosphate reductase |
RA | 2,904,478 | T→G | 42.9% | N539T (AAT→ACT) | treC ← | trehalose‑6‑P hydrolase |
RA | 2,904,485 | C→T | 45.4% | A537T (GCC→ACC) | treC ← | trehalose‑6‑P hydrolase |
RA | 2,904,683 | T→C | 29.5% | I471V (ATC→GTC) | treC ← | trehalose‑6‑P hydrolase |
RA | 2,904,690 | C→T | 29.3% | Q468Q (CAG→CAA) | treC ← | trehalose‑6‑P hydrolase |
RA | 2,905,236 | A→T | 42.1% | G286G (GGT→GGA) | treC ← | trehalose‑6‑P hydrolase |
RA | 2,905,981 | T→C | 23.2% | H38R (CAC→CGC) | treC ← | trehalose‑6‑P hydrolase |
RA | 2,906,404 | T→A | 39.3% | A387A (GCA→GCT) | treB ← | fused trehalose(maltose)‑specific enzyme IIBC component of PTS |
RA | 2,906,419 | C→T | 33.7% | G382G (GGG→GGA) | treB ← | fused trehalose(maltose)‑specific enzyme IIBC component of PTS |
RA | 2,906,647 | T→C | 23.0% | A306A (GCA→GCG) | treB ← | fused trehalose(maltose)‑specific enzyme IIBC component of PTS |
RA | 2,908,139 | T→C | 50.0% | K164K (AAA→AAG) | treR ← | DNA‑binding transcriptional repressor |
RA | 2,910,340 | G→A | 54.9% | P444P (CCG→CCA) | mgtA → | magnesium transporter |
RA | 2,910,358 | C→T | 44.3% | R450R (CGC→CGT) | mgtA → | magnesium transporter |
RA | 2,911,190 | T→C | 32.6% | L728L (TTA→CTA) | mgtA → | magnesium transporter |
RA | 2,911,207 | G→A | 43.4% | Q733Q (CAG→CAA) | mgtA → | magnesium transporter |
RA | 2,911,210 | C→T | 48.0% | N734N (AAC→AAT) | mgtA → | magnesium transporter |
RA | 2,912,163 | G→A | 53.4% | D45D (GAC→GAT) | yjgF ← | ketoacid‑binding protein |
RA | 2,912,172 | T→G | 55.4% | V42V (GTA→GTC) | yjgF ← | ketoacid‑binding protein |
RA | 2,912,718 | C→T | 26.3% | T38T (ACG→ACA) | pyrI ← | aspartate carbamoyltransferase, regulatory subunit |
RA | 2,912,729 | G→A | 15.7% | L35L (CTG→TTG) | pyrI ← | aspartate carbamoyltransferase, regulatory subunit |
RA | 2,913,681 | T→C | 12.8% | A33A (GCA→GCG) | pyrB ← | aspartate carbamoyltransferase, catalytic subunit |
RA | 2,919,237 | C→T | 47.0% | A153A (GCG→GCA) | argI ← | ornithine carbamoyltransferase 1 |
RA | 2,919,561 | A→G | 46.7% | G45G (GGT→GGC) | argI ← | ornithine carbamoyltransferase 1 |
RA | 2,919,571 | T→C | 54.8% | K42R (AAA→AGA) | argI ← | ornithine carbamoyltransferase 1 |
RA | 2,920,691 | T→A | 24.3% | I77I (ATA→ATT) | yjgM ← | predicted acetyltransferase |
RA | 2,922,600 | C→T | 38.2% | E874E (GAG→GAA) | valS ← | valyl‑tRNA synthetase |
RA | 2,922,606 | A→G | 36.0% | G872G (GGT→GGC) | valS ← | valyl‑tRNA synthetase |
RA | 2,922,614 | T→C | 19.8% | I870V (ATC→GTC) | valS ← | valyl‑tRNA synthetase |
RA | 2,922,621 | C→T | 19.8% | T867T (ACG→ACA) | valS ← | valyl‑tRNA synthetase |
RA | 2,924,094 | T→C | 34.5% | P376P (CCA→CCG) | valS ← | valyl‑tRNA synthetase |
RA | 2,928,253 | T→C | 58.7% | L218L (TTG→CTG) | yjgP → | conserved inner membrane protein |
RA | 2,928,279 | C→T | 48.5% | D226D (GAC→GAT) | yjgP → | conserved inner membrane protein |
RA | 2,931,277 | A→G | 37.7% | A57A (GCT→GCC) | yjgR ← | predicted ATPase |
RA | 2,947,155 | T→C | 35.5% | G37G (GGA→GGG) | dnaC ← | DNA biosynthesis protein |
RA | 2,949,028 | G→A | 25.8% | L41L (CTG→TTG) | yjjP ← | predicted inner membrane protein |
RA | 2,949,029 | T→C | 25.8% | A40A (GCA→GCG) | yjjP ← | predicted inner membrane protein |
RA | 2,949,119 | T→C | 41.5% | T10T (ACA→ACG) | yjjP ← | predicted inner membrane protein |
RA | 2,950,748 | G→A | 52.7% | R82Q (CGG→CAG) | bglJ → | DNA‑binding transcriptional regulator |
RA | 2,950,906 | T→C | 63.3% | L135L (TTA→CTA) | bglJ → | DNA‑binding transcriptional regulator |
RA | 2,951,444 | T→C | 24.7% | Q170Q (CAA→CAG) | fhuF ← | ferric iron reductase involved in ferric hydroximate transport |
RA | 2,954,513 | G→A | 63.5% | P13P (CCG→CCA) | rimI → | acetylase for 30S ribosomal subunit protein S18 |
RA | 2,956,162 | G→A | 59.2% | E153E (GAG→GAA) | prfC → | peptide chain release factor RF‑3 |
RA | 2,962,363 | T→C | 43.8% | E331E (GAA→GAG) | yjjI ← | conserved hypothetical protein |
RA | 2,962,938 | C→T | 29.6% | V140I (GTT→ATT) | yjjI ← | conserved hypothetical protein |
RA | 2,966,357 | A→G | 50.0% | Q155Q (CAA→CAG) | deoB → | phosphopentomutase |
RA | 2,966,996 | A→T | 49.2% | V368V (GTA→GTT) | deoB → | phosphopentomutase |
RA | 2,966,999 | T→C | 49.3% | Y369Y (TAT→TAC) | deoB → | phosphopentomutase |
RA | 2,967,020 | C→T | 30.0% | G376G (GGC→GGT) | deoB → | phosphopentomutase |
RA | 2,967,032 | T→C | 17.9% | H380H (CAT→CAC) | deoB → | phosphopentomutase |
RA | 2,967,832 | T→C | 63.5% | T220T (ACT→ACC) | deoD → | purine‑nucleoside phosphorylase |
RA | 2,969,834 | A→G | 34.2% | L192L (TTG→CTG) | lplA ← | lipoate‑protein ligase A |
RA | 2,969,931 | G→A | 78.9% | L159L (CTC→CTT) | lplA ← | lipoate‑protein ligase A |
RA | 2,971,610 | A→G | 38.6% | E142E (GAA→GAG) | serB → | 3‑phosphoserine phosphatase |
RA | 2,972,735 | G→C | 27.3% | S178S (TCG→TCC) | radA → | predicted repair protein |
RA | 2,973,590 | T→G | 54.4% | intergenic (+6/‑15) | radA → / → nadR | predicted repair protein/bifunctional DNA‑binding transcriptional repressor and NMN adenylyltransferase |
RA | 2,973,916 | T→C | 31.1% | R104R (CGT→CGC) | nadR → | bifunctional DNA‑binding transcriptional repressor and NMN adenylyltransferase |
RA | 2,975,229 | G→A | 57.9% | T528T (ACC→ACT) | yjjK ← | fused predicted transporter subunits and ATP‑binding components of ABC superfamily |
RA | 2,978,639 | C→T | 33.2% | P539P (CCC→CCT) | slt → | lytic murein transglycosylase, soluble |
RA | 2,981,016 | C→T | 16.2% | E195E (GAG→GAA) | rob ← | DNA‑binding transcriptional activator |
RA | 2,981,022 | C→T | 14.6% | E193E (GAG→GAA) | rob ← | DNA‑binding transcriptional activator |
RA | 2,985,313 | A→G | 41.4% | V282V (GTA→GTG) | creD → | inner membrane protein |
RA | 2,987,558 | G→T | 51.1% | A109A (GCG→GCT) | yjtD → | predicted rRNA methyltransferase |
RA | 2,987,586 | T→C | 52.1% | L119L (TTG→CTG) | yjtD → | predicted rRNA methyltransferase |
Unassigned missing coverage evidence | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
seq id | start | end | size | ←reads | reads→ | gene | description | |||
* | * | ÷ | minE | 149312 | 149348 | 37 | 3 [0] | [1] 6 | hrpB/mrcB | predicted ATP‑dependent helicase/fused glycosyl transferase and transpeptidase |
* | * | ÷ | minE | 252003 | 252022 | 20 | 4 [1] | [1] 2 | malZ | maltodextrin glucosidase |
* | * | ÷ | minE | 376755 | 376756 | 2 | 5 [0] | [0] 2 | fepD | iron‑enterobactin transporter subunit |
* | * | ÷ | minE | 412722 | 412722 | 1 | 5 [0] | [0] 5 | lnt | apolipoprotein N‑acyltransferase |
* | * | ÷ | minE | 444407 | 444408 | 2 | 4 [0] | [0] 3 | kdpE | DNA‑binding response regulator in two‑component regulatory system with KdpD |
* | * | ÷ | minE | 483574 | 483626 | 53 | 5 [1] | [0] 2 | tolA | membrane anchored protein in TolA‑TolQ‑TolR complex |
* | * | ÷ | minE | 571893–571903 | 571945 | 43–53 | 2 [0] | [0] 10 | ybjE/aqpZ | predicted transporter/aquaporin |
* | * | ÷ | minE | 591564 | 591580 | 17 | 3 [1] | [0] 2 | ftsK | DNA‑binding membrane protein required for chromosome resolution and partitioning |
* | * | ÷ | minE | 681849 | 681857 | 9 | 7 [1] | [0] 4 | helD | DNA helicase IV |
* | * | ÷ | minE | 698194 | 698223 | 30 | 2 [1] | [0] 4 | appA | phosphoanhydride phosphorylase |
* | * | ÷ | minE | 750868 | 750913 | 46 | 2 [0] | [0] 4 | mfd | transcription‑repair coupling factor |
* | * | ÷ | minE | 801993 | 802023 | 31 | 3 [0] | [0] 3 | dhaK | dihydroxyacetone kinase, N‑terminal domain |
* | * | ÷ | minE | 838390 | 838410–838391 | 2–21 | 4 [0] | [0] 6 | ychS | hypothetical protein |
* | * | ÷ | minE | 850402 | 850410 | 9 | 3 [0] | [0] 15 | tonB | membrane spanning protein in TonB‑ExbB‑ExbD complex |
* | * | ÷ | minE | 865556 | 865593 | 38 | 6 [1] | [0] 5 | yciQ | predicted inner membrane protein |
* | * | ÷ | minE | 875455 | 875468 | 14 | 30 [0] | [0] 8 | acnA | aconitate hydratase 1 |
* | * | ÷ | minE | 890160 | 890174 | 15 | 5 [1] | [0] 7 | fabI/ycjD | enoyl‑[acyl‑carrier‑protein] reductase, NADH‑dependent/conserved hypothetical protein |
* | * | ÷ | minE | 934800 | 934808 | 9 | 3 [0] | [1] 3 | fdnG | formate dehydrogenase‑N, alpha subunit, nitrate‑inducible |
* | * | ÷ | minE | 953683 | 953717 | 35 | 6 [0] | [1] 3 | yddW | predicted liprotein |
* | * | ÷ | minE | 1059122 | 1059140 | 19 | 4 [0] | [0] 5 | lhr | predicted ATP‑dependent helicase |
* | * | ÷ | minE | 1070441 | 1070451 | 11 | 2 [0] | [0] 12 | ribC | riboflavin synthase, alpha subunit |
* | * | ÷ | minE | 1109399 | 1109405 | 7 | 12 [1] | [0] 2 | ydiS | predicted oxidoreductase, FAD/NAD(P)‑binding domain |
* | * | ÷ | minE | 1154070 | 1154086 | 17 | 4 [0] | [0] 9 | astE | succinylglutamate desuccinylase |
* | * | ÷ | minE | 1190872 | 1190892 | 21 | 6 [0] | [1] 3 | yeaJ/rnd | predicted diguanylate cyclase/ribonuclease D |
* | * | ÷ | minE | 1333636 | 1333636 | 1 | 6 [0] | [0] 3 | wcaI | predicted glycosyl transferase |
* | * | ÷ | minE | 1371784 | 1371792 | 9 | 4 [1] | [0] 9 | cdd/sanA | cytidine/deoxycytidine deaminase/hypothetical protein |
* | * | ÷ | minE | 1420576 | 1420618 | 43 | 3 [0] | [0] 11 | ccmF | heme lyase, CcmF subunit |
* | * | ÷ | minE | 1438849 | 1438879 | 31 | 11 [0] | [1] 7 | yojL | predicted thiamine biosynthesis lipoprotein |
* | * | ÷ | minE | 1616738 | 1616747 | 10 | 9 [0] | [0] 19 | eutE | predicted aldehyde dehydrogenase, ethanolamine utilization protein |
* | * | ÷ | minE | 1618984 | 1619018 | 35 | 17 [1] | [1] 2 | eutI | predicted phosphotransacetylase subunit |
* | * | ÷ | minE | 1678277 | 1678280 | 4 | 20 [0] | [0] 3 | pbpC | fused transglycosylase and transpeptidase |
* | * | ÷ | minE | 1763696–1763706 | 1763706 | 1–11 | 2 [0] | [1] 5 | rrsG | 16S ribosomal RNA |
* | * | ÷ | minE | 1790638 | 1790646 | 9 | 4 [1] | [0] 3 | gabD | succinate‑semialdehyde dehydrogenase I, NADP‑dependent |
* | * | ÷ | minE | 1832694 | 1832712 | 19 | 7 [0] | [1] 3 | ygbK | conserved hypothetical protein |
* | * | ÷ | minE | 1945265 | 1945329 | 65 | 2 [1] | [0] 2 | ygfF/gcvP | predicted NAD(P)‑binding oxidoreductase with NAD(P)‑binding Rossmann‑fold domain/glycine decarboxylase, PLP‑dependent, subunit (protein P) of glycine cleavage complex |
* | * | ÷ | minE | 2095509 | 2095514 | 6 | 2 [0] | [0] 6 | rnpB | RNase P |
* | * | ÷ | minE | 2095599 | 2095632 | 34 | 2 [1] | [0] 2 | rnpB | RNase P |
* | * | ÷ | minE | 2554255 | 2554282 | 28 | 5 [1] | [0] 4 | envC | protease with a role in cell division |
* | * | ÷ | minE | 2560321 | 2560327 | 7 | 6 [0] | [0] 3 | yibK/lldD | predicted rRNA methylase/L‑lactate dehydrogenase, FMN‑linked |
* | * | ÷ | minE | 2560364 | 2560373 | 10 | 2 [0] | [0] 5 | yibK/lldD | predicted rRNA methylase/L‑lactate dehydrogenase, FMN‑linked |
* | * | ÷ | minE | 2618481 | 2618486 | 6 | 2 [0] | [0] 6 | yhhP/zntA | conserved hypothetical protein required for cell growth/zinc, cobalt and lead efflux system |
* | * | ÷ | minE | 2847609 | 2847629 | 21 | 23 [1] | [1] 11 | yjeO | conserved inner membrane protein |
* | * | ÷ | minE | 2858116 | 2858155 | 40 | 4 [0] | [0] 7 | amiB | N‑acetylmuramoyl‑l‑alanine amidase II |
Unassigned new junction evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | minE | = 215622 | 22 (0.460) | 285 (12.480) +27 bp |
25/50 | NT | 94.7% | coding (732/732 nt) | dnaQ | DNA polymerase III epsilon subunit |
? | minE | 2705182 = | 44 (0.930) | intergenic (+106/‑1) | damX/dam | hypothetical protein/DNA adenine methylase | |||||
* | ? | minE | = 317783 | 64 (1.350) | 18 (0.400) +GTG |
3/98 | NT | 29.8% | coding (2779/3363 nt) | kefA | fused mechanosensitive channel proteins |
? | minE | 2196242 = | 26 (0.550) | coding (218/1368 nt) | degQ | serine endoprotease, periplasmic | |||||
* | ? | minE | 436259 = | 45 (0.950) | 482 (10.990) | 48/96 | NT | 92.6% | intergenic (‑156/‑29) | ybfF/seqA | conserved hypothetical protein/regulatory protein for replication initiation |
? | minE | = 2706018 | 36 (0.820) | coding (836/837 nt) | dam | DNA adenine methylase | |||||
* | ? | minE | = 436833 | 52 (1.090) | 1027 (21.610) | 54/104 | NT | 96.1% | coding (546/546 nt) | seqA | regulatory protein for replication initiation |
? | minE | 1803907 = | 31 (0.650) | intergenic (+63/‑28) | ygaH/mprA | predicted inner membrane protein/DNA‑binding transcriptional regulator | |||||
* | ? | minE | = 2053940 | 29 (0.610) | 45 (1.090) +AATCATT |
3/90 | NT | 56.5% | intergenic (+98/+83) | cca/bacA | fused tRNA nucleotidyl transferase and 2'3'‑cyclic phosphodiesterase/2'nucleotidase/phosphatase/undecaprenyl pyrophosphate phosphatase |
? | minE | = 2316192 | 51 (1.070) | intergenic (+1/‑134) | glpK/glpX | glycerol kinase/fructose 1,6‑bisphosphatase II |